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Nicole Stephen 
End-of-life discussions in nonmalignant respiratory disease 
Nonmalignant respiratory diseases (NMRD), such as Chronic Obstructive Pulmonary 
Disease (COPD), are a leading cause of morbidity worldwide. Research has shown that 
patients with NMRD in the UK, Canada and the US have less access to palliative care 
services than patients with other respiratory diseases such as lung cancer. Discussing 
preferences for end-of-life care in NMRD can be difficult for patients, carers and health 
professionals, however it is essential to ensure that the patient’s wishes are met, particularly 
when resources are scarce. Despite similar nationalised health care systems in the UK and 
Canada, a recent report by the Economist Intelligence Unit ranked overall quality of end-of-
life care in the UK first out of forty, while Canada was ranked ninth out of forty.  Therefore, 
it was deemed useful to investigate how end-of-life for people with NMRD is discussed 
between health professionals and patients in the UK and Canada and to develop an 
instrument allowing health professionals to determine constraints and opportunities for 
facilitating such discussions in each country as comparing care between countries is helpful 
to determine the best solutions for individuals and families with complex needs. 
This study was guided by the Medical Research Council guidelines for developing and 
implementing complex interventions, and the research process followed the requirements 
for the development phase of these guidelines.  First, two systematic reviews were carried 
out to establish the evidence base regarding of end-of-life discussions.  The first focused on 
how end-of-life is discussed in NMRD, while the second focused exclusively on end-of-life 
discussions in a single NMRD (COPD) in the UK and Canada only.  The findings of the 
systematic reviews pointed toward the need for further training of health professionals to 
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discuss end-of-life with this patient group, as well as the lack indicators that this patient 
group is ready or willing to discuss end-of-life. 
Then, a Delphi study was conducted with specialist respiratory nurses in the UK to 
determine expert opinion on how health professionals know a patient with NMRD is ready 
to discuss end-of-life, and to establish the key considerations and topics in such discussions. 
This study was replicated in Canada with health professionals working with patients with 
NMRD.  Each Delphi study resulted in a country specific tool to assist less experienced 
health professionals discuss end-of-life with this patient group. 
Finally, the findings of these Delphi studies were compared to determine what health 
professionals in each country could learn from each other, as well as specific considerations 
in each country, and areas for future research.  The findings from the comparison process 
demonstrated that the emotional intelligence of health professionals, the patient education 
context and the recognition of cultural issues were all important factors when approaching 
end-of-life discussions. 
Findings from each phase of the intervention development process resulted in a 
theoretical model of how end-of-life is discussed in the UK and Canada.  This model 
identifies constraints and opportunities for such discussions from a systems level perspective 
including: end-of-life policies, prognosis in non-malignant respiratory disease, time, clinical 
indicators, initiation responsibility, the educational role of health professionals, emotional 
intelligence, cultural competence and readiness versus willingness to discuss end-of-life. 
Recommendations are made from the findings of this study for research, clinical practice, 
education and policy.  A detailed plan for the next stage of the development of the 
intervention is included. 
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Chapter 1. Introduction 
1.1 Introduction 
Discussing end-of-life care preferences is essential for people with COPD in order to 
determine treatment options and maximise quality of life.  People with nonmalignant 
respiratory diseases (NMRD) can experience acute exacerbations of their disease potentially 
leading to emergency hospitalisation or death (American Thoracic Society and European 
Respiratory Society, 2004).  Therefore, health agencies such as the American Thoracic Society 
and the European Respiratory Society recommend that healthcare providers assist patients, 
when their health is stable, to think about palliative care and end-of-life care.  End-of-life 
discussions are discussions about end-of-life care preferences and issues between health 
professionals and patients (Curtis et al., 2004).  By discussing palliative care and end-of-life care 
when the patient is stable, the patient is prepared for potentially life-threatening exacerbations 
of their disease while they continue living and enjoying life, rather than being forced into 
decisions, or having their family make decisions on their behalf when imminent death is pending 
(Celli et al., 2004).  
The significance of end-of-life discussions and access to palliative care services is 
recognised at the highest level of health service organisation.  In 2009, the Department of 
Health in the United Kingdom (UK) released the End-of-Life Care Strategy, which stated that 
many health professionals have insufficient training in communicating with patients approaching 
the end-of-life.  The strategy recommended that communication skills programmes be provided 
as a major workforce development initiative, as they are currently mandatory for oncology, but 
not for other life-limiting diseases (Department of Health, 2009).  In the United States, a New 
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York State Law was recently passed requiring health professionals to provide palliative care 
information and end-of-life options to patients diagnosed with a terminal illness, in an effort to 
ensure that end-of-life discussions take place (New York State Assembly, 2010).  However, 
there is no evidence as to the effectiveness of this new legislation for ensuring that patients and 
health professionals have end-of-life discussions.  
The unpredictable trajectory of NMRD may make timing such discussions more difficult 
than with other diseases (Murray et al., 2005).  In addition, poor health and breathlessness 
associated with NMRDs will likely add further communication barriers to engaging in such 
discussions (Booker, 2005). This is a critical issue given that there is a lack of palliative care 
services available to this population (Partridge et al., 2009), and they have a greater prevalence 
of anxiety and depression (van Ede et al., 1999).  
The World Health Organization defines palliative care as: ‘an approach that improves 
the quality of life of patients and their families facing the problem associated with life-
threatening illness, through the prevention and relief of suffering by means of early identification 
and impeccable assessment and treatment of pain and other problems, physical, psychosocial 
and spiritual’ (World Health Organization, 2011, from 
http://www.who.int/cancer/palliative/definition/en/.).  Recent research findings indicate that 
patients who were enrolled in palliative care programmes early after diagnosis of a terminal 
illness experienced significant improvements in their quality of life and mood.  The same study 
also found that patients who received early palliative care survived longer than patients 
receiving standard care and had less aggressive care at the end-of-life (Temel et al., 2010).  A 
key component of palliative care is end-of-life care; this term is used to describe care provided 
for the patient and their family in the final stage of life (Curtis, 2008).  
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Several options are available for palliative and end-of-life care in the terminal stages of 
the illness, and decisions need to be made, which can present a challenge for health 
professionals.  They must present options, assist with decision-making and ensure that 
information is communicated across clinical settings (Quill, 2000).  Despite the importance of 
this process and the recommendations by the American Thoracic Society (American Thoracic 
Society and European Respiratory Society, 2004), evidence shows that healthcare professionals 
are not adequately addressing advance-care planning and end-of-life care preferences of the 
patient (Patel et al., 2012).  Several studies have found that few patients with advanced COPD 
have discussed their end-of-life preferences with their physician, received prognostic 
information or discussed the palliative care services available to them (Heffner et al., 1996, 
Goodridge et al., 2009, Mulcahy et al., 2005). This literature demonstrates that advance-care 
planning has not improved greatly with this group of patients since the landmark SUPPORT 
study investigators found that less than 50 percent of physicians knew their terminally ill 
patient's wishes for cardiopulmonary resuscitation (The SUPPORT Principal Investigators, 1995).  
In addition, the authors of a recent integrative review found that further investigation is 
required to address the complex personal, provider, and system elements in NMRD (Disler et 
al., 2012).  Definitions of the key terms as used throughout this thesis are presented in Table 
1.1. 
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Table 1.1 Key terms and definitions 
Key Term Definition 
British Lung 
Foundation Nurses 
A group of Specialist Respiratory Nurses who work in the National Health Service 
(NHS) in the UK, who are funded in part or in whole by the British Lung Foundation. 
Chronic Obstructive 
Pulmonary Disease 
(COPD) 
The most common non-malignant respiratory disease involves chronic diffuse 
irreversible airflow obstruction and is an umbrella term for chronic bronchitis, 
emphysema and bronchiectasis. 
End-of-life care Care occurring in the last part of a patient’s life, typically in the last few months, 
depending on the underlying diagnosis and clinical course. 
Gold Standards 
Framework (GSF) 
A systematic, evidence based approach to optimising care for all patients approaching 
the end of life, delivered by generalist care providers.   
Health professionals Any person trained to work in any field of physical or mental health, including 
physicians and social workers. 
Palliative care Care that focuses on improving the quality of life of patients and their families facing 
the problem associated with life- threatening illness, through the prevention and relief 
of suffering by means of early identification and assessment and treatment of pain and 
other problems, physical, psychosocial and spiritual . 
1.2 International Comparison 
Comparing care between countries is helpful to determine the best solutions for 
individuals and their families with complex needs (Higginson, 2005).  Western countries such as 
the UK and Canada have similar approaches to palliative care that include an active approach to 
assessing, diagnosing and treating the concerns of patients and their families, and multi 
professional care (Higginson, 2005).  This care can be part of palliative care that ‘focuses on the 
relief of suffering for patients with serious and complex illness and tries to ensure the best 
possible quality of life for them and their family members’ but may be delivered at the same 
time as curative or life-prolonging treatments (Meier et al., 2010, kindle location 407).  Both 
countries have public health care systems, entitling citizens and residents to receive 
government-sponsored health insurance that covers ‘necessary care’ (Ross and Detsky, 2009). 
A report by the Economist Intelligence Unit ranked the quality of end-of-life care by 
country and revealed high variation across developed countries. The UK was ranked first 
overall, and Canada was ranked ninth along with the United States.  The ranking was based on 
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the Quality of Death Index which scored countries across four categories.  The index measures 
end-of-life care services across 40 developed countries.  The overall ranking is based on: the 
basic healthcare environment (20%), availability of end-of-life care (25%), cost of end-of-life care 
(15%), quality of end-of-life care (40%).  The following table shows the rankings of the UK and 
Canada in each category (Murray, 2010). The report states that the UK’s high ranking can be 
partially explained by the long history in the field of end-of-life care.  The UK is ranked at the 
top of the categories evaluating quality and availability.  Canada is ranked fifth in quality and 
ninth for availability (Murray, 2010). 
Table 1.2 Ranking of UK and Canada on Quality of Death Index. 
Quality of Death Index 
Category 
(percentage contribution to 
overall ranking) 
Ranking (out of 40) 
United Kingdom Canada 
The basic healthcare 
environment (20%) 
28 20 
Availability of end-of-life 
care (25%) 
1 9 
Cost of end-of-life care 
(15%) 
18 27 
Quality of end-of-life care 
(40%) 
1 5 
Overall ranking 1 9 
A recent study by Janssen et al. (2011) compared the quality of communication about 
end-of-life care for patients with COPD in the Netherlands and the US, and the authors 
propose that understanding international differences may help to improve communication in 
this area (Janssen et al., 2011).  These authors recommended that studies that account for 
international differences and patient specific factors should be conducted.  International 
research in end-of-life can provide insight into practice and help to further research in this area 
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as well as promote cross-national learning and collaboration (Raijmakers et al., 2011, Blendon 
et al., 2003, Centeno, 2014). 
Based on similarities between approaches to palliative care, similar health systems and 
epidemiology (as will be explored in the sections that follow), and the disparities between 
rankings in the Economist report (Murray, 2010), it was thought that a comparison of end-of-
life communication in COPD has potential to provide valuable insight in this area.  An 
international comparison can inform future developments in both countries, and help to 
determine the best solutions for individuals and their families with complex needs (Higginson, 
2005). 
1.3 End-of-life care in the UK and Canada 
1.3.1 Epidemiology 
The most common NMRD, Chronic Obstructive Pulmonary Disease (COPD) (an 
umbrella term for chronic bronchitis, emphysema and bronchiectasis(British Thoracic Society)), 
is a progressive, life limiting disease that is one of the top five causes of mortality worldwide 
and is a significant health burden (Seemungal et al., 2009).  Currently, COPD is the only NMRD 
with epidemiological data widely available.  By 2030, it is estimated that COPD will be the 3rd 
leading cause of mortality worldwide. In the UK it is estimated that between 1 percent and 4 
percent of the population have COPD and it accounts for approximately 5 percent of deaths 
each year, mainly affects individuals who are 45 or older, and is also linked to social deprivation 
(Department of Health, 2010).  Smoking is the most common cause of COPD, and 86 percent 
of COPD deaths are attributable to this factor (Department of Health, 2010). Despite the high 
mortality for NMRD, the disease trajectory is unpredictable. 
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The most common approach used when comparing disease prevalence across countries 
is self-reported physician diagnosis.  However, this method may underestimate the prevalence 
of COPD by 50 percent or more in individuals over 40 years old.  Differentiating between 
COPD and asthmas in older smokers also provides a challenge for prognostication and there is 
a possibility that one disease could be misdiagnosed as another (Schirnhofer, 2007).  In addition, 
the mortality rate of COPD may be higher than reported as two common complications of 
COPD: pneumonia and congestive heart failure may be listed as the cause of death for 
individuals with COPD (Schirnhofer, 2007). 
In Canada, approximately 4.4 percent of the population have been diagnosed with 
COPD (including a self-report of COPD, chronic bronchitis or emphysema) and COPD 
accounted for 4 percent of all deaths in 2004. This figure is expected to increase, as the 
prevalence of COPD rises over the next decade, particularly in the aging female population 
(Canadian Lung Association, 2008).   As in the UK, the cause of COPD in Canada is primarily 
attributed to smoking; 84 percent of Canadians with COPD had been smokers, while 40 
percent were still smoking (Canadian Lung Association, 2008).  Interestingly, a higher 
proportion of women than men aged 74 or under are being diagnosed with COPD, and this 
trend reverses in people who are 75 or older (Canadian Lung Association, 2008).  This higher 
prevalence among women under 74 will have significant implications for the health care system 
as there will be an increased need for health care as more older women live alone and an 
increased need for supportive housing and other community services (Public Health Agency of 
Canada, 2007). 
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1.3.2 Health Systems 
United Kingdom 
The UK has had a tax-funded National Health Service (NHS) since 1948, which is free at 
the point of use except for dentistry, optometry and prescriptions (de Silva and Fahey, 2008). 
The NHS is headed by a cabinet minister, and the planning and delivery system is hierarchical, 
with the Department of Health providing the policy focus (as set by the current ruling political 
party), and Foundation Trusts providing their own strategic leadership at the regional level.  
The budget is allocated to these Foundation Trusts, which then purchase services from health 
providers based on the standards set by the Department of Health.  The Foundation Trusts are 
regulated by Monitor who is the sector regulator for health services in England.  This system is 
increasingly burdened financially by the aging population and the growing prevalence of chronic 
disease and as a result there are a number of private providers that provide funded care for 
patients (de Silva and Fahey, 2008). 
The NHS Health and Social Care Model was launched by the government in 2005 to 
help improve care for people with long term conditions (Department of Health, 2005, de Silva 
and Fahey, 2008), and was based on the Chronic Care Model developed in the US, as well as 
other policies in the UK.  The model focuses on how to identify individuals with long term 
conditions so that they can get care, and aims to improve the quality of care, accessibility to 
care, and contain or reduce the costs of chronic care, and in general to shift from reactive care 
in hospitals to responsive care in communities (de Silva and Fahey, 2008).  People with chronic 
disease are viewed as a single group, however the NSFs provide evidence-based guidance on 
specific chronic diseases and develop strategies to support implementation of such guidance. 
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Canada 
The development of universal health care coverage in Canada started in one province in 
1944 and by 1971 all Canadians were guaranteed access to essential medical services regardless 
of employment, income or health, this coverage was solidified through the Canada Health Act 
of 1984 that ensures that the provinces follow the principles of public health care (Marchildon, 
2012).  As in the UK, the federal government sets the standards for the national Medicare 
system, and the provinces and territories organise and deliver the healthcare services.  Within 
provinces, healthcare is organised by Regional Health Authorities (RHAs), that coordinate and 
deliver services to defined geographic areas.  These RHAs vary in their functions by province 
(Jiwani and Dubois, 2008).  Most hospitals in Canada are private, non-profit making 
organizations and physicians also practice privately with a fee-for-service payment system.  The 
ten provinces and three territories are responsible for covering prescription pharmaceuticals, 
providing an variety of public services and for funding or subsidising some long-term care and 
home care services, however outside of this package, provinces differ in their coverage of 
medical services (Jiwani and Dubois, 2008). 
The Canadian Centre for Disease Prevention and Control (CCDPC) was established 
under the Public Health Agency of Canada and has developed and implemented a Best Practices 
Portal for Health Promotion and Chronic Disease Prevention, as well as a disease surveillance 
website (Jiwani and Dubois, 2008). Also, several national initiatives have focused on the 
prevention of chronic diseases in the community that primarily focus on lifestyle related factors 
such as physical activity, healthy eating and smoking (Jiwani and Dubois, 2008).  Specifically 
related to respiratory disease is the National Lung Health Framework (2008) that was 
supported by Health Canada and the Public Health Agency of Canada.  As most provinces and 
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territories have identified chronic disease as a key priority and developed their own strategies 
related to chronic disease, the federal government has responded by providing assistance with 
initiatives such as the Primary Health Care Transition Fund, which helped to establish 
multidisciplinary teams in primary care (Jiwani and Dubois, 2008). 
1.3.3 End-of-life care policies 
In the UK, the government developed an NHS end-of-life care programme from 2004-
2007 to improve end-of-life care.  The programme was designed to encourage the development 
and adoption of end-of-life care models such as the Gold Standards Framework (2006) to 
address the needs of local populations.  This programme was followed by the NHS End-of-Life 
Care Strategy (Department of Health, 2008) that was developed to increase access to high 
quality care for all people approaching the end-of-life, at home, in care homes, in hospitals, 
hospices and elsewhere.  The strategy was also designed to enhance choices for patients, 
quality, equality and value for money.  However, it is important to note that many hospice and 
palliative care services in the UK are provided and funded by the voluntary sector, for example 
76 percent of adult inpatient specialist palliative care units in England in the UK were provided 
by the voluntary sector (Hospice and Palliative Care Directory 2008). 
In Canada, the provinces are responsible for delivering palliative and end-of-life care, and 
these services are funded by the federal government.  In terms of policy, Health Canada, the 
Public Health Agency of Canada and the Canadian Institute of Health Research all support 
palliative and end-of-life care.  Within Health Canada’s strategic policy branch, there is a 
palliative and end-of-life care unit that addresses issues for Canadian with life limiting conditions.  
They also ensure that palliative care is considered in relevant policy initiatives throughout the 
federal government.  They work with the provinces on end-of-life related issues and they 
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provide leadership for all national initiatives related to palliative and end-of-life care (Canadian 
Lung Association, 2008).  In 2012, the Canadian government announced a nation-wide 
investment to move toward community-integrated palliative care.  Currently palliative and end-
of-life care is mostly delivered in hospitals and services vary greatly, based on the region.  The 
new initiative has the aim to deliver care in primary and community settings, supported by 
multi-disciplinary teams (The Quality End-of-life Care Coalition, 2013, Health Canada, 2012).  
The Public Health Agency of Canada is also involved by providing federal leadership through the 
Division of Aging and Seniors, and they published a palliative and end-of-life care information 
sheet and CD for seniors.  Finally, the Canadian Institute of Health Research identified palliative 
and end-of-life care as a strategic research priority in 2002, and they launched an initiative to 
support the palliative care research community to develop infrastructure, enhance 
interdisciplinary research collaboration and attract new researchers to the area.  However, 
more work must be done as the National Lung Health Framework (Canadian Lung Association, 
2008) states that the need to improve the quality of end-of-life care in Canada is a public health 
crisis, due to multiple issues such as a high prevalence of symptom distress, caregiver burden, 
use of inappropriate technologies, poor transition management, significant costs and over 
dissatisfaction with communication and the quality of care (Canadian Lung Association, 2008).  
It seems that the new model of community-integrated palliative care may assist in addressing 
some of these issues.  Table 1.3 summarises the comparison of epidemiology, health systems 
and end-of-life care policies related to COPD in the UK and Canada. 
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Table 1.3 Summary of epidemiology, health systems and end-of-life care policies in the UK and 
Canada. 
 UK Canada 
Epidemiology 
 1-4% of the population have COPD 
 Accounts for 5% of deaths each year 
 Smoking is the most common cause 
of COPD 
 4.4% of the population have COPD 
 Accounts for 4% of deaths each year 
 Smoking is the most common cause 
of COPD 
Health 
systems 
 NHS is tax-funded and free at the 
point of use 
 System is burdened by the aging 
population and growing prevalence 
of chronic disease 
 Health and Social Care Model to 
identify individuals with long term 
conditions and provide appropriate 
and cost-effective care 
 Shift from hospital to community 
care 
 Universal health care coverage for all 
Canadians 
 Chronic disease is a key priority  
 Chronic disease care through 
multidisciplinary teams in primary 
care 
End-of-life 
care policies 
 NHS End-of-life Care Strategy 
launched in 2008 to increase access 
to care for all in a variety of 
environments 
 Many hospice and palliative care 
services are funded and provided by 
voluntary sector (e.g. 76% of 
inpatient palliative care units in 
England) 
 Health Canada has a palliative and 
end-of-life care unit for life limiting 
conditions 
 Palliative and end-of-life care mostly 
delivered in hospitals 
 Services vary by region 
 Aim to deliver community-integrated 
palliative care to address multiple 
issues within the current system 
 
1.4 The research problem 
Regardless of the context or country they are in, it is clear that patients who have 
progressive illness require skilled assessment in addition to emotional, spiritual and social 
support for themselves and their families, including the opportunity to discuss their wishes for 
end-of-life care (Higginson, 2005). The model of communication between patient and 
professional proposed by Donabedian (1973) is useful to understand end-of-life discussions.  
The model posits that patients and health professionals may have differing perspectives that can 
lead to obstacles in communication—with the patient focusing on the impact of care on their 
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lives, as well as discomfort and pain, while the health professional focuses on the more scientific 
issues such as illness manifestation, progression and treatment (Donabedian, 1973).  This 
conflicts with the idea that end-of-life conversations are supported by the patient-centered view 
of medical care (Larson and Tobin, 2000).  Roter & Fallowfield (1998) defined patient-centered 
medicine as an approach that views the illness from the patient's perspective, including the 
psychosocial consequences, and seeks to empower the patient to make decisions in light of 
their personal context.  The foundation of this concept is professional understanding of patient 
needs and a focus on quality of life.   
In a study about when and how to initiate end-of-life discussions with patients with a 
terminal illness, care-givers and health professionals agreed that end-of-life discussions should 
take place when the patient is ready, but also found many patients waited for health 
professionals to raise the topic (Clayton et al., 2005). The skill of knowing when to broach the 
end-of-life discussion was described as a balancing act between listening, assessing and weighing 
the benefits versus the risks of raising the topic. The discussion may be easier to time when the 
patient and health professional have a long-standing relationship and the health professional is 
sensitive to their patient’s psychological state; however, this may be impossible in the current 
health care context, where continuity of care can be difficult and health professionals may not 
be allocated sufficient time to have meaningful conversations with their patients.  Therefore, 
health professionals need to be able to assess when a patient is ready for the discussion, as well 
as the important components of the discussion.   
The emphasis on end-of-life discussion has stemmed from advance directive programmes 
that aimed to improve the uptake of the practice of advance care planning (Johnstone and 
Kanitsaki, 2009).  Advanced care planning is defined as “a process of communication between a 
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person and the person’s family members, health care providers and important others about the 
kind of care the person would consider appropriate if the person cannot make their own 
wishes known in the future” (Shanley & Wall 2004, p.32.).  However, this older model of 
advance care planning has been devised into a new programme in the United States called 
‘Respecting Patient Choices’, which still aims to improve advance care directive use by 
providing a supportive framework to do so, primarily by training nurses as ‘Respecting Patient 
Choices’ Consultants to ultimately systematize the expression of patient end-of-life choices as 
part of a formal programme (Seal, 2007).   
Partridge and colleagues (2009) proposed developing formal policies to assist patients 
with NMRD who are nearing the end-of-life to receive detailed information to help them 
navigate palliative care services.  However, several studies have reported on the difficulties of 
establishing formal guidelines for end-of-life conversations.  This is due to the personal nature 
of such discussions, the unpredictable disease trajectory, and individual preferences through the 
identification of facilitators to end-of-life discussions as well as barriers (Anselm et al., 2005, 
Curtis and Patrick, 1997, Knauft et al., 2005, Murray et al., 2005). 
1.5 Aims and objectives of the study 
Based on the research problem stated above, the aims of this study were to: 
1) Determine how health professionals discuss end-of-life with patients with NMRD in the 
UK and Canada, and  
2) Develop an instrument allowing health professionals to determine constraints and 
opportunities within the environment to facilitate successful end-of-life discussions with 
this patient group in the UK and Canada. 
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The study aims were addressed through the following objectives: 
a) Establish how health professionals know a patient with NMRD is ready or willing to 
discuss end-of-life, 
b) Establish the key considerations and key topics in such discussions as defined by health 
professionals in the field, and 
c) Delineate the differences in end-of-life discussions for patients with NMRD in the UK 
and Canada. 
1.6 Study Design 
The aims of this study were to explore a phenomenon and then develop an instrument 
based on these findings.  This process was guided by the pragmatic stance, which focuses not on 
what has gone before, but what will happen in the future as a result of the research (Johnson 
and Onwuegbuzie, 2004).  As is stated throughout the literature, individuals and their families 
dealing with NMRD have complex and varied needs (Disler et al., 2012).  To achieve these aims, 
the guidance on developing and evaluating complex interventions (Medical Research Council, 
2008) set out by the Medical Research Council, provided the blueprint for the design of this 
study. The guidance proposes four iterative phases as key elements of the development and 
evaluation process including: development, feasibility/piloting, evaluation and implementation as 
detailed in Figure 1.1.  Due to the time and resource constraints of a doctoral study, only the 
development process was completed here, with extensive plans for future phases explicated in 
the recommendations for research section at the end of this thesis (section 9.5). 
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Figure 1.1 Key elements of the development and evaluation process for complex interventions 
reproduced from Medical Research Council (2008). 
The development phase includes three elements: identifying the evidence base, 
identifying/developing theory and modelling the process and outcomes (Medical Research 
Council, 2008). This process of development was achieved in this study through four phases as 
shown in Figure 1.2.  First, the existing evidence base was established through two systematic 
reviews.  The first was a general overview of all related literature and the second included 
literature from the UK and Canada exclusively related to COPD (as the most common NMRD) 
and a comparison of the findings from each country. The findings of the systematic reviews also 
contributed to the development of the theoretical model proposed in 8.2.1. 
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Figure 1.2 Four phases of the study to develop a complex intervention 
 
The systematic reviews were followed by two Delphi studies conducted independently in 
the UK and Canada.  These findings of these Delphi studies provided the majority of the 
evidence that led to the development of the theoretical model, while also resulting in the 
development of two interventions for use in each country.  These Delphi studies were both 
followed immediately with a questionnaire asking Delphi participants to give their opinion on 
the clinical applicability of the tools in their own practice.  The results of the Delphi studies 
were also compared to provide further insight into practice in each country for the theory 
development process.  This clinical applicability questionnaire was based on the 
recommendation in the MRC guidance that the question 'would it be possible to use this?' 
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should be asked before beginning on the involved process of the evaluation of an intervention 
(Medical Research Council, 2008, p. 7). 
The mixed methods approach was deemed the optimal method to achieve the study aims 
outlined above, allowing exploration of the research phenomenon and subsequent development 
of the intervention (Creswell, 2003).  Specifically, the mixed methods sequential exploratory 
design for instrument development guided the use of the Delphi studies for the use of 
developing an intervention (Creswell, 2003, Collins et al., 2006). The use of this research design 
will be discussed in Chapter 4. 
1.7 Reflexivity 
This study originated from an opportunity provided by the British Lung Foundation to 
explore end-of-life communication in nonmalignant respiratory disease.  This opportunity was 
of interest to me because of my background as a social worker and specifically the work I had 
done with the elderly in that role.  I did case management work for several aged people with 
nonmalignant respiratory disease, and witnessed how they were managed on an exacerbation 
by exacerbation basis.  Knowing how serious an exacerbation could be, and also the fact that 
these people were often isolated in their homes and without family support, it struck me how 
beneficial communication between health professionals and people with this condition 
approaching the end of life could be.  However, this can be an awkward topic and health 
professionals are often reluctant to broach such discussions (Larson & Tobin, 2000).  Therefore, 
I thought it would be useful to examine how health professionals know a patient is ready or 
willing to discuss end-of-life, thereby potentially breaking down barriers to such discussions and 
ultimately improving communication about this topic.  I was aware that I brought my own 
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experiences and attitudes to the topic, and indicate in Chapter 4 how I used a mixed methods 
design to enhance the rigour of the study.   
1.8 Structure of the Thesis  
The thesis is structured based on the order that the research was conducted.  Chapter 2 
includes a comprehensive account of a systematic review of end-of-life discussions in non-
malignant respiratory disease, while Chapter 3 is a thorough account of a systematic review of 
discussing end-of-life in NMRD in the UK and Canada.  These systematic reviews are presented 
first as it was important to establish the evidence base before determining exactly what further 
research should be conducted. Therefore, Chapter 4 is a detailed discussion of the mixed 
methods research design for instrument development and the Delphi method that was chosen 
to carry out the design, and a description of study participants in both the UK and Canada.  
This is followed by an in depth account of the modified Delphi study conducted in the UK, 
followed by a description of the clinical applicability process that resulted from the findings of 
the study and presentation of the tool in Chapter 5.  Then, Chapter 6 is a detailed account of 
the modified Delphi study conducted in Canada, followed by a description of the clinical 
applicability process that resulted from the findings of the study and presentation of the tool.  
This is followed by a narrative comparison of the consensus items from both the Canadian and 
UK Delphi studies.  The two Delphi studies are presented separately as it was thought 
important to discuss the results independently as related to their country specific contexts 
before comparing them.  In addition, relevant literature that was not in the systematic reviews 
was woven into the discussion sections of Chapters 5 and 6.  Then, Chapter 7 is a discussion of 
the findings of the study as a whole including a review of the research questions posed and a 
theoretical model of end-of-life discussions in non-malignant respiratory disease, followed by 
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Chapter 8, which includes a discussion of the original contributions and critical appraisal of this 
study followed by recommendations for practice, education, policy and research. 
1.9 Conclusions 
This chapter has provided an overview of end-of-life care and the importance end-of-life 
discussions in non-malignant respiratory disease as a background to the doctoral study.  This 
was followed by an examination of the value of comparing research from two or more 
countries in order to determine the best solutions for patients with complex needs and 
contextual information regarding how care for chronic diseases and end-of-life care is delivered 
in each country was provided.  Then the specific research problem that will be examined 
throughout this thesis was explicated, and followed by a statement of the aims and objectives of 
the study.  Finally, a brief description of the study was provided followed by an explanation of 
the structure of the thesis.  This chapter will be followed by a systematic review exploring end-
of-life discussions in non-malignant respiratory disease. 
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Chapter 2. End-of-life discussions in non-malignant respiratory disease: a 
systematic review 
2.1 Introduction 
In order to identify the evidence base as part of the development of a complex 
intervention, a systematic review of the literature was conducted looking at end-of-life 
discussions in NMRD.  This chapter contains a comprehensive account of the process and 
findings of the review.  Specifically, the aims of the study are explicated, followed by a detailed 
description of the design of the systematic review.  Then the results of the systematic review 
are presented in a narrative, with a discussion of the implications of the review. 
2.2 Aims 
The objectives of this review were to develop an evidence base for end-of-life discussions in 
NMRD by: 
 Examining the key components that should be included in end-of-life care discussions 
between health professionals and patients with life-limiting progressive NMRD; and 
 determining areas of future research that may be helpful for health professionals to 
understand these specific components without formalising the procedure of end-of-life 
discussions.  
2.3 Design 
A protocol outlining inclusion/exclusion criteria and the methods of analysis was 
developed according to the review method proposed by (Petticrew and Roberts, 2005).  This 
review method allows for either statistical or narrative synthesis of the studies, and includes 
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question development, literature search, study screening, data collection, data analysis, quality 
appraisal and synthesis.  However, as the guidelines are general, other sources were 
incorporated into the method when necessary, such as standards for quality appraisal (Kmet et 
al., 2004) and synthesis (Dixon-Woods et al., 2004).  The review was conducted in accordance 
with the PRISMA guidelines (Liberati et al., 2009). 
The components of the review question as defined in the objectives above using the 
PICO framework (Petticrew and Roberts, 2005) are: 
Population: Health professionals and/or patients with life-limiting, progressive nonmalignant 
disease.  While the study was undertaken to inform care of patients with NMRD (primarily 
COPD), papers were included about other nonmalignant diseases with an unpredictable disease 
trajectory.  It was felt that much could be learned as these patients may also have less access to 
palliative care services than some other patient groups (Partridge et al., 2009).  Studies on 
caregivers were included if the authors reported on the deceased patients’ experiences (Hinton, 
1996).  
Phenomena of Interest: End-of-life discussions between patients with a life-limiting 
progressive nonmalignant disease, or their carers, and health professionals.   
Context: Any setting where end-of-life discussions occur.  
Outcomes were not specified for this study this may have unnecessarily limited the search. 
2.3.1 Search methods 
A sensitive-search strategy was used in an attempt to include all relevant literature.  A 
preliminary broad-based search was conducted in PubMed and CINAHL in order to identify and 
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obtain the maximum number of keywords from relevant articles.  The keywords from each 
article were entered into an NVivo database, and this list was then analysed for the frequency 
that each keyword occurred.  The most prevalent words were used to develop the search 
strategy, and to identify thesaurus terms and free-text terms to be used in the search.  
Methodology specific filters were used for each database.  PubMed, CINAHL, BNI, ASSIA, 
PsycINFO, ScienceDirect and Web of Science were searched between November 2009 and 
February 2010 for literature published between 1999 and 2010. In addition, the contents of the 
Journal of Palliative Medicine, the Journal of Pain and Symptom Management, the Western 
Journal of Nursing Research and the American Journal of Hospice and Palliative Care were 
hand- searched as these journals yielded the most relevant results in the database search.  The 
reference lists of all articles selected for potential inclusion were also searched.  Grey literature 
was not included as time constraints did not allow a full systematic search of such sources. 
Search terms or equivalent MeSH headings are listed in Table 2.1. 
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Table 2.1  Search terms of equivalent MeSH headings. 
Search Terms 
1. terminal care; 22. disclosure; 
2. terminally ill; 23. discussion; 
3. chronic disease; 24. family; 
4. lung diseases; 25. patient; 
5. pulmonary disease, chronic obstructive; 26. patient care conferences; 
6. aged; 27. patient-family conferences; 
7. palliative care; 28. psychology; 
8. hospice care; 29. 20-28/or; 1 
9. hospices; 30. attitude of health personnel; 
10. critical illness; 31. patient satisfaction; 
11. advancing illness; 32. physician-patient relations; 
12. death; 33. nurse-patient relations; 
13. end-of-life; 34. professional-patient relations; 
14. end of life; 35. 31-34/or; 1 
15. chronic illness; 36. health professional; 
16. dying; 37. nurses; 
17. prognosis 38. physicians; 
18. 1-17/or;1 39. hospital; 
19. conversation; 40. medical staff; 
20. communication; 41. 37-40/or; 1 
21. decision making; 42. 18 and 29 and 35 and 41.2 
 
Studies were included if they: 
• focused on end-of-life discussions between patients with NMRD, or their caregivers, and 
health professionals; 
• were primary studies conducted using a specified qualitative or quantitative 
methodology;  
• were conducted in any country and were published between 1999 and 2010 in a peer 
reviewed journal in English; 
• involved participants aged 18 or over. 
• Studies were excluded if they focused upon:  
                                            
1 18, 29, 35, 41 denote that search term items listed (e.g. 1 to 17) were combined using the boolean term OR between them, meaning that the 
database searched "terminal care" OR "terminally ill" OR "chronic disease" OR etc. which provided results of any database item containing any 
of these terms. 
2 42 indicates that the results of searches conducted in 18, 29, 35 and 41 were combined using the boolean term AND in the database, which 
provided results of database items containing items from each search group e.g. a database item that included "palliative care", "communication", 
"patient satisfaction", "nurses". 
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• malignant disease, unless being compared to nonmalignant diseases; or 
• the topic of euthanasia as the focus of this study is natural death. 
In addition, reviews with duplicate evidence were excluded.  A member of the supervisory team 
reviewed 30 percent of the studies according to the inclusion criteria, and the student and the 
supervisor me to reach a consensus as to their inclusion/exclusion.   
2.3.2 Search outcome 
The search and review process conformed strictly to the PRISMA guidelines (Liberati et 
al., 2009) and is depicted in Figure 2.1. 
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Figure 2.1 PRISMA Flow Diagram of search and review process. 
 
A total of 4279 titles from all databases and 44 titles from hand-searching journals were 
identified and examined for this review. After 44 duplicates were removed, the first author 
applied inclusion/exclusion criteria in an un-blinded standardized manner to 4279 titles and 
abstracts, and narrowed the results down to 73 papers.  Citations of papers included at this 
point were searched, and a further 16 papers were added, making a total of 89 papers that 
were read in full to be assessed for eligibility.  A further 73 titles were excluded during this 
process, and the final 16 articles selected for inclusion in the review comprised of eight 
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quantitative studies, and eight qualitative studies.  The included studies are described in Table 
2.2.   
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Table 2.2 Summary table of included studies 
Reference Aim Patient group and sample  Key Findings 
Clover et al. 
(2004) 
Australia 
To explore patients’ 
understanding of their discussions 
about end-of-life care with nurses 
in a palliative care setting. 
Patient group: COPD, heart disease and 
other. 
11 people (7m, 4f), 57-84 end-of-life, early 
and late stages after diagnosis, all similar 
economic and cultural backgrounds - 
white, middle class. 
 Patients perceive health professionals as ‘all 
knowing’ 
 Patients wish to avoid confrontations with nurses 
due to possibility of repercussions for their car 
 Patients do not necessarily seek to have end-of-life 
discussions 
 Nurses miss opportunities to have end-of-life 
discussions with patients 
 Patients want health professionals to inform them of 
what may happen 
 Patients may want to put off making decisions about 
their care in order to gather research 
 There is no participatory model of care 
 Patients feel cajoled into decisions by health 
professionals 
Csikai (2006) 
United States 
To understand family caregivers’ 
perceptions of the 
communication process from 
initial discussion of the need for 
end-of-life care and hospice 
through to the decision to 
choose hospice and the transition 
home. 
Patient group: COPD, heart disease and 
other 
108 bereaved hospice caregivers (36 
months post-patient death) from three 
hospice agencies.   
 Patients should be treated as individuals when 
discussing end-of-life issues (qualitative finding) 
 In addition to physicians, social workers were often 
(71.9%) present when hospice was discussed 
 35.4% of caregivers often reported that the hospice 
option was only discussed once with their patient 
Curtis et al. 
(2004)  
United States 
To examine patient-physician 
communication amongst a group 
of patients with oxygen-
dependent COPD, in order to 
identify specific areas of 
communication about end-of-life 
care that patients report do not 
occur, and also to identify specific 
areas of good and poor quality 
communication. 
Patient group: COPD 
 
115 patients with oxygen-dependent 
COPD identified from pulmonary clinics 
in three hospitals and through an oxygen 
delivery company.  Avg 67 end-of-life, 
mostly male and 84% Caucasian 
 Talking about prognosis, spirituality, and dying needs 
to be improved for patients with severe COPD 
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Reference Aim Patient group and sample  Key Findings 
Curtis et al. 
(2008)  
United States 
To examine the interaction 
between patients’ and family 
members desire to have hope 
communicated, while also needing 
to receive specific prognostic 
information, as well as the desire 
of health professionals to support 
hope and provide prognostic 
information.  They aim to provide 
insight to clinicians. 
Patient group: COPD, heart disease and 
other 
 
Participants were patients with severe 
chronic obstructive pulmonary disease or 
advanced cancer, and their families, 
nurses, and physicians.   
 Health professionals were able to convey hope to 
patients and families while also providing truthful 
information 
 Patients’ hope was decreased when health 
professionals gave discouraging medical information, 
presented information disrespectfully or appeared 
‘cold’ 
 Hope was best communicated when prognostic 
information was given in a sensitive manner, using 
statistics ‘compassionately’ and answering patient 
questions 
Desharnais et 
al. (2007) 
United States 
To investigate the effectiveness of 
patient physician communications 
regarding health care choices at 
the end of life. 
Patient group: COPD, heart disease and 
other 
22 physicians (M = 47 end-of-life/o, 19 yrs 
experience) and 71 patients (M = 64 end-
of-life).  58% cancer, 42% CHD.  Study 
limited to Caucasians and African 
Americans 
 Patient/physician concordance low on whether 
physician knows a patient's preferences for pain 
management (14.1%) and place of death (14.1%), and 
whether the patients spiritual beliefs were affecting 
the patient's choices of care (29.6%). 
Elkington et al. 
(2001)  
United 
Kingdom 
To investigate the role that 
discussions of prognosis play in 
general practitioners’ 
management of patients with 
severe COPD and the factors 
that influence those decisions 
Patient group: COPD 
 
All GP principals in Lambeth, Southward, 
Lewisham Health Authority 
 41% of general practitioners reported often or 
always discussing prognosis with patients with 
severe COPD 
 82% of general practitioners feel that they have an 
important role in end-of-life discussions 
 72% of general practitioners thought that 
discussions of prognosis were often necessary or 
essential in severe COPD 
 50% of general practitioners were undecided as to 
whether patients with COPD wanted to know 
about their prognosis 
 The majority of general practitioners that reported 
not discussing end-of-life with patients stated the 
following reasons: felt unprepared to discuss, they 
found it hard to start such discussions, insufficient 
information in the primary care notes 
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Reference Aim Patient group and sample  Key Findings 
Farber et al. 
(2003)  
United States 
To examine the perceptions of 
patients, carers and physicians 
who are already connect with 
one another in an end-of-life care 
experience.  
 
Patient group: COPD, heart disease and 
other 
 
Convenience same of 42 patients, 29 
carers facing EOL.  Already published 
findings from interviews with 29 GPs 
were included 
 
 Relationship fluctuations between health 
professionals and patients, coping with daily living 
while managing an illness, and the personal 
experience of facing the end-of-life are key issues in 
end-of-life care 
 Patients expect their physicians to be competent 
and to provide a caring relationship 
 Coping with daily living while attempting to manage 
medication are an important issue in end-of-life care 
Fried and 
O'Leary. 
(2008)  
United States 
To understand how end-of-life 
care experiences of older patients 
and their carers can inform the 
development of new approaches 
to advance care planning 
 
Patient group: COPD, heart disease and 
other 
 
Caregivers of community dwelling people 
60 yrs+ to had died of advanced cancer, 
COPD or HF during follow-up in a 
longitudinal study 
 
 Lack of availability of treatment options can prompt 
patients and carers to consider end-of-life issues 
 There are changes in patient preferences at the very 
end-of-life 
 There is variability in patient and carer desire for 
and readiness for information about the patient’s 
illness 
 There are difficulties with patient-carer 
communication 
Fried et al. 
(2003)  
United States 
To investigate the agreement 
between patients, caregivers and 
clinicians regarding prognosis 
communication, and to examine 
patients’ and caregivers’ desire 
for prognostic information. 
 
Patient group: COPD, heart disease and 
other 
 
214 people, aged 60+ with a limited life 
expectancy due to cancer, CHF or 
COPD; and clinicians (n = 96), and their 
caregivers (informal) (n = 193) 
 
 Discrepancies in perceived life expectancy by 
patients accompanied the discrepancies in perceived 
communication 
 Agreement between patients and clinicians was low 
on whether patients had been informed that their 
disease was fatal 
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Reference Aim Patient group and sample  Key Findings 
Goldstein et 
al. (2005)  
United States 
To examine the association of 
patient race and financial status 
with patient and clinician reports 
of discussions about prognosis. 
 
Patient group: COPD, heart disease and 
other 
214 people, aged 60+ with a limited life 
expectancy due to cancer, CHF or 
COPD; and clinicians (n = 96) (same 
participants as Fried 2003) 
 Agreement about prognosis discussions was more 
likely when patients were younger (>80) 
 Patients were more likely to agree that end-of-life 
discussions about prognosis had taken place when 
patients had a lower financial status or were 
nonwhite, compared to patients who had a higher 
financial status or were white 
Grbich et al. 
(2006)  
Australia 
To retrospectively analyze the 
end-of-life care that was provided 
to 20 patients who died in the 
acute wards of a teaching 
hospital. 
Patient group: COPD, heart disease and 
other 
Records of patients who had died within a 
few days were audited.  10 m, 10 f, had 
been in hospital avg. 25.7 days - 9 had 
malignancy, death was expected for 4/12 
of non-cancer patients, 6/9 of cancer 
patients.  
Staff interviews (40) with two nurses with 
the highest number of shifts in which each 
patient in the study nursed. 
 Found a lack of a holistic palliative care model 
 There are poor levels of communication among and 
between staff, patients and families 
 
Knauft et al. 
(2005)  
United States 
Authors sought to identify the 
common barriers and facilitators 
to communication about end-of-
life care 
Patient group: COPD 
Patients with oxygen dependent COPD 
and the doctor that was primarily 
responsible for their lung disease. 
 32% of patients with COPD reported having an end-
of-life discussion with their physician 
 The more facilitators for end-of-life discussions 
reported by a patient with COPD, the more likely 
they were to report having end-of-life discussions 
 The greater number of barriers to discussing end-of-
life reported by COPD patients, the less likely they 
were to have discussed this topic 
 Found two common barriers to having end-of-life 
discussions for patients with COPD 
 ‘I’d rather concentrate on staying alive’ 
 ‘I’m not sure which doctor will be taking care of me’ 
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Reference Aim Patient group and sample  Key Findings 
Kutner et al. 
(1999)  
United States 
To describe issues that are 
important to terminally ill patients 
receiving palliative are, and to 
determine whether patient 
characteristics influence their 
needs 
Patient group: COPD, heart disease and 
other 
Patients with a terminal diagnosis, 
receiving palliative care, 18+ yrs, English 
speaking, able to consent. 
 There is no patient profile that predicts individual 
end-of-life communication needs 
 Illness related issues such as individual and social 
effects may be equally or more important to 
patients than disease issues 
Lofmark and 
Nilstun. (2000)  
Sweden 
To test whether common clinical 
conversations could be used to 
explore issues of life support 
limitations for seriously ill 
patients. 
Patient group: COPD, heart disease and 
other 
21 patients consecutively admitted to 
hospital over a 4-week period.  Three 
patients had DNR orders, others fulfilled 
criteria of serious illness.   
 Within a short conversation with a health 
professional, patients easily accepted and valued 
direct discussions about forgoing life support 
 It is important to ask the patient which family 
members or health professionals that he would like 
to be present in an end-of-life discussion 
 Seriously ill patients are not harmed by talking about 
their prognosis 
Steinhauser et 
al. (2008)  
United States 
To evaluate the impact of an 
intervention that promotes 
discussions of end-of-life 
preparation and completion on 
health outcomes in dying persons. 
Patient group: COPD, heart disease and 
other 
82 hospice patients (28 f, 35 African 
American), primary diagnosis of cancer 
(48), heart disease (5), lung disease (10) 
and other (19).  Aged from 28-96. 
 Patients in the active end-of-life discussion group 
showed improvements in functional status, anxiety, 
depress and preparation for the end-of-life 
Wenrich et al. 
(2001)  
United States 
To explore which aspects of 
communication between patients 
and physicians are important in 
end-of-life care. 
Patient group: COPD, heart disease and 
other 
Purposive sampling of patients with 
chronic and terminal illnesses 
(COPD/AIDS or cancer), their family 
members, health care professionals from 
hospice or acute care settings, and 
physicians with expertise in EOL care.   
 Health professional being willing to discuss end-of-
life, listening to patients, encouraging questions, 
being honest, being sensitive to timing of the 
discussion, and giving bad news in a sensitive manner 
are important factors for end-of-life communication 
 Health professionals need to balance honesty and 
frank information while not discouraging hope 
*Please refer to the published paper (Stephen et al 2013) included at the end of this thesis for information about the design of the included studies.
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2.3.3 Quality appraisal 
Studies were evaluated to determine methodological quality; however, studies were not 
included or excluded from the review based on this evaluation. Qualitative and quantitative 
papers were evaluated by the standard quality assessment criteria developed by Kmet et al. 
(2004). This appraisal tool consists of 14 questions for quantitative papers and 10 questions for 
qualitative papers.  To validate the critical appraisal, a member of the supervisory team assessed 
30 percent of the studies using the same criteria.  Consensus on scoring was reached in several 
areas, and minor differences in scoring were debated further until consensus was reached. Inter 
rater reliability was calculated based on the original scores from each reviewer.   
Critical appraisal resulted in a score out of one (Kmet et al., 2004).  The scores for the 
eight qualitative studies ranged from 0.65 – 0.9 (mean = 0.79), the eight quantitative studies 
ranged from 0.68 to 0.95 (mean = 0.83) with an overall mean of 0.81 for the sixteen studies.  
Detailed results of the quality appraisal process can be found in Table 2.3 and Table 2.4 and 
represent final consensus rating for papers that were assessed by a second rater.  Table 2.5 
contains calculations of percent agreement, Cohen’s Kappa and number of agreements and 
disagreements for each item (Kottner et al., 2011). 
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Table 2.3 Outcomes of quality appraisal of quantitative studies using Kmet et al. (2004) tool. 
Checklist C
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0
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4
) 
D
e
sH
ar
n
ai
s 
e
t 
al
. 
(2
0
0
7
) 
E
lk
in
gt
o
n
 e
t 
al
. 
(2
0
0
1
) 
F
ri
e
d
 a
n
d
 B
ra
d
le
y 
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0
0
3
) 
G
o
ld
st
e
in
 e
t 
al
. 
(2
0
0
5
) 
K
n
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ft
 e
t 
al
. 
(2
0
0
5
) 
St
e
in
h
au
se
r 
e
t 
al
. 
(2
0
0
8
) 
Question/objective clearly described? 2 1 2 1 2 2 2 1 
Study design evident and appropriate? 2 2 2 2 2 1 2 2 
Method of subject/comparison group selection or source 
of information/input variables described and appropriate? 
1 2 2 1 2 2 2 2 
Subject (and comparison group, if applicable) 
characteristics sufficiently described? 
2 2 2 2 1 2 2 2 
If interventional and random allocation was possible, was 
it described? 
NA NA NA NA NA NA NA 1 
If interventional and blinding of investigators was possible, 
was it reported? 
NA NA NA NA NA NA NA 2 
If interventional and blinding of subjects was possible, was 
it reported? 
NA NA NA NA NA NA NA NA 
Outcome and (if applicable) exposure measure(s) well 
defined and robust to measurement/misclassification bias? 
means of assessment reported? 
2 2 2 2 2 2 2 2 
Sample size appropriate? NA NA 1 NA 0 1 NA 0 
Analytic methods described/justified and appropriate? 1 2 2 2 2 2 2 0 
Some estimate of variance is reported for the main 
results? 
2 2 2 2 2 2 1 1 
Controlled for confounding? NA NA 2 NA 0 NA NA 2 
Results reported in sufficient detail? 2 2 2 2 2 2 2 2 
Conclusions supported by the results? 1 2 2 2 2 1 2 2 
Summary Score* 0.68 0.94 0.95 0.89 0.77 0.77 0.94 0.73 
The summary score for quantitative studies is calculated by determining the total sum of scores, and then 
subtracting it from the total possible sum (28 – number of NA x 2), and then dividing the total sum by the total 
possible sum. 
  
  
35 
 
Table 2.4 Outcomes of quality appraisal of qualitative studies using Kmet et al. (2004) tool. 
Checklist 
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(2
0
0
0
) 
W
e
n
ri
ch
 e
t 
al
. 
(2
0
0
1
) 
Question/objective 
clearly described? 
2 2 2 2 2 2 2 2 
Design evident and 
appropriate to answer 
study question? 
2 2 2 2 2 2 2 2 
Context for the study is 
clear? 
2 2 2 1 2 2 2 2 
Connection to a 
theoretical 
framework/wider body 
of knowledge? 
1 2 1 2 2 2 2 1 
Sampling strategy 
described, relevant and 
justified? 
1 2 1 2 2 2 2 1 
Data collection methods 
clearly described and 
systematic? 
2 2 2 2 2 2 2 2 
Data analysis clearly 
described and 
systematic? 
1 2 1 2 1 2 0 2 
Use of verification 
procedure(s) to 
establish credibility of 
the study? 
0 2 2 2 2 2 0 2 
Conclusions supported 
by the results? 
2 2 2 2 2 2 2 2 
Reflexivity of the 
account? 
0 0 0 0 0 0 0 0 
Summary score^ 0.7 0.9 0.75 0.85 0.8 0.85 0.65 0.8 
^The summary score for qualitative studies is calculated by dividing the sum of scores by the total possible sum (20). 
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Table 2.5 Inter rater reliability 
 Percent 
Agreement 
Cohen's 
Kappa 
N 
Agreements 
N 
Disagreements 
Csikai (2006) 71 0.53 10 4 
Curtis et al. (2004) 93 0.86 13 1 
Goldstein et al. (2005) 71 0.48 10 4 
Rogers et al. (2000) 90 0.82 9 1 
Downar and Hawryluck 
(2010) 
90 0.47 9 1 
Grbich et al. (2006) 90 0.79 9 1 
 
Inter rater agreement was assessed for six pairs of observations.  Cohen’s Kappa ranged 
from 0.48 (moderate) to 0.86 (excellent) indicating a satisfactory level of inter rater agreement 
(Landis and Koch, 1977). 
2.3.4 Data abstraction 
Data were extracted from the texts into a detailed summary table that contains a 
description of the study, the population, methods and results, in order to enable comparison 
across studies according to their relevance to the objective of the review (Garcia et al., 2002, 
Miles and Huberman, 1994, Petticrew and Roberts, 2005).  Any questions arising during this 
process were discussed with supervisors until a consensus was reached.  Due to the size of this 
table, it could not be reproduced here, instead the contents of the detailed summary table 
were summarised for the reader in Table 2.2. 
2.3.5 Synthesis 
Thematic analysis was used to identify themes and synthesise qualitative and quantitative 
findings across studies (Dixon-Woods et al., 2004).  While there is controversy regarding the 
synthesis of qualitative and quantitative evidence in systematic reviews (Mays et al., 2005, 
Dixon-Woods et al., 2001), thematic analysis is commonly used in mixed-methods reviews to 
identify the key themes in a set of studies, and using tabular summaries adds a greater degree of 
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synthesis (Mays et al., 2005, Miles and Huberman, 1994).  The method of thematic analysis used 
involved identification of the recurrent themes in the literature, and then summarizing the 
findings of the studies under the thematic headings (Dixon-Woods et al., 2004).  Equal weight 
was given to qualitative and quantitative data in the synthesis process.   
Themes were identified in each of the included papers by coding the results of each paper, 
grouping these codes into categories, and importing each category into a table.  A mind map 
was then used to group categories into common themes throughout the literature (Dixon-
Woods et al., 2004).  These themes were discussed between the student and the supervisory 
team until consensus regarding the synthesis was reached.  A diagram displaying the codes, 
categories and themes is presented in Appendix A. 
2.4 Findings 
The review process revealed several consistent components throughout the included 
studies.  The findings are organised within three themes: the discussion; the health 
professional/patient relationship; and patient perceptions.  Each theme consists of several key 
components to end-of-life discussions, which will be discussed in detail.  It has been specified 
where results were reported for physician participants rather than health professionals in 
general. 
2.4.1 The end-of-life discussion 
The style and content are key components in end-of-life communication with patients 
with nonmalignant disease. This includes how and when the discussion is initiated, barriers to 
discussion, patient concerns about end-of-life, and patient information needs.  
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Concern over initiating end-of-life discussions was raised in several of the included 
studies.  Patient prognosis is a component of such discussions, as it helps determine when to 
move away from aggressive life-sustaining treatments (Childers et al., 2007).  Patients may want 
prognostic information soon after diagnosis but may not want to raise the issue themselves 
(Clover et al., 2004), however, Elkington (2001) found general practitioners (GPs) felt 
unprepared and found it hard to start end-of-life discussions. This reluctance may be 
unwarranted; Lofmark & Nilstun (2000) found seriously-ill patients easily accepted and valued 
frank discussions about forgoing life support even within short clinical encounters.  
The willingness of the health professional to discuss end-of-life is an important 
component of this type of communication (Wenrich et al., 2001).  One study found that only 41 
percent of GPs reported they often or always discussed prognosis with patients with severe 
Chronic Obstructive Pulmonary Disease (COPD)(Elkington et al., 2001). Some GPs stated that 
they did not discuss prognostic information due to insufficient information in the primary-care 
notes (Elkington et al., 2001). This is problematic as hospice-services information is often not 
available to patients from other sources than  their physicians (Csikai, 2006). 
In a study of patients with COPD, the greater the number of barriers reported, the less 
likely that discussions occurred.  Patients cited the barriers most frequently encountered 
included not knowing what type of care they wanted, and uncertainty regarding which doctor 
would be caring for them (Knauft et al., 2005).  According to the studies in this review, patients’ 
end-of-life concerns include: facing the end-of-life and awareness of impending death (Farber et 
al., 2003); changes in daily living and managing and coping with a terminal illness (Elkington et al., 
2001); and the lack of availability of treatment options (Fried and O'Leary, 2008). The lack of 
treatment options often led patients to consider end-of-life issues (Fried and O'Leary, 2008).   
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In several studies, the style of communication was found to be an important factor, and 
highlights the need to determine individual patient preferences prior to beginning an end-of life 
discussion (Csikai, 2006).  Listening to patients and encouraging questions is important for 
successful communication (Wenrich et al., 2001), as well as determining who will be present for 
the discussion; for example, while additional health professionals (such as social workers) are 
often present for such discussions, this may not always be desired by the patient (Csikai, 2006).  
A lack of awareness regarding end-of-life options may be attributed to patient denial, therefore 
sensitivity is an important characteristic of such discussions and preparation for them (Wenrich 
et al., 2001).  However, some patients wanted to receive information soon after diagnosis 
(Csikai, 2006).  A study of bereaved caregivers reported that end-of-life discussions occurred 
only once (Csikai, 2006).  
Elkington et al. (2001) found that 72.5 percent of GPs thought that discussions of 
prognosis were necessary or essential in severe COPD, and 82 percent felt that GPs had an 
important role in such discussions.  Lofmark and Nilstun (2000) found that patients are 
generally not harmed by talking about their prognosis, yet authors of one study found that only 
32 percent of patients with COPD discussed end-of-life with their physician.  The more 
facilitators for communication that were reported, the more likely they were to report having 
end-of-life discussions (Knauft et al., 2005).  One study found that financial status and race of 
the patient may play a role in agreement between health professionals and patients about the 
occurrence of end-of-life discussions.  They found that patients were more likely to agree that 
end-of-life discussions about prognosis had occurred to those with a lower financial status and 
who were not Caucasian, compared to patients with a higher financial status who were 
Caucasian (Goldstein et al., 2005).  Two possible explanations for this finding were provided: 
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The first was that the first group may be more likely to hear bad news in general, and therefore 
may be more likely to accept a terminal diagnosis. The second was that health professionals 
may put more effort into communicating end-of-life options to these groups as they have a 
propensity to favour life-sustaining treatments.  
Curtis et al. (2004) found that discussion about prognosis needs to be improved for 
patients with severe COPD. In addition, Curtis et al. (2004) found that there needed to be an 
improvement in discussions around spiritual issues. 
2.4.2 Health professional/patient relationship 
The importance of the health professional-patient relationship has been emphasised in 
end-of-life communication.  Patients expect physicians to be competent, to provide a caring 
relationship (Farber et al., 2003), and they perceive health professionals as `all-knowing' (Clover 
et al., 2004).  There may be a power component in this relationship.  Patients may wish to avoid 
confrontation with nurses over decision-making, due to the uncertainty of their situation and of 
the repercussions they fear may arise from challenging an expert (Clover et al., 2004). In one 
study of GPs, half were undecided as to whether most patients with COPD wanted prognostic 
information (Elkington et al., 2001). 
The balance between honesty and hope when communicating about end-of-life issues 
was a common theme in several studies (Curtis et al., 2008, Wenrich et al., 2001).   Patients 
wanted to be informed of what may happen (Clover et al., 2004).  Csikai (2006) reported that 
health professionals should be more forthcoming about the reality of death, but should consider 
that patients want information that is delivered sensitively, but without  too much detailed 
information.  Health professionals are able to convey hope to patients and families while 
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balancing their duty to provide truthful information by being sensitive, using statistics 
compassionately, and answering patient questions.  Patient hope was decreased when 
discouraging medical facts were discussed, and information was presented bluntly or the health 
professional was perceived to be `cold' (Curtis et al., 2008). 
Certain health professionals may be viewed as being more helpful than others.  While 
Clover (2004) reported that nurses miss opportunities to have end-of-life discussions with 
patients, Csikai (2006) found that nurses and social workers were helpful when discussing the 
transition to hospice.  Social workers were reported to be the most comfortable, most 
knowledgeable and most available for discussions of end-of-life care (Csikai, 2006). The 
variations in reported discussions about end-of-life care may be related to the model of care. 
Clover (2004) did not find evidence of a participatory model of care, with some patients feeling 
that they had been persuaded by health professionals to make certain decisions.  Grbich et al. 
(2006) also found a lack of a holistic palliative-care model. 
2.4.3 Patient perceptions 
Patients who participated in a randomised controlled trial with an active end-of-life 
discussion intervention showed improvements in functional status, anxiety, depression and 
preparation for end-of-life (Steinhauser et al., 2008).  Despite the clear benefit of discussing 
end-of-life, discrepancies in agreement between whether end-of-life discussions had occurred 
between health professionals and patients were found in some studies.  One study found that 
when patients inaccurately predicted their life expectancy, they also inaccurately perceived that 
communication had occurred (Fried and O'Leary, 2008).  The same study found that patient 
and health professional agreement was low on whether prognosis had been discussed, as health 
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professionals felt that they had provided prognostic information more often than patients felt 
they did (Fried and O'Leary, 2008). 
2.5 Discussion 
The studies that were selected for inclusion in this review were of moderate to high 
quality, and the variety of methodological approaches indicates the wide range of research in 
this area. Findings were fairly consistent across studies.  However, the wide range of 
methodological and theoretical approaches also means that findings could not be combined 
using meta-synthesis.  Instead thematic analysis, which is well suited to coping with diverse 
types of evidence was used.  
The review adds to current knowledge by revealing several key components of end-of-
life communication in NMRD found in the literature. The most prevalent component was the 
style of the communication.  This included the desire for two-way communication, the 
existence of power issues, and the importance of honest yet hopeful communication.  In 1995, 
authors of a systematic review found a correlation between successful health professional-
patient relationships, and improved health outcomes for patients (Stewart, 1995).  The 
importance of the style that health professionals use to communicate with patients has been 
recognised in several types of patient-health professional interactions.  Buller and Buller (1987) 
found that patients reported less satisfaction when physicians used a controlling style of 
communication.  In another study, when health professionals exhibited patient-centred 
behaviours, patients were more satisfied with the interaction, felt understood, and felt their 
concerns were resolved (Henbest and Stewart, 1990, Stewart, 1984).  Likewise, in a study for 
patients with diabetes, Snoek and Skinner (2005) found this patient group reported higher 
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satisfaction with health care visits when they felt communication was two-way between 
physicians and patients.  
Awareness and recognition of patient and health professional facilitators and barriers to 
end-of-life communication was also a key component. Other key components were (1) the 
health professional's recognition of the patient's desire for information about their prognosis 
and subsequent care options, (2) the initiation of the end-of-life topic by the physician or health 
professional and (3) an appropriate environment for the discussion, and (4) the provision of 
prognostic information.  This is reflected in the findings by Jones et al. (2004) where 
information about the future course of their illness was reported as a major issue for patients 
with COPD, with patients having varied opinions on how much prognostic information they 
desired.  This is a major issue for end-of-life communication as prognostic information is 
difficult to provide in COPD due to the unpredictable disease trajectory (Murray et al., 2005).  
These factors must all be considered within the context of providing the information each 
patient needs.    
The findings of this review imply that health professionals should not assume that they 
know what patients want in terms of end-of-life communication, as preferences vary between 
patients.  Instead, individual needs can be discerned by having preliminary planning discussions 
about what the patient wants.  This preliminary conversation should be initiated by the health 
professional, and could determine who the patient wants to be present for the discussion, 
where the discussion will take place, and the appropriate environment for the discussion.  The 
health professional-patient relationship may be key to a successful discussion.  Even if they do 
not have a long-standing relationship, the style of communication, and the health professional's 
ability to communicate honestly while conveying hope is important.  Also, discussions may need 
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to occur more than once to ensure that both parties are clear on the prognosis and the agreed 
plans, and to ensure that questions get answered and that changing information needs and care 
preferences are addressed.  This is particularly important when patients may be in and out of 
the hospital due to exacerbations, as their experiences may change their care preferences or 
information needs. 
The findings in this review are applicable to health professionals, including physicians who 
work with patients with nonmalignant disease who may need to discuss end-of-life care 
preferences.  However, these findings may not be generalisable as only studies from western 
cultures were included.  Cultural variables were not explored in this review, and were rarely 
explored within any of the included studies.  In addition, the countries that produced the 
included studies all have a diverse range of health care systems, from nationalised to private.  
Further research is needed to determine applicability of these findings across countries. 
2.6 Conclusion 
This review has identified several key components of end-of-life communication in 
nonmalignant disease and provides an evidence base for the studies that follow.  These 
components are not always evident in the patient experience.  While identified in the literature, 
this means that health professionals need to be more aware of such key aspects, and also to 
ensure they are providing them when appropriate.  What may help to improve the patient 
experience and the likelihood of end-of-life discussions is the assignment of a key health 
professional for each patient who is responsible for discussing end-of-life, and for ensuring that 
wishes are communicated between settings.  While it is surprising that psychosocial issues did 
not arise as a major issue in this review, this area may arise in later phases of the study.   
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Palliative care resources are scarce for patients with NMRD, and end-of-life 
communication is critical and must be made a priority by health professionals.  This evidence 
also has implications for other health professional education, to ensure professionals are 
trained and confident enough to have these discussions.  In addition, generalists, without 
specialized training, are increasingly providing palliative care for patients, and while palliative 
care rotations are becoming more common in medical training, this area still requires 
improvement (Meier et al., 2010). This indicates the importance of more widespread 
implementation of training programmes in disease-specific palliative care communication and 
delivery.  The findings of this review will be discussed further in Chapter 7 in relation to the 
second systematic review (Chapter 3) and the findings of the Delphi studies (Chapters 5 and 6).  
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Chapter 3. A comparative systematic review of discussing end-of-life in chronic 
obstructive respiratory disease in the UK and Canada 
3.1 Introduction 
This chapter consists of a systematic review of end-of-life discussions in COPD in Canada 
and the UK, and is the first component of the comparison between end-of-life discussions in 
these countries, as introduced in Chapter 1, that will continue through this thesis.  The findings 
of Chapter 2 made clear that end-of-life discussions in NMRD are a complex process.  The aim 
of this international comparison is to provide further insight into this process to add to the 
development of a complex intervention. Literature related exclusively to COPD was reviewed 
as the most common NMRD to focus the scope of the review and to ensure that this review 
would provide unique findings to the review in Chapter 2. 
First the objectives of the review are presented in 3.2, followed by the review method in 
3.3.  This is followed by the synthesis of the data in 3.4.  The results of the review are 
presented in are discussed in 3.5, and the chapter is concluded in 3.7. 
3.2 Objectives 
The objective of this review is to compare the findings of qualitative and quantitative 
studies about end-of-life discussions in COPD in the UK and Canada to examine how health 
professionals are discussing end-of-life in these two countries with similar healthcare systems.    
Specifically, this review aims to answer the following questions: 
1. How do health professionals know a patient with COPD is ready or willing to discuss 
the end-of-life? 
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2. What types of things should be considered when discussing end-of-life with patients 
with COPD? 
3. What topics should be included in end-of-life with patients with COPD? 
This review continues the development of the evidence base for the design of the 
intervention to aid health professionals to discuss end-of-life in NMRD.  To achieve these aims, 
this review includes papers published in a peer-reviewed journal that report on studies using 
qualitative or quantitative methodology with participants with COPD or health professionals 
working with such patients from the UK or Canada having end-of-life discussions. 
3.3 Review Method 
The methods used to conduct this review including the information sources and search 
strategy (3.3.1), inclusion criteria (3.3.2), study selection (3.3.3), data collection process (3.3.4), 
and quality appraisal (3.3.5) are described in the sections below.  The resulting data synthesis is 
included in section 3.4. 
3.3.1 Information sources and search strategy 
Studies were identified by the author using a two-step search process (Petticrew and 
Roberts, 2005).  First, the MEDLINE database was searched using the terms ‘end-of-life’ AND 
‘communication’ and ‘respiratory’.  This search yielded 26 titles, of which five were relevant.  
The key words from these five papers were used to construct a more detailed search strategy, 
including MeSH terms.  An example of the search strategy from the database is provided in 
Table 3.1.  This strategy was used to search Medline and CINAHL and adapted for EMBASE for 
literature published in English between 1990 and 2010.  MeSH terms found in Table 3.1 were 
replaced with free-text terms as appropriate to the database.  The relevant results from the 
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database searches were then citation searched for relevance sources, as were any systematic 
reviews that were found. In addition, the table of contents of the Canadian Respiratory Journal, 
the Journal of Palliative Medicine, and Palliative Medicine were searched between 1990 and 
2010 for relevant studies, as these journals contained the highest numbers of relevant results in 
the database searches.  In order to determine whether all relevant sources had been captured, 
a limited update search was conducted of MEDLINE, CINAHL and EMBASE in August 2011. 
Table 3.1 Example of search strategy from MEDLINE (EBSCOhost) database. 
Search Terms 
1.  (MM “Pulmonary Disease, Chronic Obstructive+”); 12.  dying; 
2.  (MH “Lung Diseases”); 13.  (MH “Prognosis+”); 
3.  (MM “Lung Diseases”); 14.  (MM “Communication+”); 
4.  1-3/or;3 15.  (MH “Decision Making”); 
5.  palliative; 16.  (MH “Attitude to Death”); 
6.  (MM “Palliative Care”); 17.  (MH “Physician-Patient ;Relations”) 
7.  (MH “Quality of Life/PX”); 18.  discussion; 
8.  (MH “Disease Progression”); 19.  5-13/or; 
9.  (MH “Death+”); 20.  14-18/or; 
10.  (AB “end of life”); 21.  4 and 19 and 20.4 
11.  MH “Advance Directives”;  
*Items 4, 19 and 20 denote that search term items listed (e.g. 1-3) were combined using the boolean term OR between them, meaning that the 
database searched " Pulmonary Disease, Chronic Obstructive " OR " Lung Diseases " etc. which provided results of any database item 
containing any of these terms. 
* Item 21 indicates that the results of searches conducted in 4, 19 and 20 were combined using the boolean term AND in the database, which 
provided results of database items containing items from each search group e.g. a database item that included "lung diseases", "end of life", 
"decision making". 
3.3.2 Inclusion and Exclusion Criteria 
Papers were included in this review if they met the following criteria:  
 described specific components of end-of-life communication in COPD between 
patients and health professionals 
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 data were collected in either the UK or Canada were original qualitative or 
quantitative studies published in a peer reviewed journal between 1990 and 2011 in 
English (discussion papers, literature and systematic reviews and non-journal articles 
were excluded) 
 did not exclusively address discussions about mechanical ventilation as they did not 
address end-of-life discussions as a whole 
 papers in which authors did not report specific components of end-of-life 
communication in COPD were excluded. 
3.3.3 Study Selection 
Study selection was conducted by the first author in two stages.  First, the titles and 
abstracts of the search results were screened against the inclusion and exclusion criteria to 
identify potentially relevant studies.  The remaining papers were retrieved in full text and read 
in full, and again the researcher applied the inclusion and exclusion criteria to identify relevant 
studies. Any papers where inclusion or exclusion was contentious were discussed with a 
supervisor until consensus was reached.  This process is summarized in the PRISMA flow 
diagram in Figure 3.1. 
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Figure 3.1 PRISMA Flow Diagram of search and review process. 
 
3.3.4 Data collection process 
The data extraction sheet was adapted from the Centre for Reviews and 
Dissemination’s guidance (Centre for Reviews and Dissemination, 2009) on information 
requirements for data extraction and is presented in Table 3.2.  This process was amended 
slightly from the data abstraction process in the systematic review in Chapter 2 to be more 
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detailed in order to assist with data synthesis.  This included general information about the 
paper, study characteristics, participant characteristics, intervention (where applicable) details, 
setting and country information and components of end-of-life discussions in COPD (Table 3.2).  
The sheet was piloted on three included studies and amended according to the requirements of 
this review.  The data items were extracted by the author and entered into the review database 
in EPPI Reviewer Software (Thomas et al., 2010).  Data extraction was repeated by a member 
of the supervisory team on a random selection of 30 percent of the articles to verify accuracy 
and a lack of bias.  Disagreements were resolved by discussion until consensus was reached 
between the student and the supervisor. 
Table 3.2 Data extraction sheet items. 
Category Extracted Items 
Study characteristics Aim/objectives of the study 
 Study design 
 Study inclusion and exclusion criteria 
 Country of origin 
Participant characteristics Participant type e.g. health professionals, patients, 
family members 
 Age 
 Gender 
 Disease characteristics 
Results/Findings Components of end-of-life discussions 
 
3.3.5 Quality Appraisal 
Qualitative and quantitative papers were evaluated by the standard quality assessment 
criteria developed by Kmet et al. (2004).  This appraisal tool provides a quantitative method for 
evaluating quantitative and qualitative research using a separate criteria for each method, 
resulting in quantitative scores (out of 1.0) that can be compared.  The evaluation criteria are 
detailed in Table 3.3 and Table 3.4  along with the scoring for the appraisals of both the 
quantitative and qualitative studies. To validate the quality appraisal process, 30 percent of the 
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studies were assessed by a member of the supervisory team using the same criteria.  Studies 
were evaluated to determine methodological quality, however studies were not included or 
excluded from the review based on this evaluation. This strategy is recommended by Mays et al. 
(2005) when qualitative studies are included in the synthesis because studies that are appraised 
as weak may be included successfully in a synthesis, and the worth of certain studies is often 
revealed during the synthesis process. 
Table 3.3 Outcomes of the quality appraisal of qualitative studies using Kmet et al. (2004) tool. 
Checklist 
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(2
0
1
1
) 
Question/objective clearly described? 2 2 2 2 2 2 
Design evident and appropriate to answer study question? 2 2 2 2 2 2 
Context for the study is clear? 2 2 2 2 2 2 
Connection to a theoretical framework/wider body of 
knowledge? 
2 2 2 1 2 2 
Sampling strategy described, relevant and justified? 2 1 2 1 2 2 
Data collection methods clearly described and systematic? 2 1 1 1 2 2 
Data analysis clearly described, complete and systematic? 1 1 2 1 1 2 
Use of verification procedure(s) to establish credibility of 
the study? 
0 0 2 0 2 2 
Conclusions supported by the results? 2 2 2 2 2 2 
Reflexivity of the account? 0 0 0 0 0 0 
Summary Score 0.75 0.65 0.85 0.6 0.85 0.9 
The summary score for qualitative studies is calculated by dividing the sum of scores by the total possible sum (20). Items 
are scored for the degree that they meet the criteria for each question detailed by the authors of the quality appraisal 
guidance: (2 = yes, 1 = partial, 0 = no).   
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Table 3.4 Outcomes of the quality appraisal of quantitative studies using Kmet et al. (2004) tool. 
Checklist 
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0
8
) 
Question/objective clearly described? 2 2 2 2 
Study design evident and appropriate? 2 2 2 2 
Method of subject/comparison group selection or source of information/input variables 
described and appropriate? 
2 2 2 2 
Subject (and comparison group, if applicable) characteristics sufficiently described? 2 2 2 2 
If interventional and random allocation was possible, was it described? 0 1 NA 0 
If interventional and blinding of investigators was possible, was it reported? 0 1 NA 0 
If interventional and blinding of subjects was possible, was it reported? 0 1 NA 0 
Outcome and (if applicable) exposure measure(s) well defined and robust to 
measurement/misclassification bias? means of assessment reported? 
1 1 2 1 
Sample size appropriate? 0 1 2 2 
Analytic methods described/justified and appropriate? 2 2 2 2 
Some estimate of variance is reported for the main results? 0 1 2 1 
Controlled for confounding? 0 1 1 0 
Results reported in sufficient detail? 2 2 2 2 
Conclusions supported by the results? 2 2 2 2 
Summary Score 0.54 0.94 0.75 0.64 
The summary score for quantitative studies is calculated by determining the total sum of scores, and then subtracting it from 
the total possible sum (28 – number of NA x 2), and then dividing the total sum by the total possible sum. Items are scored 
for the degree that they meet the criteria for each question detailed by the authors of the quality appraisal guidance: (2 = 
yes, 1 = partial, 0 = no). 
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Table 3.5 Summary of included studies 
Reference Country Research Question Study Design Participants Quality 
assessment 
score 
Buxton et al. 
(2010) 
United 
Kingdom 
Do current and future planned 
end-of-life provision for COPD 
patients in the UK meet the 
current palliative care guidance? 
Web-based audit survey 239 respiratory units in England, 
Scotland, Wales, Northern Ireland 
and offshore islands (98%) of 
eligible trusts responded 
0.54 
Crawford 
(2010) 
 
United 
Kingdom 
What are health professionals’ 
experiences of discussing end-of-
life with patients with COPD? 
Qualitative 
phenomenological 
interviews 
3 respiratory nurses, 2 lung 
cancer nurse specialists, 2 
respiratory physicians 
0.75 
Elkington et al. 
(2001) 
 
United 
Kingdom 
What role do discussions of 
prognosis play in GPs management 
of patients with severe COPD and 
what are the factors influencing 
those discussions? 
Structured questionnaire 214 GP principals in London, 
(55%) response rate. 
0.93 
Goodridge et 
al. (2009) 
 
Canada What is the applicability, 
development and monitoring of 
indicators measuring the quality of 
end-of-life care for individuals with 
severe COPD? 
Delphi survey Patients with COPD and their 
family members 
Interdisciplinary, nationally 
represented group of 
professionals with an interest in 
end-of-life care for patients with 
COPD 
0.65 
Gore et al. 
(2000) 
 
United 
Kingdom 
How are the care needs of 
patients with COPD met in 
comparison to those with lung 
cancer? 
Semi-structured 
interviews 
Quantitative quality of life 
measures 
Medical record audits 
 
 
 
50 patients with severe COPD 
50 patients with inoperable non-
small cell lung cancer (NSCLC) 
0.75 
Gott et al. 
(2009) 
 
United 
Kingdom 
What are barriers to advance care 
planning discussions in COPD? 
 
Focus groups 39 health care professionals caring 
for patients with COPD 
0.85 
Gysels and 
Higginson 
(2010) 
 
United 
Kingdom 
How does the experience of 
breathlessness in COPD influence 
patients’ attitudes towards the 
end-of-life and their quality of life? 
Qualitative interviews and 
participant observation of 
outpatient consultations 
18 patients with COPD 0.6 
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Table 3.5 Summary of included studies (continued) 
Pinnock et al. 
(2011) 
 
United 
Kingdom 
What is the experience of patients 
with severe COPD and their 
caregivers? 
Serial qualitative 
interviews  
21 patients with severe COPD, 
13 informal caregivers, 18 
professional caregivers 
0.9 
 
Rocker et al. 
(2008) 
Canada What are the ratings of 
importance and satisfaction with 
various elements of end-of-life 
care for Canadians with advanced 
COPD? 
Quantitative survey 118 patients with severe COPD 0.64 
Spence et al. 
(2009) 
 
United 
Kingdom 
Do professionals feel that patients 
with advanced COPD have 
palliative care needs, and what are 
the barriers for health and social 
care professionals to delivering 
palliative care to these patients? 
Focus groups 23 health and social care 
professionals caring for patients 
with COPD 
0.85 
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3.4 Data Synthesis 
The data synthesis process has been adapted from the comparative review process 
detailed in Slort et al. (2011). Two tables were generated from the data extraction sheet (Table 
3.2).  The first (Table 3.5) includes the characteristics of each included study: country, research 
question, study design, participants and the score resulting from the quality appraisal process; 
while the second (Table 3.7) includes the relevant data from each study.  Specifically, Table 3.7 
contains data from each study that is organized by review question and theme.  Whether the 
data is found in a Canadian study, a UK study or both is also indicated in the table.  
3.5 Results 
This section contains a description of the studies included in the review, a summary of 
the methodological quality of included studies as presented in Table 3.3 and Table 3.4 and a 
comparison between Canadian and UK studies and finally a synthesis of the findings.   
3.5.1 Description of included studies 
Using the search strategy detailed above in Table 3.1, the author located 315 citations.  
After 71 duplicates were removed, 244 citations were screened for inclusion by reading the 
titles and abstracts.  This process resulted in 117 citations being excluded, leaving 127 to be 
retrieved in full-text and assessed for inclusion.  A further 117 citations did not meet the 
inclusion criteria, leaving 10 studies (2 Canadian, and 8 UK) included in the review. This process 
is detailed in Figure 3.1. 
3.5.2 Methodological quality of included studies 
As detailed in Table 3.3 and Table 3.4 the quality of the included studies ranged from 
medium to high according to the Kmet criteria (Kmet et al., 2004).  The scores for the 
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qualitative studies ranged from 0.6 – 0.9 (mean = 0.77), and for the quantitative studies ranged 
from 0.54 – 0.94 (mean = 0.73), with an overall mean of 0.75 for all included studies.  To 
determine inter rater reliability, Cohen’s Kappa calculation was used.  Table 3.6 contains 
calculations of percent agreement, Cohen’s Kappa and number of agreements and 
disagreements for each item (Kottner et al., 2011). Inter rater agreement was assessed for 
three pairs of observations.  Cohen’s Kappa ranged from .44 (moderate) to 1.0 (excellent) 
including a satisfactory level of inter rater agreement (Landis and Koch, 1977). 
Table 3.6 Inter rater reliability 
 Percent Agreement Cohen's Kappa N Agreements N Disagreements 
Rocker et al. (2008) 64 0.44 9 5 
Buxton et al. (2010) 64 0.46 9 5 
Goodridge et al. (2009) 100 1 10 0 
 
3.5.3 UK/Canada comparison 
Eight studies from the UK, and two studies from Canada met the inclusion criteria.  It 
was anticipated that studies would be evenly distributed between the countries, but a lack of 
Canadian studies in the area precluded this. Table 3.7 provides a comparison of findings from 
both countries, but due to the lack of Canadian studies, most findings were from the UK.  
There were very few unique Canadian findings, however some UK findings were also found in 
Canada.  One unique finding from Canada was that end-of-life discussions should be culturally 
safe for patients. 
Components of end-of-life discussions are summarised in Table 3.7.  Findings are 
categorized by whether they reported by a UK or Canadian study, or both and also by the 
research question that they address:  How do you know a patient is ready or willing to discuss 
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end-of-life?; What considerations should be made during end-of-life discussions?; and what 
topics should be included in end-of-life discussions. 
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Table 3.7 Considerations, triggers and topics for end-of-life discussions in the UK and Canada. 
1. How do you know a patient is ready or willing to discuss end-of-life? (Triggers for discussion) 
UK Canada 
Use of Gold Standards Framework (GSF) to address EOL care and 
preferred place of care (Buxton et al.) 
Discussion triggered when HCP would not be surprised if the patient died in 
the next year (Goodridge et al., 2009) 
Advance care planning has been carried out in the last 12 months of life 
(Buxton et al.) 
 
Using the advanced decisions and preferred priorities of care to start 
discussion and document decisions (Buxton et al.) 
Both 
Health professional looks for cues from patient (Crawford, 2010) Patient asks health professional about end-of-life (Goodridge et al., 2009, 
Crawford, 2010) 
Health professional reads the patient for when to initiate the discussion 
(Crawford, 2010) 
Patient experiences a serious impairment of functional status (Goodridge et al., 
2009, Gott et al., 2009, Spence et al., 2009) 
Trigger to discuss end-of-life is missed by health professional (Crawford, 
2010) 
 
Non-imminent death is not discussed with patients (Pinnock et al., 2011)  
2. Considerations for end-of-life discussions 
a. Prognosis 
UK Canada 
Patient’s family guides information provided to patient about prognosis 
(Elkington et al., 2001) 
-- 
Time constraints prevent prognostic discussions (Elkington et al., 2001, 
Crawford, 2010) 
 
Difficult to determine end-of-life phase in severe COPD (Elkington et al., 
2001, Gott et al., 2009, Spence et al., 2009) 
Both 
Discussions of prognosis remove hope for patients (Elkington et al., 2001, 
Crawford, 2010) 
Patients with severe COPD want prognostic information (Elkington et al., 2001, 
Rocker et al., 2008) 
Patients should ask for prognostic information (Elkington et al., 2001) Patients may not get prognostic information despite wanting or asking for it 
(Gysels and Higginson, 2010, Elkington et al., 2001, Pinnock et al., 2011, Gore et 
al., 2000, Rocker et al., 2008) 
Prognostic discussions are difficult to start with patients (Elkington et al., 
2001) 
 
Patients value discussions about prognosis (Elkington et al., 2001)  
Health professionals soften information about prognosis for patients 
(Crawford, 2010) 
 
Health professionals find it difficult to formally diagnose COPD (Pinnock et 
al., 2011) 
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Table 3.7 Considerations, triggers and topics for end-of-life discussions in the UK and Canada (continued) 
b. Responsibility to initiate end-of-life discussion 
UK Canada 
Lack of agreement between health professionals about whose responsibility 
it is to initiate the discussion and where (Gott et al., 2009, Spence et al., 
2009) 
-- 
It is easier for health professionals to discuss end-of-life when the patient 
initiates the discussion (Crawford, 2010) 
Both 
Patients do not realise that they have end-of-life choices to make unless 
health professionals raise the subject (Gott et al., 2009) 
Physicians have an essential involvement in end-of-life decision making 
(Goodridge et al., 2009, Spence et al., 2009) 
 End-of-life discussions should be initiated by the health professional (Goodridge 
et al., 2009, Gore et al., 2000) 
c. Understanding COPD as a life limiting illness 
UK Canada 
Lack of understanding of COPD as a life limiting illness (Gott et al., 2009, 
Gore et al., 2000) 
-- 
Inadequate information provision about the likely course of COPD at 
diagnosis (Gore et al., 2000, Gott et al., 2009, Spence et al., 2009, Pinnock 
et al., 2011) 
Both 
Patients view death as a natural process instead of an anticipated 
consequence of their disease (Pinnock et al., 2011) 
-- 
d. Roles in end-of-life discussions 
UK Canada 
GPs have important role in discussing prognosis (Elkington et al., 2001, 
Spence et al., 2009) 
Important role of families in end-of-life discussions (Goodridge et al., 2009) 
 Both 
 -- 
e. Language of care 
UK Canada 
Medical language used during end-of-life is not understood by patients 
(Crawford, 2010, Gore et al., 2000) 
Discussions should be culturally safe for all patients (Goodridge et al., 2009) 
Health professionals avoid using the words ‘death and dying’ words 
(Crawford, 2010) 
Both 
 -- 
f. Continuity of care and ability to share information between health professionals 
UK Canada 
Health professionals work with COPD patients at different points in the 
illness, making it difficult to define roles and maintain relationships 
(Crawford, 2010) 
 
-- 
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Table 3.7 Considerations, triggers and topics for end-of-life discussions in the UK and Canada (continued) 
Information about end-of-life discussions are documented and shared 
between settings (Buxton et al., Elkington et al., 2001) 
Both 
 -- 
g. When to discuss end-of-life with patients 
UK Canada 
Choosing the ‘right time’ to discuss is important (Spence et al., 2009, 
Crawford, 2010, Pinnock et al., 2011) 
-- 
Time constraints make it difficult for health professionals to discuss sensitive 
issues (Gott et al., 2009, Spence et al., 2009, Crawford, 2010) 
Both 
g. When to discuss end-of-life with patients (continued) 
End-of-life discussions should occur while patients are outpatients or in 
rehabilitation programmes and are well enough to make decisions(Buxton 
et al., Gott et al., 2009) 
End-of-life should be discussed as early as possible after diagnosis (Goodridge et 
al., 2009, Spence et al., 2009) 
Hospitals are noisy and lack privacy for end-of-life discussions  (Gott et al., 
2009) 
 
GP consultation appointments are not an appropriate time to discuss as the 
patient is typically unwell (Gott et al., 2009) 
 
Discussions should occur when deterioration worsens (Crawford, 2010)  
Difficult to discuss when patients are breathless, tired and distressed 
(Spence et al., 2009) 
 
The point of referral to palliative care services is unclear (Gott et al., 2009, 
Spence et al., 2009, Pinnock et al., 2011) 
 
Pattern of consultation prevents initiating discussions about the future 
(Pinnock et al., 2011) 
 
Uncertain disease trajectory makes timing the discussion difficult (Crawford, 
2010) 
 
Gradual change of focus from active treatment to patient comfort (Spence 
et al., 2009) 
 
h. Perceived negative effects of discussing end-of-life care 
UK Canada 
Health professionals avoid discussing palliative care to avoid distressing 
patients (Spence et al., 2009, Crawford, 2010) 
-- 
End-of-life discussions may deter patients from trying to manage their 
disease (Gott et al., 2009) 
Both 
Discussing palliative and end-of-life care with patients may result in patients 
feeling health professionals are giving up (Spence et al., 2009) 
-- 
There are a lack of palliative care services for COPD patients, making it 
difficult to discuss care wishes (Crawford, 2010) 
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Table 3.7 Considerations, triggers and topics for end-of-life discussions in the UK and Canada (continued) 
i. Feelings about discussing end-of-life  
UK Canada 
Health professionals anxiety in engaging in the discussion (Crawford, 2010) -- 
Health professionals manage their emotions in order to regularly discuss 
end-of-life with patients (Crawford, 2010) 
Both 
Patients create their own boundaries about discussing end-of-life (Crawford, 
2010) 
-- 
j. Medical profession and end-of-life discussions 
UK Canada 
Health professionals are trained to focus on a cure at all costs over 
palliative care (Gott et al., 2009, Spence et al., 2009, Crawford, 2010) 
-- 
Health professionals state that they have not received training in breaking 
bad news or end-of-life discussions (Gott et al., 2009) 
Both 
Health professionals do not understand the benefits of palliative and end-of-
life care and are therefore reluctant to use such resources (Spence et al., 
2009) 
-- 
3. Topics for end-of-life discussions 
UK Canada 
-- Surrogate decision makers (Goodridge et al., 2009) 
 Resuscitation (Goodridge et al., 2009) 
 Emergency treatment (including intubation (Goodridge et al., 2009) 
 Ongoing mechanical ventilation (Goodridge et al., 2009) 
 Both 
 -- 
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3.5.4 Synthesis of results 
The greatest number of findings from included studies were in the category labelled 
considerations for end-of-life discussions, sub-categorised into considerations relating to 
prognosis, and considerations relating to when to discuss end-of-life.  The question with the 
least number of findings was topics for end-of-life discussions.  Only one Canadian study 
reported topics that should be included in end-of-life discussions (Goodridge et al., 2009).   
Section one of Table 3.5 looks at how health professionals know that a patient is ready 
or willing to discuss end-of-life.  Studies from both the UK and Canada reported two indicators; 
(i) the patient asks the health professional about end-of-life (Goodridge et al., 2009, Crawford, 
2010), and (ii) the patient has had a decline in functional status (Goodridge et al., 2009, Gott et 
al., 2009, Spence et al., 2009).  Findings from the UK specifically reported the use of 
standardized tools such as the Gold Standards Framework (2006) and the preferred priorities 
of care documents to tell them when a patient was clinically ready to discuss (Buxton et al., 
2010).  Other findings reported that the health professional looks for indicators from the 
patient directly, implying that the health professional and patient may have a prior relationship 
whereby cues could be interpreted (Crawford, 2010).  Two studies also reported that triggers 
to discuss end-of-life were missed by health professionals, and that unless death was imminent, 
it would not be discussed with patients (Pinnock et al., 2011).  One Canadian study added to 
these results that discussions were triggered by using the ‘surprise question’ – when the health 
professional would not be surprised if the patient died in the next year (Goodridge et al., 2009). 
Section two of Table 3.7 reports considerations for end-of-life discussions.  These findings are 
subdivided further into sub-categories.  The areas with the most items were when to discuss 
end-of-life with patients and prognosis.  Timing came up as a contentious issue in several studies 
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(Spence et al., 2009, Crawford, 2010, Pinnock et al., 2011, Gott et al., 2009, Buxton et al., 2010, 
Goodridge et al., 2009).  Some stated that there was a ‘right time’ to discuss (Buxton et al., 
2010, Gott et al., 2009), and others indicated that time constraints in the current system made 
finding this time to discuss very difficult (Pinnock et al., 2011).  In addition, there were 
conflicting findings about discussing soon after diagnosis, or when the patient’s condition started 
to deteriorate (Goodridge et al., 2009, Spence et al., 2009, Crawford, 2010).  Findings were 
also contradictory about discussing when patients are well and attending outpatient 
programmes, when they were in the hospital, or during GP consultations (Buxton et al., 2010, 
Gott et al., 2009).   
The issue of prognosis in relation to discussing end-of-life was another contentious topic.  
Prognosis was acknowledged as being difficult to determine in COPD (Elkington et al., 2001, 
Crawford, 2010).  Timing was raised as an issue that prevented discussing prognosis with 
patients, that health professionals felt that discussions of prognosis would remove hope for 
patients, and that prognostic discussions were difficult to start with patients (Crawford, 2010, 
Elkington et al., 2001).  On the other hand, some studies found that patients value and want to 
discuss prognosis, but may not get such information despite asking their health professionals to 
discuss it with them (Elkington et al., 2001, Rocker et al., 2008).    
Another area of disagreement in the included papers was about whose responsibility it is 
to discuss end-of-life with patients.  Authors of several papers found that physicians should be 
involved and the discussion should be initiated by health professionals (Gott et al., 2009, 
Goodridge et al., 2009, Spence et al., 2009, Gore et al., 2000), while researchers in another 
study found that it was easier for health professionals when patients initiated the topic 
(Crawford, 2010).   
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It was also found that there was a lack of understanding by patients of the nature of 
COPD as a life limiting disease (Gott et al., 2009, Gore et al., 2000).  This is likely related to the 
inadequate provision of information to patients as mentioned previous related to prognostic 
information (Gore et al., 2000, Gott et al., 2009, Spence et al., 2009, Pinnock et al., 2011).  As a 
result of this misunderstanding patients with COPD may not view death as a consequence of 
their disease (Pinnock et al., 2011).   
Such misunderstanding may also be related to the language used in care, which was found 
to be too medical for patients, and in some cases health professionals avoided using words such 
as death and dying (Crawford, 2010, Gore et al., 2000). 
A positive area in UK findings was that information sharing between health professionals 
when end-of-life discussions do occur was sufficient (Crawford, 2010, Buxton et al., 2010, 
Elkington et al., 2001).  However, a lack of continuity of care was found to make discussions 
difficult, and related back to the issue of responsibility for such discussions (Crawford, 2010).  
Perhaps not surprisingly, health professionals viewed end-of-life as having negative effects on 
patients in terms of creating distress, feeling that they were being ‘given up on’ and deterring 
patients from managing their disease (Spence et al., 2009, Crawford, 2010, Gott et al., 2009).  
Authors of one study also found that the lack of end-of-life services for COPD patients meant 
that discussing patients’ wishes for care may be fruitless as wishes may not be met (Crawford, 
2010).   
These findings are put in context by the final area in considerations for end-of-life 
discussions, that the medical profession concentrated on cure at all costs, and therefore health 
professionals may not have adequate training in discussing death, breaking bad news and 
 66 
 
palliative care (Gott et al., 2009, Spence et al., 2009, Crawford, 2010).  The final category of 
topics for end-of-life discussions only had findings from one Canadian study (Goodridge et al., 
2009), which suggested four key topics for end-of-life discussions, which are listed in Table 3.7. 
3.6 Discussion 
The aim of this review was to synthesise evidence from research conducted in the UK 
and Canada about how health professionals discuss end-of-life with patients with COPD. Ten 
studies were included, seven of which were based on qualitative research methods and three 
on quantitative methods.  In these studies, several components of end-of-life discussions with 
patients with COPD were identified and grouped according to the research question that they 
addressed, and then further into themes.   
This work can be distinguished from other work in the area as it provides an multi-
national perspective on this difficult issue, and finds that issues are similar in both countries, but 
that also that more research is needed to ascertain the views of health professionals in Canada 
should be conducted before direct comparisons can be made.  In addition, the specificity of the 
inclusion criteria of only studies looking at COPD assists in making specific recommendations 
for this patient group. 
The finding that there is a lack of Canadian literature in this area was unexpected.  
Interestingly, the research questions from the Canadian studies and the UK studies seemed to 
differ significantly.  Authors of the two Canadian studies aimed to measure the quality of end-
of-life care and related end-of-life discussions, while most UK studies specifically focused on 
experiences and attitudes regarding discussing end-of-life from different perspectives.  It is 
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important to note that the authors of two UK studies also looked to measure whether end-of-
life needs were being met.  
The results revealed that while health professionals have an understanding of when a 
patient may be ready to discuss end-of-life, they have a negative view of the perceived effect of 
these discussions on their patients, potentially explaining why it is often reported that such 
discussions do not occur.  This perceived negative effect by health professionals which is not 
supported by the review findings that patient perceptions, may be in part related to anxiety on 
the part of the health professional over having such discussions.  This issue has been addressed 
in the literature.  Fallowfield and Jenkins (2004) found that it is difficult for health professionals 
to get the balance of being honest and encouraging/hopeful when giving bad news to patients.  
In addition, Curtis proposed a diagram for health professionals to understand the interaction 
between desire for hope and realistic prognostic information (Curtis et al., 2008).  In fact, 
recently Nolan (2011) found that the quality of the 'presence' of a support professional (in this 
case, chaplains) helped patients maintain a 'hopeful manner'.  Therefore simply being with the 
patient can be hope fostering and the same was found by Reinke et al. (2010) found similarly 
that nurses support patients' hope by developing a relationship, providing prognostic 
information and following the lead of the patient.   
Providing prognostic information was a contentious issue in the wider literature.  Those 
conducting a recent US study found that there are several high quality prognostic indices for 
older adults, but concluded that neither a clinician or a prognostic tool can predict with 
certainty how long a person will live (Yourman et al., 2012).  The UK end-of-life strategy 
recommends that there are 'effective mechanisms to identify those who are approaching the 
end-of-life' and states that people approaching the end-of-life are offered a care plan 
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(Department of Health, 2009).  The Canadian literature is more specific as it provides 
prognostic indicators and states that these patients will benefit from timely discussion about 
end-of-life issues, highlighting the value of palliative services (O'Donnell et al., 2008).   
The findings clearly demonstrated that there is a lack of agreement about who is 
responsible for initiating end-of-life discussions.  This ambiguity may be specific to COPD, as 
the UK Cancer Palliative Care guidelines state that key information should be delivered by the 
most senior health professional available, and that all health professionals should be able to 
respond appropriately to patient concerns (National Institute for Clinical Excellence (NICE), 
2004).  The Canadian guidelines for COPD state that physicians have a responsibility to help 
patients and caregivers with COPD to plan for the end-of-life and to access support (O'Donnell 
et al., 2008).  In addition, Abarshi (2011) found that GPs discussed end-of-life issues more with 
patients with cancer than with other conditions.   
The UK end-of-life strategy states that discussions about end-of-life should be undertaken 
by health professionals who are appropriately trained in communication skills, assessment, care 
planning, and symptom management as related to end-of-life care (Department of Health, 2009).  
However, the end-of-life strategy also notes that providing such training for health professionals 
should be a priority in education, perhaps explaining why health professionals may currently be 
lacking the necessary skills.   
Interestingly, the recommendation of being sensitive to the patients’ cultural needs was 
unique to the Canadian literature.   This may reflect the Canadian government’s commitment to 
cultural diversity and its expression in health policy (Department of Canadian Heritage, 2009).  
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Future research in the UK could investigate the experiences of discussing end-of-life in COPD 
in various cultural groups. 
3.7 Conclusions 
This review provides an international comparison of the literature from the UK and 
Canada related specifically to end-of-life discussions in COPD to contribute to the evidence 
base for the development of the intervention.  The findings highlight a lack of Canadian 
literature in this area, thereby indicating the need for further research.   
The review also highlights a discrepancy in the evidence base regarding initiation 
responsibility.  In Chapter 2 it is reported that it is the responsibility of the health professional 
to raise the end-of-life topic, while the findings of this review demonstrate that the patient 
indicates readiness to discuss by raising the topic themselves, or the health professional uses a 
decline of functional status to indicate that a discussion should take place.  In addition, there is a 
lack of literature regarding topics for end-of-life discussions specific to COPD in both countries, 
indicating a need to explore this area further in the Delphi studies that will follow.  The 
contribution of the evidence base established here will be discussed in relation to the studies 
that will be reported in Chapters 5 and 6, in Chapter 7.  
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Chapter 4. Research Design and Methods 
4.1 Introduction 
The findings of the systematic reviews presented in Chapters 2 and 3 demonstrate significant 
gaps in the literature related to end-of-life discussions in NMRD.  Specifically, there is a lack of 
literature addressing the psychosocial needs of patients, as well as disagreement relating to the 
responsibility to initiate end-of-life discussions.  First, training health professionals to discuss 
end-of-life with this patient group may be key to moving the care of patients with severe 
NMRD forward.  Second, indicators that this group of patients are ready or willing to discuss 
end-of-life have not been established, nor have topics for end-of-life discussion specific to 
COPD.  
This chapter presents an overview of the mixed methods research design and methods used to 
address the aims of the study: 
1) To determine how health professionals in the UK and Canada discuss end-of-life; and 
2) To develop an instrument allowing health professionals to determine constraints and 
opportunities to facilitate successful end-of-life discussions specific to NMRD in Canada 
and the UK;  
through the objectives, which were to: 
a) Establish how health professionals know a patient with NMRD is ready or willing to 
discuss end-of-life; 
b) Establish the key considerations and key topics in such discussions as defined by health 
professionals in the field; and 
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c) Delineate the differences in end-of-life discussions for patients with NMRD in the UK 
and Canada. 
 As described in section 1.6 of Chapter 1, to achieve these aims the guidance on 
developing and evaluating complex interventions set out by the Medical Research Council 
(MRC) (2008) provided the blueprint for the design of the study.  The guidance consists of four 
independent phases, of which the first was completed through this doctoral study.   This 
process is outlined in Figure 1.1and Figure 1.2 of Chapter 1.  What follows in this chapter is a 
discussion of how the specific research design and methods used to develop theory model the 
process under investigation.   
 Building on the evidence base established in the two systematic reviews, reported in 
Chapters 2 and 3 as per the MRC guidance, a sequential exploratory mixed methods design was 
employed to investigate this issue in the UK and Canada and develop a tool specific to each 
country to aid health professionals in discussing this issue with patients.  Then, the results of 
these investigations were compared to provide further insight into this area and identify areas 
for improvement in both countries.  
 In section 4.2 the research design is set in the context of the overall assumptions guiding 
the project.  In section 0 the methods used to carry out the research design is examined and 
critiqued in relation to other possible methods.  This is followed in section 4.4 by a detailed 
description of the procedures and in 4.5 by a discussion of the process of establishing the 
clinical applicability of the tools.  The method of international comparison will be described in 
section 4.6.  A discussion of how rigour was established throughout the study follows in section 
4.7.  In section 4.8, the specifics of the study participants will be explicated, including the sample 
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design and the limitations of this design.  This is followed by a description of the recruitment 
procedures in section 4.9, and by a discussion of ethical issues in the study in section 4.10.  
Finally, the chapter is concluded in section 4.11.   
4.2 Research Design 
 In this section the overall assumptions guiding this project will be discussed in section 
4.2.1.  This will be followed by an in-depth discussion of mixed methods research and the 
specific research design used for this study. 
4.2.1 Worldviews and Pragmatism 
 In research, the worldview refers to the beliefs or assumptions that guide the 
investigation (Guba and Lincoln, 2005).  Worldviews consist of common elements, but the 
approach to these elements is different.  The elements are referred to as ontology, which 
represents the views on the nature of reality, epistemology, which represents how knowledge 
is gained, axiology, which is the role of values in research, methodology, which is the research 
process and rhetoric, which is the language used in research (Creswell and Plano Clark, 2007b). 
 While there are several worldviews worthy of consideration for health researchers, 
such as postpositivism (Popper), constructivism (Lincoln and Guba, 1985) and advocacy and 
participatory view (Heron and Reason, 1997), these views are traditionally associated with 
either purely quantitative or purely qualitative methodology.  Pragmatism is the most fitting 
paradigm for mixed methods research (Creswell and Plano Clark, 2007b) and is based on using 
'what works', employing varied methods and values both objective and subjective knowledge 
(Creswell and Plano Clark, 2007b). 
 73 
 
 In research, the pragmatist seeks to clarify the significance of findings, and is focused on 
the consequences of the project (Cherryholmes, 1992). Cherryholmes (1992) explicates 
Dewey's writing on pragmatism where he states that the pragmatic view does not emphasise 
what has gone before (such as past literature on the topic of choice), but instead on will happen 
in the future as a result of the research (Dewey, 1980) .  This view means that instead of 
research being designed to 'report and register past experiences' (Dewey, 1980, p.32), it can be 
a basis for ordering what will happen in the future {Cherryholmes, 1992).  
 Overall a practical and applied view of research should guide decisions made about 
methodology (Tashakkori and Teddlie, 2003). The pragmatic approach in research is useful as it 
connects the epistemological concerns about the knowledge that is produced with the technical 
concerns of the methods used to generate such knowledge (Morgan, 2007). As elucidated 
above, pragmatism focuses on the outcomes of the research being undertaken, is centred on 
the research problem, rather than the methods used to solve it (Tashakkori and Teddlie, 2003).  
4.2.2 Mixed methods design 
In this section the definition and development of mixed methods research are examined.  
The specific research design is then presented, followed by the key decisions made relating to 
this research design.  Finally, limitations of the research design are discussed.   
Definition of mixed methods research 
 Mixed methods research is the combination of both qualitative and quantitative 
approaches to address a particular research problem (Tashakkori and Teddlie, 2003, Green et 
al., 1989, Creswell, 2003, Morse, 1991).  A fundamental principle of mixed methods research is 
that data are collected using multiple strategies, methods and approaches, resulting in a 
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combination of methods with complementary strengths and weaknesses that are not repeated 
(Johnson and Turner, 2003). The need for mixed methods research was established in medical 
clinical practice research (Stange and Zyzanski, 1989).  However, it is more than a "mechanically 
superior" (p. 73) way to answer research questions (Morgan, 2007), rather, mixed methods 
studies should result in better outcomes than studies based on only one method to answer the 
research question (Johnson and Onwuegbuzie, 2004).   
 The mixed method approach was pioneered by Jick in 1979, who advocated combining 
both qualitative and quantitative methods rather than simply collecting both types of data 
without deliberately planning integration of the two in the research design.  He stated that by 
using this approach researchers could have more confidence in their findings, as the use of 
mixed methods led to better understanding of the research questions while allowing for testing 
of competing theories (Jick, 1979).  Morse (1991) further developed the thinking about mixed 
methods by developing two types of mixed methods research design - triangulation and 
sequential design, and also emphasised that either qualitative or quantitative methods needed to 
provide the theoretical background study.  Therefore, she expanded on the idea that mixed 
methods research was not just to obtain complementary findings using two approaches, but 
could lead to the development of new knowledge and theory.  
Mixed methods design for development of a research instrument 
 The use of mixed methods must be appropriate for the given research project (Jick, 
1979).  The guidelines for reporting and conducting mixed research (Leech & Onwuegbuzie 
(2010) state that this rationale must be reported.  In this study, the rationale for instrument 
fidelity as articulated by Collins, Onwuegbuzie & Sutton (2006) is that the researcher wants to 
maximise the value or suitability of an instrument that is being created through the study.  
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Using mixed methods, the researcher can assess the fidelity of the instrument being developed 
throughout the study and make modifications as needed.  The researcher can subsequently 
assess whether the information from the instrument is valid, and put the information in context 
(Collins et al., 2006).   
 Collins et al. (2006) provide a conceptual framework to assess fidelity of the instrument.  
They state that content related validity, specifically face validity and sampling validity can be 
employed.  Face validity can be established during the tool validation process by determining 
the extent that the items are relevant, important and interesting to the respondent, while 
sampling validity addresses the extent to which the set of items sample the total content of the 
area under investigation (Collins et al., 2006).   
 The guidelines put forward by Leech and Onwuegbuzie (2010) state that the specific 
purpose for combining qualitative and quantitative approaches much be stated, while   Collins et 
al. (2006) provide a framework of 65 purposes from which to choose.  The eight potential 
purposes specific to instrument fidelity studies (Collins et al., 2006) are to: 
 assess adequacy of observational protocols in varied settings 
 validate individual scores on outcomes measures 
 identify the adequacy of measures used 
 explain within- and between-participant variations in outcomes on instruments 
 assist with conceptual and instrument development 
 determine the optimal conditions for administering instrument for specific population 
 develop items for an instrument 
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 provide some basis for identifying possible sources of error in the underlying measures 
 Based on the pragmatic view of research, the desired consequences of the research 
study guided the choice of an exploratory mixed methods design for instrument development.  
As elucidated in section 1.5, the purposes of the current study were to develop theory and 
model process and outcomes to contribute to the instrument being developed. These purposes 
are compatible with Creswell's reasons for conducting a sequential exploratory study, which is 
often to develop and test an instrument, explore a phenomenon, and to expand on qualitative 
findings (Creswell, 2003).  This study is a multiphase, mixed methods study including systematic 
review, modified Delphi studies and a comparison of the international Delphi panel results.    
 A mixed methods design was deemed appropriate for an international comparison.  
Qualitative research allowed for an exploration of the issue at hand, and quantitative methods 
were used to develop further understanding.  The combination of these approaches resulted in 
an international comparison of end-of-life discussions in NMRD.   
 Collins, Onwuegbuzie & Sutton (2006) also state that establishing instrument fidelity is 
an acceptable rationale for using mixed methods.  Therefore, in this study the mixed methods 
sequential exploratory design for instrument development was used, consisting of two distinct 
phases: qualitative followed by quantitative (Creswell, 2003).  In this type of design, the 
researcher first collects and analyses qualitative data.  This is based on the idea that qualitative 
exploration of the phenomena of interest is required before quantitative research can be done.  
It is useful when the researcher needs to design and test an instrument when one is not 
currently available.  The qualitative findings from the first phase guide the development of the 
quantitative survey instrument.  In the second phase of data collection, the researcher 
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implements and validates the instrument (Creswell, 2003).  Figure 4.1 details the process of the 
sequential exploratory design as employed in this study. 
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Figure 4.1 Sequential Exploratory Design. 
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Decisions made in mixed methods research 
 The key issues when choosing a mixed methods research design are timing, weighting 
and mixing (Creswell and Plano Clark, 2007a).  Each issue as it pertains to the specific mixed 
methods research design in this study will be addressed in detail below. 
Timing 
 The concept of timing (Creswell and Plano Clark, 2007a) has also been expressed as 
time orientation (Leech and Onwuegbuzie, 2010), sequence of collecting qualitative and 
quantitative data (Morgan, 1998) or implementation (Creswell, 2003, Green et al., 1989), and 
refers to the selection of either concurrent or sequential data collection.  The selection of 
timing is pragmatically based on the objectives of the researcher and is important to articulate 
so that readers know how the data from each type are related.  Using concurrent data 
collection, the researcher would want to determine whether findings from qualitative and 
quantitative data collection were in agreement. In sequential data collection, the researcher 
must make the additional decision of which type of data to collect first.  It is appropriate to 
collect quantitative data first, when the objective is to test variables with a large sample and 
then to explore issues in depth with a qualitative phase.  When qualitative data are collected 
first, this is usually to allow for an exploration of the research problem, and then follow this 
exploration with quantitative data (Creswell and Plano Clark, 2007a). 
 As described in the previous section, in the exploratory design for instrument 
development the results of the first method (qualitative) were used to help develop the second 
method (quantitative) in order to create and test an instrument where one was not currently 
available (Creswell and Plano Clark, 2007a).  This design is based on the proposition that 
exploration is needed as instruments are not available and variables are unknown (Creswell and 
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Plano Clark, 2007a).  Qualitative data collection is completed first to identify items to develop 
the quantitative instrument.   
Weighting 
 The concept of weighting articulated by Creswell (2007a) has also been called emphasis 
of approach (Leech and Onwuegbuzie, 2010), variation of priority or weight given to each form 
of data (Morgan, 1998), priority (Creswell, 2003) and status (Green et al., 1989), and refers to 
whether more weight is given to the qualitative or quantitative data when interpreting the 
results, or whether equal priority is given to each type (Creswell, 2003).  The decision of 
weighting may be based on: the practical constraints of data collection; the need to understand 
one type of data before collecting the next type, the preference of the audience for one type 
over the other, and the comfort level of the researcher (Creswell, 2003).  In the exploratory 
design for instrument development, the quantitative data is usually emphasised as it relates to 
the final form of the instrument (Creswell and Plano Clark, 2007a).   
Mixing 
The concept of mixing (Creswell and Plano Clark, 2007a) has also been referred to as 
level of mixing (Leech and Onwuegbuzie, 2010) and integration (Creswell, 2003), and is the 
stage or stages of research when qualitative and quantitative data are integrated (Creswell, 
2003).  This decision is again based on the purpose of the research, and in this case on the 
purpose of instrument development.  In the exploratory design for instrument development, 
qualitative findings guide the development of items and scales for the quantitative survey 
instrument.  It is this development of items that connects the initial qualitative phase to the 
following quantitative phase (Creswell and Plano Clark, 2007a). 
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Limitations of the sequential exploratory design 
 Overall, the limitations of mixed methods research are that it is more time consuming, 
complex and resource intensive than mono-method research (Creswell, 2003).  Researchers 
require a working knowledge of both quantitative and qualitative methods and how to combine 
them (Schneider and Whitehead, 2013).  As with any type of research design, the mixed 
methods sequential exploratory design has limitations (Creswell and Plano Clark, 2007a).  Each 
will be described and addressed below.   
 The two-phase sequential approach requires a considerable amount of time to execute, 
as each phase is dependent on the completion of the previous phase.  Therefore, sufficient time 
must to be allocated to each phase allowing for data collection and full analysis.  In the current 
study this was addressed by creating a detailed project plan, and allocating sufficient time for 
each phase.  The dependency of one phase on the next can be problematic to specify 
quantitative phase procedures in advance for the purpose of ethical approval, however in this 
case, the calculation of descriptive statistics was likely be the only method of analysis of the 
quantitative data, and therefore this was stated in ethics applications.   
 In this type of design, Creswell (2003) recommends that different individuals participate 
in qualitative and quantitative phases.  However, as is traditional in the specific method used 
(described in section 4.3.1), the same participants were used throughout the study.  A smaller 
group of participants, making up a maximum variation sample were used in the qualitative phase 
and more participants were recruited in the quantitative phase to allow results to be more 
generalizable to the population. 
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Another issue that can arise in a sequential exploratory design is how to decide which 
data from the qualitative phase to use in the instrument, and how to use the data to design the 
instrument.  Again, the use of a specific method to establish consensus among experts 
addresses this issue.  Content analysis of the qualitative data captured each relevant item and 
each item was included in the quantitative instrument for consideration by participants.  As is 
described above, most of the limitations of a sequential exploratory design for instrument 
develop are addressed by using a specific method.  This method will be described in detail in 
section 4.3.1. 
4.3 Methods 
In this section the methods used in the sequential exploratory design for instrument 
development are presented.  First, consensus methods and the types available are explored, 
followed by an explication of the Delphi and how it was applied in this study.  Next, the process 
of endorsement of the instrument is discussed.  This is followed by a description of how the 
results of the UK and Canadian Delphi studies were compared.  Finally, the issue of establishing 
rigour is examined.   
4.3.1 Delphi Method 
Consensus methods in research 
 The purpose of formal consensus methods is to synthesise judgements of a group of 
people, and to determine levels of agreement on controversial subjects (Fink et al., 1984, 
Murphy et al., 1998).  When published information is inadequate, consensus methods allow a 
way to harness the knowledge and experience of experts while also allowing decisions to be 
made (Jones and Hunter, 1995).  Before discussing the methods of obtaining consensus formally, 
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it is important to examine the concept of consensus in research.  There are two types of 
agreement possible within formal consensus methods: the extent to which the participant 
agrees with the issue at hand, determined by their rating on a categorical scale; and the extent 
to which participants agree with each other on a given issue, determined by calculating averages 
and dispersion statistics for each item (Jones and Hunter, 1995).  Methods of deciding 
consensus vary and can involve voting to determine percentage agreement, or using rating 
scales to reach a predetermined mean rating, or where a majority of participants must rate a 
topic at a certain level for inclusion (Nair et al., 2011).  Therefore, consensus does not 
necessarily indicate full agreement between participants on a given issue (Nair et al., 2011).  
Usually, a predetermined level of agreement is determined to establish when consensus has 
been reached.  
 Why should group decision-making be formalised? Murphy et al. (1998) refer to social 
psychological research from the mid 1900s that demonstrated the role of social facilitation.  
This research showed that performance of tasks can be improved or inhibited in front of a 
group, dependent on how well mastered this task was.  In addition, conformity research shows 
that people in groups will sometimes conform to the judgements of others, potentially because 
group members feel pressured to say what others say, and also because people use others to 
interpret the nature of reality, when that reality is ambiguous.  Therefore, the presence and 
actions of others is not neutral in its effects, and these processes may hinder group decision-
making (Murphy et al., 1998).   
 Consensus methods aim to overcome the difficulties of reaching decisions in groups, 
while allowing the inclusion of a wide range of knowledge, experience and interaction between 
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members (Jones and Hunter, 1995, Murphy et al., 1998, Nair et al., 2011).  In addition, they 
have several other useful features put forth by several authors on the subject: 
• several people are less likely to arrive at a wrong decision than an individual (Murphy et 
al., 1998); 
• a decision made by a select group of people is likely to lend authority to the decision 
produced (Murphy et al., 1998); 
• decisions are improved as they have been argued between members (Murphy et al., 
1998); 
• formal consensus methods are scientifically credible (Murphy et al., 1998); 
• they offer a method of dealing with conflicting evidence (Jones and Hunter, 1995); 
• they allow for a more significant role for qualitative assessment of evidence (Jones and 
Hunter, 1995);  
• derive quantitative estimates can be derived through qualitative approaches (Jones and 
Hunter, 1995). 
 Despite several advantages, there are some issues that must be attended to when 
utilizing these methods such as the choice of participants, avoiding one or more people 
dominating the group, the cost of bringing people together, and finally the tendency to assume 
that group decisions are unanimous and not attend to the degree of dissent within the group 
(Murphy et al., 1998).  Each method has an approach to addressing these issues.  The three 
most common formal consensus methods are: the Delphi, the nominal group technique, the 
consensus development conference, and the RAND-UCLA Appropriateness method. 
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Consensus Methods 
 This section will examine the features of the four most common methods of establishing 
consensus in order to determine the most appropriate method for this study. 
 Guidelines published by Fink et al. (1984) set out a criteria to evaluate consensus 
methods.  These guidelines are helpful in evaluating the four consensus methods that will be 
discussed in the following paragraphs and are:   
• Consensus study should focus on a clearly defined problem 
• Decisions should be made by relying on the judgements of experts as well as the 
available empirical data 
• Consensus participants should be representative of their profession, have the ability to 
implement findings, or be recognised as experts in their field 
• The consensus process should be facilitated by an objective and skilled leader 
• The level and type of consensus should be defined in advance 
• Findings of consensus studies should be presented as clear and specific guides for action 
• Large consensus studies should have backing from relevant organisations or government 
agencies 
• The dissemination and subsequent use of the findings of the consensus study should be 
monitored. 
Following the short description of each method, the advantages and disadvantages of each 
method are presented in Figure 4.2. 
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Nominal Group Technique 
 The nominal group technique was developed in the United States in the 1960s to 
investigate issues rated to social services, government, education and industry (Delbecq and 
Van de Ven, 1971).  It is a type of structured meeting with the aim of providing a method to 
acquire qualitative information from an expert group (Delbecq and Van de Ven, 1971, Fink et al., 
1984, Jones and Hunter, 1995).  It is usually conducted with a group of 9-12 participants and 
consists of two rounds where group members rate, discuss and then re-rate a series of items 
or questions. In the nominal group technique participants joining together and individually list 
their responses to the topic.  Then, after a set period of time, each person takes turns 
presenting the most important item on their list, until all lists are exhausted.  All ideas are 
recorded on a chart for the entire group to see.  A highly structured group discussion of each 
idea follows, where each idea is separately evaluated and clarified.  Next, individuals privately 
rank or rate the worth of each idea.  Items with a high ranking according to a predefined cut off 
are kept, while low ranking items are discarded.  This concludes with a prioritised list of ideas 
or solutions (Nair et al., 2011). 
The Delphi Method 
 Development of the Delphi (subsequently referred to as the Delphi) began in the 1950s 
at RAND corporation by Dalkey and Hemler (1963).  The goal of the Delphi is to turn 
individual opinion into group consensus (Hasson et al., 2000).  There are four key features to 
the method: iteration, controlled feedback, anonymity of participants and statistical aggregation 
of group response (Rowe and Wright, 1999).  In the first round, expert panellists give their 
opinion individually and anonymously on a given issue, usually via mail or internet.  The results 
are tabulated and reported to the entire group anonymously.  Then group members have the 
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ability to reconsider their response in light of the group opinion and they rate each item. 
Individual responses are then tabulated again, and once again given back to the entire group.  
Usually the Delphi is conducted over 3-4 rounds until consensus is reached (Fink et al., 1984). 
Consensus Development Conference 
 The consensus development conference (CDC) is a process developed by the US 
National Institute of Health in the 1970s.  It brings together physicians, researchers, consumers 
and others to evaluate the appropriateness of using an existing technology such as a drug, a 
procedure or a device in health care.  The method is unstructured, but is based on judicial 
decision-making methods, scientific conferences, and the town hall meeting structure (Lomas, 
1991).  A group of selected individuals meet in person to reach consensus.  Participants take 
part in a chaired open meeting where evidence is presented by interest groups or experts who 
are not part of the decision making group.  Then the decision-making group meet privately in a 
second chaired meeting to consider the evidence and to reach a consensus.  When consensus 
cannot be achieved, group members are encouraged to provide minority views (Murphy et al., 
1998).  
RAND-UCLA Appropriateness Method 
 This method was developed to evaluate the use of medical procedures in the US, and 
combines scientific evidence with expert opinion (Nair et al., 2011).  The method involves two 
interdependent groups - a core panel and an expert panel.  The core panel conducts a literature 
review.  The core panel then provides a synthesised review from the literature to the expert 
panel, and lists clinical scenarios also devised from the literature.  There are then two rounds of 
rating the appropriateness of the intervention.  In the first round, the expert panel is sent 
clinical scenarios by mail, and participants rate the interventions on Likert scales.  In the second 
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round, the expert panel meet in person and are led by a moderator.  The expert panel are 
given the results of the ratings of each scenario, and panel members can discuss their individual 
views on the appropriateness of the intervention in each scenario.  After the discussion, each 
panellist is able to reconsider their original rating and re-rate the clinical scenario.  The results 
are then summarised using descriptive statistics, and these ratings are used to determine 
whether an intervention is appropriate or inappropriate (Nair et al., 2011).   
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Figure 4.2 Advantages, disadvantages and criticisms of consensus methods. 
Method Advantages Disadvantages and Criticisms 
Nominal group 
technique (NGT) 
(Delbecq & Van de 
Ven 1971) 
 Procedures are highly reliable (Fink et al 1984) 
 Participants meet in person, there is person contact between 
experts (Nair et al 2011) 
 All participants can voice opinions (Nair et al 2011) 
 Group voting can occur if desired (Nair et al 2011) 
 An experienced moderator is required to avoid an 
individual dominating the group (Nair et al 2011) 
 Time to discuss all issues is limited, and only a small 
number of issues can be discussed and agreed on (Nair et 
al 2011) 
 Economic and time costs due to in-person group meeting 
(Nair et al 2011) 
 Produces less frequent and stable consensus than other 
consensus methods (Nair et al 2011) 
Delphi Method 
(Dalkey & Helmer 
1963) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Participants are able to express views anonymously that lead to a 
group opinion (Fink et al 1984) 
 Process is easy to understand (Fink et al 1984) 
 Participants can exchange information in an iterative process, while 
also being a low cost process (Fink et al 1984) 
 Consensus can be gained without eliminating minority views at an 
early stage (Mead 2001) 
 The process of gaining consensus is transparent to members and 
outlined in detail.  Therefore the potential that two groups come to 
a different opinion is not due to the method, but rather based on a 
true difference in opinion. (Mead 2001) 
 The data can be statistically manipulated (Mead 2001) 
 Questioning can be open-ended (Bowles 1999) 
 Attitudes can be measured (Bowles 1999) 
 Feedback is controlled but also anonymous (Bowles 1999) 
 Qualitative and quantitative analysis is possible within the same 
study (Bowles 1999).   
 Ability to collect number of opinions without geographical 
boundaries (Whitehead & Schneider 2013, Jones & Hunter 1995, 
Nair et al 2011) 
 Participants are free to express opinions without being unduly 
influenced by other participants (Whitehead & Schneider 2013, Nair 
et al 2011) 
 Individuals can participate on their own schedule and with minimal 
expense, particularly if conducted electronically (Whitehead & 
Schneider 2013, Jones & Hunter 1995, Marsden et al 2003, Nair et 
 Participant selection process may be a source of bias 
(Keeney 2001, Nair et al 2011, Jones & Hunter 1995) 
 Due to the time commitment required from participants, 
there is a risk of attrition (Beech 2001, Whitehead & 
Schneider 2013) 
 The researcher must intervene to reorder and reduce 
data between rounds, if done incorrectly statements may 
move away from their original meaning (Green 1999) 
 Study findings may lack external validity, and therefore 
must be triangulated with other data (Kennedy 2004, 
Jones & Hunter 1995) 
 Delphi method does not allow potentially positive aspects 
of the interaction of group members (such as resolving 
disagreements) (Fink et al 1984) 
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Delphi Method 
(continued) 
al 2011) 
 The study can be conducted over a short period of time 
(Whitehead & Schneider 2013) 
 The method is flexible and can be modified based on the needs of 
the researcher (Whitehead & Schneider 2013, Nair et al 2011, Fink 
et al 1984) 
 Small groups of participants can be used, number of participants can 
range from 4 to 3000 (Whitehead & Schneider 2013, Cambell & 
Cantrell 2001, Nair et al 2011) 
 It is less likely that the moderator may bias the group, unlike face-
to-face meeting methods (Nair et al 2011) 
 The method allows for qualitative and quantitative analysis within 
the same study (Bowles 1999) 
Consensus 
Development 
Conference (CDC) 
(Fink et al 1984) 
 Results are often widely circulated in lay and medical media (Nair et 
al 2011) 
 Panellists are a mix of practicing physicians, researchers and 
consumers (Nair et al 2011) 
 Interaction between group members is not structured 
(Nair et al 2011) 
 No formal feedback system (Nair et al 2011) 
 Has not been used for making new criteria sets (Nair et 
al 2011) 
 Requires resources beyond the disposal of most 
researchers (Jones & Hunter 1995) 
RAND-UCLA 
Appropriateness 
Method (RAM) 
 Published literature is incorporated into the method (Nair et al 
2011) 
 Includes both confidential individual ratings and group discussion 
(Nair et al 2011) 
 Panel is often interdisciplinary which encourages consensus from a 
wide group (Nair et al 2011) 
 Method is easily reproducible (Nair et al 2011) 
 Significant amount of time required from conducting the 
systematic review to multiple rounds of consensus (Nair 
et al 2011) 
 In person meeting is costly, may lead to time delay and 
opinionated individuals may dominate the group (Nair et 
al 2011) 
 Core panel must construct the clinical scenarios and 
analyse and interpret the results (Nair et al 2011) 
 Items are rated on a nine-point Likert scale which can be 
unwieldy (Nair et al 2011) 
 Expert panellists are required to vote on several 
(sometimes 1000+) case scenarios (Nair et al 2011) 
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 There are several methodological issues that need to be considered when using 
consensus methods (Jones and Hunter, 1995).  The first is the selection of experts for the panel 
and the potential for bias.  This can be resolved by using a different mix of participants in 
further panels.  In addition, the question can be asked as to whether health professionals who 
are willing to participant in expert panels are representative of their colleagues.  One study 
found no significant differences in participants and non-participant physicians.  Another issue is 
whether the composition of the panel can affect the results (McKee et al., 1991).  However, 
particular individuals are unlikely to have an impact on the group decision if there are enough 
participants (Murphy et al., 1998).  Instead, it is recommended to recruit a representative 
sample, which will result in credibility and acceptance of the findings.  The final issue is of 
measuring the accuracy of the answer that is obtained.  It cannot be assumed that the answer 
found by consensus panels is 'correct' and it should be matched to observable events or 
scientific literature (Pill, 1971).  These issues will be addressed in further sections. 
Using the Delphi Method 
 The Delphi has been found to be an effective way of gaining and measuring consensus in 
healthcare (Endacott et al., 1999, Keeney et al., 2001, Keeney et al., 2006, Skulmoski et al., 
2007).  It has been established as being an accurate way of establishing consensus among 
experts in a particular field.  It is effective in the health care field where there will usually be an 
available group of experts in a specific area, and is appropriate when a large survey is not (de 
Meyrick, 2003).  There is no clear evidence in favour of meeting based methods over the 
Delphi (Pill, 1971).  While some critics state that the nominal group technique is superior, their 
specific differences are due to practical rather than theoretical difficulties with the technique.  
They agreed that the Delphi is the superior method of gaining consensus when experts are not 
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able to meet physically (Rowe and Wright, 1999).  Mead and Moseley (2001) stated that the 
benefits of the Delphi overcome the limitations of other consensus methods such as the 
nominal group technique or consensus conferences (see  4.3.1).   
The use of the Delphi in nursing can be linked back to a study by (Lindeman) in 1975 
when it was used to determine nursing research priorities.  Since the evidence based 
movement in healthcare and subsequent focus on the integration of the best available clinical 
evidence, the Delphi is highly relevant as it makes use of expert opinion where evidence is 
lacking.  Mead (2001) states 'the Delphi starts where the evidence leaves off' (p. 10), while  
Crisp (1997) succinctly describes the philosophy of the Delphi "the underlying assumption of 
the Delphi is that n + 1 heads are better than one, and the sum of potentially useful information 
from a group is at least as great as, but usually greater than that of any one individual” (p. 117).  
In addition, while the development of theory is not usually the objective of most Delphi 
research, it can be used to produce theoretically relevant research (Okoli and Pawlowski, 2004).  
In line with the pragmatic view of research, this means that Delphi studies can rapidly  
contribute to theory and practice, as health professionals will immediately have lists available to 
them of factors that have gained consensus in the study, and have been developed by experts in 
the field.  In addition, the Delphi technique may promote change, as participants may be 
inspired to implement the changes that have been decided on in the study (Bowles, 1999). 
Limitations of the Delphi Method 
Like any research method, there are limitations to the Delphi that must be addressed by 
the researcher.  The limitations can be divided into five categories: participant selection, 
response rates and attrition, problems with data collection, problems with data analysis and the 
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accuracy of the findings.  Issues related to each of the five categories and how they were 
addressed for this study will be examined below. 
Participant selection 
 The use of experts in the Delphi can be a source of bias as the formation of the panel 
can affect the results (Keeney et al., 2001, Nair et al., 2011, Jones and Hunter, 1995).  
DeMeyrick (2003) suggested the idea that some participants who are too expert may be biased 
in coming up with, or considering new ideas.  The issue of variable definitions of who is expert 
in the given field may also be an issue (Beech, 2001).  Finally, often Delphi participants are not 
described in detail, and therefore the reader may be unsure who has developed consensus on 
the issue (Schneider and Whitehead, 2013). 
Response rates and attrition of participants 
 As a time commitment is required from participants of Delphi studies (de Meyrick, 
2003), studies based on the Delphi may suffer from poor response rates (Beech, 2001), and 
variable attrition rates (Schneider and Whitehead, 2013, Beech, 2001), which may contribute to 
sample bias (Bowles 1999).   
Data analysis 
 The definition of consensus in Delphi is often inconsistent (Schneider and Whitehead, 
2013, Beech, 2001).  In fact, Crisp (1997) states that the definition of consensus is one of the 
most controversial aspects of the Delphi. Often researchers oversimplify the research problem 
to make answering easier for participants (de Meyrick, 2003).  In addition, the iterative process 
does require some intervention by the researcher, who must reorder and reduce the data 
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somewhat.  When done incorrectly, the statements can move away from the verbatim 
responses that they were originally based on (Green et al., 1999).  
Accuracy of findings 
 The findings of Delphi studies represent expert opinion, but are not indisputable fact 
(Schneider and Whitehead, 2013, Jones and Hunter, 1995). Methodological rigor will be 
ensured through the production of an audit trail of all theoretical, methodological and analytical 
decisions made throughout the research project.  This will be achieved through the use of a 
journal to chronicle such decisions and thought processes.  While Delphi studies have the 
potential to provide very valuable information, few researchers take steps after completion of 
the Delphi to support or refine their findings.  This may be a threat to applicability or external 
validity of the results, therefore efforts  must be made  to match the results to observable 
events (Kennedy, 2004, Jones and Hunter, 1995). The way that these issues were approached in 
this study will be addressed in the sections that follow.  
4.4 Description of Delphi procedures in the UK and Canada 
 In the following sections, the procedures for the Delphi studies conducted in the UK and 
Canada are described.  The procedures for both studies were a similar as possible, however 
areas where there was some divergence are highlighted. The process of data collection and data 
analysis are explicated for each round of the Delphi studies.  Due to the iterative nature of the 
Delphi, these procedures are best explained together by round rather than separately as may 
be traditional when reporting research methods.  Figure 4.3 demonstrates how each stage of 
the Delphi alights with the sequential exploratory design for instrument development. 
 
 95 
 
Figure 4.3 Parallel processes in the sequential exploratory design for instrument development 
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4.4.1 Round 1 
 Due to the gaps in the literature established in the systematic reviews, exploratory 
interviews rather than existing literature was deemed appropriate for the first round of the 
Delphi (Rowe and Wright, 1999, Kennedy, 2004).  Exploratory interviews can provide in-depth 
understanding of a particular area, while also generating a framework for further research or 
improving the quality of survey design (Atkinson et al., 2000).  Using interviews in the first 
round of the Delphi rather than a questionnaire can increase the return rates of questionnaires 
in the second round, thereby providing an additional advantage to using interviews in the first 
round (McKenna, 1994).  Therefore, round 1 of the Delphi consisted of semi-structured 
telephone interviews with nine participants.  Interviews took place during October and 
November, 2010.  Each interview lasted between 20 to 40 minutes.  Before starting the Delphi, 
each participant completed a demographic questionnaire and a consent form.  
 Developing questions for the initial round of data collection in the Delphi can be 
problematic as the researcher must not be too specific, thereby leading participants to certain 
answers, but structure is needed so that participants are clear on the information desired 
(Green et al., 1999).  It is important to allow unstructured responses in the first round so that 
Delphi panel members can raise issues that they think are important, rather than responding 
only to what the researcher asks about.  Therefore, the interview schedule (figure 4.2) was 
designed to give participants sufficient opportunity to share their thoughts on the topic (Rowe 
and Wright, 1999).   
 The questions for the interview arose from the author's interpretation of the literature 
including the systematic reviews in chapters 2 and 3.  Participants were asked three primary 
questions: how they knew patients with NMRD were ready or willing to discuss end-of-life,  
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what are the key considerations in end-of-life discussions in NMRD and what are the key topics 
in end-of-life discussions in non-malignant respiratory disease?  Each  question was supported 
by a number of prompts available to the researcher.  In addition, the interviewer asked if there 
was anything important that had not been covered at the end of each interview.  The interview 
guide used in both Canadian and UK Delphi is displayed in Table 4.1. 
Table 4.1 Round 1 Delphi interview guide 
Interview guide questions 
 Tell me about what your role entails in relation to end-of-life care? Discussions? 
 Cast your mind back to your experiences discussing or not discussing end-of-life care with patients - how 
did the discussion come about and what happened, or why did you not bring up end- of-life care? 
 Why didn't the discussion take place?  
 What made it easier to have the discussion?  
 How did you know the patient was ready to discuss?  
 What were the clinical indicators/psychosocial indicators?  
 How did your professional knowledge and experience contribute to the situation?  
 What do you view as barriers to having end-of-life discussions with patients?  
 What do you view as facilitators to having end-of-life discussions with patients? 
 Based on everything you have told me today, what do you think are the key elements to end of life 
discussions 
 
 The interviews for the UK Delphi were conducted on the telephone, using a call 
recorder attachment for the digital voice recorder. Calls were recorded into sound files, which 
were then transcribed verbatim. The interviews for the Canadian Delphi were conducted using 
Skype to call telephone lines in Canada.  Call recorder software was used to record these calls 
into sound files, which again were transcribed verbatim. Transcripts were entered into an 
NVivo database (2008) to be analysed. Using NVivo facilitates the exploration of many codes, 
groups and ability to sort the data.  It also speeds up the manual process of analysing first round 
responses and enables data errors to be spotted quickly (Mead, 2001). 
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 First, a content analysis was conducted on the interview data to extract all relevant 
content and organize the data by interview question (Endacott et al., 1999, Powell, 2003).  
Interviews were read first, and then during a second reading, content relevant to any of the 
interview questions was highlighted and coded in vivo.  When conducting analysis of Delphi 
data it is important to use participants’ own wording to enhance construct validity, while also 
minimize the potential for researcher bias (Endacott et al., 1999, Green et al., 1999, Hasson et 
al., 2000). While Mead (2001) cautions against categorizing the results to avoid producing an 
effect where respondents pay more attention to the categories than the individual statements, 
the researcher felt given the number of items that codes may help to organize the thinking of 
participants, and grouping items where possible may reduce fatigue from looking at a long list of 
items.  
Items were organized by research question, and then by group into an online 
questionnaire for participants.  The items and their groupings were reviewed by the 
researcher's supervisors to ensure that data were fairly presented before being sent to 
participants (Hasson et al., 2000). 
4.4.2 Round 2 
 There were two aims of Round 2: 1) to present Round 1 items to all participants and 
allow them to rate each item, and 2) to give participants joining in Round 2 an opportunity to 
propose additional items.   The questionnaire was designed to be completed online for the 
convenience of the study participants and due to the wide geographic spread of participants 
(Chang et al., 2010, Skulmoski et al., 2007).  Surveys were designed using survey monkey 
https://www.surveymonkey.com/ and participants were sent a link to each round of the Delphi 
via email.  Participation was tracked using a spreadsheet in Google docs 
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(www.docs.google.com). Prior to data collection, the researcher informally investigated 
whether potential participants for the UK study were internet literate and were comfortable 
with online interaction.  While not all health professionals are regular email users, the nurse 
manager confirmed that these participants were comfortable using online methods of 
communication. 
 Using online data collection can complement findings collected offline, and online 
research allows for a more representative sample, leading to potentially greater generalizability 
of results. In addition, using online methods to collect data will help to save money and will 
speed up the process in sequential mixed methods design (Hesse-Biber and Griffin, 2012).  In 
addition to an online questionnaire, an identical paper questionnaire was also available for 
participants preferring this approach.  
 Participants were asked to indicate their agreement with each item on a 5-point Likert 
type scale, ranging from strongly agree to strongly disagree. They were provided with space to 
enter additional comments on each item and were encouraged at the end of each section to 
add any items that were not included in the list, for consideration in the next round.   
 The online questionnaire was tested by four people (two experienced supervisors,  one 
respiratory consultant nurse, and one nurse manager) before being sent to participants in round 
2 to ensure rigour (Hasson et al., 2000) and ease of use. Questionnaire testers were asked to 
evaluate whether the tool was clear, whether items needed further clarification, and to report 
the length of time the spent completing the questionnaire.  
 This process led to some re-wording in the biographical questionnaire, clarification of 
wording on several items in the questionnaire and some re-ordering of items.  After this was 
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amended and approved by the director of studies, electronic access to the questionnaire was 
provided to participants.  The paper version of the Round 2 questionnaire was also sent to the 
same four people for review to ensure consistency with the online questionnaire.   
 The questionnaires were as similar as possible, however, the online questionnaire 
required a response to each item, and participants would get an error message if they tried to 
proceed having skipped an item.  This meant that no data were missing from the online group 
surveys, however the paper questionnaire yielded some missing data.  Respondents did not 
report any technical difficulties with the online questionnaires. 
 Quantitative analysis of the Round 2 Delphi data included the following descriptive data 
analysis (Keeney et al., 2006, Holey et al., 2007): 
 Percentage response rates for each item 
 Percentages for each level of agreement (i.e. strongly disagree to strongly agree) for 
each statement to compensate for varying response rates between rounds and items 
 Median and range 
 Mean and standard deviation. 
All of the items with a mean score of three or higher were included in the next round 
(Mead and Moseley, 2001).  There are no specific rules regarding the cut off point for moving 
items to the next round, therefore, this decision was made because in most items there was 
relatively high agreement between panel members on most items, thereby indicating that items 
with a lower mean than three and a low level of agreement were unlikely to reach consensus.  
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Participants also used the additional comments areas to clarify items, amend the items and 
suggest new items for the Round 3 questionnaire (Okoli and Pawlowski, 2004). 
4.4.3 Round 3 
 The goal of the third round was to enable participants to consider their opinions in light 
of the group response in Round 2 (Chang et al., 2010, Rowe and Wright, 1999).  Therefore, the 
questionnaire was designed to include both the comments and the mean response from Round 
2.  Comments were not labelled so their author remained anonymous.  There was also an 
opportunity to rank each item again, and provide comments.   Mean scores from the previous 
round were provided, and were accompanied by their value label (e.g. agree or undecided) to 
provide meaning for participants as they had assigned a word in the previous round, not a value 
(Chang et al., 2010).  As in the previous round, a testing process occurred for the round 3 
questionnaire, where some concerns regarding formatting of the questions for the ease of 
understanding and responding were addressed. 
 This questionnaire was in similar format to that used in the previous round. Items that 
had been changed due to participant response in the previous round were labelled for 
participants.   As with the previous round, participants were asked to rate each item on a 5-
item Likert-type scale from 'strongly agree' to 'strongly disagree' and were provided with space 
to add additional comments on each item.   Unlike the previous round, they were not asked to 
add additional items at the end of each section, as this was thought to be the final round of the 
Delphi, due to the high degree of agreement in the previous round.  The scores for each item 
were entered into a SPSS database to calculate descriptive statistics as in the previous round.   
Consensus for each individual item was determined based on: 
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• Items having an agreement (agree or strongly agree) level of 70 percent or more 
(Powell, 2003); 
• Items having a median rating of 4 or above (Chang et al., 2010); 
• Range level of items, 2 or less was considered to indicate strong agreement, but items 
with a higher range were still considered to have consensus if the percentage of 
agreement and the median were high enough (Holey et al., 2007). 
While suggested by Holey (2007) that Kappa values be used to determine agreement between 
rounds, Kappa values were not used to determine consensus for individual items due to the 
inherent problems with this statistic.  After doing kappa calculations (both weighted and 
unweighted) on each item in the Delphi and consulting with a statistician, a fatal flaw in using 
this statistic was revealed.  With a low n (number of participants), which is inherent to the 
Delphi, perfect agreement within may result in a kappa of 0 when it should actually be 1.  The 
formula does not work when the sum of the expected values and the sum of the observed 
values are identical.  Therefore, the kappa statistic was not used to calculate agreement on 
individual items in the Delphi. 
4.4.4 Tool Development 
 Items that had gained consensus opinion in Round 3 of the Delphi were formatted into a 
tool to aid health professionals when having end-of-life discussions with patients who have 
NMRD.  While the author had an approximate idea about the type of tool needed to address 
the needs of health professionals in this area, the final format of the tool was informed by the 
round one interviews and the existing literature.  Figure 4.3 shows how the tool items were 
developed through each stage of the Delphi process and how the procedures of tool 
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development posited by DeVellis (1991) mirror the process of the sequential exploratory 
research design.  The tool was divided into three sections: how do you know a patient is ready 
to discuss, key considerations in a discussion and key topics to discuss.  Each section lists the 
items that reached a stable consensus in the Delphi study using the criteria set out by Holey 
(2007) in the Delphi study.  The tools developed in each Delphi are presented in Chapters 5 
and 6 in Figure 5.6 and Figure 6.6.   
4.5 Establishing clinical applicability of the tool 
The following sections explicate the tool endorsement procedure that was employed for 
the tools developed from the results of the Delphi studies conducted in Canada and the UK in 
order to establish clinical applicability of the tool. 
While the Delphi is intended for exploratory research and can provide valuable information, 
it is important that this information be corroborated for validity of the results (Kennedy, 2004).  
Often, the process of following up on Delphi findings is forgotten due to the limited description 
of the panel, the imprecise measures of consensus or high attrition (Bowles, 1999).  However, 
it is important to follow up with participants regarding the final consensus to determine 
applicability and credibility of the findings (Powell, 2003).  In this study, it was also important to 
establish face validity of the instrument that was created, in order to be able to prepare for 
further development as described in section 8.4.1.  Therefore, the final round of data collection 
was intended to establish the face validity of the tool, while also providing participants with an 
opportunity to view the results of the Delphi study and determine their applicability and 
credibility.   
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Participants were sent a questionnaire and asked to view a draft copy of the tool online.  
The questionnaire was conducted online with survey monkey, and the draft tool was created as 
a Google doc (docs.google.com) to enable access to those with permission.  Participants were 
asked to answer a short questionnaire about the tool, whether they agreed that it represented 
the views that they have provided in the Delphi study (Mead, 2001), and to determine whether 
the tool would be useful in clinical practice.   
 The questionnaire consisted of the following questions: 
 Does this tool accurately reflect end-of-life discussions in NMRD 
 How useful would the tool be in clinical practice? 
 As an experienced practitioner, would you use this tool in your clinical practice? 
 Do you think this tool would be useful to a clinician with little experience with end-of-
life discussions in non-malignant respiratory disease? 
 Would you recommend this tool to a clinician with little experience with end-of-life 
discussions in non-malignant respiratory disease? 
 How might you use this tool in your clinical practice? (open ended) 
 Is there anything that could be added or changed about this tool to make it more useful 
for clinical practice? (open ended). 
The results of this process are reported in Chapters 5 and 6. 
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4.6 Comparison of Delphi Studies 
 As outlined in the introduction chapter, one aim of this study is to delineate the 
differences in end-of-life discussions for patients with NMRD in order to provide insight into 
the process.  International comparisons in health care, and specifically end-of-life care, are not 
uncommon in the literature (Higginson, 2005, Janssen et al., 2011, Kirk et al., 2004).    
 There is great variation in the reasons for conducting international studies.  Some 
examples include to compare outcomes between countries, to test interventions with different 
populations, to recruit more patients, or to develop international consensus about the 
management of a condition.  Some international studies do not distinguish between findings 
from different countries, while others focus entirely on the comparison of these differences 
(Endacott et al., 2009). 
 There is a substantial body of literature indicating that comparison of practice across 
countries is an appropriate methodological approach.  Janssen et al (2011) compared quality of 
patient-clinician communication about end-of-life care, and facilitators and barriers to 
communication in the USA and the Netherlands. To do this they compared survey data from 
outpatients with COPD in each country.  Specifically they compared data from the Quality of 
Communication questionnaire and Barriers and Facilitators questionnaire.  Overall they found 
that the quality of communication in end-of-life care needed to be improved in both countries, 
and that future research should examine international differences, as well as patient specific 
facilitators and barriers to such communication.  Klinger et al. (2013) conducted an analysis of 
literature, policy documents and interviews with key informants to determine why many 
patients do not die at their preferred location in four countries: Canada, England, Germany, and 
the United States.  They conducted a case study in each country and then used the cross-
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country health policy analysis to make comparisons.  Barriers to caring for the terminally ill 
were legislative, regulatory, financial issues, and public perception of end-of-life care.  
Facilitators were standards of practice and guidelines, an aging population, stable funding for 
hospice and palliative care and advance care planning.  The authors concluded that the system 
level issues need to be addressed so that policy can be implemented as intended.  In an effort to 
promote cross-national learning and collaboration, Blendon et al. (2003) carried out a survey in 
Australia, Canada, New Zealand, the UK and the United States looking at the experiences of 
sicker adults.  The authors screened an initially random sample of adults to find non-
institutionalized sicker adults, then 750 or more qualifying individuals in each country 
participated in a telephone structured survey.  General findings were dissatisfaction in each 
country with the health care system, medical and medication errors, inadequate care 
coordination and poor patient-physician communication.  Kirk et al. (2004) conducted a 
qualitative study with patients receiving palliative care for cancer and their families in Australia 
and Canada, exploring information sharing during their illness.  They found the way that the 
communication process affects how patients and their families perceive information.  They also 
found six requirements for sensitive information sharing: "playing it straight, staying the course, 
giving time, showing you care, making it clear and pacing information' (p.3).  Junger et al. (2012) 
conducted an online Delphi study to understand palliative care delivery across Europe, with 
members of the European Association for Palliative Care.  The expert consensus allowed 
clarification of issues needing attention such as definitions for end-of-life care, and the 
recognition of cultural aspects of care need to be recognized.   
 Comparing findings between countries is not without challenge.  One issue mentioned 
by Bosch and Titus (2009) is the difficulty in comparing international datasets, when differences 
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in terminology and constructs need to be interpreted and may lead to bias. In addition, 
Endacott et al (2009) pointed out that factors specific to each country such as health care 
resources, epidemiology and culture should be highlighted during data comparisons.  
 Specifically, comparing the results of two Delphi studies is not common in the literature.  
To the author's knowledge, a comparison has only been carried out by Duffield (in 1993), and 
Kennedy (in 2000).  Comparing Delphi studies can add validity to their findings (Duffield, 1993), 
and can result in interesting discussion regarding the similarities and differences between 
countries. 
4.6.1 Method of international comparison 
 The process of examining differences in how health professionals know that patients 
with NMRD are ready or willing to discuss end-of-life was two-fold.  First, a narrative 
comparison of the epidemiology of non-malignant respiratory disease, health systems in Canada 
and the UK and end-of-life care policies in each country was undertaken in the introduction 
chapter to provide context.  Then, a comparison of the findings of the two Delphi studies 
conducted in Canada and the UK was carried out.  As mentioned previously, there are few 
models for the comparison of Delphi studies as only two appear to exist in the literature.  One 
is a PhD thesis by Kennedy (1999) and was not available at the time of writing.  Some details of 
the study were available in (Kennedy, 2000), however the full details of the comparison were 
not provided.  Briefly, Kennedy (1999) compared the results of a Delphi study with midwives to 
determine whether the consensus items were supported by the recipients of care. 
 Duffield (1993) provides an excellent model of how to compare Delphi studies.  She 
tabulated the means from the final round for each item, and then discussed similarities and 
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differences.  Then, items that were excluded by only one panel (12 items out of 168) were 
tabulated and discussed.  This process led to the validation of the 93 percent of the items.   
 However, the present study differed from previous comparisons of Delphi studies as 
rather than presenting a list of competencies to participants to be evaluated, qualitative 
interviews were used to collect data in the first round.  Therefore, there were likely to be 
many more differences between groups.  In addition, the researcher needed to match items 
between panels that conveyed the same concept, but were described using different language 
due to the use of in vivo coding.  Due to likely major differences between panels, the 
comparison will be narrative rather than statistical.  It was not thought to be valuable to 
compare the means of the consensus items, as they would all have similar means due to 
reaching the predetermined level of consensus as discussed in 4.3.1.  Therefore, the process of 
comparison of Delphi studies was as follows.  Consensus items from each Delphi were matched 
like for like and listed in a table and divided by category as in the Delphi studies. The wording 
from each panel for each item was included to provide maximum transparency.  Items that 
were not matched with a like item from the other panel were tabulated.  Items that were 
excluded by one or both panels throughout the Delphi process were listed in a table. 
As the reason for the comparison was to provide insight into the practices in each 
country, the interesting similarities and differences between the panels’ findings will be 
considered during the development of the theoretical model in Chapter 7. 
4.7 Establishing rigour 
 In mixed methods research, rigour is established by determining the trustworthiness of 
qualitative and quantitative data interpretations (Johnson and Onwuegbuzie, 2004, Creswell and 
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Plano Clark, 2007a).  In a sequential exploratory design, the development and testing of a new 
instrument leads to more meaningful results for the entire study (Creswell and Plano Clark, 
2007a).  In the following two sections, the process of determining trustworthiness of qualitative 
data, and determining the validity and reliability of the quantitative data will be discussed. While 
the Delphi is believed to be inherently valid (Kennedy, 2004), the rigour of both qualitative and 
quantitative methods will be discussed.  Finally, the rigour of the comparison of UK/Canadian 
data will be discussed. 
4.7.1 Establishing trustworthiness and dependability in qualitative research 
 In qualitative research, it is important to assess trustworthiness - whether the data 
collected accurately represents the participants' experiences (Lincoln and Guba, 1985).  Two 
methods of establishing trustworthiness in qualitative research are inherent in the Delphi - 
member checking and triangulation.  Member checking, where the findings are shown to 
participants to check whether they are an accurate representation of their experiences 
(Creswell, 1998), is achieved as qualitative data collected in the first round is developed into an 
instrument that is then viewed by the same participants.  In addition, triangulation of data from 
several participants through the development of consensus demonstrates trustworthiness of 
the data that has been collected (Creswell, 1998).   
 The maximum variation sampling strategy used to recruit participants for the qualitative 
phase of the Delphi also helped to establish the trustworthiness of the study by resulting in a 
sample that was both geographically diverse and varied in experience. The sampling strategy is 
described in section 4.8.1. 
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 In addition, the use of the Delphi, meant that participants were able to share their 
experiences and expertise in an anonymous environment, where they were able to express 
their opinions without the influence of other group members who could be potentially 
dominating, as described in section 4.8.1. 
4.7.2 Establishing validity and reliability 
 Validation is built into the mixed methods sequential exploratory design for instrument 
development as qualitative responses are given back to participants in quantitative form to 
reconsider, thereby enhancing the accuracy of the data (Creswell, 2003).  Meanwhile, the 
Delphi is inherently valid as the contents of the study are dictated by the expert panellists. The 
use of participants who have knowledge and an interest in the topic will help to ensure the 
content validity of the Delphi, and the use of successive rounds of the questionnaire helps to 
establish face validity (Goodman, 1987, Beech, 2001, Sharkey and Sharples, 2001).  Decisions to 
include items in the final consensus opinion are strengthened by reasoned argument in which 
assumptions are challenged, thus helping to enhance validity of the method (Hasson et al., 2000). 
 An early study was conducted on the Delphi at RAND to compare the Delphi process 
to another group making decisions without feedback in between.  The authors found that it was 
the reconsideration of the questions between rounds in both groups fostered convergence 
over time.  In addition, a sharper consensus was obtained by the Delphi group, and that their 
process was more efficient, however the accuracy of the judgement was no different with the 
control group (Brown, 1968).   
 There is no evidence of reliability of the Delphi, as it is impossible to determine whether 
two groups of experts would develop the exact same results.  However, the reliability of the 
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instrument produced by using the Delphi may be determined using Cronbach's Alpha for 
internal consistency if the sample size is large enough (Nunnally and Bernstein, 1994, p. 228).  
This process was undertaken and the results are presented in chapters 5 and 6. 
 Holey et al. (2007) recommend the use of the mean and standard deviation statistics for 
each item, combined with the range and median descriptive statistics to demonstrate whether 
convergence has occurred.  As was discussed in section 4.4.3.  It is mentioned here as it is 
believed that the use of these simple statistics can demonstrate maximum stability and reduce 
subjectivity.  
 The process of comparing the UK and Canadian Delphi panel results may help to 
establish validity in this study.  As mentioned previously, authors of two known studies have 
compared results of two Delphi panels.  In the first, Duffield (1993) used a validation study to 
compare the findings of two Delphi panels.  There was 93 percent agreement between the 
panels, suggesting the validity of the first panel's findings.  Authors of the second comparison 
study looked at codes from a narrative phase and the Delphi phase of the study and found 
congruence between the two (Kennedy, 2000).  These findings suggest not only that 
congruence may be found between the UK and Canadian panels in the present research, but 
also that the Delphi produces valid results.   
4.8 Study Participants 
The following section outlines how study participants were selected to take part in both the 
Canadian and UK Delphi studies.  First, the sample design is described, then the concept of 
expert, which is central to the Delphi, is discussed, next the recruitment procedures are 
outlined and finally the number of participants is examined. 
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4.8.1 Sample design 
 In order to best address the research question, decisions were made about which 
individuals could provide the best information.  In qualitative research individuals are 
purposefully selected based on their ability to provide the best information, whereas, in 
quantitative research, where generalisability of results is paramount, individuals are chosen in 
order to best represent the population being studied.  As the first stage of this mixed methods 
study was qualitative, the qualitative approach to sampling was taken here.  Two types of 
purposive sampling have been employed in this study: maximum variation and criterion. The 
issues related to this approach are discussed in the sections that follow. 
 Maximum variation sampling is ideal in a qualitative study as it enables the researcher to 
gain the views of a range of participants and identify cases that can provide meaningful 
information, thereby gaining rich data from a small number of cases (Patton, 1990, Patton, 2005, 
Corbin and Strauss, 1990).  As discussed previously, using a panel of experts ensures high 
content, face-to-face and concurrent validity (Sharkey and Sharples, 2001, Beech, 2001).   
 The concept of expert is central to the Delphi, as selecting experts in the field of inquiry 
rather than a random sample of individuals will result in significantly better and considerably 
different responses than those of non-experts (Goodman, 1987).  The expert in a Delphi study 
can be defined in various ways, such as knowledge defined by professional qualification or 
registration as a certain group or by a predefined number of years of experience (Baker et al., 
2006).  Therefore, the expert groups often consist of informed individuals who are specialists in 
their field or people with knowledge on a particular subject (Keeney et al., 2001).  Keeney 
(2001) stated that the commitment of participants to participating in the Delphi study is directly 
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related to their interest in the research question.  Those who are willing to discuss the issue 
are likely to be affected by the results of the study.  
 As discussed previously, one of the key features of Delphi is iteration, and participants 
must be questioned several times about the same topic.  Therefore, it is important that 
participants are able to maintain involvement throughout the study.  Attrition is a known 
problem with Delphi studies, and it may contribute to sample bias (Polit and Hungler, 1999, 
Bowles, 1999).  As the purpose of the quantitative stage is to validate the qualitative data, it is 
inherent in the Delphi that participants are involved in all phases of the data collection.  As with 
any multi-phase study, some participant drop out is to be expected (Beech, 2001).   
 Keeney (2001) stated that decisions about the size of the sample as well as 
heterogeneity in Delphi studies should be made, based on the purpose of the project, the 
research design and the time frame.  The primary assumption of the Delphi is that the sum of 
information that comes from a group is as great or but usually greater than the sum of 
potentially useful information from one individual (Crisp et al., 1997).   It is stated in the 
literature that there is little empirical evidence that the number of participants in a Delphi study 
affects the reliability or validity of the process (Murphy et al., 1998, Rowe and Wright, 1999); 
representativeness of the group is more important than size (Powell, 2003).  However, other 
authors do state limits on participant numbers.  Baker (2006) stated that Delphi studies should 
have no more than 20 participants, and as the sample size is not based on a statistical calculation, 
and previous studies using the Delphi in healthcare used as few as 12-15 respondents (Downar 
& Hawryluck, 2010; Fiander & Burns, 1998).   
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Members of different disciplines are rarely included on one Delphi panel, and therefore 
the range of professionals included in the Canadian Delphi, and the comparison between the 
Canadian and UK studies is unique (Baker et al., 2006). 
Round 1 sampling method 
The first round of the Delphi was conducted using telephone interviews.  For this round 
only a maximum variation sampling strategy was used to select participants who had already 
been recruited to participate in the first round.  A lack of representativeness in qualitative 
research can threaten validity, and therefore the maximum variation sampling strategy is 
important for the integrity of the study (Morse, 1991).  It was anticipated that approximately 8-
15 people would participate in the first round, until data saturation had been reached.  This 
strategy was used to ensure that issues from the spectrum of experience that respiratory 
health professionals have were captured in the study.  This sample of participants also 
participated in subsequent rounds of data collection. Of eleven participants who consented to 
the Delphi before round 1 began, nine were selected to be interviewed for the first round.  
Selection was based on their geographic location and work setting to achieve a maximum 
variation sample (Patton, 2005). 
Round 2-4 sampling method 
The purposive sampling method, specifically criterion sampling, has influenced the choice 
of experts.  British Lung Foundation nurses were chosen to participate (see inclusion criteria 
below) based on their experience with the research problem being explored as well as their 
geographic location (Creswell and Plano Clark, 2007a, Keeney et al., 2006).   
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Inclusion and exclusion criteria 
In the past, Delphi panels have been criticised as the health care 'experts' are not close 
enough to the realities of clinical practice to provide useful feedback (Baker et al., 2006).  The 
members of both Delphi panels were all currently in clinical practice with the patient group that 
we wished to study.  Meier (2010) stated that nurses are well suited to participate in end-of-life 
care research as they see the patient 'even when other health professionals have disappeared'.  
The inclusion and exclusion criteria for members of both the UK and Canadian Delphi studies 
are below. 
Inclusion and exclusion criteria in the UK Delphi 
Individuals were included if they were Specialist Respiratory Nurses working in the NHS, 
whose posts were funded in part or in whole by the British Lung Foundation (BLF). A badged 
nurse is an existing respiratory nurse specialist and the main benefit badging offers to nurses 
and their Primary Care Trust (PCT) is the opportunity to work in partnership with a voluntary 
organisation.  The contracts signed with PCTs for badged nurses are generally for 3 years with 
an option to extend, and commit the BLF to the provision of study days, uniforms and the 
other benefits.  In order to achieve BLF status for their role, these nurses had to demonstrate a 
level of expertise in respiratory nursing, hence this was considered a useful proxy for expertise 
in this Delphi study.  Specialist respiratory nurses who were not employed by the BLF were not 
eligible to participate in the study. 
Inclusion and exclusion criteria in the Canadian Delphi 
 Individuals were included if they were members of the professional arm of the Canadian 
Lung Association - the Canadian Respiratory Health Professionals (CRHP).  The CRHP group 
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aims to engage health care professionals and provide national leadership to achieve the 
promotion of lung health, prevention of lung disease and the management of lung disease (2013). 
 Members of the CRHP must be members in good standing of a recognised clinically 
based discipline (e.g. nurses, physiotherapists, respiratory therapists, pharmacists, dieticians, 
occupational therapists, social workers) and have a primary role in education, patient care, 
research or management in respiratory care.  They must be a Canadian citizen or a landed 
immigrant and have an interest in the prevention, management, treatment, research or 
surveillance of respiratory disease.  Registration with this group was considered to be a proxy 
for expertise discussing end-of-life and was therefore sufficient for inclusion in the Delphi panel.  
Unlike the UK, where specialist respiratory nurses do the majority of work with respiratory 
patients, in Canada, respiratory care is provided by a wide range of professionals working 
together, often in multi-disciplinary teams (Canadian Lung Association, 2008).  Respiratory health 
professionals who were not members of CRHP were not eligible to participate. 
4.8.2 Limitations of the sampling strategy 
 While it is important to involve service users in research, including them in a Delphi 
study alongside professionals can be difficult as they may not feel credible within this group 
(Baker et al., 2006).  As one of the aims of the study was to establish how health professionals 
know a patient with NMRD is ready or willing to discuss end-of-life, the opinions of service 
users were not featured in this study.  A separate study to look at ready or willingness to 
discuss end-of-life from the perspective of patients and carers could be designed to follow this 
study. 
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4.9 Recruitment procedures 
 In this section the process of recruiting participants for both the UK and Canadian 
Delphi studies is presented, together with some limitations of the recruitment process. 
4.9.1 Recruitment of participants in the UK 
 In order to gain access to participants, the BLF granted access to their population of 
nurses to approach for recruitment into the study.  Approximately 40-50 people were provided 
with information about the study.  Recruitment took place via the BLF staff email 
communication system and the staff website.  Personal information was not collected at this 
time. It was estimated that approximately 40 people would volunteer to participate.  However, 
it was considered that if a lower number consented to take part, it would not affect the results 
of the study. 
Potential participants were informed by reading the study information sheet that they 
might be asked to be interviewed for the first round of data collection before the online survey 
component began, and that if they wished to participate they could still decline to be 
interviewed.  To prevent attrition in Delphi studies, it is important for the researcher to clearly 
outline what is involved in each stage of the Delphi (Mead, 2001).  The initial recruitment phase 
took place from September to November 2010, and a total of 11 nurses indicated interest in 
participating.  Recruitment was conducted by sending study information to the nurse manager, 
who sent it out to all of the BLF Nurses via email.  The researcher also attended the BLF nurse 
study day to recruit participants in person and an additional eight participants joined.  In total, 
19 participants completed the consent process; nine agreed to be interviewed and eleven 
agreed to complete the online questionnaires. 
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4.9.2 Recruitment of Participants in Canada 
Potential participants received information about the study from the monthly e-
newsletter sent out to members of the Canadian Respiratory Health Professionals group.  The 
newsletter included a link for interested parties to provide contact information to the 
researcher.  Once contact information was received from a potential participant, an email 
including an attached information sheet and link to the online consent form was sent.  The initial 
period of recruitment took place from August to October 2011, and 19 people requested 
further information about the study.  In total, 14 participants consented, and 11 were selected to 
be interviewed based on their geographic location, professional designation and work setting to 
achieve a maximum variation sample (Patton, 2005). 
4.9.3 Limitations of the recruitment procedure 
 As participants were recruited through their professional associations and not directly 
by the researcher, non-participants were not followed up, as the researcher did not have access 
to their contact information.  Participants that initially expressed interest by filling out the 
interest form for the study were contacted several times regarding participation.  The 
researcher stopped attempting to contact them after three emails. 
4.10 Ethical Issues 
This section includes a discussion of ethical principles in research and information about 
ethical approval of both Delphi studies.  This is followed by descriptions of the relevant ethical 
principles of confidentiality and anonymity, informed consent and the risks, burdens and benefits 
of participating in research and how they were addressed in this study. 
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4.10.1 Ethical principles in research 
 The conduct in this study was guided by the guidelines for ethical conduct in research 
set out by the National Health Service Health Research Authority.  Ethical approval of both UK 
and Canadian Delphi studies was received from the Plymouth University Faculty of Health 
Ethics Committee and the UK Delphi study was approved by the National Research Ethics 
Service South West 4 Research Ethics Committee (REC reference: 10/H0102/11) in 2010 
(letters of approval are presented in Appendix B).  In Canada, the chair of the research 
committee of the CRHP agreed that the approval of the Plymouth University Faculty of Health 
Ethics Committee was sufficient to conduct the Canadian Delphi study.  Therefore, further 
ethical approval was not sought from a Canadian institution. 
 The ethical issues that were relevant to the conduct of this study were confidentiality 
and anonymity, informed consent, and the risks, burdens and benefits to participants. These 
issues will be addressed below. 
Confidentiality/anonymity 
 The Caldicott Principles were followed to ensure the maximum level of confidentiality 
(Department of Health, 1997).  True anonymity is ensured when no one can link a response to a 
respondent.  Due to the iterative process inherent in the Delphi technique, true anonymity 
could not be achieved.  While an individual's responses were not identifiable to other 
participants, they were known to the researcher (Keeney et al., 2006).  This has been termed 
'quasi--anonymity' (McKenna, 1994). 
 Personal (job, experience, and qualification information) information was only used to 
determine whether the person met the inclusion criteria and could participate in the study.  
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Access to this identifiable information was restricted to the researcher and her supervisory 
team.  The respondent names were disassociated from their responses during the coding and 
recording process.  As an additional precaution, data transmitted from participants via survey 
monkey was done over a secure website and encrypted using SSL, 128 bit encryption 
technology, thereby minimising the risk of submitting personal information over the internet.  
Direct quotations from respondents from Delphi Round 1 were published in this thesis, 
however any identifiable information has been removed.  Data from the online survey were 
printed and will be kept in paper form along with printed copies of the electronic consent forms 
for seven years in a locked cabinet in the director of studies' office, in adherence with the 
Plymouth University data protection policy. 
Informed consent 
 Potential participants were provided with a written information sheet (prepared 
according to guidelines outlined by the National Research Ethics Service (UK)) prior to 
consenting to the study.  As the recruitment process was executed electronically, this 
information sheet was provided as an attachment to an email.  Participants were also invited to 
visit the study website, where they were invited to contact the researcher to discuss 
participation.   
 When participants stated that they would like to participate, they were directed to the 
survey website, where consent was taken electronically, following the guidelines for taking 
informed consent from adult participants.  All potential participants were provided with an 
electronic information sheet and were given a minimum of 24 hours to consider participation 
prior to electronic consent being sought.  In addition, paper copies the information sheet and 
the consent forms were made available upon request.   
 121 
 
 When respondents agreed to participate, they were informed of exactly what they 
would be asked to do, using written information that accompanied each online questionnaire. 
Hasson, Keeney and McKenna (2000) recommend that participants have an understanding of the 
aims of the study as well as the process, in order to build a research relationship which may be 
helpful in maintaining participation throughout the Delphi. Therefore, this information 
accompanied each round of the online questionnaire. 
Risks, burdens and benefits 
 Each participant received a series of three surveys to complete online over a period of 
approximately six months.  As described above, the responses were confidential and anonymous 
to other participants, but the respondent's identity was known to the researcher.  Due to the 
iterative nature of the Delphi process, participants were not able to withdraw their data from 
the study after it was submitted online.  
 Respondents were informed that they might find aspects of the interview and surveys to 
be distressing due to the sensitive nature of end-of-life discussions with patients.  To minimise 
this risk, respondents were informed of the sensitive nature of the topic in the patient 
information sheet.  Furthermore, they were informed that contact details of local support 
services were available to them, should they request it at any time during the study. 
Specialist respiratory nurses are busy health professionals and therefore to minimise 
interference with their professional and private lives, the online format of the survey allowed 
them to complete it at a convenient time. 
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 In addition, checking the accuracy of the data or member checking is inherent in the 
iterative design of the Delphi.  As part of the Delphi, data were analysed and sent back to 
participants to ensure that their views were accurately represented and interpreted. 
Potential benefits to taking part included the opportunity to anonymously share thoughts 
with colleagues about end-of-life discussions.  In addition, respondents may have come to have a 
better understanding of the Delphi process, which may later inform their own research work. 
4.11 Conclusions 
 The research design and methods considered in this chapter demonstrate that the 
sequential exploratory mixed methods design for instrument development was most 
appropriate given the lack of literature on the topic (established in the systematic reviews in 
Chapters 2 and 3), to address how health professionals know a patient is ready or willing to 
discuss end-of-life, and to establish a tool to aid them in this discussion.  This research design 
employed the Delphi, which was justified after a critique of alternate consensus methods was 
presented.   Finally, a method used to compare the UK and Canadian Delphi studies was 
discussed.  
 The findings of the Delphi studies conducted in the UK and Canada will be presented in 
chapters five and six.  These chapters will include the tool that resulted from each Delphi 
process.  The UK and Canadian Delphi studies will then be compared in chapter seven. 
The narrative comparison of Delphi results from the UK and Canada can be found in 
Chapter 7.  The findings from each stage of the research discussed here will be developed into a 
model of end-of-life discussions in NMRD, which will be presented in section 8.2.1. 
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Chapter 5. A modified Delphi study with specialist respiratory nurses in the UK 
5.1 Introduction 
The objectives of this phase of the study were to use the Delphi to establish how health 
professionals in the UK know a patient with NMRD is ready or willing to discuss end-of-life and 
the key considerations and topics for such discussions.  This is in line with objectives one and 
two of the doctoral study as listed in 1.5.  The findings of this Delphi study address the first aim 
of the study (to determine how health professionals discuss end-of-life with patients with 
NMRD) and facilitate the achievement of the second aim (to develop an instrument allowing 
health professionals to determine constraints and opportunities within the environment to 
facilitate successful end-of-life discussions with this patient group).   
As described in Chapter 4, this Delphi study consisted of one round of qualitative 
interviews, and three rounds of online questionnaires, and was a ‘mixed methods’ study 
(Bowles, 1999).  A summary of this process can be found in Figure 5.1.  The study was designed 
to answer three questions as per the objectives of the doctoral study (section 1.4): 1) How do 
health professionals know a patient is ready or willing to discuss end-of-life?; 2) What are the 
key considerations in end-of-life discussions with patients with NMRD?;  3) What are the topic 
areas that need to be addressed in such discussions? 
In line with the MRC guidelines for the development of a complex intervention (1.6), the 
Delphi process resulted in the development of a tool for use by health care professionals in 
end-of-life discussions for patients with NMRD. The tool summarises the findings of each of the 
three questions that the study was designed to answer, and once the tool was developed, a 
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fourth and final questionnaire went to participants to ascertain its usefulness and applicability 
(Mead and Moseley, 2001). 
A description of the recruitment procedures and the participants is included in 5.2.  Next, 
in the findings for each round of the Delphi, as well as a discussion of how this process resulted 
in the development of the tool described above are presented.  Finally, conclusions are made in 
5.9.  A discussion of how the results of this Delphi study contributed to the development of 
theory and modelling of the process of end-of-life discussions in NMRD can be found in 
Chapter 7. 
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Figure 5.1 UK Delphi overview diagram. 
 
Round 1 
•Experts: Specialist 
respiratory nurses (n 
= 9) 
•Aim: Gather 
qualitative data for 
research questions 
to inform further 
rounds 
•Results: Thematic 
analysis of interview 
transcripts lead to 
items for the 
questionnaire (Braun 
& Clarke, 2006) 
•Outcome: 
Quantitative itemised 
questionnaire 
requesting rating and 
comments for each 
item 
Round 2 
•Experts: Specialist 
respiratory nurses (n 
= 19) 
•Aim: Obtain 
quantitative 
agreement data for 
each item 
•Results: Median, 
range and level of 
agreement for each 
item 
•Outcome: 
Quantitative 
itemised 
questionnaire 
showing mean and 
comments for each 
item 
Round 3 
•Experts: Specialist 
respiratory nurses (n 
= 14) 
•Aim: Obtain 
quantitative 
agreement data in 
light of group opinion 
from previous round 
•Results: 
Established 
statistical consensus 
and stability for 
items 
•Outcome: Draft of 
tool for health 
professionals 
Clinical 
Applicability Round 
•Experts: Specialist 
respiratory nurses 
(n = 15) 
•Aim: Determine 
whether the tool 
represents the 
results of the Delphi 
accurately and is 
applicable in clinical 
practice 
•Results: Qualitative 
and quantitative 
data showing 
approval of tool by 
Delphi participants 
•Outcome: Ideas for 
use of tool and 
suggestions for 
improvement 
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5.2 Recruitment and participants 
The purposive sample for this Delphi study consisted of Specialist Respiratory Nurses 
working in the NHS, whose posts were funded in part or in whole by the British Lung 
Foundation (BLF). In order to achieve BLF status for their role, these nurses have to 
demonstrate a level of expertise in respiratory nursing; hence this was considered a useful 
proxy for expertise in this Delphi study (section 4.8).    
Nineteen of a possible forty-five nurses participated in the study, achieving a response 
rate of 42 percent.  The BLF nurse manager considered this a low response rate caused by 
uncertain conditions in the NHS, mainly job insecurity and understaffing (Jackson 2010).  
However, the validity of the study was not affected as the number (n=19) is within the ideal 
number of Delphi participants (Bowles, 1999, Okoli and Pawlowski, 2004, Baker et al., 2006).  
This issue is addressed in detail in section 4.3.1 and Figure 5.2 shows the number of participants 
for each round of the Delphi. 
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Figure 5.2 UK Delphi participants by round 
 
The initial recruitment phase took place from September to November 2010, and a 
total of 11 nurses indicated interest in participating. Recruitment was conducted by sending 
study information to the nurse manager, who sent it to all BLF Nurses via email.  The 
researcher also attended the BLF nurse study day, to recruit participants in person where an 
additional eight participants joined.  In total, 19 participants completed the consent process, and 
nine of these people agreed to be interviewed, the remaining 10 consented participants agreed 
only to complete the online questionnaires.  
Of 11 participants who consented to the Delphi before Round 1 began, only nine were 
selected to be interviewed for the first round: selection for interview was based on their 
geographic location and work setting to achieve a maximum variation sample (Patton, 2005), as 
described in section 4.8.1.  Demographic details of the participants are provided in Table 5.1.   
In the first round of semi-structured interviews, data saturation was reached after nine 
interviews. Participants who were interviewed for Round 1 (n=9) had a similar demographic 
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profile to the whole Delphi participant panel (n=19) as shown in Table 5.1. In the following 
sections, quotes from participants have been anonymised, and assigned a code denoting the 
country of origin (UK) and a participant number. 
Table 5.1 UK Delphi participant demographic information. 
  Round 1 Rounds 2-4 
  N % N % 
Sex (f) 9 
 
19 
 
UK Region   
   
East Midlands 1 11 1 5 
London 1 11 4 21 
North East 1 11 1 5 
North West 2 22 3 16 
Scotland 2 22 2 11 
South East   
 
1 5 
South West 1 11 3 16 
Wales 1 11 1 5 
Yorkshire 
  
3 16 
Education   
   
Diploma 2 22 5 26 
Bachelor’s 5 55 9 47 
Master’s 
  
1 5 
Unknown 2 22 4 21 
Age 
    
30-39 2 22 5 26 
40-49 6 66 12 63 
50-59 1 11 1 5 
60-65 
  
1 5 
Professional Designation    
   
RGN  9 100 19 100 
Professional Role (all that apply)   
   
Practitioner 8 88 18 95 
Manager 2 22 3 16 
Educator 
  
1 5 
Work Setting    
   
Community 6 66 13 68 
Primary Care Trust 3 33 6 32 
Years in respiratory health 
    
1-3 2 11 3 17 
4-10 2 11 2 11 
11-15 2 11 3 17 
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  Round 1 Rounds 2-4 
16-19 
  
2 11 
20+ 5 44 8 44 
5.3 Round 1 Findings 
Thematic analysis of the interview data was guided by the three questions: 1) How do 
health professionals know a patient is ready or willing to discuss end-of-life?; 2) What are the 
key considerations in end-of-life discussions in NMRD?;  3) What are the topic areas that need 
to be addressed in such discussions in line with the objectives of the doctoral study (section 
1.5).  Specifically, seven items were generated for Question 1, 36 items for Question 2, and 28 
items for Question 3.  Unlike a typical thematic analysis where only items that were mentioned 
by more than one participant would be included in the findings (Braun and Clarke, 2006), in this 
study, all items that were mentioned in the interviews, even by only one participant, were 
included for consideration by participants in Round 2, and will be described below.  Each of the 
three research questions was a question for the Round 2 survey. 
5.3.1 Question 1: How participants knew a patient was ready to discuss end-of-life 
Participants were asked directly how they knew a patient was ready or willing to discuss 
end-of-life.  This question was met with a variety of responses, which were grouped into five 
themes:  
 Intuition of nurses 
 Body language and patient demeanour 
 Clinical indicators 
 Verbal cues from the patient 
 Response when health professional alludes to end-of-life topic. 
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Intuition of nurses 
Six participants mentioned their use of intuition when negotiating end-of-life discussions.  
However the word 'intuition' was not always used to describe this phenomenon; it was 
sometimes referred to as  ‘just knowing' that the patient was ready to have the discussion; for 
example, one participant said:  
'there are numbers of patients that I know want to talk, intuition tells me' (UK8).   
In other cases, participants used cues coming directly from their patients to determine 
readiness to discuss.   
Body language and patient demeanour 
The body language of the patient was used by participants to determine whether to 
broach an end-of-life discussion:  
'Some people… just looking… withdraw into their self, or other times … their body language is 
quite open.' (UK5).   
Another participant linked body language and the demeanour of the patient to gauge whether 
or not a patient was ready to discuss:   
'I know by the language they use, by their body language, by their general demeanour.  You just 
know.  You just know whether that’s a conversation that needs to go further or whether they 
don’t want to go any further with it at that moment, and sometimes they do.  Sometimes, 
people start a discussion about end of life and then realise they can’t go any further.  So it’s 
picking up the cues, picking up and listening to what they say and respecting… and I mean it’s 
experience I think.  Good communication.' (UK8). 
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Clinical indicators 
One participant outlined in detail the clinical indicators that she and her colleagues used 
to determine when a patient had reached a stage in their illness when such discussions were 
appropriate:  
'Well, obviously they’ve got to be on… we have some clinical indicators that we use....So, poor 
prognostic factors.  So, through spirometry they’ve got severe COPD, that they’ve had above 
three acute exacerbations in the last 12 months, that they have possibly respiratory failure 
or...that they’re on maximum inhaled therapy, whether it be inhaler or nebulised therapy, where 
they’ve got a presence of any co-morbidities, especially obviously heart failure.  They’ve been 
reviewed by a consultant and all surgical options have been explored and you know the most 
crucial question, would you be surprised if they passed away in the last… in the next 6 to 12 
months.'(UK7) 
The use of these indicators was mentioned by eight participants to explain how they knew from 
a clinical perspective that a patient was ready to discuss end-of-life. 
Verbal cues from the patient 
Some participants stated that they only knew patients were ready to discuss the end-of-
life topic when patients themselves initiated the discussion; specifically, by asking 'am I going to 
die?’.   
Patient is responsive when the health professional alludes to end-of-life topic 
Some participants indirectly prompted the end-of-life discussion; for example,  
‘…quite often it can be prompted, particularly if they’ve had an episode into the hospital and 
they’ve maybe had some treatment that they’ve maybe not liked.' (UK9).  
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These indicators can be divided into two groups: indicators that the patient is ready to discuss 
end-of-life, and indicators that the patient is willing to discuss end-of-life.   
Readiness to discuss end-of-life 
 Intuition of nurses 
 Patient is responsive when HP alludes to the end-of-life topic 
 Clinical indicators 
 Body language and general demeanour 
Willingness to discuss end-of-life: 
 Verbal cues from the patient 
The distinction between cues indicating readiness and cues indicating willingness was 
unexpected as the wording of the question was not meant to indicate two separate concepts.  
However, this is potentially important to the development of theory as part of the tool 
development process, and as such is discussed in detail in section 8.2.2. 
The above themes were transformed into items for the round 2 survey.  Participants were 
asked ‘Which of the following factors indicate that a patient is ready or willing to discuss end-
of-life?’ to ensure that both paths toward end-of-life communication were considered.  They 
were given the following options: 
 Clinical signs 
 Professional intuition 
 Cues from the patient such as stating ‘I do not want to go back to hospital’ 
 Questions from the patient such as asking if s/he is going to die 
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 Body language 
 General patient demeanour 
Patient is responsive when health-care professional alludes to the end-of-life topic. 
5.3.2 Question 2: Key considerations in end-of-life discussions 
Participants stated 36 unique items that were categorised into five themes: the patient, 
the environment, the family, the health professional and timing.  These themes and the 
considerations within each are presented in Figure 5.3. 
  
 134 
 
Figure 5.3 Themes and categories of key considerations in end-of-life discussions. 
 
As there are many items in these themes, examples are presented in Figure 5.4  below.   
Further data are presented in Appendix C.   Further clarification or explanation of items was 
sought using comments in further rounds.   
  
 135 
 
Figure 5.4 Key considerations when discussing end-of-life: samples from Round 1 of the UK Delphi 
 
• …not just talking to the patient but get… make it a two way conversation 
and just take guidance from the patient, don’t dictate, feel from them. 
(UK7) 
Allowing the patient to 
lead the conversation 
• …everybody’s individual you deal with it you know as you think your 
relationship with that patient… I don’t know quite what the words are, 
to… each individual will do it slightly differently, or will want something 
slightly different, so you pick and run with it as it’s presented to you. 
(UK10) 
Recognising the 
individual needs of the 
patient 
• The patient being ready, the patient indicating that they want to have this 
discussion, is the most important.  (UK8) 
Patient indicates 
readiness to discuss 
• …people will talk about it.  People can be very open about dying… 
(UK10) 
Patient being open 
about dying 
• I think the joy I have from going to people’s homes is, there’s more time.  
There’s less interruptions, people feel safer because they’re in their own 
environment and that’s one thing you do notice when you actually work 
in the community compared to a hospital, is that you are being invited 
into their home and therefore you know, that’s one thing they are 
leading the whole consultation because it’s in their environment, and so 
it’s definitely a different dynamic when you visit somebody in a home 
(UK11) 
Where the discussion 
occurs 
• I think as well sometimes, that once they acknowledge it, again if there’s a 
family member there, they might be thinking it, but they don’t want the 
carer or the wife or whoever, to know that that’s how they’re thinking, 
because it’s a kind of helplessness and the loss of hope (UK9) 
Patient's wish to protect 
others from end-of-life 
information 
• We’ve been in their homes, we know their families, you know we’ve 
looked at the pictures on the wall.  It’s all about building relationships and 
they trust you to look after them, and actually talking about it with us is 
probably easier than talking about it with anybody else (UK10) 
Having a strong 
relationship with the 
patient 
•…we then see them again through a nastier exacerbation and things 
and sometimes again they bounce back and but the disease 
trajectory with COPD compared to cancer, it’s so very different, 
and can be so much longer, and so you do go on that journey with 
them for many, many years, but you are the professional at the end 
of the day, and for your own sanity I suppose, for want of a better 
word, it’s that you have to ensure that you protect yourself. (UK11) 
Your professional 
boundaries 
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5.3.3 Questions 3: Key content of discussion 
Participants suggested 28 unique items that were grouped into this category and three 
sub themes emerged - hospice, perceptions of death and practical needs.  Again, a sample of 
these items is presented in Figure 5.5 below. Examples from all categories and sub categories 
can be found in Appendix D. 
Figure 5.5 Key content when discussing end-of-life: samples from Round 1 of the UK Delphi. 
 
• It’s the National Council of Palliative Care, and it’s called Planning for Your Future 
Care, A Guide, and it goes through what is advanced care planning, the aspects of 
it, having open conversations, exploring all your options, about refusing treatments, 
lasting power of attorney, that’s all I think it goes through. (UK3) 
Introduction of an 
advanced care 
planning document 
• …if things deteriorate again and you don’t want to go into hospital, what would 
you like to happen (UK5) 
The type of care the 
patient wants 
• You know, they tell you that they’re feeling fine when you can see the relatives sat 
next to them sort of shaking their head and disagreeing with what they’re saying 
and it’s just slowly you’ve got to just explain to them and explain to them as well, 
that because they’re going on the palliative care case load doesn’t mean to say that 
they’re dying now (UK3) 
Explaining palliative 
care 
• But one of the big issues for us really is about the ceiling of treatment...this is a 
difficult one really, as you’re wanting to know whether, if it gets to that stage, 
whether they want to take advantage of having non-invasive vent or they just want 
to pass away peacefully. (UK8) 
Ceiling of treatment 
• …have they got any goals, anything that... in other... anything they would like to do 
or achieve or see or fulfill.  You know, other things that they still want to do, 
because although we’re talking end of life, we are still talking... it’s still their life, 
there’s still got to be some quality in it, what do they want and what do they not 
want.  (UK9) 
Patient goals 
•...spiritually I would say is more to me about their overall 
wellbeing, and how they are actually dealing with things.  Are 
they dealing with it, or do they need further assistance to deal 
with that, and is there somebody they need to speak to. (UK5) 
Spirituality 
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5.4 Round 2 Findings 
In general, there was a high level of agreement (more than 70 percent of participants 
rating the item ‘agree’ or ‘strongly agree’ (Downar and Hawryluck, 2010) on many of the items 
in Round 2: 71 percent of items in Question 1, 83 percent of items in Question 2 and 86 
percent of items in Question 3.  In Round 2, space for comments on individual items and at the 
end of each section were well utilised by participants.  Table 5.2 reports the median, range and 
level of agreement for each item in rounds 2 and 3, and Table 5.3 provides a sample of 
comments from rounds 2 and 3. 
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Table 5.2 Quantitative results from Rounds 2 and 3 of the UK Delphi. 
  Round 2 Round 3 
Delphi Item Median Range 
Level of 
agreement 
(%) 
Median Range 
Level of 
agreement 
(%) 
How do health professionals know a patient is ready or willing to 
discuss end-of-life? 
            
Clinical signs 2 4 32 2.5 3 35 
My professional intuition 4 3 84 4 3 93 
Cues from the patient such as stating 'I do not want to go back to hospital 5 2 95 4 1 100 
Patient asks if s/he is going to die 5 2 95 4.5 2 93 
Body language e.g.: open posture, appears relaxed 4 4 52 3 3 14 
General patient demeanour 4 3 74 3 3 21 
Patient is responsive when I allude to the end-of-life topic 4 1 100 4 1 100 
Patient refers to their own death       4 2 86 
Patient talks about or asks about hospice options     4 2 93 
Patient appears to be getting their affairs in order       4 2 93 
Family whispers to you in the hall 'John wants to die'     3 4 36 
Patient states that they have 'had enough' or that they want to die       4 3 92 
Patient asks about intubation in the hospital     4 2 57 
Patient does not comply with treatment       3 2 21 
Recent death in the family and patient has concerns about the same issue     4 2 78 
What are the key considerations in end-of-life discussions in 
nonmalignant respiratory disease? 
            
Allowing the patient to lead the conversation 4 2 84 4 2 84 
Answering patients questions regarding the condition 5 1 100 5 3 93 
Maintaining hope for the patient 3 3 42 4 2 76 
Being open and honest with the patient 5 1 100 5 1 100 
Establishing the patient's understanding of their condition 5 1 100 4 1 100 
Recognising the individual needs of the patient 5 0 100 5 1 100 
 Table 5.1 Quantitative results from Rounds 2 and 3 of the UK Delphi (continued). 
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  Round 2 Round 3 
Delphi Item Median Range 
Level of 
agreement 
(%) 
Median Range 
Level of 
agreement 
(%) 
Explaining to patients what is feasible regarding their wishes 5 1 100 5 1 100 
Educating the patient about their condition 5 2 85 4 1 100 
Patient indicates readiness to discuss 5 3 94 4 1 100 
Patient wanting to hear the information 4 3 89 4 1 100 
Patient being open about dying 5 2 74      
Having an appropriate environment for discussion 5 2 94 4 1 100 
Where the discussion occurs e.g. clinic, hospital or patient's home 4 4 79 4 2 77 
Having the patient's family involved in the discussion 4 4 52 4 2 61 
Having the family's support during the discussion 4 2 74 4 2 92 
Patient's wish to protect others from end-of-life information 4 4 58 3 3 23 
Being an expert on the condition 4 3 79 4 2 69 
Nurses having counselling skills 4 2 90 4 3 61 
Having the appropriate clinician to discuss end-of-life with the patient 4 3 79 4 2 83 
Having a strong relationship with the patient 4 3 74 4 3 61 
Emphasising a holistic care approach 5 1 100 5 1 100 
Rapport between health professional and patient 4 1 100 4 1 100 
Health professional having the confidence to discuss 5 1 100 4 1 100 
Health professional's understanding of the condition 5 1 100 4 1 100 
Using non-medical language 5 3 94 4 2 93 
Your professional boundaries 4 3 79 4 2 93 
Avoiding euphemisms - saying 'dying' or 'death' instead 4 3 58 4 3 62 
Health professional taking responsibility to oblige the patient's wishes 4 3 58 4 2 69 
Using humour 3 3 21 4 2 54 
Nurse having attended conferences or professional development specific to 
end-of-life discussions 
4 3 69 4 3 69 
Nurse having experience in caring for dying patients 4 2 89 4 1 100 
Discussing end-of-life at the time of diagnosis 3 3 5 3 3 23 
 Table 5.1 Quantitative results from Rounds 2 and 3 of the UK Delphi (continued). 
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  Round 2 Round 3 
Delphi Item Median Range 
Level of 
agreement 
(%) 
Median Range 
Level of 
agreement 
(%) 
Developing the discussion over time 4 2 95 4 1 100 
Finding the right opportunity to discuss 4 2 95 4 1 100 
Patient having time to hear information and ask questions later 5 3 84 4 2 93 
Availability of time to discuss 5 1 100 4 2 92 
Health professional being unafraid of talking about dying whenever the 
opportunity occurs - from diagnosis onwards when patient initiates 
    
4 2 93 
What are the topic areas that need to be addressed in such 
discussions? 
            
Introduction of an advance care planning document 4 1 100 4 1 100 
The type of care the patient wants 5 2 95 5 1 100 
Emergency management preferences 5 3 100 4 1 100 
Explaining palliative care 5 1 100 4 1 100 
Anticipatory prescribing 4 2 89 4 1 100 
Ceiling of treatment 4 2 89 4 1 100 
Medication options 4 1 100 4 1 71 
Treatment options 4 2 95 4 1 100 
Patient goals 5 2 94 4 1 101 
Intubation and ventilation options 4 2 89 4 3 84 
Preferred place of care 5 1 100 5 1 100 
Preferred place of death 5 1 100 5 1 100 
When the patient is likely to die 3 4 32 4 2 93 
Sedation availability/options 4 2 69 4 2 85 
Social services involvement 4 2 94 4 1 100 
Spirituality 4 2 89 4 1 100 
Transferring to palliative care 4 2 89 4 2 92 
Who the patient wants present at the very end-of-life 4 3 74 4 2 69 
Dealing with breathlessness 5 2 95 5 3 93 
 Table 5.1 Quantitative results from Rounds 2 and 3 of the UK Delphi (continued). 
141 
 
  Round 2 Round 3 
Delphi Item Median Range 
Level of 
agreement 
(%) 
Median Range 
Level of 
agreement 
(%) 
Explaining hospice (if available)(moved to question 1 in Round 3) 4 1 100       
Options for hospice (if available)(moved to question 1 in Round 3) 4 1 100      
How they feel about death 4 2 95 4 2 92 
Reassuring the patient he won't suffer 3 3 32 4 2 54 
Understanding of death 4 3 69 3 2 38 
Getting affairs in order (moved to question 1 in Round 3) 4 1 100      
Practical equipment needs 5 1 100 4 1 100 
Support in the home 5 1 100 4 1 100 
Transportation needs to facilitate care 4 2 89 4 2 92 
Needs of the partner/significant other     4 1 100 
Option to change your mind about end-of-life decisions       4 1 100 
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Table 5.3 A selection of comments from Round 2 and 3 of the UK Delphi 
Delphi Item Round 2 Comments Round 3 Comments 
How do health professionals know a patient is ready or willing to discuss end-of-life? 
Clinical signs Be led by patient. Patient needs to know 
that they are severe COPD, make sure 
that patient is informed of diagnosis. Be 
there for answering questions and 
further advice (support when needed), 
clinical severity does not always 
represent a willingness to engage  
The symptoms don't indicate a 
willingness to discuss end-of-life 
however, recognising a deteriorating 
patient would I hope lead to the 
professional exploring with the patient 
if they recognise that deterioration and 
the possibility of discussing the future 
or planning ahead. 
My professional intuition 'Gut’ feeling is helpful, supported by 
professional expertise, emotional 
intelligence  
Gut feeling is usually recognition of 
signs from the patient that they want 
to discuss this. 
Patient asks if s/he is 
going to die 
This could be explored to see if want to Agree that this may be an open door 
but need to be certain that the patient 
wants to discuss further, i.e. Use of 
communication skills, intuition and 
emotional intelligence but should be 
taken at their pace 
What are the key considerations in end-of-life discussions in nonmalignant respiratory disease? 
Maintaining hope for the 
patient 
Honesty is the best way forward, false 
hope can be detrimental  
Prepare for the worst but hope for the 
best 
Educating the patient 
about their condition 
This depends - hopefully I will have had 
the opportunity to establish their level 
of understanding  
Identifying what their fears are about 
dying allows it to be related to 
symptom control sometimes and is 
more specific to end-of-life 
Patient wanting to hear 
the information 
Patient need realistic information it may 
not be information that they want to 
hear  
But sometimes you need to discover 
what information they DON'T want 
too 
Having the family's 
support during the 
discussion 
Only if patient wishes  Definitely agree two sets of ears are 
better than one 
Being an expert on the 
condition 
You don't need to be an 'expert' to 
discuss end of life matters 
You need to know what you are 
talking about when dealing with such 
an emotive subject, 
Having a strong 
relationship with the 
patient 
Helpful in starting conversation  With the right skills I think you can 
talk to any patient 
Using humour If patient likes or uses humour  Patient led 
What are the topic areas that need to be addressed in such discussions? 
Ceiling of treatment Need to talk about i.e. NIV  Not at the first meeting unless the 
patient brings up the subject. 
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5.4.1 Development of Round 3 Questionnaire 
The comments from Round 2 resulted in five items being added to Question 1, one item 
to Question 2, and two items to Question 3.   
After careful consideration and discussion with the three supervisors (who were all 
nurses), some items that had initially been classified under questions two or three were moved 
to Question 1.  Relocated items were marked with their former category for participants.  In 
addition, some items were re-worded if the comments indicated that they were difficult to 
understand, or needed to be altered to be more representative of the experience of the nurses.  
These new, reworded or relocated items were clearly marked as such for the participants in 
the Round 3 questionnaire. 
Items with a mean score of less than two were to be excluded; however, there were no 
items that met this criterion in the second round of data collection, and therefore all items 
were reconsidered by participants in Round 3. 
5.5 Round 3 Findings 
Individual items, their scores from each round, and notes regarding any changes made to 
the item can be found in Table 5.2.  Items that gained consensus opinion of the participants are 
listed in Table 5.4.  Consensus for each individual item was determined based on: 
 items having an agreement (agree or strongly agree) level of 70 percent or more 
(Downar and Hawryluck, 2010), 
 items having a median rating of 4 or above (Chang, Gardner et al.), 
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  range level of items: 2 or less was considered to indicate strong agreement, but items 
with a higher range were still considered to have consensus if the percentage of 
agreement and the median were high enough (Holey, Feeley et al. 2007).  
There were fewer comments on items from participants in Round 3, potentially indicating 
increasing stability.  The percentage of items that did not gain consensus was 29 percent, and 
clear qualitative feedback was provided by participants on these items.
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Table 5.4 Items that reached consensus opinion in the UK Delphi. 
Question Item 
How do you know a 
patient with 
nonmalignant 
respiratory disease is 
ready or willing to 
discuss end-of-life? 
Cues from the patient such as stating ‘I do not want to go to hospital’ 
Patient asks if s/he is going to die 
Patient is responsive when I allude to the end-of-life topic 
Patient refers to their own death 
Patient talks about or asks about hospice options 
Patient appears to be getting their affairs in order 
Patient states that they have ‘had enough’ or that they want to die 
 
 
 
 
 
 
 
 
 
 
 
 
 
What are the key 
considerations in an 
end-of-life discussion in 
nonmalignant 
respiratory disease? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allowing the patient to lead the conversation 
Answering the patient’s questions regarding the condition 
Maintaining hope for the patient that symptoms can be managed effectively, while being 
honest about the likelihood of progress of the disease 
Being open and honest with the patient 
Establishing the patient’s understanding of their condition 
Recognising the individual needs of the patient 
Explaining to patients what is feasible regarding their wishes 
Educating the patient about their condition 
Patient indicates readiness to discuss 
Patient wanting to hear the information 
Having an appropriate environment for discussion 
Where the discussion occurs e.g. clinical, hospital or patient’s home (merged into 
‘having an appropriate environment for the discussion’) 
Having the family’s support during the discussion 
Having the appropriate clinician to discuss end-of-life with the patient 
Emphasising a holistic care approach 
Rapport between health professional and patient 
Health professional having the confidence to discuss 
Using non-medical language 
Working within your professional boundaries 
Nurse having experience in caring for dying patients 
Developing the discussion over time 
Finding the right opportunity to discuss 
Patient having enough time to hear information and then ask questions later 
Availability of time to discuss 
Health professional being unafraid of talking about dying whenever the opportunity 
occurs - from diagnosis onwards when patient initiates 
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Question Item 
What are the key 
topics that should be 
addressed in an end-of-
life discussion in 
nonmalignant 
respiratory disease? 
Introduction of an advance care planning document 
The type of care the patient wants 
Emergency management preferences 
Explaining palliative care 
Anticipatory prescribing 
Ceiling of treatment 
Medication options 
Treatment options  
Patient goals 
Intubation and ventilation options 
Preferred place of care 
Preferred place of death 
When the patient is likely to die 
Sedation availability/options 
Social services involvement 
Spirituality  
Transferring to palliative care 
Dealing with breathlessness 
How they feel about death 
Practical equipment needs 
Support in the home 
Transportation needs to facilitate care 
Needs of the partner/significant other 
Option to change your mind about end-of-life decisions 
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5.6 Tool development 
The tool was designed from the list of items that had reached consensus.  After the tool 
was designed, items were reviewed with the researcher’s supervisors, and two items were 
subsequently removed. The item ‘health professional being unafraid of talking about dying whenever 
the opportunity occurs from diagnosis onwards when patient initiates’ was removed as it was very 
similar to the item ‘health professional having the confidence to discuss’.  The latter was rated 
higher than the first item, and so the lower rated item was removed from the list.   Also, ‘having 
a strong relationship with the patient’ was similar to ‘rapport between health professional and patient’, 
which was rated higher in the previous round, therefore ‘having a strong relationship…’ was 
removed to avoid repetition in the tool.  Finally the term used in question 2 ‘key components’ 
was changed to ‘key considerations’ as the supervisor felt this was more appropriate for the topic.  
As the point of this tool was to encourage discussion between health professionals and patients, 
‘key considerations’ was thought to be a more acceptable term.  The results of the tool 
development process can be found in Figure 5.6. 
The items on the tool were found to be highly reliable, with Cronbach’s Alphas of .85 for 
Question 1 items, .94 for Question 2 items, and .96 for Question 3 items. 
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Figure 5.6 Tool developed from the UK Delphi. 
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5.7 Round 4 Findings 
In the fourth round of data collection, participants were provided with a copy of the tool 
and asked to give their opinion on the potential usefulness of the tool in clinical practice (Mead 
and Moseley, 2001).  The questions and their responses are detailed in Table 5.5.   
Participants stated that the tool was an accurate representation of end-of-life discussions 
in NMRD.  In addition, they rated it as ‘somewhat to very useful in clinical practice for 
experienced practitioners and novice practitioners’.  Open-ended questions gave participants 
the opportunity to provide suggestions regarding potential uses for the tool.  They suggested 
possible formats for the tool, such as an interactive website.   These suggestions will be used to 
determine how best to disseminate this information to health professionals in the UK.  One of 
the most prominent suggestions was that the tool could be used to train less experienced 
health professionals about end-of-life discussions.   
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Table 5.5 UK Delphi Round 4 questionnaire results. 
Question Response % (number) n 
Does this tool accurately reflect 
end-of-life discussions in 
nonmalignant respiratory disease? 
Yes 92.3 (12) 13 
Unsure 7.7 (1)   
No 0   
How useful would the tool be in 
clinical practice? 
Very useful 23.1 (3) 13 
Somewhat useful 76.9 (10)   
Not useful 0   
As an experienced practitioner, 
would you use this tool in your 
clinical practice? 
Definitely 15.4 (2) 13 
Very probably 38.5 (5)   
Probably 23.1 (3)   
Possibly 15.4 (2)   
Probably not 7.7 (1)   
Not at all 0   
Do you think this tool would be 
useful to a clinician with little 
experience with end-of-life 
discussions in non-malignant 
respiratory disease? 
Very useful 91.7 (11) 12 
Somewhat useful 8.3 (1)   
Not useful 0   
Would you to recommend this 
tool to a clinician with little 
experience with end-of-life 
discussions in non-malignant 
respiratory disease? 
Definitely 23.1 (3) 13 
Very probably 69.2 (9)   
Possibly 7.7 (1)   
How might you use this tool in 
your clinical practice? (a sample 
of participant comments) 
‘Education and training to junior staff, guide to treatment, support for 
personal clinical reasoning process, guide to developing local [end-of-life] 
protocols and procedures’ 
‘I think it will be helpful as a prompt to assess whether a patient is ready to 
discuss end-of-life topics but also to identify whether there are other factors 
that need to be addressed before these discussions can take place, e.g. 
understanding their condition’ 
‘I would use it during education for other health care professionals and as 
an aide memoire to add to my medical notes.’ 
Is there anything that could be 
added to or changed about this 
tool to make it more useful for 
clinical practice? (a sample of 
participant comments) 
‘Could it be in more diagramatical form, could it be extended to provide 
examples. If available on the web, could there be hyper links to other useful 
sites? e.g. GSF, preferred place of care?’ 
‘It would be useful if it sat within a framework or pathway for end-of-life in 
nonmalignant respiratory disease’. 
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5.8 Discussion 
The findings reveal that health professionals can perceive whether a patient is ready or 
willing to discuss end-of-life by understanding patient cues. Using this knowledge, health 
professionals may be able to initiate meaningful end-of-life discussions. The use of participants 
with knowledge and interest in the topic helps to ensure the content validity of the Delphi, 
while the use of successive rounds of the questionnaire helps to establish concurrent validity 
(Goodman, 1987) 
Clear qualitative feedback was provided by participants for items that did not gain 
consensus, however one non-consensus item is interesting, as it is contrary to current 
guidelines in the UK.  This study revealed clear disagreement between experts in the field as to 
whether clinical indicators helped them to establish whether a patient was ready or willing to 
discuss end-of-life, revealing lack of clear support for recommendations to use the Gold 
Standards Framework Prognostic Indicator Guidance to determine when to initiate end-of-life 
discussions with patients with COPD (2006). Items that did gain consensus, such as the 
importance of developing the discussion over time and discussing whenever the opportunity 
occurs after diagnosis (see Table 5.5), show that perhaps such emphasis in the policy guidelines 
on clinical indicators may inhibit health professionals from starting discussions early in the 
disease process, rather than allowing for the iterative process of such discussions to occur as 
mentioned in the end-of-life care strategy (2009).  
5.9 Conclusions 
Gaining the consensus opinion of specialist respiratory nurses in the UK was essential in 
order to address objectives one and two of the doctoral study.  This led to the development of 
a tool to help health professionals to determine constraints and opportunities specific to the 
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UK context to facilitate successful end-of-life discussions.  The findings of this phase show that 
health professionals can be sensitive to patient cues to determine whether they are ready to 
engage in an end-of-life discussion.  This knowledge may help increase professional confidence 
in interpreting patient cues, and thus ease some of the anxiety that health professionals may 
have about approaching end-of-life discussions. 
For the purposes of gaining further insight into how end-of-life is discussed, the findings of 
this phase will be compared to the findings of the Canadian Delphi phase in Chapter 7.  In 
addition, the distinction between the concepts of readiness versus willingness to discuss end-of-
life emerged, and will be addressed along with the other findings from this phase, in terms of 
developing theory and constructing a model for such discussions in Chapter 8. 
 153 
 
Chapter 6. A modified Delphi study with Canadian respiratory health 
professionals in Canada 
6.1 Introduction 
The objectives of this phase of the study, in line with objectives one and two of the 
doctoral study: to use the Delphi to develop a tool about how health professionals know a 
patient with NMRD is ready or willing to discuss end-of-life and delineate key considerations 
and topics for such discussions in the Canadian context. 
As laid out in Chapter 4 and summarized in section 5.1 for the UK Delphi study, this 
mixed methods study involved one round of qualitative interviews and three rounds of online 
questionnaires (Figure 6.1).  Details of the Canadian recruitment process and the findings of the 
study can be found in section 6.2. 
In line with the MRC guidelines for the development of a complex intervention (section 
1.6), this Delphi study resulted in the development of a tool to aid health professionals in 
discussing end-of-life in NMRD (section 6.2.4) specific to the Canadian context.  The tool is 
presented in Figure 6.6 along with findings from the clinical applicability and usefulness 
questionnaire in section 6.2.5.  This is followed by a discussion of the findings in section 6.3.   
This is followed in section 6.4 by a comparison of the findings of this Delphi study and the 
UK Delphi presented in Chapter 5 in order to achieve the third overarching study objective 
(section 1.5) of delineating the difference in end-of-life discussions in NMRD in the UK and 
Canada.  A discussion of how the results of this Delphi and the international comparison 
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contributed to the development of theory and modeling of the process of end-of-life 
discussions follows in Chapter 7. 
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Figure 6.1 Canadian Delphi Overview. 
 
 
Round 1 
•Experts: Canadian 
Respiratory Health 
Professionals (n=11) 
•Aim: Gather 
qualitative data for 
research questions 
to inform further 
rounds 
•Results: Thematic 
analysis of interview 
transcripts lead to 
items for the 
questionnaire (Braun 
& Clarke, 2006) 
•Outcome: 
Quantitative 
itemised 
questionnaire 
requesting rating and 
comments for each 
item 
Round 2 
•Experts: Canadian 
Respiratory Health 
Professionals (n=15) 
•Aim: Obtain 
quantitative 
agreement data for 
each item 
•Results: Median 
range and level of 
agreement for each 
item 
•Outcome: 
Quantitative 
itemised 
questionnaire 
showing mean and 
comments for each 
item 
Round 3 
•Experts: Canadian 
Respiratory Health 
Professionals (n = 
15) 
•Aim: Obtain 
quantitative 
agreement data in 
light of group 
opinion from 
previous round 
•Results: Established 
statistical consensus 
and stability for 
items 
•Outcome: Draft of 
tool for health 
professionals 
Clinical Applicability 
Round 
•Experts: Canadian 
Respiratory Health 
Professionals (n = 
13) 
•Aim: Determine 
whether the tool 
represents the 
results of the Delphi 
accurately and are 
useful in clinical 
practice. 
•Results: Qualitative 
and quantitative data 
showing approval of 
tool by Delphi 
participants 
•Outcome: Ideas for 
use of tool and 
suggestions for 
improvement 
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6.2 Participants and Findings 
Initial recruitment for the Canadian Delphi took place in from August to October 2011, 
and a total of 18 health professionals indicated interest in participating.  As discussed in section 
4.10.2, recruitment was conducted by advertising the study in the monthly email newsletter to 
members of the Canadian Respiratory Health Professionals group.  Of the 18 participants, 11 
were selected to be interviewed for the first round: selection for the interview was based on 
geographic location, health profession and work setting to achieve a maximum variation sample 
(Patton, 2005) (see section 4.9.1).  The number of participants for each round of the Delphi is 
displayed in Figure 6.2, and is well within the idea number of Delphi participants (Bowles, 1999, 
Okoli and Pawlowski, 2004, Baker et al., 2006). 
Figure 6.2 Canadian Delphi participants by round. 
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In the first round of semi-structured interviews (see section 4.4.1), data saturation was 
reached after 11 interviews.  Participants who were interviewed for Round 1 (n = 11) had a 
similar demographic profile to the whole Delphi participant panel (n = 18).  Participant 
demographic information is presented in Table 6.1. Throughout this chapter, quotes from 
participants have been anonymised, and assigned a code denoting the country of origin (CAN) 
and a participant number.  Where applicable, a reference to the relevant section of Chapter 4 
describing the methods used will be provided. 
  
  
158 
 
Table 6.1 Canadian participant demographic information. 
  Round 1 Rounds 2-4 
  N % N % 
Sex (f) 11 58% 18 88% 
Province         
Alberta 3 27% 4 22% 
British Columbia     2 11% 
New Brunswick 2 18% 3 17% 
Nova Scotia 1 9% 2 11% 
Ontario 3 27% 5 28% 
Saskatchewan 2 18% 2 11% 
Education 
  
    
Diploma 6 55% 8 44% 
Bachelor’s 3 27% 6 39% 
Master’s 2 18% 3 17% 
Age 
  
    
30-39 3 27% 5 28% 
40-49 4 36.50% 6 33% 
50-59 4 36.50% 6 33% 
60-65 
  
1 6% 
Professional Designation (all that apply)         
RRT 6 55% 12 67% 
COPD Educator 8 73% 14 78% 
CAE 7 64% 12 67% 
RN 3 27% 3 17% 
Nurse Practitioner 1 9% 1 6% 
Social Worker 1 9% 2 11% 
Professional Role (all that apply) 
  
    
Clinical (including counselling) 8 73% 15 83% 
Teaching 7 64% 12 67% 
Research 3 27% 3 17% 
Administration 1 9% 2 11% 
Work Setting (all that apply)         
Community 7 64% 10 56% 
Hospital 5 45% 7 39% 
Outpatient clinic 2 18% 4 22% 
Years in respiratory health         
01-Mar 2 18% 3 17% 
04-Oct 2 18% 2 11% 
Nov-15 2 18% 3 17% 
16-19     2 11% 
20+ 5 45% 8 44% 
Years discussing end-of-life         
01-Feb 
  
1 6% 
03-May 4 36% 5 28% 
06-Oct 3 27% 6 33% 
Nov-15 3 27% 4 22% 
15-20 1 9% 1 6% 
>20     1 6% 
 
6.2.1 Round 1 
Thematic analysis of the round 1 (see section 4.4.1) interviews resulted in 12 items for 
Question 1, 47 for Question 2, and 13 items for Question 3.  Unlike a typical thematic analysis, 
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all items that were mentioned in interviewees were included for consideration by participants 
in the next round (Braun and Clarke, 2006). One additional questionnaire item for Round 2, 
asking participants to rate their agreement with the following statement was added as: 1b) 
‘There are situations when ‘readiness’ is not important; for example, when the topic must be 
discussed immediately for practical purposes’ as this was an idea that was raised by interview 
participants but did not fit under an existing research question.  In total, eleven issues were 
categorised into Question 1 and one in question 1b; 47 items into Question 2, and 13 into 
Question 3.  
Question 1: How participants knew a patient was ready to discuss end-of-life 
Participants were asked directly how they knew that a patient was ready or willing to 
discuss end-of-life.  Participants gave 12 unique responses in this category.   
• Clinical indicators; for example, the patient has recently had an acute episode and 
required hospitalization; 
• The health professional uses their emotional intelligence to gauge patient readiness; 
• Patient cues such as body language, facial expressions, open personality; 
• Patient initiates end-of-life topic with health professional; 
• Patient responds when end-of-life topic is alluded to or initiated by the health 
professional; for example, asking whether the patient has made a will, sharing a personal 
story about a death in the family where end-of-life decisions were not made,  explaining 
what the first health professional to arrive on the scene would be expected to do in the 
event of a patient crisis, and that patient wishes would not be met if they had not been 
expressed;  
• All patients are ready if the health professional frames the discussion appropriately; 
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• You know a patient is ready to discuss because you know them 
Several participants who were qualified as COPD educators and discussed end-of-life with 
patients in respiratory education programme contexts.  As such, some responses were 
categorized under the theme of ‘readiness in the patient education context’.  The following is a 
description of each theme and example quotes from interview participants. 
Clinical indicators 
Two participants mentioned using clinical indicators as a cue to indicate readiness or 
willingness to discuss.  If the patient had recently had an acute episode that required 
hospitalization, then the health professional would initiate a discussion about what the patient 
would want next time.  One participant said:  
‘so i'll look at the clinical stuff and that'll...if I think they're doing poorly I will try to bring it up 
sooner, um, and I try to make sure I cover, well, I don't get them to fill anything else and hand it 
back to me, I give them the form and say, you know, discuss this with your family, and with your 
doctor, make sure that he knows or she knows what kind of care you want, and so I make sure 
I cover, sort of the levels of advance care directives’ (CAN5) 
They also mentioned that the more severe the patient’s condition is, the more opportunities 
there are for discussion.   
The health professional uses their emotional intelligence to gauge patient readiness 
Three participants discussed using their emotional intelligence to gauge whether 
someone was ready to discuss.   
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‘In our clinical team we talk about the emotional intelligence factor, and just being able to 
connect enough with people’ (CAN9).   
Another participant described how she used emotional intelligence to gauge readiness. 
‘but you have to really guage it, you have to be very good, I think at reading people, and 
knowing how much you can say, or you know, recognizing if you say something and you see a 
reaction that's not positive, then you know not to go down that path again.  It's a delicate 
dance, it really is.’(CAN6). 
Patient cues 
Several participants mentioned the use of cues from the patient such as body language, 
facial expressions and an open personality as an indicator that they were ready to discuss. 
‘Um, definitely an openness to the conversation, you know, you can tell by the energy and by 
their facial expressions, by their body language whether or not they're ready for that 
information’ (CAN1) 
Patient initiates end-of-life topic with the health professional 
Three participants discussed whether or not they had experienced patients initiating the 
discussion themselves.  One participant stated that there was no way to discern readiness 
unless the patient initiated the discussion themselves.  While others stated that they had never 
experienced a patient who had initiated the topic with them:  
‘I have not seen that...I have not had anybody ask me directly or bring it up themselves, it's 
always - i've always been the one who brought it up.’ (CAN5)  
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However, when experienced, initiation was not always verbal, in the case of COPD education 
sessions, attendance to the end-of-life session, and following up with a phone call to the health 
professional was viewed as initiation.  
‘So like, they're ready, because they've showed up to start with.  And they're even more ready to 
talk about it by making the phone call.  So it's kind of a dual initiation...yah.’ (CAN4) 
Patient responds when end-of-life topic is alluded to or initiated by the health 
professional 
One participant (CAN1) discussed how patients could show an ‘openness to the 
conversation’ after she had initiated the topic.  Openness could be relayed through facial 
expressions or body language, and therefore this cue is related to the earlier category of 
‘patient cues’.  This could also mean that the patient accepted the health professional’s 
‘invitation to discuss the topic further’, and was willing to ‘increase knowledge about their 
condition’.   
All patients are ready if the health professional frames the discussion appropriately 
One participant described how any patient would be willing to discuss end-of-life if the 
discussion was framed appropriately.  She said:  
‘I can't think of anyone (where) I can honestly say that they were not ready, and even the 
toughest ones, I can think of a couple men who would just make jokes and 'oh, oh I guess I 
must be about to fall off the block' and I go 'no, this is not about, you know, and I use a lot of 
joke and I tend to, I feel, I think I feel good about who I can joke with who I can't, and you 
know who you can't, you know if they kinda push back with a joke and say 'oh yah, this isn't 
good, look it, she came here to talk to me about puffers and now suddenly she says I’m dying', 
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and I say 'no I’m not saying you’re dying, I could be smoked by a truck when I leave your 
driveway, but I’m in a bit of a different position, because if I get smoked by a truck, um, you 
know, I would want everything done, I’m young and have children, and I’m willing to risk the 
outcome of everything, but, what does everything mean and look like for you, and would you 
want that, would you want those same things.  And if you want what the system provides by 
default with no communication you're fine, but if you don't want that, then what are the possible 
decisions.’(CAN9) 
You know a patient is ready to discuss because you know them 
This category relates to the emotional intelligence category.  One participant discussed 
how when you know people enough to understand their values and belief systems, and to 
understand how that influences their decision making, then you can gauge readiness.  In addition, 
participants stated they were able to initiate a discussion once the relationship between health 
professional and patient had been established.   
‘I don't bring it up in the first appointment.  It's usually something later once I have a bit of a 
relationship with them.’ (CAN5) 
Some themes related directly to the role of COPD educator in Canada and how readiness may 
have been expressed in this context.   
Readiness in the patient education context 
Indicators of readiness in the patient education context included: 
• Attending end-of-life session implies readiness to discuss 
• Group setting encourages patients to discuss 
• Patient follows up on end-of-life information received in education session 
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• Patients are not given the option of being ready to hear the information in the education 
context. 
An additional item was labelled as question 1b was added as it could not be categorized 
appropriately under the existing question 1: 
• There are situations when ‘readiness’ is not important such as when the topic must be 
discussed immediately for practical purposes. 
Attending end-of-life session implies readiness to discuss 
This category is relevant when a patient has had the opportunity to attend a COPD 
education program, a service provided by some health regions by certified COPD Educators.  
There is often a session as part of the programme about end-of-life planning, and by attending 
this session as they would have been advised of the topic in advance, a patient is indicating an 
openness to the topic of end-of-life. 
‘And in a group situation that we teach once a week, it's part of the curriculum, so it's not a 
subject that we avoid.  So we talk about it, they don't even, it's whether they're ready to talk 
about or not is...it's almost irrelevant in a group setting, but you do open up for it.’ (CAN7) 
Group setting encourages patients to discuss 
Again, relating to the context of COPD education sessions, being in a group of other 
patients with COPD was thought to be a facilitator of readiness or willingness to discuss. 
…’even if you don't have that experience, you can relate to somebody else's, and when you 
relate to somebody else's situation, you set up a rapport with the patient and their family, that 
they then get an idea, well you know what, you understand, or have an understanding.’(CAN5) 
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Patient follows up on end-of-life information received in education session 
Another indicator of readiness or willingness relating to COPD education was the 
possibility of follow-up between the patient and health professional.  Patients would have access 
to the COPD educators running the session and likely be able to make appointments to see 
them.  By doing this in order to address end-of-life issues, patients were thought to be 
indicating readiness or willingness to discuss.   
‘So what I tend to do when I have those clients that come in and that are followed under the 
practice that I'm participating in, I do follow up and say, you know, was there anything out of 
the education session that you wanna talk further about, you know, have you looked at...or else 
I'll even say 'you know, I noticed that you were a little uncomfortable speaking about that, you 
know, is there anything that I can help you with.' And I try to open that door for them, because 
sometimes it's an outsider that needs to open that door and they can't talk to their family about 
it.’ (CAN5) 
Patients are not given the option of being ready to hear the information in the 
education context 
One participant mentioned that patients may not be warned in advance about the end-
of-life component of their COPD education, and therefore they would not have the option to 
choose to avoid the subject.   
‘Well in our classes I don't really give the option...it's just brought in as part of the discussion 
and I have to say overall it is well received. I mean I try to keep the topic as upbeat as you 
possibly could, and simply stating that this is a fact, at some point we're all going to go, so if 
there is a way that you want to go, then we should start talking about it.’ (CAN2) 
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An additional item was labelled as question 1b was added as it did not fit with the items above: 
Being ready to discuss end-of-life is not relevant, such as when the topic must be 
discussed immediately for practical purposes 
This item was developed from comments made by a participant that readiness is not 
always important, such as when accessing palliative care, the patient has to agree to a ‘do not 
resuscitate’ order.  
‘but it was something that had to be discussed because we had to register patients um, for the 
ambulance that they would be a no code if they got called, if the patient agreed to you know, a 
do not resuscitate, which if they were palliative, they had to, that was the policy here, if you 
were on the palliative home care team, or on the palliative home care program, you had to 
agree to um, you know, you weren't going to be resuscitated at all.’ (CAN6)  
Another example given is when a home care professional has to ask questions about end-of-life 
because they need to know practical details if the patient dies while they are there, such as 
wishes for funeral arrangements. 
Question 2: Key considerations in end-of-life discussions 
Participants stated 47 unique items that were categorized here, and these were 
subdivided into a further four themes: family, approaching the discussion, the health 
professional, and the context of the discussion. These themes and the considerations within 
them are presented in Figure 6.3. 
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Figure 6.3 Canadian Delphi themes and categories for key considerations. 
 
Items requiring further clarification or refinement were developed by having participants 
provide comments in the next round. A sample of these items and quotes is presented in Figure 
6.4.  Example quotes from all categories can be found in Appendix E. 
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Figure 6.4 Key considerations in end-of-life discussions: samples from Round 1 of the Canadian 
Delphi. 
 
• ‘And i would try and talk about it, and I would bring 
humour into it a lot of times, whenever I could, because 
that always sort of breaks the ice a little bit, and makes 
it easier’ (CAN10) 
Sense of humour 
•You just go and you know if you approach the 
topic…with a matter of factness… I think people 
respond to that no matter where they are. (CAN1) 
Approaching topic 
with a ‘matter-of-
factness’ 
• 'Letting the patient or whoever you're talking to about 
the end-of-life discussion, guide the journey, you know, 
they are the captain, and going wherever they go.  But 
that doesn't mean like being a, you know a pushover 
either.  Right? If they're going down a path um, you can, 
you know, having that trust, that therapeutic 
relationship enough to say 'hey, you know, uh, I don't 
know, do you want to think about that a little bit or?' 
(CAN1) 
Letting the patient 
guide the discussion 
• ‘Um, well definitely the person has to be ready, you 
can't force a discussion’ (CAN4) 
Readiness of the 
patient to discuss 
• 'I think what's really important i've found through the 
years is getting a relationship with the patient, so that 
they know that they can trust you, and that um, you 
know, you're not just a stranger coming into the house 
or seeing them in a clinic a situation and they have no 
relationship, so I think relationships a little bit 
important’(CAN11) 
Having a pre-existing 
good relationship with 
the patient 
• ‘Whenever you talk about that when you're in a 
hospital, they have a tendency not to believe you 
because when you go to a hospital, you come out 
better, that's what most people think.  So once the 
doctors have the initial discussion with them, they are in 
shock, and if you go in and discuss it, it's like you know 
what, I just wanna go home and think about all of this, 
so it really has to be on their terms.’(CAN6) 
Setting of discussion 
• 'Credibility, um, you know, patients will say, some 
patients will say that they want their physicians to lead 
this discussion and because their physician is credible, 
um, so, so I think that's an important piece’ (CAN9) 
Credibility of the 
health professional (as 
recognised by the 
patient) 
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Question 3: Key topics for end-of-life discussions 
Participants stated 13 unique items that were categorized here.  These items were not 
subdivided into themes as they were all felt to be sufficiently unique.  Again, participants were 
able to modify or clarify items in the next round by providing comments. A sample of these 
items and quotes is presented in Figure 6.5. Example quotes from all categories can be found in 
Figure 6.5. 
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Figure 6.5 Key topics in end-of-life discussions: samples from Round 1 of the Canadian Delphi. 
 
• ‘I cover with them that you can rescind this at any time, this is, this 
document, you can rip it up at any moment, you aren't bound by this, if you 
are still able to communicate and you wanna change that, that's absolutely 
your perogative, you can, you know, this isn't a permanent document, and if 
you change your mind, you can change your mind, that's entirely up to you at 
the last minute.’ (CAN5) 
Option to change 
your mind after 
making end-of-life 
decisions 
• ‘I give them the form and say, you know, discuss this…with your doctor, 
make sure that he knows or she knows what kind of care you want’(CAN5) 
Making sure the 
doctor knows what 
kind of care the 
patient wants 
• ‘a lot of times they have a lot of questions about, you know when he moves 
on, what's it going to be like? Is there going to be a mess, um, you know, who 
do I call if I wake up and he is lying in the bed and he is dead, what do I do, 
you know.  It truly is walking them through process, and if they're willing to 
listen to it, you just say 'okay this likely what will happen you know, if, this is 
his choice to stay at home, these are the things that will occur over the next 
little while and we will be there with you if you want us there, every step of 
the way.'’ (CAN6) 
Walking the family 
through the 
process of what 
will happen when 
the patient dies 
• ‘If the burden of therapy is outweighing the benefit of thereapy then we need 
to make new decisions, and there like oh my god that makes so much sense, 
because you're right this is making me so crazy it's not worth it, so yah, 
which is - the is it giving you more benefit than bother, or more bother than 
benefit, because that is an easy way to decide whether we're gonna continue 
doing all this stuff with machines that are making you stay up all night, and 
your family crazy’(CAN11) 
Discussing the 
‘bother versus 
benefit’ of 
treatments or 
interventions with 
patients 
• ‘So they come in, they're at the the end of life, and there they are intubated, 
they're doing everything because no one's been paperworked...you know 
what I mean, nobody's aware of what the patient really wanted..’ (CAN11) 
How patient wants 
things to look at 
the end-of-life 
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6.2.2 Round 2 
In the second round, participants had space to provide comments on each item, in addition to 
rating their agreement on a five-point Likert-type scale.  Participants made several comments, 
and these resulted in one item being added to Question 1, and two items being added to 
Question 2 for participants to consider in round 3.  No new items were added to Question 3. 
In addition, clarification or modification of items was clearly denoted in the Round 3 survey for 
participants to consider.   
Items with a mean score of less than three were excluded from the following round (section 
4.4.2); therefore, four items were removed.  In general there was a high level of agreement 
(more than 70 percent of participants rating the item ‘agree’ or ‘strongly agree’ (Downar and 
Hawryluck, 2010)) on many items in Round 2: 100 percent agreement on question 1b, 81 
percent agreement of items in Question 2 and 100 percent agreement of items in Question 3.  
Question 1 was more contentious with a level of agreement on 33 percent of items.  Table 6.2 
reports the descriptive statistics for rounds two and three. 
6.2.3 Round 3 
Participants made 28 percent, 41 percent and 40 percent fewer comments in questions one, 
two and three respectively.  Question 1b had the same number of comments in Round 3.  This 
may indicate that stability of agreement on items increased from Round 2.   
Consensus for each item was determined based on (section 4.4.3): 
 items having an agreement level of 70 percent or more (Downar and Hawryluck, 2010); 
 items having a median rating of 4 or higher (Chang et al.); 
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 range of scores – items with a range of 2 or less were considered to indicate strong 
agreement; however, items with a higher range were still considered to have consensus 
if the percentage agreement and the median were high enough (Holey et al., 2007). 
Individual items along with their mean scores from rounds two and three can be found in Table 
6.2, and a sample of comments from some items can be found in Table 6.3.  Items that gained 
consensus are listed in Table 6.4. 
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Table 6.2 Quantitative results from rounds 2 and 3 of the Canadian Delphi. 
  Round 2 Round 3 
  Median Range 
Level of 
agreement 
Median Range 
Level of 
agreement 
Question 1 
  
  
  
  
Clinical indicators 4 4 56% 4 3 75% 
The health professional uses their emotional intelligence to gauge patient readiness 4 2 100% 4 1 100% 
Patient cues 4 2 88% 4 1 100% 
Patient initiates end-of-life topic with health professional 5 2 94% 5 2 94% 
Patient responds when end-of-life topic is alluded to or initiated by the health professional 4 1 100% 4 1 100% 
All patients are ready if the health professional frames the discussion appropriately 2 4 25% - -   
You know a patient is ready to discuss because you know them 3 2 19% - -   
Attending end-of-life session implies readiness to discuss 3.5 2 50% 3 2 25% 
Group setting encourages patients to discuss 3 3 38% 3 3 38% 
Patient follows up on end-of-life information received in education session 4 2 56% 4 3 63% 
Patients are not given the option of being ready to hear the information in the education 
context 
3 4 25% - -   
Comments from family to the health care professional - - - 3 2 38% 
Question 1b 
4 3 88% 4 3 88% There are situations when ‘readiness’ is not important such as when the topic must be 
discussed immediately for practical purposes 
  
  
 
    
 
  
Question 2 
Family issues for the patient  4 3 88% 4 1 100% 
Communicating patient wishes to family 5 1 100% 5 1 100% 
Presence or absence of family support 4 2 94% 4 2 94% 
Sense of humour 3.5 3 50% 4 2 81% 
Sensitivity to the patient’s culture 5 1 100% 5 1 100% 
Approaching the topic calmly 5 1 100% 5 1 100% 
 Table 6.2 Quantitative results from rounds 2 and 3 of the Canadian Delphi (continued) 
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Approaching topic with a ‘matter-of-factness’ 4 3 56% 3 3 44% 
Approaching the topic with a caring nature 5 1 100% 5 1 100% 
Being open 5 1 100% 5 1 100% 
Being honest 5 1 100% 5 1 100% 
Being respectful of the client 5 1 100% 5 1 100% 
Listening to the patient 5 1 100% 5 1 100% 
Giving advice when it’s asked for 4 3 75% 4 2 63% 
Letting the patient guide the discussion 4 3 88% 4 2 81% 
Readiness of the patient to discuss 4 2 94% 4 2 94% 
Accepting the patient’s reactions 4 3 94% 4 1 100% 
Knowing when to step back from the topic 4 2 94% 4 1 100% 
Having a pre-existing good relationship with the patient 4 3 63% 3 3 44% 
Avoiding dashing hope 4 3 63% 3 3 31% 
Raising the topic early before critical situation 5 2 100% 5 2 75% 
Having end-of-life on a list of things that need to be talked about 4 3 88% 4 3 94% 
Having handouts of example advance care directives (paper resources) 4 2 94% 4 1 100% 
Responsibility of health professional to meet patient wishes 4 3 88% 4 2 75% 
Sensitivity to health literacy level of the patient 5 1 100% 5 1 100% 
Sensitivity to patient's language needs 5 1 100% 5 1 100% 
Health professional being comfortable with approaching end-of-life topic 5 1 100% 5 2 94% 
Health professional having experience and practice having end-of-life discussions 4 1 100% 4 3 81% 
Health professional is familiar with end-of-life planning process 4 3 94% 4 2 94% 
Health professional has attended education sessions about discussing end-of-life 4 2 69% 4 2 88% 
Health professional has knowledge of palliative care and end-of-life issues 4 2 100% 4 2 81% 
Emotional intelligence of health professional 4 2 94% 4 2 94% 
Heath professional acts as a neutral party to talk to the family about what is happening to 
the patient 
4 2 94% 4 2 88% 
Patient's condition for discussion   4 3 69% 4 2 75% 
Having a support person present during discussion 4 3 56% 4 2 56% 
Patient understanding that their condition is life limiting 4 3 75% 3 3 56% 
Patient understanding that they can receive palliative care 4 3 81% 4 3 94% 
 Table 6.2 Quantitative results from rounds 2 and 3 of the Canadian Delphi (continued) 
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Time available to discuss 4.5 2 94% 4 3 94% 
Time available for follow up discussions 4 2 88% 4 3 94% 
Setting of discussion 4 2 63% 3 2 19% 
Privacy for discussion 4.5 2 94% 4 3 75% 
Life experience of person that you are having the discussion with in emergency scenario 
(usually a family member) 
4 3 75% 4 2 50% 
Multi-disciplinary team available to patient 4 2 94% 4 2 94% 
Confirming patient understanding of the discussion 4 1 100% 4 1 100% 
Personality of the patient 4 3 75% 3 1 44% 
Credibility of the health professional (as recognized by the patient) 4 2 94% 4 1 100% 
Whether the patient is taking care of themselves 3 2 25% - -   
Individual patient needs 4 2 94% 4 1 100% 
The patient's spiritual beliefs and how they may be incorporated into the end-of-life care 
plan 
- -   4 1 100% 
Health care professional checking that day to day as well as longer term needs will be met - -   4 2 88% 
Question 3 
  
  
  
  
Patient understanding of their option to make end-of-life choices 5 1 100% 5 1 100% 
Patient deciding on a substitute decision maker 4 2 94% 4 2 94% 
Patient understanding of  the ‘chain of command’ of decision makers, should there be a 
dispute when patient is unable to speak for themselves 
4 3 94% 4 2 94% 
Option to change your mind after making end-of-life decisions 5 3 94% 5 1 100% 
Making sure doctor knows what kind of care the patient wants 5 1 100% 5 1 100% 
Levels of advance care directives (supportive care only to full resuscitation) 5 2 94% 5 1 100% 
Walking the family through the process of what will happen when the patient dies 4 2 81% 4 2 81% 
Explaining implications of end-of-life decisions and care to family 5 2 94% 4 1 100% 
Discussing the ‘bother versus benefit' of treatments or interventions with patients 4 2 88% 4 2 81% 
How patient wants things to look at the end-of-life 4 3 75% 4 2 88% 
Educating patients about their end-of-life choices and implications 4.5 3 94% 4 1 100% 
Goals of care 4.5 2 94% 4 1 100% 
Explaining where they are in their disease  4.5 2 88% 4 2 94% 
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Table 6.3 Comment samples from Round 2 and 3 of the Canadian Delphi 
Delphi Item Round 2 Round 3 
How do health professionals know a patient is ready or willing to discuss end-of-life? 
Clinical 
indicators 
An acute episode might signal a good 
opportunity for a health care 
professional to approach the topic of 
end-of-life care with a patient, however 
it may not correlate into patient 
readiness or willingness to talk about 
the topic. 
While clinical indicators may indicate that we 
should start the discussion, it does not mean the 
patient is ready or willing 
The health 
professional 
uses their 
emotional 
intelligence to 
gauge patient 
readiness 
Patients give cues and clinicians need to 
be intuitive enough to hear and read 
these cues 
Agree whole-heartedly with last comment.  
Emotional intelligence is helpful but it's really 
about being able to broker a therapeutic 
relationship and being able to follow up on 
patients' cues. 
What are the key considerations in end-of-life discussions in nonmalignant respiratory disease? 
Sensitivity to 
health literacy 
level of the 
patient 
Vital to assess the patient's 
understanding by having feedback on 
what is discussed and frequent checking 
back with the patient/family.  Assessing 
the patient/family's ability to understand 
and navigate the health care system, 
information and able to access what 
they need is a part of health literacy. 
Great comment 
If you lose your patient early on because of 
communication barriers, then the door to these 
discussions may also be closed. 
Emotional 
intelligence of 
health 
professional 
Some people are just 'not wired' in an 
emotional intelligence way to be able to 
lead these discussions effectively with 
patients / families.  Others are not 
'wired' to place various catheters in 
various body parts.   While skills can be 
taught, it doesn't mean you will excel in 
it, nor even become proficient.  If you 
are less capable, desirous, etc., it is wise 
to enable those with capabilities and 
desires on the team to lead with their 
skill sets.  Being professional enough to 
admit your limitations is becoming more 
and more the norm for our professional 
practice and accepting our limitations. 
There will always be people better than 
us and always be people worse than us 
in doing these things. Being humble 
enough to admit it, and do something 
about it is the mark of a graceful 
practitioner. 
 
 
 
 
 
 
I believe that it plays a major role in how a health 
professional presents themselves in this situation. 
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What are the key topics in end-of-life discussions in nonmalignant respiratory disease  
Explaining 
where they are 
in their disease  
I believe this is important, however, I have had 
experiences where clients don't want to know 
how "bad" they actually are and want the 
treatment to continue but are comfortable with 
dying. 
Patient dependent, need to watch cues 
from patient to know when to stop 
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Table 6.4 Items that reached consensus opinion in the Canadian Delphi. 
Question Item 
Question 1. How do 
you know a patient is 
ready or willing to 
discuss end-of-life? 
Clinical indicators; for example, length of disease process, burden of disease, the 
patient has recently had an acute episode and required hospitalization. 
The health professional uses their emotional intelligence to gauge patient readiness. 
Patient cues; for example, body language, facial expressions, open personality. 
Patient initiates end-of-life topic with health professional - either directly or indirectly 
by bringing up death or end-of-life care in relation to something or someone else. 
Patient responds when end-of-life topic is alluded to or initiated by the health 
professional; for example:  asking whether the patient has made a will; sharing a 
personal story about a death in the family where end-of-life decisions were not made; 
explaining what the first health professional to arrive on the scene would be expected 
to do if the patient were in crisis, and that it would be unfortunate if they had wishes 
that had not been expressed.  
Question 1b. There are 
situations when the 
patient's ‘readiness’ to 
discuss end-of-life is 
not important, such as 
when the topic must 
be discussed 
immediately for 
practical purposes. 
  
 
 
 
 
 
Question 2.  What are 
the key considerations 
in end-of-life 
discussions? 
 
 
 
 
 
 
 
 
 
 
 
Family issues for the patient; for example, young children at home, unresolved family 
problems 
Communicating patient wishes to their family 
Presence or absence of family support in the patient's life 
Sense of humour when appropriate 
Sensitivity to the patient’s culture 
Approaching the topic calmly 
Approaching the topic with a caring nature 
Being open 
Being honest 
Being respectful of the patient 
Listening to the patient 
Letting the patient guide the discussion 
Readiness of the patient to discuss 
Accepting the patient’s reactions 
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Question 2.  What are 
the key considerations 
in end-of-life 
discussions? 
(continued) 
Knowing when to step back from the topic 
Raising the topic early before a critical situation 
Having end-of-life on a list of things that need to be talked about 
Having handouts of examples of advance care directives (paper resources) 
Responsibility of health professional to meet patient wishes 
Sensitivity to health literacy level of the patient 
Sensitivity to patient's language needs 
Health professional being comfortable with approaching end-of-life topic 
Health professional having experience and practice having end-of-life discussions 
Health professional is familiar with end-of-life planning process 
Health professional has attended education sessions about discussing end-of-life 
Health professional has knowledge of palliative care and end-of-life issues 
Emotional intelligence of health professional 
Heath professional acts as a neutral party to talk to the family about what is 
happening to the patient 
Patient's condition for discussion; for example, the patient is in the hospital with an 
acute episode, or patient is trying to get their breathing under control early in the 
morning 
Patient understanding that they can receive palliative care 
Time available to discuss 
Time available for follow up discussions 
Privacy for discussion 
Multi-disciplinary team available to patient 
Confirming patient understanding of the discussion 
Credibility of the health professional (as recognized by the patient) 
Individual patient needs 
The patient's spiritual beliefs and how they may be incorporated into the end-of-life 
care plan 
Health care professional checking that day-to-day as well as longer term needs will be 
met  
 
 
Question 3. What are 
the key topics in an 
end-of-life discussion? 
 
 
 
Patient understanding of their option to make end-of-life choices 
Patient deciding on a substitute decision maker 
Patient understanding of the ‘chain of command’ of decision makers should there be a 
dispute when patient is unable to speak for themselves 
Option to change your mind after making end-of-life decisions 
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Question 3. What are 
the key topics in an 
end-of-life discussion? 
(continued) 
Making sure doctor knows what kind of care the patient wants 
 Levels of advance-care directives (supportive care only to full resuscitation) 
Walking the family through the process of what will happen when the patient dies 
 Explaining implications of end-of-life decisions and care to family 
Discussing the positive and negative consequences of treatments or interventions 
with patients *phrase 'bother vs benefit' has been replaced due to participant 
comments 
How patient wants things to look at the end-of-life 
Educating patients about their end-of-life choices and implications 
Goals of care 
Explaining where they are in their disease; for example: at a stage where there is  no 
cure: focus on symptom management 
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6.2.4 Tool Development  
The tool development process followed the same procedures as the UK Delphi study.  
Cronbach’s alphas were calculated on each question to determine reliability of the findings.  
Items in Question 2 and Question 3 were found to be highly reliable with alphas of .86 and .88 
respectively (Bland and Altman, 1997).  However, items in Question 1 had a very low level of 
reliability with an alpha of .095.  This may be due to the small sample size or it may indicate that 
this component of the tool requires further refinement (Nunnally and Bernstein, 1994).  As 
part of the development process for complex interventions, this issue will be addressed in the 
next phases of research as detailed in Chapter 8.  Therefore, despite the reliability of Question 
1, the tool was created and then sent to one supervisor for comments before being sent out to 
participants for review.  The results of the tool development process are reported in Table 6.5.  
The tool presented below is different in appearance from the tool resulting from the UK Delphi 
as it was thought by the author that a pamphlet format may be more effective than a single 
sheet as it would allow more space and thereby improve readability. 
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Figure 6.6 Canadian tool for end-of-life discussions in nonmalignant respiratory disease 
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6.2.5 Round 4 
After the tool had been developed, participants were provided with a digital copy and 
asked to give their opinion on the usefulness of the tool in clinical practice (Mead and Moseley, 
2001) (section 4.5). The questions that they were asked along with their responses are in Table 
6.5.   
A majority (86%) of participants felt that the tool was an accurate representation of 
end-of-life discussions in non-malignant respiratory disease.  They also stated that it would be 
somewhat-to-very-useful in clinical practice, as well as for a reference for both expert 
practitioners and less experienced practitioners.  
  
 
 
186 
 
Table 6.5 Round 4 questionnaire and results 
Question Response % n 
Does this tool accurately reflect end-of-life 
discussions in nonmalignant respiratory disease? 
Yes 86% (12) 14 
No 7% (1)   
Unsure 7% (1)   
How useful would the tool be in clinical practice? Very useful 36% (5) 14 
Somewhat useful 64% (9)   
As an experienced practitioner, would you use this 
tool in your clinical practice? 
Definitely 29% (4) 14 
Very Probably 7% (1)   
Probably 29% (4)   
Possibly 21% (3)   
Probably not 14% (2)   
Do you think this tool would be useful to a 
clinician with little experience with end-of-life 
discussions in non-malignant respiratory disease? 
Very useful 57% (8) 14 
Somewhat useful 43% (6)   
Would you to recommend this tool to a clinician 
with little experience with end-of-life discussions in 
non-malignant respiratory disease? 
Definitely 43% (6) 14 
Very probably 7% (1)   
Probably 21% (3)   
Possibly 21% (3)   
Probably not 7% (1)   
How might you use this tool in your clinical 
practice? (a sample of participant comments) 
‘To get coworkers engaged in end of life discussions with their 
patients’ 
‘Because I am in the process of moving to another job, this tool 
would be very useful in orienting new staff. There has been 
huge reluctance and, consequently, resistance, for other staff to 
take over this responsibility. I am anticipating this tool would 
be very useful in the transition.’ 
‘If I come across a "difficult" situation where I feel it might be 
challenging to discuss the issue.’  
‘I would use it in my COPD education class and Pulmonary 
Rehab class to help raise their awareness and open discussion 
with family members and their (Doctor).’ 
‘available as electronic medical record compatible, or 
downloadable to put into patient charts… Much needed and 
helpful for hopefully thousands of people and more.’ 
Is there anything that could be added to or 
changed about this tool to make it more useful for 
clinical practice?  
‘Specific examples of how to start an End-of-Life conversation 
would be great. Or examples of how to respond to different 
reactions that patients may have to the topic.’ 
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6.3 Discussion 
This study builds on the Delphi study conducted in the UK.  Again, it is the first study 
known to the author that resulted in a tool specifically to help health professionals discuss end-
of-life in NMRD.  While items related to Question 1 did gain consensus, there was a lower 
percentage agreement in this category than others, therefore the findings in this category might 
require further development.  However, in all areas a fairly high level of agreement in Round 2, 
and higher level of agreement in Round 3 shows that the findings are stable (Holey et al., 2007), 
and that they represent a range of health professionals. 
The findings of this phase show that emotional intelligence of health professionals may 
be an important factor in approaching end-of-life discussions.  The idea that health professionals 
use their emotional intelligence to gauge patient readiness gained consensus among  the 
participants.  Emotional intelligence is defined as an ability (Mayer and Salovey, 1997), a set of 
traits and abilities (Bar-On, 2005) or a combination of skills and competencies (Goleman, 1998), 
however, a convergent definition does not exist (Bulmer Smith et al., 2009).  While there is a 
lack of overall agreement on the definition,  emotional intelligence is thought to be an essential 
part of decision making for nurses as they may contextualize decision making, leading to more 
empathetic and patient-centred decisions, and as such may have a positive impact on patient 
outcomes (Bulmer Smith et al., 2009).  
Interestingly, patient education activity was not seen as the context where discussions 
took place, or that assumptions about patient readiness could be made, but rather where the 
end-of-life topic was introduced to patients, and where they could begin to consider their 
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options.  This may be contrary to the idea that if patients have attended education sessions, 
then they have addressed end-of-life issues and communicated their wishes to the relevant 
health professionals and their families. Lists of factors to consider and topics to cover during 
end-of-life discussions were also established, and may give less experienced healthcare 
professionals some guidance on how to approach this topic.  This study has also identified the 
importance of the recognition of cultural issues for patients and families as well as health 
literacy levels when approaching end-of-life discussions.  
The findings of this Delphi were similar to the UK findings and were also consistent with 
the literature,  however some differences between findings reflect the difference in culture in 
each country.  Items such as ‘sensitivity to patient culture’, ‘health professional being 
comfortable when approaching end-of-life topic’ and ‘health literacy of the patient’ highlight 
differences between health professionals in each country.  These differences will be discussed 
further in section 7.2. 
6.4 Conclusions 
Gaining the consensus opinion of respiratory health professionals in Canada was necessary in 
order to meet objectives one and two of the doctoral study.  This process resulted in a tool 
specific to the Canadian context that can help health professionals determine the constraints 
and opportunities when discussing end-of-life.   
The findings of this phase also brought to light differences between UK and Canadian panels, 
which will be discussed in Chapter 7.  As outlined in chapter one, the findings of this phase of 
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the study will be compared to the UK study in Chapter 7.  This will lead to the development of 
a theory and constructing a model for end-of-life discussions in Chapter 8. 
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Chapter 7. Comparison of findings from the UK and Canada 
The objective of this phase of the study, as listed in section 1.5, was to delineate 
differences in end-of-life discussions in nonmalignant respiratory disease between the UK and 
Canada.    
The international comparison was conducted as a way to find innovative ways to meet 
the needs of people with COPD who are facing the end-of-life as it contributes an in-depth 
understanding of the issues by examining different cultures.  It is also highly relevant when 
considering the increasingly multi-cultural client group in both the UK and Canada.  As 
discussed in Chapter 1, the UK and Canada were chosen as countries to compare because of 
the recent quality of end-of-life care rankings of first (UK) and ninth (Canada) (Murray, 2010)) 
and the similarities between the two healthcare systems (government funded, nationalised and 
freely accessible)(see Table 1.3).  In addition, both countries have a similar  disease 
epidemiology (Department of Health, 2010, Canadian Lung Association, 2008).   
In section 7.1.1 the characteristics of the Delphi panels will be compared and discussed, 
and this will be followed by a comparison of the results of the UK and Canadian Delphi studies 
in section 7.1.2.  The results of these comparisons will be discussed in section 7.2, and the 
chapter will be concluded in section 7.3.  
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7.1.1 Characteristics of the Delphi Panels 
The recruitment of health professionals in the UK and Canada took place through 
professional associations in each country.  The details of the recruitment strategy for each 
Delphi study are detailed in section 4.9.   
Overall, the Canadian panel was more experienced in respiratory care than the UK 
panel, with 72 percent of the Canadian panel having more than 10 years experience in 
respiratory care, compared with 26 percent of UK participants.  Figure 7.1 shows participant 
experience by country. 
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Figure 7.1 Years of participant experience by country. 
 
The educational levels also varied slightly between panels.  More UK panelists reported 
a bachelor’s degree as their highest level of education (27% UK, 16% Canada), while more 
Canadians reported a Master’s degree as their highest level of education (8% Canada, 3% UK).  
Figure 7.2 shows the highest level of education reported by country.  
Figure 7.2 Highest level of education reported by participants by country. 
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Data from the CRHP show that 11 percent of all members report a Master’s degree as 
their highest level of education; unfortunately this information was not available for the BLF 
nurse population.  While there are several differences between the groups, they are 
comparable as each panel represented how care is provided in their respective countries. 
7.1.2 Comparison of Delphi Study Results 
The results from the UK and Canadian Delphi studies are compared in the form of a 
narrative discussion regarding items that appear to be related to each other (section 7.1.2).  
Items from each Delphi were ‘matched’ thematically by inserting all Delphi consensus items into 
a table, and then looking for thematic similarities.  Then all systematic review findings were 
entered into the table and again analysed for thematic similarities.  The discussion of ‘matched 
items’ is followed by a narrative discussion of items that were not matched between Delphi 
studies. A discussion of implications of these findings and how the findings of this comparison 
contributed to the development of the theory of end-of-life discussions in NMRD can be found 
in Chapter 8. 
Matched items in the UK and Canadian Delphi Studies 
Given the similarities in prevalence, health systems and end-of-life care policies 
discussed in section 1.2, there was limited agreement between the Delphi panels from the two 
countries. Of 56 consensus items from the UK Delphi, only 22 had matching items from the 
Canadian Delphi.  First, these matched items have been tabulated and briefly discussed, 
followed by tables and discussion of non-matched items from both Delphi studies in the next 
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section. Figure 7.3 shows the number of items from each round in the UK and Canadian Delphi 
studies. 
Figure 7.3 Number of Delphi items in each round by country. 
 
The matched items are organised by question as per the Delphi studies, and presented 
in Table 7.1, Table 7.2 and Table 7.3. 
As shown in Table 7.1, the first matched item is that patient cues (verbal or non-verbal) 
indicate to health professionals that a patient is ready or willing to discuss end-of-life.  However, 
it seems that the UK health professionals relied on verbal cues, while Canadians looked for 
non-verbal cues.  Both of these items must be perceived by the health professional, thereby 
putting the onus on them to respond to such cues and may rely on the emotional intelligence of 
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Q1 
Q1 
Q1 
Q1 
Q1 
Q1 
Q2 
Q2 
Q2 
Q2 
Q2 
Q2 
Q3 
Q3 
Q3 
Q3 
Q3 
Q3 
0 10 20 30 40 50 60 70 80 90 
R1 
R2 
R3 
R1 
R2 
R3 
U
n
it
e
d
 K
in
gd
o
m
 
C
an
ad
a 
Number of items 
 
 
195 
 
The UK panel also listed several specific examples of how patients may initiate the 
discussion themselves, or verbal indicators, while the Canadian panel stated simply that the 
patient may initiate the topic themselves, directly or indirectly.  The specific examples provided 
by the UK panel may be more helpful for novice practitioners, while the Canadian version 
leaves more room for interpretation and flexibility, and as such again may be highly dependent 
on the emotional intelligence of the health professional.  The issue of emotional intelligence will 
be discussed in 8.2.2. 
Table 7.1 Matched items for Question 1: How do health professionals know a patient is ready or 
willing to discuss end-of-life? 
UK Item Canadian Item 
Cues from the patient such as stating ‘I do not want to 
go to hospital’ 
Patient cues: for example, body language, facial 
expressions, open personality 
Patient is responsive when I allude to the end-of-life topic 
Patient responds when end-of-life topic is alluded to or 
initiated by the health professional  
Patient states that they have ‘had enough’ or that they 
want to die 
Patient initiates end-of-life topic with health 
professional – either directly or indirectly by bringing 
up death or end-of-life care in relation to something or 
someone else 
Patient asks if s/he is going to die 
Patient refers to their own death 
Patient talks about or asks about hospice options 
 
Within the category of considerations in end-of-life discussions, there were several 
matches between the Canadian and UK Delphi studies as shown in Table 7.2.   
The items Allowing the patient to lead the conversation (UK), and letting the patient guide the 
discussion (Canada) indicates that the discussion should be on the patient’s terms.  This may 
pertain to the idea of readiness versus willingness to discuss as raised in the UK Delphi as the 
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discussion would likely be shaped by the level of readiness or the willingness of the patient.  
Indeed, the level of readiness is another item that was matched in both Delphis.  This issue is 
discussed in section 8.2.2.    
Regarding the presence or absence of family support in the patient’s life (Canada), or having 
the family’s support during the discussion, these may not seem to the same, however they were 
matched because they both raise the issue that the absence or presence of family must be a 
consideration when having a discussion, as this would raise further considerations such as 
whether the patient needed the health professional to act as an advocate for their views with 
the family, or whether the patient wanted family members to be involved in decision making.  
The issue of family can be associated with cultural consideration and is discussed as further in 
section 8.2.2. 
Three items from the Canadian Delphi were matched to the UK item nurse having 
experience in caring for dying patients.  The Canadian panel divided the issue of experience into 
three areas: familiarity with the end-of-life process, experience and practice having discussions 
and knowledge of palliative care and end-of-life issues.  This specificity of what experience in 
end-of-life discussions entails is potentially helpful for novice practitioners trying to gain such 
experience, as well as for educators.  The assignment of a key health professional to discuss 
end-of-life with patients has been raised throughout this study, and this item may be helpful in 
determining who is most appropriate to be assigned on a team.  This issue pertains to end-of-
life policies in health care organisations and is addressed further in 8.2.2. 
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Table 7.2 Matched items from Question 2: Key considerations for end-of-life discussions. 
UK Item Canadian Item 
Allowing the patient to lead the conversation Letting the patient guide the discussion 
Being open and honest with the patient Being open/being honest (2 items) 
Recognising the individual needs of the patient Individual patient needs 
Patient indicates readiness to discuss Readiness of the patient to discuss 
Where the discuss occurs e.g. clinical, hospital or 
patient’s home (merged into ‘having an appropriate 
environment for the discussion’ 
Privacy for discussion 
Having the family’s support during the discussion 
Presence or absence of family support in the 
patient’s life 
Health professional having the confidence to discuss 
Health professional being comfortable with 
approaching end-of-life topic 
Nurse having experience in caring for dying patients 
Health professional is familiar with end-of-life 
planning process/ Health professional having 
experience and practice having end-of-life 
discussions/ Health professional has knowledge of 
palliative care and end-of-life issues (3 items) 
Patient having enough time to hear information and then 
ask questions later 
Time available for follow up discussions 
Availability of time to discuss Time available to discuss 
 
In the category of key topics in end-of-life discussions there were six matching items 
between the UK and Canadian Delphi studies, as compared to 18 UK items that were not 
matched in this category.  This may be reflective of the impact of policy differences between 
countries as to what the important issues to address are, or cultural differences between 
populations.  These issues are discussed in 8.2.2. 
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Table 7.3 Matched items from Question 3: Key topics for end-of-life discussions. 
UK Items Canadian Items 
Introduction of an advance care planning document 
Levels of advance care directives (supportive care only 
to full resuscitation) 
The type of care the patient wants How patient wants things to look at the end-of-life 
Explaining palliative care 
Patient understanding that they can receive palliative 
care 
Patient goals 
Health professional checking that day-to-day as well as 
longer term needs will be met 
Spirituality 
The patient’s spiritual beliefs and how they may be 
incorporated into the end-of-life care plan 
Option to change your mind about end-of-life 
decisions 
Options to change your mind after making end-of-life 
decisions 
 
7.1.3 Unmatched items in UK and Canadian Delphi Studies 
Unmatched items for each Delphi question are listed in Table 7.4, Table 7.5, and Table 
7.6.  Overall, these items reveal key differences between the UK and Delphi panel findings, 
which is essential for meeting the third objective of delineating the differences in end-of-life 
discussions for patients with NMRD. The items will be summarized here and discussed in depth 
in Chapter 8. 
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Table 7.4 Unmatched items for Question 1: How health professionals know a patient is ready or 
willing to discuss end-of-life. 
UK Items Canadian Items 
Patient appears to be getting their affairs in order 
Clinical indicators e.g. length of disease process, burden 
of disease, recent acute episode 
 
The health professional uses their emotional intelligence 
to gauge patient readiness 
  
There are situations when the patient’s readiness to 
discuss end-of-life is not important, such as when the 
topic must be discussed immediately for practical 
purposes 
 
Interestingly, the unmatched item ‘clinical indicators’ was proposed in early rounds of 
Question 1 in the UK Delphi, as was the use of intuition (relating to emotional intelligence) by 
health professionals, but neither gained consensus. In addition, the idea that there are 
emergency scenarios where the debate as to whether a patient is ready or willing is not 
relevant was novel in the Canadian Delphi. 
The first four listed under the UK heading in Table 7.5 point to the educational role of 
health professionals for patients.  This was not emphasized in the considerations of the 
Canadian Delphi perhaps because of the ‘patient education context’ section of Question 1.  
This difference demonstrates in the delivery of patient education in each country and 
implications are discussed in section 8.2.2. 
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Table 7.5 Unmatched items for Question 2: Key considerations in end-of-life discussions. 
UK Items Canadian Items 
Answering the patient’s questions regarding the 
condition 
Family issues for the patient e.g. young children at 
home, unresolved family problems 
Establishing the patient’s understanding of their 
condition 
Communicating patient wishes to their family 
Explaining to patients what is feasible regarding their 
wishes 
Sense of humour when appropriate 
Educating the patient about their condition Sensitivity to the patient’s culture 
Patient wanting to hear the information Approaching the topic calmly 
Having an appropriate clinician to discuss end-of-life 
with the patient 
Approaching the topic with a caring nature 
Emphasising a holistic care approach Being respectful of the patient 
Rapport between health professional and patient Listening to the patient 
Using non-medical language Accepting the patient’s reactions 
Working within your professional boundaries Knowing when to step back from the topic 
Developing the discussion over time Raising the topic early before a critical situation 
Finding the right opportunity to discuss 
Having end-of-life on a list of things that need to be 
talked about 
  
Having handouts of examples of advance care 
directives (paper resources) 
 
Responsibility of health professional to meet patient 
wishes 
  Sensitivity to health literacy level of the patient 
 
Sensitivity to patient’s language needs 
  
Health professional has attended education sessions 
about discussing end-of-life  
 
Emotional intelligence of the health professional  
  
Health professional acts as a neutral party to talk to 
the family about what is happening to the patient 
 
Patient’s condition for discussion e.g. the patient is in 
the hospital with an acute episode or patient is trying 
to get their breathing under control early in the 
morning 
  Multi-disciplinary team available to the patient 
 
Confirming patient understanding of the discussion 
  
Credibility of the health professional (as recognized by 
the patient) 
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The item ‘having the appropriate clinician to discuss end-of-life with the patient’ implies 
that this clinician has been assigned to the patient, or has a certain level of expertise or 
knowledge of the patient.  What is not clear is whether the term ‘appropriate’ means from the 
view of other health professionals, or whether it is from the patient.  If it is from the patient’s 
view, then this item might be related to the Canadian item ‘credibility of the health professional 
(as recognised by the patient)’, but this cannot be assumed.  The issue of the confidence of 
health professionals, again perhaps to assume they are the appropriate person, is raised.  This is 
also associated with communication between health professionals to determine who this 
appropriate person is, so that they may acknowledge and carry out their role to discuss end-of-
life with the patient as addressed in section 8.2.2. 
Referring to the unmatched item; consideration of the rapport between the patient and 
the health professional’, it is important to note here that this item is not about the necessity of 
the existence of a rapport, but rather considering whether such a rapport exists before having a 
conversation.  This is indirectly associated with several items from the Canadian Delphi 
regarding specifics on how to approach the discussion that may help to establish a rapport, or 
at least make the patient comfortable such as ‘approaching the topic calmly, with a caring 
nature, being respectful of the patient, listening to the patient, accepting the patient’s reactions, 
using a sense of humour and knowing when to step back from the topic.  Again, these Canadian 
items imply the existence of emotional intelligence in the health professional, and the explicit 
use of such intelligence when approaching end-of-life discussions, as will be discussed in section 
8.2.2. 
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Using non-medical language was another UK item that was not matched in the Canadian 
Delphi.  However, this item may correspond to the issue of sensitivity to the health literacy 
level of the patient, as well as sensitivity to the patient’s language needs.  While the latter item 
likely refers to the patient’s language of origin, sensitivity to both aspects may imply the 
avoidance of the use of non-medical language.  The issue of language is also connected to the 
unmatched Canadian item ‘sensitivity to the patient’s culture’.  These items are dealt with in 
section 8.2.2. 
The UK item of working within your professional boundaries was unique to the UK panel. 
However, it brings to light an issue of whether professional boundaries are different for 
Canadian and UK health professionals.  Several of the Canadian health professionals shared in 
Round 1 interviews how they used their own personal experiences with death when discussing 
end-of-life with patients (section 6.2.1 – framing the discussion appropriately).  This was 
contrary to UK health professionals, who stated that to bring their own personal beliefs or 
experiences to patient conversations would be taboo and inappropriate.  This points to a 
potential difference in the openness of health professionals in each country and the potential 
impact that this may have on end-of-life discussions. 
One issue that was raised in several items in the Canadian Delphi was the role of the 
health professional to mediate between the patient and their family, in some cases acting as an 
advocate on the patient’s behalf.  Another item exclusive to the Canadian Delphi findings was 
the training and experience of the health professional, and again the explicit statement regarding 
the emotional intelligence of the health professional.  The feeling of responsibility for the health 
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professional to meet the patient’s wishes once they were communicated was also unique to the 
Canadian Delphi.  While health literacy, language and culture have already been mentioned, the 
patient’s physical condition for discussion was also raised as a consideration in the Canadian Delphi.  
Finally, the availability of a multi-disciplinary team was an item raised only in the Canadian 
Delphi. 
Table 7.6 Unmatched items from Question 3: Key topics in end-of-life discussions. 
UK Items Canadian Items 
Emergency management preferences Patient understanding of their option to make end-of-
life choices 
Anticipatory prescribing Patient deciding on a substitute decision maker 
Ceiling of treatment Patient understanding of the ‘chain of command’ of 
decisions makers should their be a dispute when the 
patient is unable to speak for themselves 
Medication options Making sure doctor knows what kind of care the 
patient wants 
Treatment options Walking the family through the process of what will 
happen when the patient dies 
Intubation and ventilation options Explaining implications of end-of-life decisions and 
care to family 
Preferred place of care Discussing the positive and negative consequences of 
treatments or interventions with patients 
Preferred place of death Educating patients about their end-of-life choices and 
implications 
When the patient is likely to die Goals of care 
Sedation availability/options Explaining where they are in their disease; for 
example: at a stage where there is no cure: focus 
symptom management 
Social services involvement  
Transferring to palliative care  
Dealing with breathlessness  
How they feel about death  
Practical equipment needs  
Support in the home  
Transportation needs to facilitate care  
Needs of the partner/significant other  
 
The unmatched items for Question 3 from the UK and Canada are highly distinguishable.  
The UK consensus items are all practicalities regarding current and planned end-of-life care, 
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while the Canadian items are all related to confirming understanding with patients and clarifying 
understanding with other health professionals and family members.  Again, this difference could 
be related to the roles that health professionals hold in each country.  While all items relate to 
education, the UK findings seem more in-line with a case management support approach, 
compared to the Canadian findings, which seem to be more related to the provision of 
psychosocial support. 
7.2 Discussion 
There was an interesting difference in the educational role of health professionals in 
each country.  Several items from the UK panel were related to this role, and the Canadian 
Delphi resulted in an entire subcategory of findings regarding the patient education context. 
In Canada, most patients attend sessions related to their COPD run by a certified 
COPD educator, which is a specific qualification to perform this role.  Often, information about 
end-of-life care is provided, although it is may be delivered in an informational ,rather than a 
conversational, context.  This is in contrast to one-on-one patient education, which is the 
primary method delivered by the British Lung Foundation Nurse Programme. 
One key difference between the findings of the Delphi panels was related to the 
educational role of health professionals for patients.  It was clear from the UK items such as 
answering the patient's questions regarding the condition, establishing the patient's understanding of 
their condition and educating the patient about their condition that educating the patient is a part of 
the role of health professionals in the UK.  However, in the Canadian Delphi, an entire sub-
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section of responses to Question 1 was related to the patient education context, pointing to 
the difference in delivery of patient education in non-malignant respiratory disease.  
An Evaluation of the British Lung Foundation Nurse Programme (2008) stated that 
education was delivered one-to-one to patients and also in group contexts, while in Canada a 
range of health professionals deliver educational interventions to patients and there is a 
professional designation 'COPD educator' held by several participants (Stolikova et al 2013).  
The issue of patient education and the potential implications for end-of-life communication are 
discussed in Chapter 8. 
Sensitivity to patient culture was an item from the Canadian Delphi that did not arise in 
the UK Delphi.  This highlights the important consideration that patients come from various 
cultural backgrounds and health professionals should not assume that patients’ values are 
consistent with those that guide western-based medicine, as cultural variants are highly likely to 
have a direct impact on how patients and their families understand death (Bullock, 2011). 
The item Health professional having experience and practice having end-of-life discussions 
gained consensus in the Canadian Delphi.  This may relate to the provider’s personal or 
professional experience.  This item had developed out of several participants in Round 1 stating 
that they shared their personal experiences of death and dying with their patients as examples 
of why end-of-life discussions are important, in addition to emphasis on the idea that you get 
better at discussions as you practice them. Along with the item Health professional being 
comfortable with approaching end-of-life topic, this brings in an important point about professional 
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boundaries in end-of-life communication in Canada.  Using personal experience may be 
something that is not often discussed in the literature, or recommended because of the 
potential for this to go wrong, however, when done appropriately it can be a very effective way 
to start an open and honest discussion about end-of-life with patients as was relayed by the 
participants.  Interestingly, there are currently no guidelines issued by the Nursing and 
Midwifery Council specifically related to self-disclosure, unlike Canadian nursing bodies such as 
the College of Registered Nurses of British Columbia and Nova Scotia (College of Registered 
Nurses of British Columbia, 2006), which have issued specific guidance on self-disclosure in 
nurse-client relationships.  For example:  
‘Self-disclosure occurs when the nurse shares personal information with a client. Self-disclosure 
may be used in moderation as long as it is focused on the needs of the client. In these situations 
disclosing personal information may have the therapeutic intent of reassuring, counselling or 
building rapport with clients. Disclosing personal information that is lengthy, self-serving or 
intimate is never acceptable.’ (Nurse-Client Relationships, College of Registered Nurses of British 
Columbia, p. 13) 
 
This relates to the social penetration theory and the norm of reciprocity from the 
communication literature.  Social penetration theory, often described using the onion metaphor, 
suggests that there are layers upon layers of self-disclosure (Bylund et al., 2012).  Surface levels 
of information are regularly shared with others, but the intermediate and central layers 
containing private information are not until they are revealed as relationships develop through 
reciprocal self-disclosure.  However, patients and providers are unlikely to regularly have 
reciprocal levels of disclosure, leading to a violation of the normal pattern of social penetration 
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(Bylund et al., 2012).  Therefore, perhaps some self-disclosure of provider’s experiences with 
making end-of-life decisions may help to encourage patients to do the same. 
One interesting consideration in end-of-life discussions in the Canadian Delphi was 
health literacy of the patient.  This was not mentioned in the UK Delphi, however it is an 
important issue.  Health literacy is defined as ‘The ability to access, understand, evaluate and 
communicate information as a way to promote, maintain and improve health in a variety of 
settings across the life-course’ (Rootman and Gordon-El-Bihbety, 2008, p. 11).  Approximately 
55 percent of Canadians between the ages of 16 to 65 scored below Level 3 on the 
International Adult Literacy and Skills Survey Health literacy scale (Learning, 2007).  Only one in 
eight adults (12%) over the age of 65 appears to have adequate health literacy skills (Rootman 
and Gordon-El-Bihbety, 2008) which is concerning given that patients with lower health literacy 
are more likely to be hospitalized, have poorer understanding of treatment and lower 
adherence to medical regimens (Mahadevan, 2013).  This is particularly important in COPD as 
this group have complex treatment regimens, and often have multiple meetings with a range of 
healthcare professionals (Roberts et al., 2008), while cognitive impairment in elderly patients 
may be an additional barrier to understanding (Allen and Ragab, 2002). 
As an example of the prevalence of limited health literacy, it was shown that 59.2 
percent of COPD patients did not understand the term ‘exacerbation’, and only 1.6 percent 
could explain the term correctly (Kessler et al., 2006).  A minimum of 15 percent of patients 
may have diminished literacy and it is emphasized in the health literacy literature that the 
‘magnitude’ of low health literacy should be recognized rather than trying to identify specific 
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individuals.  Therefore, strategies to improve understanding for all patients such as decision aids, 
pictograms, leaflets and videos may be helpful to use in consultations (Roberts et al., 2008). 
7.3 Conclusions 
In order to meet the third objective of the doctoral study: to delineate the differences 
between end-of-life discussions in NMRD in Canada and the UK, a comparison of results of the 
UK and Canadian Delphi studies was conducted and findings were briefly discussed in section 
6.4.  While differences in the literature from each country are delineated in chapter 3, further 
differences between the UK and Canada regarding patient education and the roles of the health 
professional regarding providing psychosocial support and cultural issues in each country were 
highlighted from this comparison of Delphi studies. The findings also demonstrated that issues 
such as patient culture and health literacy levels are key issues that perhaps are not properly 
addressed by health professionals in the UK.  The discrepancies between findings in each 
country highlight the benefit of conducting international comparative studies as a way to 
provide insight into practice and inform future developments in each country, as well as to 
determine the best solutions for individuals with complex needs and their families (Higginson, 
2005).  The way that these findings and others from this phase contribute to the development 
of theory and construction of the model of end-of-life discussions is delineated in Chapter 8. 
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Chapter 8. Discussion 
8.1 Introduction 
The findings of each of the four phases of this study have been discussed in relation to the 
previous literature in sections 2.5, 3.6, 5.8 and 6.3.  As per the MRC guidelines for the 
development of complex interventions, the key findings of each phase will be translated into a 
theoretical model of end-of-life discussions in NMRD. In this chapter, first, the aims and 
objectives of the study will be reviewed as a reminder to the reader in section 8.2.  This will be 
followed by the presentation of the theoretical model of end-of-life discussions in NMRD 
(section 8.2.1) and an examination of each of the components of this model in relation to the 
current literature (section 7.2.2).  Conclusions and recommendations resulting from the study 
are presented in Chapter 8. 
8.2 Study Aims and Objectives Reviewed 
As outlined in the introduction chapter, the aims of this doctoral study were to: 1) 
determine how health professionals discuss end-of-life with patients with NMRD in the UK and 
Canada, and 2) develop an instrument allowing health professionals to determine constraints 
and opportunities within the environment to facilitate successful end-of-life discussions with this 
patient group in the UK and Canada.  The study aims were addressed through the following 
objectives: a) establish and validate how health professionals know a patient with NMRD is 
ready or willing to discuss end-of-life, b) establish and validate the key considerations and key 
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topics in such discussions as defined by health professionals in the field, and delineate the 
differences in end-of-life discussions for patients with NMRD in the UK and Canada. 
The aims and objectives were achieved through four phases of study including two systematic 
reviews and two Delphi studies.  Figure 8.1 summarises this process.   
Figure 8.1 Four phases of a study to develop a complex intervention adapted from MRC (2008). 
 
The study was designed to achieve the development phase for complex interventions as 
outlined by the MRC (2008), and included identifying the evidence base, modelling the 
intervention and developing a theory.   
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The following theoretical model encapsulates the findings relating to the first study aim 
of how end-of-life is discussed in NMRD that emerged from each phase of the study.  The tools 
that were developed as a result of the UK and Canadian Delphi study to model the intervention 
achieve the second aim of the study are presented in Figure 5.6 and Figure 6.6.  The plans for 
the piloting and evaluation of these tools as per the next stages of developing an intervention 
(Figure 1.1) are discussed in detail in the recommendations for research in section 9.5 of 
Chapter 8. 
8.2.1 Theoretical Model of Findings – facilitators and barriers to end-of-life 
discussions in nonmalignant respiratory disease 
Several themes were identified throughout the systematic reviews and Delphi studies 
that contributed to the model.  In the first systematic review the responsibility of the health 
professional to initiate the discussion, along with the patient's desire for end-of-life information 
were identified as issues in end-of-life discussions.  The first systematic review also brought 
forth the importance of the recognition of facilitators and barriers for individuals discussing 
end-of-life, and the importance of having an ongoing discussion over time, and power issues 
between health professionals and patients in such discussions. 
The second systematic review identified the use of clinical indicators as a contentious 
issue in end-of-life discussions, as well as the complication surrounding providing patients with a 
prognosis in NMRDs.  The relation of end-of-life policies to the occurrence of discussions was 
also raised, in relation to the use of advance care planning documents.  The significance of the 
role of family, as well as sensitivity to cultural issues was also identified through this review.  
212 
While again, the issue of the health professional's responsibility to initiate end-of-life discussions 
was evident throughout the findings of the second systematic review. 
The findings of the Delphi studies conducted in phases 3 and 4 of the doctoral study 
complimented and built on the findings of the systematic reviews.  The importance of the role 
of health professionals as educators in end-of-life discussions evident in both studies, as was the 
importance of recognising cultural, spiritual and individual needs for patients.  Interestingly, the 
use of emotional intelligence by health professionals to gauge end-of-life discussions was raised 
in each Delphi study, yet the UK findings focused exclusively on perceiving verbal cues, while 
the Canadian study focused on the perception of non-verbal cues.  Finally, the differentiation 
between readiness and willingness to discuss emerged as an important issue in the analysis of 
the UK Delphi findings, and is believed to be a key issue in end-of-life discussions. 
These issues, along with the key theme of time that was evident throughout the phases 
of the study will be discussed in the following sections in relation to the theoretical model of 
end-of-life discussions in NMRD that has been developed as a result of the findings. 
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Figure 8.2 Theoretical model of how health professionals discuss end-of-life in nonmalignant 
respiratory disease. 
 
This model presented in Figure 8.2 is based on the systems theory of social work, which is an 
organizing conceptual framework for understanding individuals within their environment (1983).   
This model applies to all health professionals, not just social workers, and it was thought that 
the multi-level system model would be helpful to explain the considerations that need to be 
made regarding the individual in the larger social context in relation to end-of-life discussions in 
non-malignant respiratory disease.  Systems theory is useful for understanding the dynamics of 
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an individual patient in order to make sense of problems and develop balanced intervention 
strategies (Meyer, 1983). 
This model is divided into three systems – macro, mezzo and micro. Briefly, 
Microsystems refer to small social systems like individuals and health professionals, mezzo 
systems typically include groups, and networks, and macro systems are large systems like 
communities and organizations (Friedman and Neuman, 2011).  In this system, the macro level, 
which can represent health care in general, the health system in a given country and the society 
in which it functions includes three components: end-of-life policies; prognosis issues in non-
malignant respiratory disease; and the notion of time.  Policies related to end-of-life care govern 
end-of-life discussions as they dictate priorities and access to resources for health professionals, 
patients and families.  For example, as discussed in the introduction, the fact that 76 percent of 
adult inpatient specialist palliative care units in the UK are run by charities, will dictate 
availability to patients in certain areas, and therefore whether inpatient palliative care is offered 
as an option to patients during end-of-life discussions. 
At the Macro level, discussions related to end-of-life in non-malignant respiratory 
disease are also determined by the difficulties in providing a prognosis for this type of disease.  
As addressed in the introduction chapter, the problems related to providing a prognosis, along 
with the lack of a consistent disease trajectory can severely hamper end-of-life discussions 
(Clayton et al., 2005).   
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The notion that time is passing for people and health professionals working with a life 
limiting condition is key and relates to policies, the use of clinical indicators or not, the issue of 
providing a prognosis and the responsibility to initiate a discussion.  Time also provides a 
specific problem in certain environments such as hospitals where health professionals state that 
sufficient time is to discuss end-of-life issues is not allocated in their clinical practice. 
Next, at the Mezzo level, which includes the role of the health professional with a given 
patient and within a given institution are three important components of end-of-life discussions 
in non-malignant respiratory disease: the use of clinical indicators to signal timing for end-of-life 
discussions, the responsibility to initiate end-of-life discussions, and the educational role of 
health professionals.  As discussed in sections 5.3.1, 5.86.2.1, the use of clinical indicators to 
indicate the timing of end-of-life discussions arose as a contentious issue throughout the 
doctoral study.  It gained consensus in the Canadian Delphi, but not in the UK Delphi, but is 
identified as a key trigger for end-of-life care in policy (2006).  As a part of this model of end-of-
life discussions, it is present as something that must be considered by health organisations and 
the health professionals within them.   
Next, the issue of whose responsibility is it to initiate end-of-life discussions arose 
throughout the study.  As discussed in section 3.5.4, this is another issue that must be 
considered when approaching end-of-life discussions and is in the mezzo section as again it 
applies to both health organisations and the health professionals within them. In section 3.6 it 
was recommended that a key health professional be assigned to each non-malignant respiratory 
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disease patient with the explicit responsibility for end-of-life discussions, with a clear 
understanding of the components within the Macro and Micro Levels. 
The role of health professionals as educators for patients with non-malignant respiratory 
disease was significant in the Delphi findings in both the UK and Canada.  This educational role 
may include formal education sessions for groups of patients, as well as informal education such 
as answering patient and family questions about their condition, explaining palliative care, and 
accessibility of services. This educational role arose as highly imperative as it is can be the 
gateway to end-of-life discussions, and the processes that occur at the micro level. 
The issue of emotional intelligence at the Micro Level is a key component. This issue 
came out in both Delphi studies.  While the Canadian Delphi panel agreed that the health 
professional uses emotional intelligence to gauge patient readiness (section 6.3), the UK Delphi 
stated that the health professional must perceive verbal cues from patients (section 5.8).  It 
seems clear that emotional intelligence is not only related to gauging patient readiness, but also 
to the educational role of health professionals and cultural competence.   
The next key issue that arose throughout the findings of this doctoral study was cultural 
awareness or cultural competence including health literacy and language.  In this discussion it is 
important to distinguish that culture can mean the culture within a family, within a group of 
individuals, or even within a particular hospital.  The key issues here are the role of family and 
end-of-life discussions and this came out in the systematic reviews and the Delphi studies as 
something that could either be beneficial or detrimental to the end-of-life discussion.   
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Within the consideration of cultural issues, the consideration of the health literacy of 
the family and patient was brought forward as an issue.  This could involve ensuring that the 
patient understands their condition, which also relates to the role of the health professional as 
an educator, but also to providing information using non-medical language and providing ample 
opportunity for the patient and family to ask questions. 
The use of the terms ‘readiness’ and ‘willingness’ were not initially meant to 
conceptually distinguish between readiness versus willingness, instead it was meant to provide 
further explanation to the reader to Question 1.  However throughout analysis of the data it 
turned out that there was a difference between readiness and willingness to discuss (section 
5.3).  It transpired that this is a key distinction when perceiving the ability of a patient to have 
an end-of-life discussion and therefore it is one of the key aspects of this model of end-of-life 
discussions in NMRD. 
This model is not meant to be prescriptive as it has been established that formal 
processes for discussion are problematic (section 1.4).  Indeed many components could easily 
be placed within an additional level, such as emotional intelligence and cultural competence, 
which could be related to how health professionals are trained at the macro level. Therefore 
each component should be thought of as equally important when approaching end-of-life 
discussions in non-malignant respiratory disease.  This model simply identifies the key 
components identified in this doctoral study that must be considered in such discussions, and 
may be helpful when addressing the education of health professionals down to approaching a 
discussion with an individual patient or family.  Each of the considerations in this model will be 
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discussed in relation to their contexts in current end-of-life policy and research in the sections 
that follow. 
In addition to the tools developed for the UK and Canada outlining 'how health 
professionals know a patient is ready or willing to discuss end-of-life’, this model helps to 
understand the issues at hand when approaching such discussions. The considerations and 
topics for discussion make up the components of end-of-life discussions.  The model can be 
viewed as per Donabedian’s(1973) model of patient-professional communication and Roter and 
Fallowfield’s (1998) view of patient centered medicine, as raised in section 1.4, where the 
different perspectives of health professionals and patients may create obstacles in 
communication.  The model proposed here may help health professionals to gain insight into 
the perspective of the patient, leading to more patient-centered consideration of psychosocial 
consequences and allowing them to make choices appropriate to their individual context.  It is 
hoped that this would thereby enable more successful communication about end-of-life.   
8.2.2 Context of Findings within the Model 
Emotional intelligence 
The idea that health professionals use their emotional intelligence to gauge patient 
readiness gained the consensus opinion of the participants, as did the need to interpret verbal 
and non verbal cues from patients. Bulmer Smith et al. (2009) review the concept of emotional 
intelligence and examine the various definitions put forth by the key scholars in the field who 
define it as an ability (Mayer and Salovey, 1997), a set of traits and abilities (Bar-On, 2005), or a 
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combination of skills and competencies (Goleman, 1998), and state that a convergent definition 
does not exist (Bulmer Smith et al., 2009).  However, it is thought to include the ability to 
know and manage one’s own emotions, expressing empathy to others and the ability to 
recognize subtle cues of changes of emotions in others (Goleman, 1995). 
Emotional intelligence of nurses may have a positive impact on patient outcomes, as 
nurses who enter the patient’s home as guests are often confronted with emotionally charged 
situations and therefore they must be prepared to manage their own and others’ emotions 
(Bulmer Smith et al., 2009, Davies et al., 2010).  Emotions are key indicators of the moral 
aspects of a situation where a decision must be made, therefore can contextualise decision-
making processes and ultimately help the health professional to be more empathetic and patient 
focused (Freshwater and Stickley, 2004, Evans and Allen, 2002, Gooch, 2006). 
In concordance with the findings of this study, being able to recognize the right timing to 
have end-of-life discussions has been described as a skilled process of ‘feeling your way’, which 
includes knowing the patient, and possessing emotional intelligence (Crawford, 2010).  The 
discussion of end-of-life topics may bring forward deep fears or feelings of the health 
professional (Teasdale et al., 2001). The possession and development of emotional intelligence 
are fundamental for growth for nurses and other health professionals (Heffernan 2010), but in 
order to enable growth, formal and informal supervision and reflection processes are an 
essential part of the process (Davies et al., 2010, Teasdale et al., 2001). 
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Educational role of health professionals 
Patient education emerged as a key issue throughout the doctoral study.  Several consensus 
items in both Delphi studies included items related to patient education such as: 
 Explaining palliative care 
 Answering patient questions about the condition 
 Educating patient about the condition.   
In addition, a lack of consensus in one area of the Canadian Delphi brought to light that 
assumptions may be made, particularly in the patient education context, of which we should 
perhaps be aware.  
Patient education has been defined as the ‘teaching or training of patients regarding their 
own health needs’, and more specifically as providing disease specific information and skills by 
Bodenheimer (2002).  Patient education interventions may range from the provision of leaflets 
to educational programmes that involve several sessions on various topics.   
An Evaluation of the British Lung Foundation Nurse Programme (2008) found that the 
most important elements of the BLF Nurse role were clinical activities and patient education. 
The principle method of education was one-to-one education supplemented by printed 
materials, while they also reported delivering group education (Angus Forbes, 2008).  Education 
was for both patients and carers and other health professionals.  It was delivered formally and 
informally.  An important part of this education was establishing the Breathe Easy groups for 
patient support throughout the UK.  Indeed, this is reflected in the literature stating that 
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educating patients has historically been a key feature of nursing practice (Henderson, 1966), and 
that patients may find nurses more approachable for information than physicians (Collins, 2005).  
However, the demographics of the Canadian Delphi study show that a range of health 
professionals, often respiratory therapists, in Canada deliver educational interventions to 
patients, and this is supported by a study by Stoilkova et al. (2013).  A recent systematic review 
found that it is difficult to assess whether the profession of the health professional delivering 
the education was important for the effectiveness of the intervention, as many studies do not 
report the profession of the health professional (Coster and Norman, 2009).   
Round 1 interviews of the Canadian Delphi revealed that often respiratory patient 
education programmes include a session about end-of-life decision making; however, the 
experts did not agree that attending such a session meant that patients were necessarily ready 
to discuss end-of-life (section 6.2.1). 
Therefore, as patient education is also a large part of the role of BLF nurses (Angus 
Forbes, 2008), and is essential for COPD patients, perhaps it can be viewed as part of the 
process to move patients to moving patients towards readiness to discuss (as discussed in the 
following section).  However, in patient education, the level of health literacy of the patient 
must be taken into consideration.  Patients with lower health literacy have been found to have 
higher rates of hospitalization, poorer health outcomes, increased mortality, a poorer 
understanding of the disease process (Eckman et al., 2012) and therefore it is essential that 
patient education interventions be targeted to the health literacy level of the individual patient, 
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and that a lack of interest or participation by the patient not be necessarily dismissed for this 
reason.  
Readiness versus willingness to discuss end-of-life 
The previous section regarding the educational role of health professionals brings us 
back to the concept of readiness, as raised in the UK Delphi Chapter (section 5.3). The concept 
of readiness is part of the transtheoretical stages of change model proposed by Prochaska et al. 
(1994).  This model is focused on the decision making process of the individual and relates to 
intentional change, assuming that change in behaviour occurs through a cyclical process. 
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Figure 8.3 Transtheoretical stages of change model. 
 
Through the lens of this model, Patients may be guided toward readiness to discuss end-
of-life by the health professional using a semi-structured approach, such as the one discussed in 
Rizzo (2010).  Perhaps then this stage of the patient education process does not indicate 
readiness, but is a stepping stone in preparation to discuss.  Attending the education may be 
part of the stage that Fowler (1998) describes when the patient realizes that making a change 
would be beneficial.  Alternatively, it would be explained by Prochaska et al. (1994) as the pre-
 
 
224 
 
contemplation phase is where the patient increases their awareness of the benefits of discussing 
end-of-life.   
This could be directly related to the lack of consensus that the participants had on the 
item that a patient following up on information from such an education session implies 
readiness to discuss (Table 6.4).  Instead, this could be part of the contemplation phase 
(Prochaska et al., 1994) where the patient is seeking more information, but is not necessarily 
ready to address this issue.   
In both of these situations in the patient education context, it is up to the health 
professional to assist patients to move toward the next stage of behavioural change - the 
preparation and action phases (Prochaska et al., 1994).  Therefore, it is important that health 
professionals are aware of the concept of readiness, how it can be established, and the stages of 
change transtheoretical model, so that they can apply it in their work, and perhaps design their 
patient education programmes around it. 
Understanding ways patients indicate readiness or willingness to discuss can help to 
facilitate end-of-life conversations.  Differentiation of the concepts of readiness and willingness 
when discussing end-of-life may be an important distinction.   
The concept of readiness in the context of patient behavior is discussed by Fowler 
(1998), Medvene et al. (2007) and Rizzo et al. (2010).  While Fowler (1998) gives a clear 
definition of readiness in the context of patient behavior, Medvene et al. (2007) and Rizzo et al. 
(2010) view patient readiness as a continuum within the Stages of Change Transtheoretical 
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Model (TTM) (Prochaska and DiClemente, 1985).  Informed by the stages of change theory 
(Prochaska and DiClemente, 1985), stages of readiness theory (Rohren et al., 1994) and 
reversal theory (Lafreniere, 1993), Fowler (1998) claims that there are five elements that 
indicate a person’s readiness: 1) The person realizes that change would be beneficial; 2) The 
person has identified barriers to change and is willing to remove these barriers; 3) The person 
has taken responsibility for making the change; 4) The person is in control of their own 
behavior;  5) The person must want to take action. With this approach, health professionals are 
looking for indication of readiness rather than guiding patients toward it. This is compared to 
the purely TTM approach, where health professionals guide patients toward readiness by 
assisting them to weigh the pros and cons of changing their behavior (deciding to talk 
about/make plans for end-of-life) using a semi-structured approach.   
 Therefore, while Fowler (1998) gives an explicit definition of readiness, Rizzo et al. (2010) 
and Medvene et al. (2007) link explicit readiness with the preparation (‘someone intends to 
take action but is not yet ready to make change’ (Prochaska and DiClemente, 1985)) and the 
action stage of TTM (where ‘behaviour is modified enough to produce clinically-significant 
change’(Prochaska and DiClemente, 1985)).  Fowler (1998) believes that the role of the health 
professional is to identify readiness in their patients, while Rizzo et al. (2010) and Medvene et al. 
(2007) view the health professional as someone to guide the patient toward readiness.  This is 
compared to the concept of willingness, which is not influenced by the health professional, but 
is instead spontaneously exhibited by the patient.   
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The concept of ‘willingness’ to communicate has been identified as the likelihood that a 
person will initiate communication when there is opportunity to do so (Burgoon, 1976, 
McCroskey and Baer, 1985, MacIntyre, 1994). While willingness to communicate is 
acknowledged to be a personality trait, there is high variation across situations (McCroskey and 
Richmond, 1987).  It has been found that a person’s willingness to communicate about their 
health is related to the amount of health information they desire, as well as their assertiveness 
in communicating with health professionals, and this may vary on a daily basis. Therefore, 
willingness is not influenced necessarily by the health professional, as compared to the concept 
of readiness, which is something that the health professional may help the patient to move 
toward (Wright et al., 2007).  The indicators from the Delphi study that demonstrate a patient 
is ready to discuss end-of-life are summarised in Table 8.1 Indicators of 'readiness' and 
'willingness' to discuss end-of-life from the UK Delphi.Table 8.1. 
 
Table 8.1 Indicators of 'readiness' and 'willingness' to discuss end-of-life from the UK Delphi. 
‘Readiness’ indicators ‘Willingness’ indicators 
 Verbal cues from the patient such as stating ‘I do 
not want to go to hospital’ 
 Patient is responsive when I allude to the end-
of-life topic 
 Patient appears to be getting their affairs in 
order 
 Patient asks if s/he is going to die 
 Patient refers to their own death 
 Patient talks about or asks about hospice 
options 
 Patient states that they have ‘had enough’ or 
they want to die 
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Cultural competency 
The recognition of the culture of the patient and the family has been established as a key 
component of end-of-life discussions in NMRD.  In this discussion, culture refers to “patterns of 
explanatory models, beliefs, values and customs” (Crawley, 2005) which are expressed either 
materially (such as in dress, diet or ritual practices) or nonmaterially (such as in language, social 
order or kinship systems) (Crawley, 2005); while ethnicity is a way of grouping people based on 
historical identity, geographic identity or shared cultural patterns (Crawley et al., 2002).  In the 
UK, the term ‘minority ethnic group’ is used for purposes of official classification by the Office 
for National Statistics to describe groups of people who do not identify themselves as ‘white 
British’ (Evans et al., 2011). The author would like to acknowledge that while it is essential to 
understand differences between cultural and ethnic groups, it is also important to understand 
how individuals within such groups vary, and not use a prescriptive approach (Kwak and Haley, 
2005).    
The recognition of the cultural beliefs, values and patterns of behaviour in patients and 
their families is of essential importance when planning end-of-life care as these cultural variants 
are likely to determine how specific groups make sense of life and death, and how they make 
end-of-life decisions.  As the population in the UK and in Canada becomes more diverse, it is 
less likely that patients and families values, structures and functioning will be consistent with 
those upon which traditional Western medicine is based.  Therefore, in order to meet the 
needs of patients and their families, cultural competence on the part of health professionals is 
essential (Bullock, 2011).  
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While the influence of culture and ethnicity on end-of-life decision making has been 
acknowledged in the literature, particularly since the Macpherson Report highlighting the 
disparities for health care for minorities in the UK (1999), there has been limited uptake of 
advance care planning by minority groups in Canada and the UK (Johnstone and Kanitsaki, 2009, 
Evans et al., 2012).  In the UK, several policy initiatives related to ensuring equal access for 
minority ethnic groups to end-of-life care services such as the End-of-life Care Strategy (2008) 
state the importance of sensitivity to cultural and religious differences, and highlights the need 
for cultural competency training in order to provide culturally sensitive care (Johnstone and 
Kanitsaki, 2009).  Despite such initiatives, health professionals are often unaware of, and 
surprised by the extent that patients and families of such groups distrust the medical system 
and feel unsafe within it (Johnstone and Kanitsaki, 2009).  As a result, health professionals may 
be exasperated by what they may view as hostile resistance regarding end-of-life planning, and 
an incapability to understand and accept the benefits of such planning and discussion.  On the 
other side, patients and families feel perplexed by the health professionals incapability of 
understanding the meaning of their actions which are meant to protect their loved ones 
(Johnstone and Kanitsaki, 2009).  It is with this view that patients from minority groups are 
fearful that policies related to end-of-life care and planning may not benefit them, but work to 
their detriment (Baker, 2002).   
One of the key misunderstandings that arises is that in some cultures, discussing death 
and terminal illness is interpreted as an immediate death sentence. This was identified as the 
‘Nocebo’ phenomenon by Helman (1990), which is the negative effect that beliefs and 
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expectations can have on health outcomes, the reverse effect of the ‘placebo effect’, where 
inappropriate disclosures regarding end-of-life is problematic because of the potentially harmful 
‘nocebo’ effect that may be triggered.  As a result, disclosures that are culturally inappropriate 
can be perceived and experienced as ‘authoritarian, paternalistic, disrespectful and demeaning, 
and received with shock and dismay’, despite the good intentions of the health professional who 
is coming from a place of compassion and ethical practice (Candib, 2002, p. 222)  This may 
explain why in some groups the family acts as a gatekeeper to ensure that any disclosures that 
are made do not result in a loss of hope for the patient ((Johnstone and Kanitsaki, 2009, 
McGrath et al., 2005, Kwak and Haley, 2005). 
A hindrance in end-of-life discussions is the lack of understanding by health professionals 
of the dominance of the Western bioethical view.  (Johnstone and Kanitsaki, 2009).  The 
primary feature of this viewpoint is the overriding concept of autonomy, which some groups 
may feel is alienating and oppressive (Candib, 2002).  Therefore, the mainstream view of 
autonomy must include respecting the cultural values of individuals, and their right to cultural 
liberty (the right to maintain their ethnic, linguistic and religious identities) (Johnstone and 
Kanitsaki, 2009).  In some cases, the ultimate expression of autonomy may be the choice not to 
make a decision, but to waive their right to autonomy to another person (Candib, 2002).   
These issues of poor communication between health professionals and patients and 
families from minority ethnic groups were repeatedly emphasized in a systematic review of the 
primary research on minority ethnic groups and end-of-life care from the UK by Evans et al. 
(2012).  This review highlighted the specific issues of differences in social taboos about death 
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and illness, the lack of information in appropriate languages and formats, the inadequate 
provision of interpreting and advocacy services and difficulties in understanding and 
communicating verbally and nonverbally.  It is clear that understanding cultural values, attitudes 
and behaviours can help to create more positive interactions with patients and their families 
and ultimately result in better patient outcomes (Reith and Payne, 2009).  There are several 
examples of ethnic variation in end-of-life preferences in the literature (Bowman and Singer, 
2001, Carrese and Rhodes, 1995, Matsumura et al., 2002, Perkins et al., 2002, Murphy et al., 
1996) however, due to the scope of this discussion, the findings of these studies will not be 
discussed here. 
However, the issue of providing culturally competent care is problematic in itself as the 
literature makes recommendations regarding this issue, but not how to achieve it (Evans et al., 
2011).  There is no consensus on a definition of cultural competence and a lack of information 
regarding what should be included in training programmes for cultural competence.  In addition, 
many health professionals were unaware of the training that was available and many did not 
desire detailed information on cultural practices.  Such training programmes were often 
criticized as creating stereotypes.  There were also no studies that evaluated the effect of 
training on patient outcomes (Evans et al., 2012).  One definition by an organization that places 
extreme importance on cultural competency is the National Association of Social Workers (US) 
(2007).  This organisation also provides standards for cultural competence in practice: “the 
process by which individuals and systems respond respectfully and effectively to people of all 
cultures, languages, classes, races, ethnic backgrounds, religions, and other diversity factors in a 
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manner that recognizes, affirms, and values the worth of individuals, families and communities, 
and protects and preserves the dignity of each” (p. 12).  However, this is an American definition, 
and may not necessarily be adopted by the UK and Canada, however this issue is outside the 
scope of this thesis.  
Indeed, the UK End-of-life Strategy (2009) highlights the need for ‘spiritual, religious and 
cultural care competencies’ to be adopted within all core training.  however in a scathing 
critique of the document, Evans et al. (2011) points out that these needs were not repeated in 
the sections of the strategy that identified core principles and competencies or education, in 
fact, no mention of minority ethnic groups was made in these areas or improving the 
environments and future research. 
As discussed here, and identified in each phase of the doctoral study, cultural 
competence is essential to end-of-life communication in NMRD. While it seems simple to 
recommend that health professionals need to be trained to recognize patterns of explanatory 
models, beliefs, values and customs (Crawley, 2005), and act in way that respects and values the 
culture of each patient and family they encounter, much work must be done to determine how 
to put this into practice.  This may start with the End-of-life Strategy in the UK, and an 
understanding of the dominant Western bioethical view that pervades health practice and may 
unintentionally exclude minority groups from receiving appropriate end-of-life care and 
communicating about this care in health contexts.  Recommendations related to cultural 
competence will be made in section 9.4. 
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Initiation responsibility 
The findings clearly demonstrate that there is a lack of agreement about who is 
responsible for initiating end-of-life discussions.  This ambiguity may be specific to COPD as the 
UK Cancer Palliative Care guidelines state that key information should be delivered by the most 
senior health professional available, and that health professionals should be about to respond 
appropriately to patient concerns (National Institute for Clinical Excellence (NICE), 2004).  The 
Canadian guidelines for COPD state that physicians have a responsibility to help patients and 
caregivers with COPD to plan for the end-of-life and to access support (O'Donnell et al., 2008).   
A study of GPs and nurses in the community found that both groups of health 
professionals tended to wait for patients to raise issues regarding advance care planning before 
approaching the topic (Munday et al., 2009).  In addition, Abarshi et al. (2011) found that GPs 
discussed end-of-life issues more with patients with cancer than with other conditions.  The UK 
End-of-life Strategy (2008) states that discussions about end-of-life should be undertaken by 
health professionals who are trained in communication skills, assessment, care planning, and 
symptom management as related to end-of-life care (Department of Health, 2009).  However, 
the End-of-life Strategy also notes that providing such training for health professionals should be 
a priority in education, perhaps explaining why health professionals may currently be lacking the 
necessary skills.   
While the nurses in the UK Delphi study are responsible for initiating end-of-life 
discussions with their patients, this may not be representative of most nurses or health 
professionals and depending on the care context, non-physician health professionals may 
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instead be responsible for following up on end-of-life discussions after bad news has been 
received by the patients from physicians (Reinke et al., 2010).  However, it has been argued that 
often the nurse has a leading role in communication between patient, family members and staff.  
Often nurses spend more time with patients and families than other health professionals, 
thereby creating more opportunities to develop a rapport (Hidalgo Kehoe, 2006), and are also 
more likely to be present at the moment of death than physicians and for these reasons in 
acute care settings, nurses play a crucial role in initiating end-of-life discussions (Crump et al., 
2010). The nursing role is in contrast with the role of the physician, who may hesitate to 
discuss end-of-life because of the unpredictability of death, particularly with certain conditions 
like COPD which are known to have an unpredictable disease trajectory (Murray et al., 2005, 
Clabots, 2012).  In addition, physicians may be overly optimistic about the time that patients 
with a terminal illness have to live, and therefore may not see the need to initiate end-of-life 
discussions (Vigano et al., 2000).   
Regardless of the type of health professional initiating the discussion, Crawford (2010) 
states that it is the role of the health professional to create an open environment for discussion 
to allow patients to share their feelings and have productive end-of-life discussions.  A recent 
Canadian study found that less that 10 percent of elderly patients admitted to the hospital had 
communicated their end-of-life wishes to nurses, social workers or spiritual care workers.  
Given that this population has unmet needs in regards to emotional, psychological, spiritual and 
informational care, it is recommended that non-physician led initiatives toward such discussions 
in the community rather than in acute care contexts may be more sensible.  However ensuring 
 
 
234 
 
that preferences are documented and then communicated across contexts is essential (Heyland, 
2013). 
A study of community nurses found that this group acknowledged their key role in 
starting end-of-life discussions, they were concerned with ability to time such discussions 
sensitively, as well as the difficulty of raising such topics in a culture that predominantly does 
not promote the open discussion of death (Seymour et al., 2010).  In addition, facilitating 
potentially time consuming end-of-life discussions for nurses in the community with 
unpredictable workloads proved difficult (Burt et al., 2008).   
Clinical indicators 
While the Canadian Delphi identified the use of clinical indicators to indicate readiness 
or willingness to discuss end-of-life, the UK Delphi study revealed clear disagreement between 
participants as to whether clinical indicators helped them to establish whether a patient was 
ready or willing to discuss end-of-life, revealing lack of clear support for recommendations to 
use the Gold Standards Framework Prognostic Indicator (2006).  Other items that did gain 
consensus, such as the importance of developing the discussion over time and discussing 
whenever the opportunity occurs after diagnosis show that perhaps such emphasis in the policy 
guidelines on clinical indicators may inhibit health professionals from starting discussions early in 
the disease process, rather than allowing for the iterative process of such discussions to occur 
as mentioned in the end-of-life care strategy.  In fact, it has been recently recommended that 
the Prognostic Indicators for COPD should be tested to determine at which point they may 
trigger a discussion about end-of-life (Blackmore et al 2011).  Overall, this study points toward 
 
 
235 
 
the idea that health professionals can perceive whether a patient is ready or willing to discuss 
end-of-life, particularly within the model presented above.  Therefore, using this knowledge 
instead of clinical or prognostic indicators may be the way forward for initiating meaningful end-
of-life discussions. 
End-of-life policies 
The use of advance care planning documents was raised as an important consideration 
throughout the study. Participants of Canadian Delphi study discussed how they were 
mandated as part of a hospital intake to do an advance care plan, regardless of patient readiness 
or willingness to discuss.  In the UK, the ‘Preferred Priorities of Care’ (PPC) document is a 
patient held rather than institutionally held document that identifies a patient’s preferences and 
wishes at the end-of-life.  The factsheet about the PPC states that it is a tool to facilitate end-of-
life discussions, but also states that it is up to the individual whether information in the 
document is shared with family and health professionals (NHS).   
This difference in policy may be related to accessibility of palliative care services.  In 
some health regions in Canada, to access palliative care services, patients must sign a DNR and 
agree that they will not receive active treatment (Hodgson, 2012).  Therefore, end-of-life 
discussions may become more important or essential to have in order to start receiving 
palliative care services.  This is contrasted with the availability of services in the UK, where 
patients can receive active and palliative treatment at the same time, therefore making the end-
of-life discussion less essential or urgent even for those receiving palliative care services.   
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The Canadian approach may be problematic in NMRD when there is rarely a clear 
transition point from active to palliative care, and therefore concurrent services may be most 
appropriate (Coventry et al., 2005).  The difference between these two countries points to the 
necessity of two separate tools for discussing end-of-life. 
Prognosis issues in nonmalignant respiratory disease 
The difficulty in providing a prognosis for patients with NMRD emerged throughout the 
study as a reason that end-of-life discussions do not occur and is widely acknowledged in the 
literature (Pinnock et al., 2011, Curtis et al., 2004, Dean, 2008).  Specifically, in COPD, 
identifying patients who are in the last year of life (based on disease parameters) is largely 
unsuccessful (Celli et al., 2004, Small et al., 2009), and a recent systematic review found that 
while there are several high quality prognostic tools in existence, neither clinicians or tools can 
predict with certainty how long a person will live (Yourman et al., 2012).  However, these 
findings are contrasted with the idea that the problem with prognostication in NMRD is the 
lack of simple, well validated, prognostic models with good calibration, reliability and 
generalizability (Coventry et al., 2005, Puhan et al., 2009).  In addition, current models of 
prognostication do not consider the role of social factors.  For example, in the context of 
cancer care, patients spiritual beliefs have been shown to be predictive of clinical outcomes and 
these are unlikely to be taken into account by prognostic tools (Coventry et al., 2005).    
Such uncertainty with prognostication seems to negatively effect communication about 
end-of-life and ultimately limits access to palliative care services (Curtis et al., 2008).  Health 
professionals may feel anxious about delivery information to patients when prognosis is 
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uncertain (Crawford, 2010), and patients with COPD are more likely than patients with cancer 
or AIDS to express concern regarding the amount of information that they have received about 
their condition, including treatment, prognosis and advance care planning (Curtis et al., 2002).  
It seems that this issue of prognostication must not be viewed by health professionals as a 
barrier to discussing end-of-life.  This view implies that clinical indicators must signal that end-
of-life discussions should occur and it has been shown here that this is not necessarily an 
indicator to readiness or willingness to discuss end-of-life. 
Time 
The issue of time arose in every stage of this study, from finding the right opportunity to 
discuss, to developing discussions over time and having multiple discussions, to the problem of 
time constraints in medical practice.  This is clearly an overarching issue in end-of-life 
discussions.  While the limited literature indicates that patients with COPD prefer to wait until 
their condition is advanced to discuss end-of-life (Momen et al., 2012), other studies indicate 
the importance of considering the individual needs of the patient before making this judgment 
(Crawford, 2010).  The recent systematic review by Momen et al. (2012) states that discussions 
should be patient centred and that the timing, content and pace should be decided by the 
patient, but this is concerning as it may be interpreted as guidance that the patient is 
responsible for initiating such discussions, which has been established previously in this 
discussion as highly problematic. 
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8.3 Transferability 
Initially, the literature about end-of-life communication in malignant diseases was not 
included in this thesis.  This was due to the different disease trajectory between conditions, the 
difference in patient awareness of the fatality of their disease and the lack of resources available 
to broaden the scope of this thesis to include such literature.  However, in this discussion some 
literature related to malignant conditions will be brought in to demonstrate that despite the 
differences stated above between conditions, similarities between patients in each condition 
may contribute to the transferability of these findings to be useful for working with patients 
with malignant conditions. 
For example, research with patients with cancer shows that, like patients with 
nonmalignant respiratory disease, patients want to have conversations about end-of-life care 
with their health professionals and often expect the health professional to initiate the discussion 
(Steinhauser et al., 2000, Wenrich et al., 2001, Jefford & Tattersall, 2002).   As a result of this 
expectation, patients with cancer do not always discuss end-of-life with their clinician, despite a 
desire to do so (Gattellari et al., 1999, Gattellari et al., 2002, The et al., 2001).  Similar to non-
malignant respiratory disease, it is thought that conversations about end-of-life care are 
beneficial as they may result in a greater chance of patients’ wishes being met (Detering et al., 
2010), better quality of life (Temel et al. 2010), less use of futile life sustaining treatment 
(Wright et al., 2008), more use of hospice care (Wright et al., 2008), reduced distress for the 
family (Wright et al., 2008) and reduced resource use overall (Teno et al., 2007).  However, 
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health professionals, particularly physicians, are uncomfortable with raising this topic, due to the 
highly emotive nature of this subject (Bernacki et al., 2013). 
However, despite similarities, there are some key differences in care between lung 
cancer patients and patients with nonmalignant respiratory disease as found by Partridge et al. 
(2009), which has been discussed previously.  In addition, Epiphaniou et al. (2014) found in the 
UK that while patients with lung cancer have access to a key worker who coordinates care 
between settings, referred patients to palliative care services in the community, helped with 
financial issues and provided support, while COPD patients did not have a key worker.  This 
has the potential to influence end-of- life discussions due to the nature of the key worker 
relationship. This area of research also demonstrates the importance of different considerations 
in such discussions for patients from different conditions.  For example, Murray and colleagues 
(2004) found that different disease trajectories lead to different patterns of spiritual needs – 
patients with cancer had needs regarding recognising the imminence of dying, while 
nonmalignant patients had needs regarding feelings of isolation, hopelessness and a loss of 
confidence.  In addition, recent research exploring needs of patients with advanced cancer in 
the USA and Australia for a question prompt list to discuss end-of-life care found that tailoring 
a communication aide for individual populations was highly appropriate given the differences of 
their findings between countries (Walczak et al., 2013) as well as complex cultural influences on 
end-of-life decision making (Michael et al., 2013).   
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8.4 Conclusions 
This chapter presents a theoretical model of the findings of the four phases of the 
doctoral study and then contextualizes these findings in relation to the existing literature and 
finally addresses the potential transferability of these findings. Conclusions and 
recommendations based on the findings of the study, in addition to a critical appraisal where 
the strengths and limitations of the study are discussed are presented in Chapter 8. 
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Chapter 9. Conclusion and recommendations 
9.1 Introduction 
This chapter builds on the previous discussion chapter (Chapter 7) to explicate the 
original contribution of this study to knowledge regarding end-of-life discussions in NMRD, as 
well as to provide recommendations based on the findings for practice, education, policy and 
finally future research. 
9.2 Contributions of the study to theory, methods and practice 
As discussed in the introduction chapter the authors of a recent study concluded that 
future research should examine international differences as well as patient specific facilitators 
and barriers to end-of-life discussions (Janssen et al., 2011).  In addition, the authors of a recent 
integrative review found that further investigation was required to address the complex 
personal, provider and system elements involved in COPD (Disler et al., 2012).  This doctoral 
study answers the call of both studies and extends on elements of previous work regarding 
end-of-life discussions in NMRD, including COPD.  It is novel in the exploration of indicators of 
readiness or willingness to discuss end-of-life and contributes a theoretical model of facilitators 
and barriers to end-of-life discussions in NMRD and the development of tools to address 
discussing end-of-life with this specific patient population in the UK and Canada, and in the 
international comparison of two Delphi study findings. Ultimately, the first stage of 
development of a complex intervention for end-of-life discussions in NMRD has been 
completed through this work. 
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9.2.1 Theory 
The theoretical model of findings summarises the facilitators and barriers to end-of-life 
discussions that emerged in this study using a systems theory perspective and identifies items 
that can be either facilitators or barriers to discussion at the Macro, Mezzo and Micro levels.  
This model can be employed by health professionals to investigate the facilitators and barriers 
to discussion in their own context.  Particularly, the model establishes the importance of 
cultural competence, which is currently lacking in the literature, particularly as COPD is poised 
to become the third most common cause of death in the world . While a recent Delphi Study 
by Junger et al. (2012) with members of the European Association of Palliative Care 
acknowledged the differences in cultural needs dependent on country, the literature on 
facilitators and barriers, particularly in non-malignant respiratory disease has not widely 
acknowledged the importance of cultural competency with individual patients and families. 
9.2.2 Methods 
This doctoral study contributes to research methods by comparing two Delphi studies 
that were conducted in separate countries in order to develop a tool and discern the specific 
concerns of health professionals in each country.  Specifically, comparing the results of two 
Delphi studies is not common in the literature, and comparing the findings of two panels from 
different countries is entirely novel.  To the author's knowledge a comparison of Delphi panels 
has only been carried out by Duffield in (1993), and Kennedy in (2000). Members of different 
disciplines are rarely included on one Delphi panel and therefore the range of professionals 
included in the Canadian Delphi is a unique aspect of the methods used in this study. 
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Comparing Delphi studies can add validity to their findings (Duffield, 1993) and by comparing 
international panels, allows for the understanding of cross-country differences and similarities, 
providing insight into practice in each country.  The findings from this study point to the benefit 
of using international comparative studies to bring awareness and comprehension to areas in 
need of development and to help find innovative solutions for complex situations. 
9.2.3 Practice 
This is the first study to develop a tool that includes items on how health professionals 
know that a patient is ready or willing to discuss end-of-life in NMRD. The findings reveal that 
health professionals can perceive whether a patient is ready or willing to discuss end-of-life by 
understanding patient cues.  Using this knowledge, health professionals may be able to initiate 
meaningful end-of-life discussions.  In addition, the findings regarding considerations in end-of-
life discussions and topics for such discussions from both Delphi studies are consistent with the 
current literature (Buxton et al., 2010, Gore et al., 2000, Spence et al., 2009), however, this is 
the first study to develop a tool specific to the patient population to be developed further for 
use by health professionals in clinical practice. 
9.3 Critical appraisal of the study 
The four phases of data collection in this study including two systematic reviews and two 
Delphi studies enabled the aims and objectives of the study to be met.  By identifying the state 
of the science in the literature, and then establishing an expert consensus on the topic, a 
greater understanding of end-of-life discussions in non-malignant respiratory disease was 
developed.  Ultimately, the findings of the study as a whole has resulted in a model of how end-
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of-life is discussed in this patient group in the UK and Canada, as well as the development two 
tools to aid health professionals approach end-of-life discussions.  This development process, in 
line with the MRC guidelines for complex interventions, will provide a building block towards a 
validated instrument to use with this patient group. 
Through the use of systematic reviews, an evidence base regarding how end-of-life is 
discussed in non-malignant disease in general and specifically in respiratory diseases worldwide 
and also specific to the UK and Canada has been established.  Many end-of-life interventions 
and services have been designed specifically for patients affected by cancer, and have been 
'adapted' in some way to extend to other patient groups.  However, the literature related to 
discussing end-of-life in non-malignant respiratory disease is often focused on the difficulties due 
to the unpredictable disease trajectory and it is clear that this patient group has very different 
needs and often much less resources available to them related to end-of-life.  Therefore, 
throughout this study, literature related to cancer was purposely excluded. 
After the findings of the systematic reviews indicated a lack of literature regarding how 
health professionals know a patient was ready or willing to discuss as well as further 
investigation required regarding key considerations and topics when discussing end-of-life with 
this patient group, the use of the Delphi method was considered most appropriate to establish 
expert consensus on these topics. However, there were some limitations regarding the sample 
selection. In addition to the recruitment advertising through the British Lung Foundation and 
the Canadian Health Professionals group, a snowball sampling method could have been used to 
have experts in the field identified by other health professionals.   
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In the UK, the expert views are from nurses who work primarily in the community and 
have established relationships with their patients. However, the majority of contact that 
patients with non-malignant respiratory disease have with health care professionals is in a 
primary care setting, and trends in health care provision at the time of writing (Spence et al., 
2009) are moving towards blurred primary/secondary care boundaries.  Furthermore, in 
Canada, the sample could have consisted of only one type of health professional in order to be 
able to make more definite conclusions from the Canadian Delphi data, but perhaps this would 
not have reflected the diversity of health professional that conducts end-of-life discussions in 
non-malignant respiratory disease in Canada.  In addition, it must be acknowledged that 
differences in findings may be partly due to the diversity of Canadian health professionals, 
however as this was a pragmatic, service based study, it was appropriate to use more than one 
group. 
Finally with regarding to the samples it must be acknowledged that in any study where 
participants are self-selecting, it is most likely the case that they have a particular interest in the 
topic.  In fact, more than one participant described end-of-life communication as her 'pet topic' 
and was very eager to share her views.  While this is not major limitation, particularly given the 
nature of the Delphi to gain a consensus opinion from experts in the area, it does mean that a 
wide range of experiences may not be identified.  However, there are already several studies 
that address the reasons why health professionals do not address this topic (Janssen et al., 2011, 
Abarshi et al., 2011, Crawford, 2010, Anselm et al., 2005). 
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As mentioned previously, the systematic review process that was meant to inform the 
initial Delphi questionnaire did not return any findings related to readiness or willingness to 
discuss end-of-life, therefore the decision was made to interview participants for the first round 
of Delphi data collection instead.  Alternatively, an initial Delphi questionnaire from what was 
found through the systematic review with regards to key considerations and topics could have 
been used in the first round in addition to interviews to address the readiness/willingness 
component.  This could have resulted in more commonalities in the first round of the Canadian 
and UK Delphi data and may have enabled more in depth statistical comparison between 
studies. 
Another option would have been to use a structured interview guide rather than a topic 
guide for the Round 1 Delphi interviews.  This would have enabled a more straightforward 
analysis, and perhaps would have resulted in more comparable data between the Canadian and 
UK Delphis.  However, allowing participants to explore the topic using the topic guide did 
result in a wealth of data and so perhaps the trade-off of a inability to statistically compare UK 
and Canadian Delphi data was sensible. 
In hindsight, the topic of the entire study should have been specific to COPD rather than 
non-malignant respiratory disease.  This would have allowed for a more focused comparison 
with the relevant literature in the systematic reviews.  Also, would have provided clarity for 
Delphi participants as to which aspects of their job to focus on.  Some of the Canadian Delphi 
participants worked with patients with cystic fibrosis, and due to the early onset and likely 
mortality rate of this disease, considerations may not be the same for these patients. 
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While the data analysis process was rigorous and guided by literature from the field there 
was a minor oversight, which was that there was not a common baseline mean score for 
eliminating items in Round 2 of the Delphi studies.  Ultimately, this did not affect the results of 
the study as only consensus items and non-consensus items were compared narratively rather 
than statistically. Finally, the mean statistic was used determine whether items moved from one 
round to the next in the Delphi studies.  In hindsight, it would have been prudent to use the 
median statistic instead to be consistent with the median statistic that was used to establish 
consensus.  
9.4 Recommendations for Practice, Education and Policy 
In light of the findings of this study, a number of recommendations can be made for end-
of-life discussions in non-malignant respiratory disease, the education of health professionals 
regarding end-of-life communication with this group as well as policy related to this topic.  
9.4.1 Recommendations for end-of-life discussions 
 Emotional intelligence should be used to gauge patient readiness for end-of-life 
discussions, and these discussions should be followed by informal and formal supervision 
and reflection processes. 
 Patient education should be used by health professionals as a stepping stone towards 
moving patients forward toward the next stage of behaviour change to be ready to 
address end-of-life issues.  As such, health professionals must be made aware of the 
concept of readiness and the stages of change transtheoretical model and how it applies 
to the patient education context. 
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 Patient education interventions must be targeted to the health literacy level of the 
individual patient, and a lack of interest or participation in end-of-life issues must not be 
immediately dismissed as such before their level has been established.   
 Where a health professional perceives that a patient is not ready to discuss, the health 
professional may guide the patient towards readiness by using the Transtheoretical 
Stages of Change Model. 
 Health professionals should be aware of the concept of readiness, how it can be 
established and apply this knowledge when designing patient education programmes. 
 Health professionals should be aware of the concept of willingness, and be wary of 
approaching end-of-life discussions when the patient does not appear willing to discuss 
end-of-life. 
 The recognition of the cultural beliefs, values and patterns of behaviour of patients and 
their families should be used to understand how individual patients and families may 
make end-of-life decisions.    
 To avoid missing opportunities, or approaching the topic insensitively, health 
professionals should not rely on clinical indicators or the existence of a poor prognosis 
as a signal to initiate discussions and instead use indications of patient readiness as 
established by the current research. 
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9.4.2 Recommendations for the education of health professionals 
 Further development of expert to novice transfer of knowledge regarding end-of-life 
communication through use of tools such as the one developed in this study, and 
perhaps mentorship programmes. 
 More emphasis on emotional intelligence and communication skills during training of 
health professionals has been highlighted in the literature as beneficial, but specific needs 
are not addressed.  Based on the findings of this study cultural competence training 
must be a priority, but definitions of what this would involve and what should be 
included in such training require more research, such training may include awareness of 
dominance of western medical model and focus on autonomy creating 'problematic' 
relationships with ethnic minority groups. 
9.4.3 Recommendations for Policy 
 The assignment of a key health professional to each patient with non-malignant 
respiratory disease may improve the likelihood of end-of-life discussions and resolve 
ambiguity about initiation responsibility and ensure that wishes are communicated 
between settings. 
 The UK End-of-life Strategy (Department of Health, 2009) should be updated to include 
competencies regarding cultural competence, emotional intelligence and understanding 
of readiness to discuss. 
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9.5 Recommendations for research 
The MRC Guidance for Developing and Evaluating Complex Interventions (2008) suggests 
a five stage process for the development, evaluation and implementation of complex health 
related interventions.  As discussed in the introduction and research design and methods 
chapters the focus of this doctoral study was to develop an intervention, and further stages in 
the process are required to prepare the intervention for use in clinical practice.  A potential 
piloting and evaluation phase is briefly described below for each tool in the UK and Canada.  
Only the UK proposed pilot and evaluation studies are described below.  However, similar pilot 
and evaluation studies would be carried out in Canada, with some modification for the 
Canadian context.  
9.5.1 Pilot study to evaluate the effectiveness of a tool in improving end-of-life 
communication between health professionals and patients with COPD. 
This pilot study would aim to determine how the tool can be used by health professionals in 
practice, and to determine how best to administer the outcome measures in the planned 
randomised control trial.  Health professional participants in each location would be asked to 
attend an education session about the tool and how to use it in practice.  Then, they would be 
asked to use to tool with patients with COPD over the period of one year.  Participants would 
also be asked to reply to questions relating to outcome measures to determine how the tool 
was used.  The information gathered in the pilot study will be used to design a cluster 
randomized trial with several PCTs in England, Scotland, Wales and Northern Ireland.  Further 
explanation of this pilot study is included in Appendix G. 
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9.5.2 A Systematic Review of Interventions For Health Professionals to Improve 
end-of-life Communication 
The objective of this systematic review is to review the effectiveness of end-of-life 
communication skills training programmes for health professionals on improving communication 
about end-of-life between health professionals and patients, and to identify experience of 
learning about end-of-life communication and changed perceptions as a result of such training.  
This review will be used to inform the educational session in the pilot study, and to determine 
how best to educate health professionals about this end-of-life communication tool.  The 
protocol for the systematic review developed using the JBI method of systematic reviews (The 
Joanna Brings Institute, 2008) and includes the PICO outline for inclusion criteria, the search 
strategy, the assessment of methodological quality, data collection and methods for data 
synthesis are outlined in Appendix H. 
9.6 Study Conclusion 
In this study the author examined how end-of-life is discussed in NMRD.  The findings and 
the theoretical model that resulted from the study highlight the complex and dynamic process 
of end-of-life discussions specific to NMRD.   This model consists of nine key areas that can act 
as facilitators or barriers to discussing end-of-life including: prognosis, end-of-life policies, time, 
clinical indicators, initiation responsibility, the educational role of health professionals, 
emotional intelligence, cultural competence and readiness versus willingness to discuss.  The 
four phase, mixed methods design for instrument development was successful in leading to the 
development of two country-specific tools to assist health professionals in approaching end-of-
 
 
252 
 
life discussions in NMRD.  These tools are ready for the next stages of development for use by 
health professionals as a complex intervention, and recommendations for how this could be 
achieved using a pilot study, leading to a cluster randomized trial and a systematic review were 
provided. 
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Appendix C. UK Delphi Round 1 – Key considerations: quotes from each item 
UK Delphi Round 1 – Key considerations: quotes from each item. 
The patient   
Allowing the patient to lead 
the conversation 
…not just talking to the patient but get… make it a two way conversation and just 
take guidance from the patient, don’t dictate, feel from them. (AR1) 
Answering patient’s question 
about the condition 
…because they want to know more about the condition as a rule.  They tend to 
ask the questions anyway. (ZWR) 
Maintaining hope for the 
patient 
We’ll do our best to try and keep things at bay and hopefully keep you as well as 
we can, but actually, this is going to progress.  So I really think at any point, you 
should really be thinking about... but you know, for real kind of end of life 
discussions, it should be... you know you’re going to be picking your most... the 
patients that are more [unintelligible 11:57] to it, that you think are going to be 
heading down that kind of slippery slope. (KM1) 
Being open and honest with 
the patient 
There’s no point hiding things from the patient, because like I said, they don’t have 
the trust in you if you hide things from them. (ZWR) 
Establishing patient’s 
understanding of their 
condition 
…establish the patient understands what you’re talking about (KM1) 
Recognising the individual 
needs of the patient 
…everybody’s individual you deal with it you know as you think your relationship 
with that patient… I don’t know quite what the words are, to… each individual 
will do it slightly differently, or will want something slightly different, so you pick 
and run with it as it’s presented to you. (AS1) 
Explaining to patients what is 
feasible regarding their 
wishes 
…but you have to instil some realism into that, because you know with the best 
will in the world, if you want to die at home, but your family just can’t cope with 
that, then it’s a real dilemma because we can’t provide 24 hour, seven day a week 
care in the domiciliary setting. (SP1) 
Educating the patient about 
their condition 
Well why am I not getting any better question, or, I’ve been given this treatment 
by my doctor but I actually don’t feel any better, and to kind of... you know, sort of 
take it from there to say well, why do you think that is, that you’re not getting any 
better.  Can you think... and then to sort of lead them into me trying to give them 
very sort of simple explanations, that it’s not getting better and this is why, but this 
is what we can do for you… (KM1) 
Patient indicates readiness to 
discuss 
The patient being ready, the patient indicating that they want to have this 
discussion, is the most important.  (SP1) 
Patient wanting to hear the 
information 
…the patient being receptive and willing and them wanting to know… (IB1) 
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Patient being open about 
dying 
…people will talk about it.  People can be very open about dying… (AS1) 
The environment   
Having an appropriate 
environment for discussion 
e.g. privacy, quiet 
I would say the environment, setting the right environment, to a point, as much as 
you possibly you can.  You know, privacy, dignity, respect, quiet.  That sort of 
thing, and sometimes relatives present, and sometimes not (SP1) 
Where the discussion occurs 
e.g. clinic, hospital or 
patient’s home 
I think the joy I have from going to people’s homes is, there’s more time.  There’s 
less interruptions, people feel safer because they’re in their own environment and 
that’s one thing you do notice when you actually work in the community 
compared to a hospital, is that you are being invited into their home and therefore 
you know, that’s one thing they are leading the whole consultation because it’s in 
their environment, and so it’s definitely a different dynamic when you visit 
somebody in a home (SJP) 
The family   
Having the patient’s family 
involved in the discussion 
…(if the) pt does not have family around makes it more difficult to give them bad 
news (ND1) 
Well, I mean obviously if the family members are present or there, then I would... 
with the patient’s consent, would include them in the discussions. (KM1) 
Having family’s support 
during the discussion 
I think good family support makes things quite a bit easier as well, so you know 
that you’re not just having this conversation and then going away and leaving them 
to sit on their own and dwell about everything, but then on the other hand, that’s 
what some people want (AR1) 
Patient’s wish to protect 
others from end-of-life 
information 
I think as well sometimes, that once they acknowledge it, again if there’s a family 
member there, they might be thinking it, but they don’t want the carer or the wife 
or whoever, to know that that’s how they’re thinking, because it’s a kind of 
helplessness and the loss of hope (KM1) 
The health professional   
Being an expert on the 
condition 
…you want to discuss it with family; I think if you’re coming from an informed 
position as an expert, then you would hope that people would recognise that 
(KM1) 
Nurses having counseling 
skills 
…basic counselling skills, have to be reinforced at every level of training (SJP) 
Having the appropriate 
clinician to discuss end-of-life 
with the patient 
…you need the appropriate skills and experience to be able to enter those 
discussions. (SJP) 
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Having a strong relationship 
with the patient 
We’ve been in their homes, we know their families, you know we’ve looked at the 
pictures on the wall.  It’s all about building relationships and they trust you to look 
after them, and actually talking about it with us is probably easier than talking about 
it with anybody else (AS1) 
Emphasising a holistic care 
approach 
Well, I think we do, but it’s more as in, like their wellbeing, like their overall 
feelings, and wellbeing and how comfortable they are. (IB1) 
Rapport between health 
professional and patient 
…advantageous to know the patient, to have built some kind of rapport with them 
before you start embarking on it. (KM1) 
Health professional having 
the confidence to discuss 
I think a lot if it depends on how you feel yourself about how confident the person 
who’s delivering the discussion feels (DW1) 
Health professional’s 
understanding of the 
condition 
And it’s now that I feel equipped, that I can answer those questions for them and 
sit down with the knowledge and be able to address the issues with the patients. 
(IB1) 
Using non-medical language I think patients are brought up to a clinic, told that you’re... told in very medical 
language that you have this condition, probably not given a huge opportunity to ask 
an awful lot of questions and sent on their way, you know and I don’t know if it’s... 
if that’s likely to change, and it probably happens to lots of things, but I think we 
are very bad at using jargon that patients don’t understand. (KM1) 
Your professional 
boundaries 
…we then see them again through a nastier exacerbation and things and 
sometimes again they bounce back and but the disease trajectory with COPD 
compared to cancer, it’s so very different, and can be so much longer, and so you 
do go on that journey with them for many, many years, but you are the 
professional at the end of the day, and for your own sanity I suppose, for want of a 
better word, it’s that you have to ensure that you protect yourself. (SJP) 
Avoiding euphemisms – 
saying the words ‘death’ or 
‘dying’ instead 
They don’t like using the word dying very much…They always have some 
euphemistic phrase (AS1) 
Health professional talking 
responsibility to oblige the 
patient’s wishes 
I sometimes feel, how can I honour what they tell me, can I possibly give them 
what they want and that… and once you’ve had the conversation, you know what 
they want, there’s a huge pressure and obligation to… I feel, to ensure that they 
get what they want and that’s sometimes very difficult. (SP1) 
Using humour …you can take it as a joke - very often we deal with that first respose as humour 
'oh well I hope not quite yet because there's all the paperwork to sort out' (AS1) 
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Nurse having attended 
conferences or professional 
development specific to end-
of-life discussions 
I think having been to those two study days was a great benefit to me, particularly 
the Impress one because I was put in a position where I had to speak to ‘a patient’ 
and it made me recognise that actually, yes, I can talk to patients about this.  It’s 
just recognising that they’re all different.  Not all of them want to hear what you 
have to say, so you don’t have to tell them everything.  I’m not there to frighten 
people.  There’s always another day I can go back when they’re ready to have a bit 
more information from me. (DW1) 
Nurse having experience in 
caring for dying patients 
…with experience and you know getting into different situations, that you build 
that experience up as well…(AR1) 
Timing   
Discussing end-of-life at time 
of diagnosis 
…really to be honest, at the point that these patients are diagnosed, whenever 
that is.  I mean, obviously somebody who can be diagnosed and still have a very 
good quality of life and a very long life still to come, but you know I think patients 
who... particularly that we see, that come into secondary care, they tend to be 
further down the line and I think if we’re as honest with them as possible that 
yeah, we can still treat you, however they need to know that this condition will 
deteriorate. (KM1) 
Developing the discussion 
over time 
…we’d be ongoing and that’s the nature of our work really, is that we see people 
repeatedly, over and over and as they get nearer to death we would see them 
more often and so these discussions develop, because again, people forget what 
you tell them. (AS1) 
Finding the right opportunity 
to discuss 
It’s really hard.  I try and instigate a visit when I know they’re going to be on their 
own, so that they have the opportunity (SP1) 
Patient having time to hear 
information and ask 
questions later 
…allow the patient the time to go away and then come back and ask what does 
this all mean. (KM1) 
Availability of time to discuss I would make sure I had the time.  If I went to a patient and even if I was busy, I 
wouldn’t leave that patient until I knew I had finished.  If that conversation started, 
I would have the time to do it (IB1) 
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Appendix D. UK Delphi Round 1 – Key content: quotes from each item 
UK Delphi Round 1 Key considerations: sample quotes from each item 
Introduction of an advanced care 
planning document 
It’s the National Council of Palliative Care, and it’s called Planning for Your 
Future Care, A Guide, and it goes through what is advanced care planning, 
the aspects of it, having open conversations, exploring all your options, 
about refusing treatments, lasting power of attorney, that’s all I think it goes 
through. (ZWR) 
The type of care the patient 
wants 
…if things deteriorate again and you don’t want to go into hospital, what 
would you like to happen (IB1) 
Emergency management 
preferences 
You know, would they want to be aggressively managed, would they want an 
IV attempt or, so I suppose if they don’t want to be resuscitated, where 
would they want to die. (KM1) 
Explaining palliative care They tend to avoid the subject.  They play down their symptoms a lot.  You 
know, they tell you that they’re feeling fine when you can see the relatives 
sat next to them sort of shaking their head and disagreeing with what 
they’re saying and it’s just slowly you’ve got to just explain to them and 
explain to them as well, that because they’re going on the palliative care case 
load doesn’t mean to say that they’re dying  now, which is a lot… it’s 
something that a lot of the patients have got in their head isn’t it, they think 
palliative care like the cancer is, end of life care, rather than advancing 
disease. (ZWR) 
Anticipatory prescribing So, anticipatory prescribing is very important, but that doesn’t have to be 
done immediately. (AS1) 
Ceiling of treatment But one of the big issues for us really is about the ceiling of treatment 
because a lot of these COPD patients, we manage at home as much as 
possible.  It’s the best place for them, unless they have a hypercap in, in 
which case they may benefit from non-invasive ventilation, which is not a 
pleasant experience and these… this is a difficult one really, as you’re 
wanting to know whether, if it gets to that stage, whether they want to take 
advantage of having non-invasive vent or they just want to pass away 
peacefully. (SP1) 
Medication options …we can get medication to ease the anxiety and the breathlessness. (IB1) 
Treatment options Different treatment options (IB1) 
Patient goals …have they got any goals, anything that... in other... anything they would like 
to do or achieve or see or fulfill.  You know, other things that they still want 
to do, because although we’re talking end of life, we are still talking... it’s still 
their life, there’s still got to be some quality in it, what do they want and 
what do they not want.  (KM1) 
Intubation and ventilation 
options 
…intubation… (ND1) 
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Preferred place of care …where their preferred place of care would be (SP1) 
Preferred place of death …do they want to die at home, or do they want to die at hospital, or do 
they want to go into a hospice or maybe respite care somewhere. (AS1) 
When the patient is likely to die …they’ll all want to know when and you can’t say when (AS1) 
Sedation availability/options …how they feel about the use of opiates, morphine, syringe drivers, 
whether they want to be… you know I’ve had patients say oh I just want to 
be sedated.  I don’t want to know anything about it, and yet I’ve had other 
patients that say well no, I want to be you know, I want to be as alert as I 
can, right to the last minute, and that can be… that can happen.  That can be 
facilitated. (SP1) 
Social services involvement …social services, you know do they need any help or can they go to the 
hospice for a bit, you know to respite.  (AS1) 
Spirituality That’s what I would say more for spiritually.  Yes, and also like if they’re 
needing to… if they want to see any of their own… like their faith, if they 
want to deal with anything like that, yes, but spiritually I would say is more 
to me about their overall wellbeing, and how they are actually dealing with 
things.  Are they dealing with it, or do they need further assistance to deal 
with that, and is there somebody they need to speak to. (IB1) 
Transferring to palliative care It’s quite a hard discussion to have with some of them.  I mean, some of the 
patients are aware, because we don’t lie to them, we do tell them it’s a 
progressive condition.  So they can see things are getting worse and their 
conditions are deteriorating.  So, some of them are quite happy to be moved 
across [to palliative care].  Some of them find it quite a difficult transition 
and you know, it’s another six months before they accept it. (ZWR) 
Who the patient wants present 
at the very end-of-life 
Who would they want to have with them? (KM1) 
Dealing with breathlessness And overwhelmingly they talk about breathlessness and they’re fighting for 
breath, and they just can’t bear the thought that it would be even worse.  
And then we talk about, well, can you remember going into hospital when 
you had your last exacerbation?  And they have no memory of it.  So I 
reassure them by saying, you know, there are things that we can give you 
that will help to relieve breathlessness, but the chances are you’ll not be 
aware of it.  (DW1) 
Hospice   
Explaining hospice (if available) …what kind of care they would get if they do eventually go to the hospice 
(IB1) 
Options for hospice (if available) …hospice or respite care…(ND1) 
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UK Delphi Round 1 Key considerations: sample quotes from each item 
Perceptions of death   
How they feel about death …how they feel about death…what their fears are (SP1) 
Reassuring the patient s/he 
won’t suffer 
I’ve recently nursed a chap that’s just died aged 58 and his father died of 
COPD in his late fifties and his brother died of COPD in his early sixties and 
his… a lot of the conversations that we had about death were really 
discussing his previous experiences of horrendous respiratory death, many 
years ago and ensuring that he had confidence that’s not the way it was 
going to be for him (SP1) 
Understanding of death …enabling people as much as I can, to be in control, in as much as I can, 
because some people will not want to do that and you have to respect that 
as well (SJP) 
Practical needs   
Getting affairs in order Have they managed to get all their affairs into order? (KM1) 
Practical equipment needs …practical stuff like beds, commode, all that sort of stuff that the district 
nurses can order (AS1) 
Support in the home What would you like us to do and then we would be able to say well we can 
get district nurses in, we can get your GP involved  (IB1) 
Transportation needs to 
facilitate care 
well how am I going to get there, because the physical effort of getting 
themselves to that place and everything that that involves, is the next hurdle 
that you have to try and overcome. (KM1) 
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Appendix E. Canadian Delphi Round 1 Key considerations: quotes from each item 
Canadian Delphi Round 1 Key considerations: quotes from each item 
The Family   
Family issues for the patient ‘You know, sometimes it is and sometimes you do have to push the envelope a 
little bit and say 'hey your pulmonary function is really low, and I know that you 
don't feel that but um, maybe we need to start having some discussions because 
you have little ones at home' you know, where it involves young children, then 
you push the envelope a little bit quicker, you put a little bit more pressure 
because the stakes are higher, you know.  (CAN1) 
Communicating patient wishes 
to family 
‘this is what she wants, she didn't want to go to the city or she wants to stay 
here, she doesn't want to be intubated’ (CAN5) 
Presence or absence of family 
support 
‘to prepare them, and to encourage them to bring their support person if they 
want them’ (CAN4) 
Approaching the discussion   
Sense of humour ‘And i would try and talk about it, and I would bring humour into it a lot of 
times, whenever I could, because that always sort of breaks the ice a little bit, 
and makes it easier’ (CAN10) 
Sensitivity to the patient’s 
culture 
‘of course there's gonna be huge differences when you think about the um 
issues of, um, what patients are comfortable, whether it has to do with um, 
their own culture, and cultural acceptances, um, we've had difficulties, for 
example, with Native American people wanting to do smudging and things like 
that, and the process that they're dying, and that's been a barrier because of 
now the smoking cessation and the requirements for having nonsmoking and 
those things are not available, and those cultural things can be big barriers’ 
(CAN10) 
Approaching the topic calmly ‘You just go and you know if you approach the topic with um a calmness… 
(CAN1) 
Approaching topic with a 
‘matter-of-factness’ 
You just go and you know if you approach the topic…with a matter of 
factness… I think people respond to that no matter where they are. (CAN1) 
Approaching the topic with a 
caring nature 
You just go and you know if you approach the topic … with a caring nature, I 
think people respond to that no matter where they are. (CAN1) 
Being open ‘I mean I don't know how much it plays into it but it's just, it's not something 
that I can um, it's not something that I have a problem discussing I guess, is 
really, i'm very open about and I think that my clients know that about 
me’(CAN7) 
Being honest ‘I believe in presenting it in a respectful manner, I don't believe in sugar coating 
it. I tell people I'm not going to lie to you, and they seem - no one has ever 
gotten offended with that.  They say 'okay, thank you' right...because the stakes 
are high and it is what it is, sort of a thing.’ (CAN1) 
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Canadian Delphi Round 1 Key considerations: quotes from each item 
Being respectful of the client ‘You know, and taking that time to ask questions, you know, I think those are all 
really, those are all really important things, because everyone just wants to be 
heard, and they want to know that they are important, that they count.  
Especially, man, especially at the end of your life, you know, if any time were 
more important, this is the time right? People, I think health professionals need 
to honour that, and respect that, and know the difference between, or know 
when to push it and when not to, when to step back, so...yah.’ (CAN1) 
Listening to the patient (When I’ve asked patients) you know, when people talked about it with you, 
what was helpful and what was not helpful (they said): 'When they listen to me, 
when they actually listened to me and they heard what I was saying and not 
what they wanted to hear, or they didn't have an agenda when they came into 
the room and they got mad at me because I didn't follow that agenda' (CAN1) 
Giving advice when it’s asked 
for 
‘giving advice when it's only asked for’ (CAN1) 
Letting the patient guide the 
discussion 
‘letting the patient or whoever you're talking to about the end-of-life discussion, 
guide the journey, you know, they are the captain, and going wherever they go.  
But that doesn't mean like being a, you know a pushover either.  Right? If they're 
going down a path um, you can, you know, having that trust, that therapeutic 
relationship enough to say 'hey, you know, uh, I don't know, do you want to 
think about that a little bit or?' (CAN1) 
Readiness of the patient to 
discuss 
‘Um, well definitely the person has to be ready, you can't force a discussion’ 
(CAN4) 
Accepting the patient’s 
reactions 
‘But, it is, it's suprising sometimes when people are kind of, quite shocked about 
'why are you talking to me about this?'.  And there's a disconnect between, 
sometimes, between um, so, you know, we kind of guide them, wherever they 
are in that journey, we meet them where they're at.’ (CAN1) 
Knowing when to step back 
from the topic 
‘People, I think health professionals need to honour that, and respect that, and 
know the difference between, or know when to push it nad when not to, when 
to step back, so...yah’. (CAN1) 
Having a pre-existing good 
relationship with the patient 
‘I think what's really important i've found through the years is getting a 
relationship with the patient, so that they know that they can trust you, and that 
um, you know, you're not just a stranger coming into the house or seeing them 
in a clinic a situation and they have no relationship, so I think relationships a 
little bit important’(CAN11) 
Avoiding dashing hope ‘Um, I'm very forthright and very honest in my answers.  If somebody asks me a 
question they're going to get the truth.  I've never been one to dash hope, but 
hope is a very hard thing to bring up when you're talking about death, and when 
you've got the patient that says 'I know i've only got three months but i'm gonna 
try and fight this and see if I can live longer', you know it's probably not going to 
happen, but you say to them 'we can help you by teaching you things, by 
providing you this, and offering you this, and aiding you this way just to make it 
comfortable, and I know you're going to have good days, you're gonna have bad 
days and you're gonna have days you wish you were gonna be dead’(CAN6) 
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Canadian Delphi Round 1 Key considerations: quotes from each item 
Raising the topic early before 
critical situation 
‘I usually frame it in the reality that if i'm a healthcare professional out visiting 
with them in their home, that if something were to happen, if I were to arrive 
and they were feeling quite short of breath or they were having chest pain or 
they were having those things...I'm the first responder, i'm the one who is in 
their home and I usually try to talk to them a little bit about what the default 
expectations for me as a healthcare professional will be if I come across a crisis.  
And usually the discussion sorta slides into 'you know, i've known you for quite 
a long time, and if I were to arrive and there was some sort of medical 
emergency I would think it was really unfortunate that I didn't have a chance to 
talk to you about what your expectations would be and what you would want 
from me, how you would want me to advocate for you on your behalf for all the 
times that we've had on this couch and had conversations about a bazillion 
things, this is something I think we should chat about, and not necessarily today, 
but over the next few visits about what would you like to know and talk about 
the what if kinda stuff’(CAN9) 
Having end-of-life on a list of 
things that need to be talked 
about 
‘I show them my sheet of things i'm supposed to cover, and i'll say, 'you know, 
we're supposed to talk about this, it can be uncomfortable for some people, but 
have you ever thought about this or is this something you have questions about', 
and that will usually open the door there.’  (CAN5) 
Having handouts of example 
advance care directives (paper 
resources) 
‘I like having a handout, a couple of handouts about um advance care directives 
or examples of those to show to people and uh, as sort of a starting point for 
conversation, um, and I do like having it on our list of things to talk about 
because it's an easier, it's easier for me I guess, I don't know if it's easier for 
them, it's easier for me to bring it up then, you know, 'it's not that I think you're 
sick, it's just that we're supposed to talk about this'.  So it helps to have that 
printed on our form, of you know, we talked about all this and this is the one 
thing we haven't talked about and...uh, so that helps, that helps me bring it up, 
and then having some paper resources to give them helps too.’ (CAN5) 
Responsibility of health 
professional to meet patient 
wishes 
‘I think it's thier right, um I think that they have every right to have their wishes 
met, and so that is part of our responsibility to make sure those are met, and 
the thing that's very important for me, because this did not happen for me, is I 
think everyone has, families have the right to say goodbye to patients and I don't 
think they know their family members are dying or at an end stage of life, and so 
it's not even ever given them the ability to say goodbye because nobody's ever 
talked to the family members about what we're doing and what that means, and 
so our patients will just get sicker and sicker and sicker, and honestly from 
having been a family member, and not knowing what's going on, my god, come 
on, let's include them too, and let them know what we're doing, what it means 
and where this patient is actually, I mean, I deal with respiratory failure, that is 
end-of-life, you know, and I don't think we're giving it the importance that it 
deserves, is my feeling.’ (CAN11) 
 
 
285 
 
Canadian Delphi Round 1 Key considerations: quotes from each item 
Sensitivity to health literacy 
level of the patient 
‘health literacy and understanding certainly...that has rarely been addressed, um, 
and a lot of it is out of sheer ignorance, um, of these discussions, of the need for 
these discussions, um, in Canada we have, well in Ontario we have, uh, um 
power of attorney for personal care, and most people at this point in time when 
they have done wills, also have done this power of attorney for personal care, 
which will bring up some of that, but it is very poorly explained in the provincial 
literature, nor do they really have a good basic standard, from which to do, and 
there are lots of different standards or bases on which either various hospitals 
or groups have put together, discussions about living wills, um, and what kinda 
things, could be discussed, should be discussed, or based on um, health 
concerns, um, perhaps those kind of things could be worked on together, so 
that's a health literacy thing that is not only systemic from medical issues and 
legal issues, and family dynamics, it's putting all those parts together, and getting 
that information out in a comprehensive and yet understandable way to the 
majority of the population is a big issue.’ (CAN10) 
Sensitivity to patient’s language 
needs 
‘language can be a huge barrier’(CAN6) 
The Health Professional   
Health professional being 
comfortable with approaching 
end-of-life topic 
‘a greater degree of comfort, you know, switching in and out of conversations 
and you know, not being scared or apprehensive…I think is a skill that you 
develop’ (CAN1) 
Health professional having 
experience and practice having 
end-of-life discussions 
‘I think the more you do it, the more comfortable you are.  And the more easy 
the conversations come and the more experience you get too, you know’ 
(CAN1) 
Health professional is familiar 
with end-of-life planning 
process 
‘they'll book an appointment with me to go into it in more detail - they want to 
see a copy of the living will, they want to see what types of things that they 
could be asking for, they wanna discuss those details.  They want to discuss 
details about palliative care in our health region, you know, um how to access 
it.’ (CAN4) 
Health professional has 
attended education sessions 
about discussing end-of-life 
‘a bunch of us had gone to a conference, and this one physician started his 
lecture with...'if you don't talk to your patients about end-of-life, who is?'.  And I 
thought, oh my goodness you're absolutely right’ (CAN4) 
Health professional has 
knowledge of palliative care and 
end-of-life issues 
‘you're switching over from regular home care to another team, to palliative 
home care and you know it's palliative, and you know what that means, you 
know that means end-of-life, you know that means that um, that this is another 
chapter in your life now, it's a shift right, and so some people are quite okay 
with that, and quite um, relieved with it, but some people it creates a lot of 
anxiety and apprehension, and they're just not ready for it yet.’ (CAN1) 
Emotional intelligence of health 
professional 
‘effective communication, um, i'd say emotional intelligence, because there's 
some really really bright clinicians who just can't read people at all’ (CAN9) 
Health professional acts as a 
neutral party to talk to the 
family about what is happening 
to the patient 
‘a lot of times they want to have the homecare person because it's the neutral 
party who is going to tell them the truth.’ (CAN6) 
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Canadian Delphi Round 1 Key considerations: quotes from each item 
 
Context of the discussions   
Patient’s condition for 
discussion 
‘Somebody has a chronic disease and if they've had repeated admissions to 
hospital and each time you see them they're physical condition is declining, and 
their disease is worsening, then um, that's certainly the time to talk to people’ 
(CAN12) 
Having a support person 
present during discussion 
‘You know and it should be noted that it's not just the person with chronic lung 
disease, sometimes it's their support person who makes the call. Yah, so it 
varies’ (CAN4) 
Patient understanding that their 
condition is life limiting 
‘the shortness of breath will get worse and worse and worse, to the point 
where you will have difficulty speaking.  Before you get to that point, you want 
to discussions with your family about what you would like done in your final 
days. And you know again, we put the ball right back in the court.  You're 
relatively - you don't feel like it, but you're relatively healthy now, so have those 
discussions now.’ (CAN4) 
Patient understanding that they 
can receive palliative care 
‘They want to discuss details about palliative care in our health region, you 
know, um how to access it.’ (CAN4) 
Time available to discuss ‘it's only when you actually sit there with the client and you actually have the 
time, and i'm talking I probably spend anywhere from 7 to 20 minutes before a 
physician sees them, so you, in that time I have to gather an awful lot of 
information, but I also have to pick and choose as to what I can expand on as 
well.’(CAN7) 
Time available for follow up 
discussions 
‘It may be discussed with their physician, whether it's their primary care 
physician or their respirologist, but alot of the times I don't see them after 
they've seen the respirologist at that visit, so it's not until the next time I would 
see them that i'll say - or that i'll see that the respirologist has written end-of-life 
care was discussed, so if that's been discussed, a lot of the times I bring that up, 
in the conversation that I have the next visit, because I want them to be able to 
understand that it was discussed and it is something that needs to be looked 
at.’(CAN7) 
Setting of discussion ‘Whenever you talk about that when you're in a hospital, they have a tendency 
not to believe you because when you go to a hospital, you come out better, 
that's what most people think.  So once the doctors have the initial discussion 
with them, they are in shock, and if you go in and discuss it, it's like you know 
what, I just wanna go home and think about all of this, so it really has to be on 
their terms.’(CAN6) 
Privacy for discussion ‘And often privacy can be issues when you have people who are in ward rooms, 
how do you get privacy to discuss things when they are basically immobile.  You 
know, um, so how do you do that well, how do you do that in an emergency 
setting when it's like a curtain that's separating you as well, and there's a lot of 
noise going on.  A lot of the time you need some privacy and quiet time, you 
need a quiet room to be able to go and discuss those things, some people are 
capable of moving to those places and other people are not, so there's a lot of 
issues that need to be looked at in those factors.’(CAN10) 
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Canadian Delphi Round 1 Key considerations: quotes from each item 
Life experience of person that 
you are having the discussion 
with in emergency scenario 
(usually a family member) 
‘just today actually I just got off the phone with an 18 year old who is power of 
attorney for her father who's in his early 60s, and it's a question of how much is 
understood, and um, life experiences that the person has had that you're having 
the discussion with and how ready are they to say yes let's just keep them 
comfortable.’ (CAN12) 
Multi-disciplinary team available 
to patient 
‘we need to have group discussions and patients need to perceive that they can 
have discussions within the teams, um, with anyone in the team and it will be 
shared to the point where it's not only getting information from the physicians, 
but the patient will know that they'd be getting information in discussions and 
it's equally valid between any team member.’(CAN9) 
Confirming patient 
understanding of the discussion 
‘Ensuring patient understanding (having the patient tell you what they 
understand about what you’ve discussed’ (CAN12) 
Personality of the patient ‘Just personality, the person's personality. I mean you talk to some people and it 
doesn't matter how you say things, you know you're never going to get through 
to them, you have to realize that and understand that you just kinda quit.  I 
mean not everybody wants to hear it, you know, our job is to explain it and tell 
it. But, once you say it once, and if they don't want to hear it again, you don't 
bring it up again. Unless they approach it, and sometimes that's the only way you 
can do it’ (CAN6) 
Credibility of the health 
professional (as recognised by 
the patient) 
‘credibility, um, you know, patients will say, some patients will say that they 
want their physicians to lead this discussion and because their physician is 
credible, um, so, so I think that's an important piece’ (CAN9) 
Whether the patient is taking 
care of themselves 
‘Or if the patient is at um, high risk for um, not suicide I wouldn't say, but if 
because of their denial they're neglecting themselves, then you push the 
envelope a little bit further, right, you bring up the conversations more’ (CAN1) 
Individual patient needs ‘it's really tough because you have to guage every single person differently, it's 
like you have to feel them out first and see where they're at with things, and see 
how far you can go before you watch the reaction in their face go to you know’ 
(CAN6) 
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Appendix F. Canadian Delphi Round 1 Key topics: sample quotes 
Canadian Delphi Round 1 Key topics: sample quotes 
Patient understanding of 
their option to make end-
of-life choices 
‘But the older group… now that group is quite anxious to know the truth, and 
they also want to know what it means by what we're doing.  And they wanna have 
a choice.  They don't all want us to give them all this stuff. And, and so, they seem 
to be more willing to go through what the consequences are of not pursing 
intervention, and then making some new decisions at that point. Not necessarily 
with me but with their doctors, so they'll hear our schpeil about why we think 
they should go on this stuff, but also consequences of not going on it, and then 
they seem to make a decision and then they're gonna pursue speaking about this 
in more detail and getting some written direction down with their physicians.’ 
(CAN11) 
Patient deciding on a 
substitute decision maker 
‘I talk about substitute decision maker, and with the Ontario booklet they have 
the little wallet card that you can actually write in your substitute decision maker, 
and a phone number.’ (CAN2) 
Patient understanding of 
the ‘chain of command’ of 
decision makers, should 
there be a dispute when 
patient is unable to speak 
for themselves 
‘briefly discuss that there's sort of a chain of command when it comes to making a 
decision, and that if you think your spouse is the one and only who could give an 
answer, that's not necessarily the case....should their be any dispute.’ (CAN2) 
Option to change your 
mind after making end-of-
life decisions 
‘I cover with them that you can rescind this at any time, this is, this document, you 
can rip it up at any moment, you aren't bound by this, if you are still able to 
communicate and you wanna change that, that's absolutely your perogative, you 
can, you know, this isn't a permanent document, and if you change your mind, you 
can change your mind, that's entirely up to you at the last minute.’ (CAN5) 
Making sure the doctor 
knows what kind of care 
the patient wants 
‘I give them the form and say, you know, discuss this…with your doctor, make 
sure that he knows or she knows what kind of care you want’(CAN5) 
Levels of advance care 
directives (supportive care 
only to full resuscitation) 
‘I make sure I cover, sort of the levels of advance care directives, the form that we 
have has supportive care only, um, I forget what the second level is, and the third 
level is sort of full resuscitation’(CAN5) 
Walking the family through 
the process of what will 
happen when the patient 
dies 
‘a lot of times they have a lot of questions about, you know when he moves on, 
what's it going to be like? Is there going to be a mess, um, you know, who do I call 
if I wake up and he is lying in the bed and he is dead, what do I do, you know.  It 
truly is walking them through process, and if they're willing to listen to it, you just 
say 'okay this likely what will happen you know, if, this is his choice to stay at 
home, these are the things that will occur over the next little while and we will be 
there with you if you want us there, every step of the way.'’ (CAN6) 
Explaining implications of 
end-of-life decisions and 
care to family 
‘nobody's ever talked to the family members about what we're doing and what 
that means, and so our patients will just get sicker and sicker and sicker, and 
honestly from having been a family member, and not knowing what's going on, my 
god, come on, let's include them too, and let them know what we're doing, what 
it means and where this patient is actually, I mean, I deal with respiratory failure, 
that is end-of-life, you know, and I don't think we're giving it the importance that it 
deserves, is my feeling’ (CAN11) 
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Discussing the ‘bother 
versus benefit’ of 
treatments or 
interventions with patients 
‘If the burden of therapy is outweighing the benefit of thereapy then we need to 
make new decisions, and there like oh my god that makes so much sense, because 
you're right this is making me so crazy it's not worth it, so yah, which is - the is it 
giving you more benefit than bother, or more bother than benefit, because that is 
an easy way to decide whether we're gonna continue doing all this stuff with 
machines that are making you stay up all night, and your family crazy’(CAN11) 
How patient wants things 
to look at the end-of-life 
‘So they come in, they're at the the end of life, and there they are intubated, 
they're doing everything because no one's been paperworked...you know what I 
mean, nobody's aware of what the patient really wanted..’ (CAN11) 
Educating patients about 
their end-of-life choices 
and implications 
  
‘I start with 'have you ever thought of, or have you ever discussed with your 
family, should you become so will that we would have to consider life support for 
you, or that if your heart should stop, would you want us do the compressions 
like you've seen on TV?', and then I go on to say 'there's pros and cons to both, 
the pro is, you may live longer, the con is, you may have to go down into the 
intensive care unit on a breathing machine where you will be tied down and you 
can't talk and you'll have to be fed through a tube, and you're dependent on care, 
totally'.  Um, so that's sort of how I frame it.’ (CAN12) 
‘we made some goals of getting him out of the house so he could have a life’ 
(CAN11) 
Explaining where they are 
in their disease e.g. no 
cure, focus on symptom 
management 
‘Somebody has a chronic disease and if they've had repeated admissions to 
hospital and each time you see them they're physical condition is declining, and 
their disease is worsening, then um, that's certainly the time to talk to 
people.’(CAN12) 
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Appendix G. Protocol for proposed pilot study 
This pilot study would aim to determine how the tool can be used by health 
professionals in practice, and to determine how best to administer the outcome measures in 
the planned randomised control trial.  The pilot study would be conducted in two PCTs in 
England where several BLF nurses are in practice.  At the time of writing this would likely in 
Liverpool and Southhampton as these two areas have the highest number of nurses registered 
with the BLF (Liverpool (12), Southhampton (8)).  A researcher in each area would be 
employed to carry out the administration of the project.  The pilot study would only include 
patients with a diagnoses of COPD at any stage in their disease and would be carried over one 
year.  The limit of only COPD patients, rather than any patient with NMRD would be imposed 
during the pilot study in order to simplify recruitment and to provide clarify for health 
professional participants as to which patients they should be using the tool with. 
Health professional participants in each location would be asked to attend an education 
session about the tool and how to use it in practice.  This session will be informed by the 
findings of the proposed systematic review. 
Several copies of the tool, with a set of questions printed on the back will be provided 
to participants.  The questions on the back will relate to outcome measures one and two. 
The pilot study will have three outcome measures: 
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1. A question about whether the health professional used the tool when meeting with a 
patient, and whether or not they decided to initiate a discussion or not based on 
guidance from the tool, with room for comments. 
2. A question about whether the tool increased their confidence in initiating an end-of-life 
discussion, asking them to rate their confidence level on a scale of 1-10.  This will be 
compared with a rating of confidence approaching end-of-life discussions at the 
beginning of the study to enable establish a baseline confidence rating. 
3. The Quality of Communication Questionnaire (Engleberg, 2006) would be used by the 
researcher on a follow-up visit to patients with which end-of-life discussions have been 
initiated by the health professional.  This validated questionnaire includes two scales: the 
General Communication Skills scale and the Communication about End-of-Life scale. 
This measure will be used to determine whether patients who have health professionals 
who have used the tool to guide an end-of-life discussion have a high score.  The scores 
could be compared with the COPD patient data provided by (Engleberg, 2006) to 
determine whether the scores using this intervention are higher, but in the randomized 
control trial following the pilot study, the outcome measure would also be applied on a 
control group receiving no intervention and this is where the meaningful data will 
emerge. 
The information gathered in the pilot study will be used to design a cluster randomized trial 
with several PCTs in England, Scotland, Wales and Northern Ireland.  Details of the cluster 
randomized trial are not able to be explicated until after the pilot study has been carried out. 
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Appendix H.  Protocol for proposed systematic review 
The objective of this systematic review is to review the effectiveness of end-of-life 
communication skills training programmes for health professionals on improving communication 
about end-of-life between health professionals and patients, and to identify experience of 
learning about end-of-life communication and changed perceptions as a result of such training.  
This protocol was developed using the JBI guidelines for protocol development (JBI, 2008).   
Inclusion criteria  
Types of participants 
The quantitative and qualitative components of this review will consider studies that 
include health professionals (physicians, nurses and allied health professionals) currently in 
education or already qualified and practicing. 
Types of intervention(s)/phenomena of interest 
• The quantitative component of the review will consider studies that evaluate educational 
interventions to improve end-of-life communication. 
• The qualitative component of this review will consider studies that investigate 
educational interventions to improve end-of-life communication 
• The quantitative component of the review will consider studies that evaluate educational 
programmes to teach health professionals about how to communicate with patients about end-
of-life. 
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• The qualitative component of this review will consider studies that investigate students' 
experiences of undertaking training about how to communicate with patients about end-of-life 
issues. 
Types of outcomes 
This review will consider studies that include the following outcome measures:  
• reported increase in confidence to have end-of-life discussions with patients 
• reported increase in end-of-life discussions after education programme 
• reported increase in palliative care uptake in patients 
Types of studies 
The qualitative component of the review will consider studies that focus on qualitative 
data including, but not limited to, designs such as phenomenology, grounded theory, 
ethnography, action research and feminist research.  In the absence of research studies, other 
text such as opinion papers and reports will be considered. 
The quantitative component of the review will consider both experimental study designs 
including randomised controlled trials, non-randomised controlled trials, quasi-experimental, 
before and after studies, prospective and retrospective cohort studies, case control studies and 
analytical cross sectional studies for inclusion. 
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Search strategy 
The search strategy aims to find both published and unpublished studies. A three-step 
search strategy will be utilised in this review. An initial limited search of MEDLINE and CINAHL 
will be undertaken followed by analysis of the text words contained in the title and abstract, 
and of the index terms used to describe article. A second search using all identified keywords 
and index terms will then be undertaken across all included databases. Thirdly, the reference 
list of all identified reports and articles will be searched for additional studies. Studies published 
in English will be considered for inclusion in this review. Studies published 2000-2013 will be 
considered for inclusion in this review. 
The databases to be searched include: MedLine, CINAHL, Embase, JBI Library, 
Cochrane Colaboration, TRIP.  The search for unpublished studies will include:  Google 
(Scholar), Mednar, WorldWideSscience, PsychExtral, OAlster, SIGLE Initial keywords to be 
used will be: education, medical education, communication, education, end-of-life. 
Assessment of methodological quality 
Quantitative papers selected for retrieval will be assessed by two independent 
reviewers for methodological validity prior to inclusion in the review using standardised critical 
appraisal instruments from the Joanna Briggs Institute Meta Analysis of Statistics Assessment 
and Review Instrument (JBI-MAStARI). Any disagreements that arise between the reviewers will 
be resolved through discussion, or with a third reviewer. 
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Qualitative papers selected for retrieval will be assessed by two independent reviewers 
for methodological validity prior to inclusion in the review using standardised critical appraisal 
instruments from the Joanna Briggs Institute Qualitative Assessment and Review Instrument 
(JBI-QARI). Any disagreements that arise between the reviewers will be resolved through 
discussion, or with a third reviewer. 
Quantitative papers selected for retrieval will be assessed by two independent 
reviewers for methodological validity prior to inclusion in the review using standardised critical 
appraisal instruments from the Joanna Briggs Institute Meta Analysis of Statistics Assessment 
and Review Instrument (JBI-MAStARI). Any disagreements that arise between the reviewers will 
be resolved through discussion, or with a third reviewer. 
Qualitative papers selected for retrieval will be assessed by two independent reviewers 
for methodological validity prior to inclusion in the review using standardised critical appraisal 
instruments from the Joanna Briggs Institute Qualitative Assessment and Review Instrument 
(JBI-QARI). Any disagreements that arise between the reviewers will be resolved through 
discussion, or with a third reviewer. 
Data collection 
Quantitative data will be extracted from papers included in the review using the 
standardised data extraction tool from JBI-MAStARI. The data extracted will include specific 
details about the interventions, populations, study methods and outcomes of significance to the 
review question and specific objectives. 
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Qualitative data will be extracted from papers included in the review using the 
standardised data extraction tool from JBI-QARI. The data extracted will include specific details 
about the interventions, populations, study methods and outcomes of significance to the review 
question and specific objectives. 
Data synthesis 
Qualitative research findings will, where possible be pooled using JBI-QARI. This will 
involve the aggregation or synthesis of findings to generate a set of statements that represent 
that aggregation, through assembling the findings (Level 1 findings) rated according to their 
quality, and categorising these findings on the basis of similarity in meaning (Level 2 findings). 
These categories are then subjected to a meta-synthesis in order to produce a single 
comprehensive set of synthesised findings (Level 3 findings) that can be used as a basis for 
evidence-based practice. Where textual pooling is not possible the findings will be presented in 
narrative form. 
Quantitative papers will, where possible be pooled in statistical meta-analysis using JBI-
MAStARI. All results will be subject to double data entry. Effect sizes expressed as odds ratio 
(for categorical data) and weighted mean differences (for continuous data) and their 95 percent 
confidence intervals will be calculated for analysis.  Heterogeneity will be assessed statistically 
using the standard Chi-square and also explored using subgroup analyses based on the different 
quantitative study designs included in this review. Where statistical pooling is not possible the 
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findings will be presented in narrative form including tables and figures to aid in data 
presentation where appropriate. 
Qualitative research findings will, where possible be pooled using JBI-QARI. This will 
involve the aggregation or synthesis of findings to generate a set of statements that represent 
that aggregation, through assembling the findings (Level 1 findings) rated according to their 
quality, and categorising these findings on the basis of similarity in meaning (Level 2 findings). 
These categories are then subjected to a meta-synthesis in order to produce a single 
comprehensive set of synthesised findings (Level 3 findings) that can be used as a basis for 
evidence-based practice. Where textual pooling is not possible the findings will be presented in 
narrative form 
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BLF Delphi Round 2
1. Please enter your first and last name.
2. Have you been interviewed by Nicole in round one of the Delphi (telephone
interview)? 
1. 
*
First name
Last name
*
Yesnmlkj
Nonmlkj
Appendix I.  UK Delphi Round 2 Questionnaire
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2. 
*1. Have you filled out the consent form and biographical information pages? If not you
will be redirected to provide consent and biographical information before continuing with 
the Delphi Round Two survey. 
Yesnmlkj
Nonmlkj
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Please take time to read and sign this page. You may not proceed to the survey until it has been completed. 
1. I confirm that I have read and understand the information sheet dated 20 July 2010 for
the study "Readiness/Willingness to discuss end-of-life in nonmalignant disease". I 
have had the opportunity to consider the information, ask questions and have had 
these answered satisfactorily. Please initial box if you are in agreement with this 
statement. 
2. I understand that my participation is voluntary and that I am free to withdraw at any
time without giving any reason, and without my legal rights being affected. Please initial 
below if you agree with this statement. 
3. Consent form
*
*
*3. I understand that I can withdraw my data up until it becomes anonymised. Please
initial below if you agree with this statement. 
4. I give consent for anonymised quotes from my responses to be used in
publications/reports. Please initial below if you agree with this statement. 
*
*5. I agree to take part in the above study. Please initial below if you agree with this
statement. 
6. Please type your name below as your electronic signature and today's date.
7. Please enter the email address where you would like the next questionnaire to be
sent. 
*
*
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1. What year were you born?
2. Please indicate your ethnicity:
4. Biographical Questionnaire
*
*
6
*3. What type of setting do you work in? (e.g. PCT, community, hospital ward, etc.)
4. What town or city do you work in?
5. How many years of respiratory nursing experience do you have?
*
*
*6. What are your nursing qualifications? (choose all that apply)
7. What are your post registration qualifications? OR What post registration qualification
are you working towards? 
5
6
Other (please specify) 
Less than 2 yearsnmlkj
2-4 yearsnmlkj
5-7 yearsnmlkj
8-10 yearsnmlkj
More than 10 yearsnmlkj
RNgfedc
RGNgfedc
BA (Hons) in Nursinggfedc
BSc in Nursinggfedc
Diploma in Nursinggfedc
Other (please specify)gfedc
Other (please specify) 
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8. What is your current job title?
9. Which of the following best describes the main focus of your current post?
*
*
Practionernmlkj
Educatornmlkj
Researchernmlkj
Managernmlkj
Other (please specify)nmlkj
Other (please specify) 
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Dear Participant, 
Thank you for agreeing to take part in this Delphi study about end-of-life care discussions with patients with nonmalignant 
respiratory disease. 
A major aim of this study is to gather the knowledge and opinions of health professionals on how they know a patient is 
ready or willing to discuss their end-of-life care preferences. 
As an expert in your field your opinions on this topic are extremely valuable to us, and we thank you for your time. 
Once you have completed the Delphi Round Two survey, please press the exit button to submit your responses 
electronically over a secure connection provided by the website. If possible, please complete this survey by December 
17 as online access may be disabled after this time. If you are unable to do so, then please let us know and we will 
make arrangements to accommodate your needs if possible. 
Please don't hesitate to contact me if you have any questions, or concerns about the study or if you have technical 
difficulties with the online questionnaire at nicole.stephen@plymouth.ac.uk. 
Thank you again for your participation. 
Kind Regards, 
Nicole Stephen 
5. Letter to participants
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Which of the following factors indicate that a patient is ready or willing to discuss end-of-life? Please indicate 
your level of agreement with each statement below. 
1.  
2.  
3.  
4.  
5.  
6. Question One
*
Strongly agree Agree Undecided Disagree Strongly disagree
Clinical signs e.g.: 
spirometry indicates severe 
COPD, 3 acute 
exacerbations in 12 
months, on maximum 
therapy.
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
My professional intuition nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Cues from the patient such 
as stating 'I do not want to 
go back to hospital'
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Patient asks if s/he is going 
to die
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Body language e.g.: open 
posture, appears relaxed
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
304
Page 8
BLF Delphi Round 2
6.
7.  
8. Are there any factors not included here that indicate to you that a patient is ready or
willing to discuss end-of-life? (please explain below) 
*
Strongly agree Agree Undecided Disagree Strongly disagree
General patient 
demeanour
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Patient is responsive when I 
allude to the end-of-life 
topic
nmlkj nmlkj nmlkj nmlkj nmlkj
5
6
Additional comments 
Additional comments 
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Which of the following factors are important when conducting an end-of-life discussion? Please indicate your 
level of agreement with each statement below. 
Factors relating to: THE PATIENT 
1.   
2.  
3.  
4.  
5.  
7. Question Two
*
Strongly agree Agree Undecided Disagree Strongly disagree
Allowing the patient to 
lead the conversation
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Answering patient’s 
question about the 
condition
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Maintaining hope for the 
patient
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Being open and honest 
with the patient
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Establishing patient’s 
understanding of their 
condition
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
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6.
7.  
8.  
9.  
10.  
11.  
Factors related to: THE ENVIRONMENT 
*
Strongly agree Agree Undecided Disagree Strongly disagree
Recognising the individual 
needs of the patient
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Explaining to patients what 
is feasible regarding their 
wishes
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Educating the patient 
about their condition
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Patient indicates readiness 
to discuss
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Patient wanting to hear the 
information
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Patient being open about 
dying
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
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12.
13.  
Factors related to: THE FAMILY 
14.   
15.  
16.  
Factors related to: THE HEALTH PROFESSIONAL 
17.   
*
Strongly agree Agree Undecided Disagree Strongly disagree
Having an appropriate 
environment for discussion 
e.g. privacy, quiet
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Where the discussion occurs 
e.g. clinic, hospital or 
patient’s home
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Having the patient’s family 
involved in the discussion
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Having family’s support 
during the discussion
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Patient’s wish to protect 
others from end-of-life 
information
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Being an expert on the 
condition
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
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18.
19.  
20.  
21.  
22.  
23.  
*
Strongly agree Agree Undecided Disagree Strongly disagree
Nurses having counselling 
skills
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Having the appropriate 
clinician to discuss end-of-
life with the patient
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Having a strong 
relationship with the 
patient
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Emphasising a holistic care 
approach
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Rapport between health 
professional and patient
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Health professional having 
the confidence to discuss
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
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24.
25.  
26.  
27.  
28.  
29.  
*
Strongly agree Agree Undecided Disagree Strongly disagree
Health professional’s 
understanding of the 
condition
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Using non-medical 
language
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Your professional 
boundaries
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Avoiding euphemisms - 
saying the words ‘dying’ or 
‘death’ instead
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Health professional taking 
responsibility to oblige the 
patient’s wishes
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Using humour nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
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30.
31.  
Factors related to: TIMING 
32.   
33.  
34.  
35.  
*
Strongly agree Agree Undecided Disagree Strongly disagree
Nurse having attended 
conferences or professional 
development specific to 
end-of-life discussions
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Nurse having experience in 
caring for dying patients
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Discussing end-of-life at 
time of diagnosis
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Developing the discussion 
over time
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Finding the right 
opportunity to discuss
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Patient having time to hear 
information and ask 
questions later
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
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36.
37. Are there any factors that have not been included here that are important when
conducting an end-of-life discussion? (please explain below) 
*
Strongly agree Agree Undecided Disagree Strongly disagree
Availability of time to 
discuss
nmlkj nmlkj nmlkj nmlkj nmlkj
5
6
Additional comments 
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Which of the following would you include in an end-of-life discussion? Please indicate your level of agreement 
with each statement below 
1.  
2.  
3.  
4.  
5.  
6.  
8. Question Three
*
Strongly agree Agree Undecided Disagree Strongly disagree
Introduction of an advance 
care planning document
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
The type of care the 
patient wants
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Emergency management 
preferences
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Explaining palliative care nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Anticipatory prescribing nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Ceiling of treatment nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
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7.
8.  
9.  
10.  
11.  
12.  
13.  
*
Strongly agree Agree Undecided Disagree Strongly disagree
Medication options nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Treatment options nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Patient goals nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Intubation and ventilation 
options
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Preferred place of care nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Preferred place of death nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
When the patient is likely to 
die
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
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14.
15.  
16.  
17.  
18.  
19.  
HOSPICE 
*
Strongly agree Agree Undecided Disagree Strongly disagree
Sedation 
availability/options
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Social services involvement nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Spirituality nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Transferring to palliative 
care
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Who the patient wants 
present at the very end-of-
life
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Dealing with breathlessness nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
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20.
21.  
PERCEPTIONS OF DEATH 
22.   
23.  
24.  
PRACTICAL NEEDS 
25.   
*
Strongly agree Agree Undecided Disagree Strongly disagree
Explaining hospice (if 
available) nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Options for hospice (if 
available) nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
How they feel about death nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Reassuring the patient s/he 
won’t suffer
nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Understanding of death nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Getting affairs in order nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
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26.
27.  
28.  
*
Strongly agree Agree Undecided Disagree Strongly disagree
Practical equipment needs nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Support in the home nmlkj nmlkj nmlkj nmlkj nmlkj
*
Strongly agree Agree Undecided Disagree Strongly disagree
Transportation needs to 
facilitate care
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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You have completed round two of the Delphi study. 
Thank you very much for your participation. You will be notified via email when the next questionnaire is ready for your participation. 
To exit the survey, click exit below. 
9. Thank you
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Round Three of the Delphi Study 
Dear Participant, 
The purpose of this round of the Delphi is to give you a chance to see how 
other participants have responded to each item. 
Please review each item, considering the mean score and the comments from 
the previous round. Based on this information re-consider your opinion 
and then rate the item. Also, feel free to add any comments that you feel 
may clarify the item, but note that comments are not required. 
You may notice that some items have been moved from one question to 
another, and some items have been added from suggestions made in the 
previous round. In such cases, there will be no prior information such 
as a mean or comments provided, and therefore you should rate the item 
based on your professional experience. 
Please would you be kind enough to complete the survey by 28TH JANUARY - please contact me if you have any questions, technical 
difficulties or 
problems with completing the survey before 28 January as it is very 
important to the validity of the study that you are able to respond. 
Sincerely, 
Nicole Stephen 
nicole.stephen@plymouth.ac.uk 
1. First name:
2. Last name:
Welcome!
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Which of the following factors indicate that a patient is ready or willing to discuss end-of-life? 
Please read the mean (average) rating and consider the comments made by participants in the previous round before 
indicating your level of agreement with each item below. 
1. 
Mean (average rating in previous round) 
3.32 (undecided) 
Comments from previous round 
l Clinical symptoms don’t indicate willingness to discuss end-of-life  
l Exacerbations and decreased time between them is one main factor -not getting better  
l Be lead by patient. Patient needs to know that they are severe COPD, make sure that patient is informed of diagnosis. Be there for 
answering questions and further advice (support when needed)  
l Clinical severity does not always represent a willingness to engage 
l These signs do not mean much to the patient  
l Helpful but not sensitive enough  
1.  
2. 
Mean (average rating in previous round) 
4.16 (agree) 
Comments from previous round 
l sometimes  
l sometimes  
l "Gut' feeling is helpful. Supported by professional expertise, emotional intelligence 
2.  
Question One
Strongly agree Agree Undecided Disagree Strongly disagree
Clinical signs  
e.g. spirometry indicates 
severe COPD, 3 acute 
exacerbations in 12 
months, on maximum 
therapy
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
My professional intuition nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
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3. 
Mean (average rating in previous round) 
4.53 (agree) 
Comments from previous round 
l Can be a prompt to follow 
3.  
4. 
Mean (average rating in previous round) 
4.74 (agree) 
Comments from previous round 
l If they ask, the door is open  
l This gives an opportunity to discuss end of life. Be lead by the patient. As questions which will prompt the patient. Sometimes patient 
wants to know but hasn't confidence to ask the question. 
l This could be explored to see if they want to  
4.  
5. 
Mean (average rating in previous round) 
3.42 (undecided) 
Comments from previous round 
l Not necessary a sign willing to discuss end-of-life 
5.  
Strongly agree Agree Undecided Disagree Strongly disagree
Cues from the patient such 
as stating 'I do not want to 
go back to hospital'
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Patient asks if s/he is going 
to die
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Body language indicates 
openness to discussion e.g.: 
open posture, appears 
relaxed 
changed from: Body 
language
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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6. 
Mean (average rating in previous round) 
3.79 (undecided) 
Comments from previous round 
l No comments 
6.  
7. 
Mean (average rating in previous round) 
4.47 (agree) 
Comments from previous round 
l If patient is responsive - take it further with discussion, look for patient reaction and participation 
l Another helpful clue for nurses  
7.  
8. 
Mean (average rating in previous round) 
not applicable 
Comments from previous round 
l not applicable 
8.  
Strongly agree Agree Undecided Disagree Strongly disagree
General patient 
demeanour
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Patient is responsive when I 
allude to the end-of-life 
topic
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Patient refers to their own 
death 
previously 2.11 ‘patient 
being open about dying'
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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9. 
Mean (average rating in previous round) 
not applicable 
Comments from previous round 
l not applicable 
9.  
10. 
Mean (average rating in previous round) 
not applicable 
Comments from previous round 
l not applicable 
10.  
11. 
Mean (average rating in previous round) 
not applicable 
Comments from previous round 
l not applicable 
11.  
Strongly agree Agree Undecided Disagree Strongly disagree
Patient talks about or asks 
about hospice options 
previously 3.20/21 'patient 
talking about/asking about 
hospice options'
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Patient appears to be 
getting their affairs in order 
previously 3.25 'Getting 
affairs in order'
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Family whispers to you in 
the hall ‘John wants to die’ 
*new item added from
participant comments
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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12. 
Mean (average rating in previous round) 
not applicable 
Comments from previous round 
l not applicable 
12.  
13. 
Mean (average rating in previous round) 
not applicable 
Comments from previous round 
l not applicable 
13.  
14. 
Mean (average rating in previous round) 
not applicable 
Comments from previous round 
l not applicable 
14.  
Strongly agree Agree Undecided Disagree Strongly disagree
Patient states that they 
have ‘had enough’ or that 
they want to die 
*new item added from
participant comments
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Patient asks about 
intubation in the hospital 
*new item added from
participant comments
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Patient does not comply 
with treatment 
*new item added from
participant comments
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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15. 
Mean (average rating in previous round) 
not applicable 
Comments from previous round 
l not applicable 
15.  
Strongly agree Agree Undecided Disagree Strongly disagree
Recent death in the family 
and patient has concerns 
about the same issue 
*new item added from
participant comments
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
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Which of the following factors are important when conducting an end-of-life discussion? 
Please read the mean (average) rating and consider the comments made by participants in the previous round before 
indicating your level of agreement with each item below. 
1. 
Mean (average rating in previous round) 
4.05 (agree) 
Comments from previous round 
l This varies patient to patient  
l You need to get decisions made so open questions but you need to guide sometimes  
l It is fine to initiate an end-of-life discussion but progress should be lead by the patient 
l Usually from cues or leading questions  
l Let them lead, however prompt to expand discussion further  
l They may want to, listen a lot, resist temptation to take  
l Patient can initiate the conversation but probably not leading  
l Patient starts the conversation but practitioner leads the discussion  
l Some patients will prefer to be 'led' or are not sure how to lead the conversation  
1.  
2. 
Mean (average rating in previous round) 
4.58 (agree) 
Comments from previous round 
l Always answer patient questions as fully as possible or sign post when appropriate 
l They may need to understand more to deal with it  
2.  
Question Two
Strongly agree Agree Undecided Disagree Strongly disagree
Allowing the patient to 
lead the conversation
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Answering patient's 
questions about the 
condition
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
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3. 
Mean (average rating in previous round) 
3.47 (undecided) 
Comments from previous round 
l Honesty is the best way forward. False hope can be detrimental  
l Realistic goals  
l Hope that symptoms can be managed effectively  
l Give facts, evidence based answers i.e. in COPD explain it is a progressive disease 
l Difficult one  
l You don't generally give patients false reassurance  
l This could be unrealistic  
l If they are going to die what hope can one maintain?  
l Not sure - hope for what?  
3.  
4. 
Mean (average rating in previous round) 
4.89 (agree) 
Comments from previous round 
l Always best  
l Treat carefully when being open and honest. Answer questions with tact and appropriateness 
l I think this is important, but sometimes they don't want to know  
l Even if that means saying 'I don't know'  
4.  
5. 
Mean (average rating in previous round) 
4.79 (agree) 
Comments from previous round 
l No comments 
Strongly agree Agree Undecided Disagree Strongly disagree
Maintaining hope for the 
patient that symptoms can 
be managed effectively, 
while being honest about 
the likelihood of disease 
progression 
previously: Maintaining 
hope for the patient
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Being open and honest 
with the patient
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
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5.  
6. 
Mean (average rating in previous round) 
5.0 (strongly agree) 
Comments from previous round 
l and families  
l May be other than health issues, may need to refer on 
6.  
7. 
Mean (average rating in previous round) 
4.84 (agree) 
Comments from previous round 
l Make sure any decisions are communicated to multidisciplinary team and family if appropriate 
l What is realistic and conceivable  
7.  
8. 
Mean (average rating in previous round) 
4.37 (agree) 
Comments from previous round 
l Specific to end-of-life care  
l Be lead by patient  
l What to expect  
l This depends - hopefully I will have had the opportunity to establish their level of understanding 
Strongly agree Agree Undecided Disagree Strongly disagree
Establishing patient's 
understanding of their 
condition
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Recognising the individual 
needs of the patient (and 
their family where 
applicable) 
previously: recognising the 
individual needs of the 
patient
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Explaining to patients what 
is feasible regarding their 
wishes
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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8.  
9. 
Mean (average rating in previous round) 
4.58 (agree) 
Comments from previous round 
l Patients may have no insignt into the risk of their mortality and therefore may be unlikely to raise end-of-life discussion themselves 
l Take the opportunity. Be lead by patient. Prompt patient to take discussion wider if appropriate.  
l Some patients will never be ready  
l Not always obvious - goes back to intuition  
9.  
10. 
Mean (average rating in previous round) 
4.32 (agree) 
Comments from previous round 
l Patient needs realistic information but it may not be information that they want to hear 
l They may want to hear but they may find difficult to understand or accept  
l Some patients will never be ready  
l You still need to start the conversation to establish what they don't want to hear  
10.  
Strongly agree Agree Undecided Disagree Strongly disagree
Educating the patient 
about their condition and 
what to expect 
previously: educating the 
patient about their 
condition
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Patient indicates readiness 
to discuss
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Patient wanting to hear the 
information
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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11. 
Mean (average rating in previous round) 
4.63 (agree) 
Comments from previous round 
l Environment is important but this may alter person to person. Some patients wish family to be present  
l Sometimes we have to make use of the opportunity rather than setting the scene  
l Important to discuss in an environment suitable for the patient and the patient knowing what the discussion is about to be able to 
choose the right environment  
l Wherever patient is comfortable 
l No disruptions if possible  
l But not always possible  
11.  
12. 
Mean (average rating in previous round) 
4.11 (agree) 
Comments from previous round 
l Not sure what this question is asking...best for health professional or patient?  
l Appropriateness to patient  
l Sometimes due to patient's condition you have to do where's available - you would prefer at home - sometimes too poorly 
l Wherever best opportunity occurs  
l Better in their own environment  
12.  
Strongly agree Agree Undecided Disagree Strongly disagree
Having an appropriate 
environment for discussion
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Where the discussion occurs 
e.g. clinic, hospital or 
patient's home
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
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13. 
Mean (average rating in previous round) 
3.63 (undecided) 
Comments from previous round 
l With patients prior consent to which family member  
l Varies patient to patient  
l If patient consents  
l It should be up to the patient of they want their next of kin present  
l Only if patient wishes  
l Can vary from individual cases but some may benefit from family being present to reinforce info  
l Should be led by the patient, if they would like somebody to be present  
l Patient's decision  
l Some patient want to discuss stuff without relatives present so some discussion with patient some with relatives and some with both so 
everyone knows how they feel  
l Find out patients wishes first encourage family involvement 
l This depends on patient's wishes and need for privacy  
l Depends if patient wants family involved in discussion  
l Only once I've had the discussion with the patient first  
13.  
14. 
Mean (average rating in previous round) 
4.11 (agree) 
Comments from previous round 
l If patient wishes this  
l If they want to be  
l Is always helpful to support the patient and because two sets of ears are often better than one 
l Depends on situation  
l Patient's decision  
l This depends on patient's wishes and need for privacy  
l Can be helpful but not imperative  
Strongly agree Agree Undecided Disagree Strongly disagree
Having the family involved 
in the end-of-life discussion 
if the patient wishes 
previously: Having the 
patient's family involved in 
the discussion
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
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14.  
15. 
Mean (average rating in previous round) 
3.63 (undecided) 
Comments from previous round 
l Depends on individual situation  
l I recommend that patients be honest with those closest to them to allow them time to adjust. Having a patient try to protect relatives is 
almost as difficult as the next of kin trying to persuade me not to be honest with a patient  
l May not be ready to share info, can be done later  
l Need patient to realise all information given is confidential, although may wish to guide patient if it is in the best interest. Therefore 
important to recognise patients ability to retain information and make informed decisions 
l Patient's decision  
l Can you find out why  
l Important but as a topic for discussion  
15.  
16. 
Mean (average rating in previous round) 
4.0 (agree) 
Comments from previous round 
l I do not feel like an expert - I am still learning  
l All end-stage organ failure can apply across the board. However, being a respiratory specialist, I may be able to offer more info than a 
generalist  
l You don't need to be an 'expert' to discuss end of life matters.  
l I don't think this is essential  
l Need not be expert in specific condition but expert in needs of long term conditions 
Strongly agree Agree Undecided Disagree Strongly disagree
Having family support 
during the discussion if 
patient wants their 
involvement 
previously: Having family's 
support during the 
discussion
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Patient's wish to protect 
others from their end-of-life 
wishes (keeping information 
from the family if the 
patient wishes) 
previously: Patient's wish 
to protect others from end-
of-life wishes
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
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16.  
17. 
Mean (average rating in previous round) 
4.05 (agree) 
Comments from previous round 
l Not necessarily from a course. Natural skills are sometimes better  
l Or at least excellent communication skills but who can measure this?  
l Nurses develop communication skills from training. Communication is one of the most important skills.  
l Definitely very helpful as sometimes can feel out of depth  
l In an ideal world but often patients will ask the most difficult question of the most junior member of staff 
17.  
18. 
Mean (average rating in previous round) 
4.11 (agree) 
Comments from previous round 
l But they have to be good at breaking bad news - some are hopeless!  
l Be lead by patient. It may be better from GP in some cases  
l May think that consultant may be and they may not necessarily have skills 
l The most appropriate person may not be acceptable to the patient  
l Who decides who is appropriate - may be me, may be GP or PI nurse  
18.  
Strongly agree Agree Undecided Disagree Strongly disagree
Being an expert on the 
condition
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Nurses having attended 
counselling skills training 
previously: Nurses having 
counselling skills
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Having the appropriate 
clinician to discuss end-of-
life
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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19. 
Mean (average rating in previous round) 
3.84 (undecided) 
Comments from previous round 
l Occasionally the consultant may be best placed but other health care professionals who know the patient can offer on-going support 
l Each patient is an individual - one clinician to discuss end of life may not by appropriate for another  
l Can make easier  
l Helpful in starting conversation  
19.  
20. 
Mean (average rating in previous round) 
4.68 (agree) 
Comments from previous round 
l Addressing all patients issues  
l The bedrock of all we do, I hope 
20.  
21. 
Mean (average rating in previous round) 
4.47 (agree) 
Comments from previous round 
l Led by patient  
l Very important 
21.  
Strongly agree Agree Undecided Disagree Strongly disagree
Having a strong 
relationship with the 
patient
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Emphasising a holistic care 
approach
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Rapport between health 
professional and patient
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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22. 
Mean (average rating in previous round) 
4.84 (agree) 
Comments from previous round 
l Staff who are not confident should acquire relevant skills and experience 
l The time to discuss at numerous times - it requires a lot of time  
22.  
23. 
Mean (average rating in previous round) 
4.63 (agree) 
Comments from previous round 
l No comments 
23.  
24. 
Mean (average rating in previous round) 
4.48 (agree) 
Comments from previous round 
l Depends on patient's knowledge/background/education 
l Keeping simpler for patient  
l In any discussion! 
24.  
25. 
Mean (average rating in previous round) 
4.16 (agree) 
Comments from previous round 
l What boundaries? Something like this is difficult to separate yourself from 
l I'm not re what professional boundaries you refer to  
Strongly agree Agree Undecided Disagree Strongly disagree
Health professional having 
the confidence to discuss
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Health professional's 
understanding of the 
condition
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Using non-medical 
language
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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25.  
26. 
Mean (average rating in previous round) 
3.68 (undecided) 
Comments from previous round 
l Varies person to person  
l What does the patient call it.  
l Some patients may be in denial so would these terms be more appropriate?? Then again, who are we to decide that patients need to 
know? Maybe they already do but do not want to hear...  
l Depends on the type of personality some patients don't mind hearing dying 
l Tempting to do this to make easier?  
l Depends on patient and carer  
l Depends  
26.  
27. 
Mean (average rating in previous round) 
3.63 (undecided) 
Comments from previous round 
l Two way process  
l Try to undertake wishes  
l If facilities available to do so /explain to patient why if not possible 
l Depends upon the wishes..... 
l Within their professional boundaries  
l Depends  
l You must acknowledge their wishes but be honest and not collude where their wishes are not practical, etc. 
Strongly agree Agree Undecided Disagree Strongly disagree
Working within realms of 
own expertise and 
maintaining professional 
boundaries 
previously:Your 
professional boundaries
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Echoing patient's language 
for death and dying words 
previously: Avoiding 
euphemisms - saying the 
words 'dying' or 'death'
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
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27.  
28. 
Mean (average rating in previous round) 
3.05 (undecided) 
Comments from previous round 
l Where appropriate  
l Varies person to person  
l If patient likes or uses humour  
l If appropriate  
l Depends on relationship with patient and their personality  
l Sometimes depends on the situation  
l Can vary... one patient may be happy to talk openly and 'make light' of the situation whereas this can be very inappropriate with a 
different patient  
l Requireed to be led by patient  
l Appropriateness with patient  
l Again this depends on the type of patient your relationship with the patient 
l Depends on circumstances  
l But appropriately  
28.  
29. 
Mean (average rating in previous round) 
3.68 (undecided) 
Comments from previous round 
l Experience of situations and empathy just as important as theoretical knowledge 
l Especially to know what local and national guidelines, etc are available  
l Some nurses it comes naturally having courses helps increase confidence  
l Does make easier  
l But should not stop you from having the conversation  
Strongly agree Agree Undecided Disagree Strongly disagree
Health professional 
acknowledges and tries to 
undertake patient's end-of-
life wishes if facilities are 
able to do so, and if not 
explaining why 
previously: Health 
professional taking 
responsibility to oblige the 
patient's wishes
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Using humour when 
appropriate to the 
individual 
previously: using humour
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
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29.  
30. 
Mean (average rating in previous round) 
4.16 (agree) 
Comments from previous round 
l For own personal strength in dealing with how we can cope 
l Helps nurse confidence  
30.  
31. 
Mean (average rating in previous round) 
2.74 (disagree) 
Comments from previous round 
l Should be introduced as part of the discussion regarding ongoing progressive illness and may require discussion in the future 
l Varies person to person  
l But should be told treatable but not curable  
l Not really best time but I do discuss it briefly not in depth  
l Patients may be inclined to 'give up' - again, can vary...  
l Not necessarily but important patients recognise it is a long-term condition  
l We need to get confident in starting at discussions at diagnosis  
l Not appropriate at all  
l Depends on disease severity at diagnosis  
l Depends on patient  
l Difficult to balance the need for patients to understand the disease is life limiting with giving a bleak picture and no hope  
31.  
Strongly agree Agree Undecided Disagree Strongly disagree
Nurse having attended 
conferences or professional 
development specific to 
end-of-life discussions
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Nurses having experience 
in caring for dying patients
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Discussion of life-limiting 
nature of disease at time of 
diagnosis 
previously: discussing end-
of-life at time of diagnosis
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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32. 
Mean (average rating in previous round) 
4.32 (agree) 
Comments from previous round 
l More comfortable  
l This depends on patients 
32.  
33. 
Mean (average rating in previous round) 
4.32 (agree) 
Comments from previous round 
l Should be over time 
33.  
34. 
Mean (average rating in previous round) 
4.42 (agree) 
Comments from previous round 
l Different patients ask different questions  
l All questions should be addressed at time 
34.  
Strongly agree Agree Undecided Disagree Strongly disagree
Developing the discussion 
over time
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Finding the right 
opportunity to discuss
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Patient having time to hear 
information and ask 
questions immediately or in 
the future 
previously: patient having 
time to hear information 
and ask questions later
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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35. 
Mean (average rating in previous round) 
4.63 (agree) 
Comments from previous round 
l Sometimes the right for patients is never, the right time for us so being honest about what you can discuss and how to come back to it 
35.  
36. 
Mean (average rating in previous round) 
not applicable 
Comments from previous round 
l not applicable 
36.  
Strongly agree Agree Undecided Disagree Strongly disagree
Availability of time to 
discuss
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Health professional being 
unafraid of talking about 
dying whenever the 
opportunity occurs - from 
diagnosis onwards when 
patient initiates 
*new item added from
participant comments
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
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Which of the following would you include in an end-of-life discussion? 
Please read the mean (average) rating and consider the comments made by participants in the previous round before 
indicating your level of agreement with each item below. 
1. 
Mean (average rating in previous round) 
4.83 (agree) 
Comments from previous round 
l No comments 
1.  
2. 
Mean (average rating in previous round) 
4.37 (agree) 
Comments from previous round 
l At some point - probably not first meeting 
l If that's what the patient wanted  
2.  
3. 
Mean (average rating in previous round) 
4.47 (agree) 
Comments from previous round 
l No comments 
3.  
Question Three
Strongly agree Agree Undecided Disagree Strongly disagree
The type of care that the 
patient wants
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Introduction of an advance 
care planning document
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Emergency management 
preferences
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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4. 
Mean (average rating in previous round) 
4.68 (agree) 
Comments from previous round 
l No comments 
4.  
5. 
Mean (average rating in previous round) 
4.39 (agree) 
Comments from previous round 
l Later in discussions 
l Not first off  
5.  
6. 
Mean (average rating in previous round) 
4.16 (agree) 
Comments from previous round 
l Need to talk about i.e. NIV 
6.  
7. 
Mean (average rating in previous round) 
4.32 (agree) 
Comments from previous round 
l No comments 
Strongly agree Agree Undecided Disagree Strongly disagree
Explaining palliative care nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Anticipatory prescribing nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Ceiling of treatment nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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7.  
8. 
Mean (average rating in previous round) 
4.33 (agree) 
Comments from previous round 
l No comments 
8.  
9. 
Mean (average rating in previous round) 
4.63 (agree) 
Comments from previous round 
l No comments 
9.  
10. 
Mean (average rating in previous round) 
4.32 (agree) 
Comments from previous round 
l No comments 
10.  
Strongly agree Agree Undecided Disagree Strongly disagree
Medication options nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Treatment options nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Patient goals nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Intubation and ventilation nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
Additional comments 
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11. 
Mean (average rating in previous round) 
4.84 (agree) 
Comments from previous round 
l No comments 
11.  
12. 
Mean (average rating in previous round) 
4.89 (agree) 
Comments from previous round 
l No comments 
12.  
13. 
Mean (average rating in previous round) 
3.17 (undecided) 
Comments from previous round 
l No just that they are dying  
l This is very difficult to predict in this condition  
l This is impossible to predict  
l Difficult to predict and patients can become very fixed on this time span  
l I would not be able to say  
l They always ask this but how do we know?!  
l In a non malignant case it is difficult to predict when death is likely to occur 
l This is too difficult to predict  
l Difficult to quote  
13.  
Strongly agree Agree Undecided Disagree Strongly disagree
Preferred place of care nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Preferred place of death nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Explaining to patient that it 
is difficult to predict when 
death is likely to occur 
previously: When the 
patient is likely to die
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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14. 
Mean (average rating in previous round) 
4.21 (agree) 
Comments from previous round 
l No comments 
14.  
15. 
Mean (average rating in previous round) 
4.42 (agree) 
Comments from previous round 
l If appropriate, patient needs to know options available 
15.  
16. 
Mean (average rating in previous round) 
4.37 (agree) 
Comments from previous round 
l Led by patient and family  
l Define spirituality. It means different things to different people and is much more than just religion 
l Only if the patient wants to include this  
l If appropriate  
16.  
17. 
Mean (average rating in previous round) 
4.26 (agree) 
Comments from previous round 
l We have end-of-life coordinator 
l Only if patients want this option 
Strongly agree Agree Undecided Disagree Strongly disagree
Sedation 
availability/options
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Social services involvement nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Spirituality, if relevant to 
the patient/family 
previously: Spirituality
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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17.  
18. 
Mean (average rating in previous round) 
4.26 (agree) 
Comments from previous round 
l Only if patient initates discussion  
l Explain this is not always possible 
l May not be possible to achieve  
18.  
19. 
Mean (average rating in previous round) 
4.84 (agree) 
Comments from previous round 
l No comments 
19.  
20. 
Mean (average rating in previous round) 
4.21 (agree) 
Comments from previous round 
l No comments 
20.  
Strongly agree Agree Undecided Disagree Strongly disagree
Transferring to palliative 
care
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Who the patient wants 
present at the very end-of-
life
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Dealing with breathlessness nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
How they feel about death nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
Additional comments 
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21. 
Mean (average rating in previous round) 
3.42 (undecided) 
Comments from previous round 
l This needs to be explained that we will do the utmost to ensure this won't occur but cannot guarantee  
l Important not to give false hope. I explain that we will do our utmost to prevent suffering and that often it is relatives that are distressed 
due to potential loss etc  
l Could I offer this?? I would hope so but if the patient does not want palliative care involvement, could I guarantee this? 
l Difficult to predict 100%. It is an aim for all patients to die without suffering  
l Explain they will have symptoms we help ease them  
l Not sure this can be done  
l Can't do that as the end can be unpredictable  
l Hard to predict process  
21.  
22. 
Mean (average rating in previous round) 
3.95 (undecided) 
Comments from previous round 
l May be more appropriate to sign post patient if they wish to discuss this further due to personal belief 
22.  
23. 
Mean (average rating in previous round) 
4.63 (agree) 
Comments from previous round 
l No comments 
23.  
Strongly agree Agree Undecided Disagree Strongly disagree
Explaining to patient that 
everything will be done to 
prevent suffering at the 
end-of-life 
previously: Reassuring the 
patient s/he won't suffer
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Understanding of death nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Practical equipment needs nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
347
Page 30
BLF Delphi Round 3
24. 
Mean (average rating in previous round) 
4.58 (agree) 
Comments from previous round 
l No comments 
24.  
25. 
Mean (average rating in previous round) 
4.37 (agree) 
Comments from previous round 
l If necessary 
25.  
26. 
Mean (average rating in previous round) 
not applicable 
Comments from previous round 
l Not applicable 
26.  
27. 
Mean (average rating in previous round) 
Not applicable 
Comments from previous round 
l Not applicable 
Strongly agree Agree Undecided Disagree Strongly disagree
Support in the home nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Transportation needs to 
facilitate care
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Needs of the 
partner/significant other 
*new item added from
participant comments
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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27.  
Strongly agree Agree Undecided Disagree Strongly disagree
Option to change your 
mind about end-of-life 
decisions 
*new item added from
participant comments
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
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Many thanks for participating in Round 3 of the Delphi study. You will receive a link to the fourth and final round of the 
Delphi in February. 
Survey Complete!
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1. Please enter your first and last name:
2. Have you been interviewed by Nicole?
*
First name
Last name
*
Yesnmlkj
Nonmlkj
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Appendix K. Canadian Delphi Round 2 Questionnaire
1. Have you filled out the consent form and biographical information questionnaire? If
not you will be redirected to provide consent and biographical information before 
continuing with this survey. 
*
Yesnmlkj
Nonmlkj
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Please take time to read and sign this page. You may not proceed to the survey until it has been completed. 
1. I confirm that I have read and understand the information sheet dated 16 June 2011
for the study "Willingness/readiness to discuss end­of­life with nonmalignant disease 
patients". I have had the opportunity to consider the information, ask questions and have 
had these answered satisfactorily. Please initial box if you are in agreement with this 
statement. 
2. I understand that my participation is voluntary and that I am free to withdraw at any
time without giving any reason, and without my legal rights being affected. Please initial 
below if you agree with this statement. 
Consent form
*
*
3. I understand that I can withdraw my data up until it becomes anonymized. Please
initial below if you agree with this statement. 
4. I give consent for anonymized quotes from my responses to be used in
publications/reports. Please initial below if you agree with this statement. 
*
*
5. I agree to take part in the above study. Please initial below if you agree with this
statement. 
6. Please type your name below as your electronic signature and today's date.
7. Please enter the email address where you would like the next questionnaire to be
sent. 
*
*
*
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Please answer the following questions so that we can learn more about you. 
1. Please provide your contact and location information
2. Which province or territory do you work in?
3. What year were you born?
4. What is your first language?
Biographical Survey
*
Name:
Organization (if applicable):
Address:
Address 2:
City/Town:
Email Address:
*
*
*
Albertanmlkj
British Columbianmlkj
Manitobanmlkj
New Brunswicknmlkj
Newfoundland and Labradornmlkj
Northwest Territoriesnmlkj
Nova Scotianmlkj
Nunavutnmlkj
Ontarionmlkj
Prince Edward Islandnmlkj
Quebecnmlkj
Saskatchewannmlkj
Yukonnmlkj
Frenchnmlkj
Englishnmlkj
Other (please specify)nmlkj
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5. Which language do you use primarily when speaking with patients?*
6. Please tell me about your education and professional designation(s) Please check all
that apply 
7. Please provide the year that you obtained the degrees or designations above: (e.g.
Bachelor's/1996) 
*
*
5
6
8. Where do you practice as a respiratory health professional? check all that apply*
Englishnmlkj
Frenchnmlkj
Other (please specify)nmlkj
Diplomagfedc
Bachelor'sgfedc
Master'sgfedc
MDgfedc
PhDgfedc
CAEgfedc
COPD Educatorgfedc
RNgfedc
RRTgfedc
PTgfedc
Pharmacistgfedc
Social Workergfedc
Other (please specify)gfedc
Universitygfedc
Communitygfedc
Hospitalgfedc
Outpatient clinicgfedc
Other (please specify)gfedc
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9. What are your practice activities? Check all that apply
10. What is your current job title?
11. How many years of experience do you have as a respiratory health professional?
Please enter a number between 0 and 50 
12. How many years of experience do you have discussing end­of­life with patients with
nonmalignant respiratory disease? Please enter a number between 0 and 50 
Thank you for completing the consent form and biographical questionnaire. You will now enter the survey. 
*
*
*
Teachinggfedc
Researchgfedc
Administrationgfedc
Clinicalgfedc
Counsellinggfedc
Other (please specify)gfedc
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Dear Participant, 
Thank you for agreeing to take part in this Delphi study about end­of­life care discussions with patients with nonmalignant respiratory disease. 
A major aim of this study is to gather the knowledge and opinions of Canadian health professionals on how they know a patient is ready or willing 
to discuss their end­of­life care preferences. As an expert in your field your opinions on this topic are extremely valuable to us, and we thank you for 
your time.  
The items on the following survey have been taken from interviews conducted with health professionals, and this is your chance to agree or 
disagree on their opinions based on your experience. When possible, interviewees' own words have been used. Please rate your agreement with 
each item, and provide comments as you wish. Your anonymous comments will be visible to other participants in the next questionnaire.  
Please try to relate your answers to your experience with patients with nonmalignant respiratory disease exclusively. 
Please don't hesitate to contact me if you have any questions, or concerns about the study or if you have technical difficulties with the online 
questionnaire. 
Thank you again for your participation. 
Kind Regards, Nicole Stephen 
Letter to participants
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Which of the following factors indicate that a patient is ready or willing to discuss end­of­life? Please indicate 
your level of agreement with each statement below and provide comments if you would like to clarify or modify an item 
1. Clinical indicators
e.g. the patient has recently had an acute episode and required hospitalization 
2. The health professional uses their emotional intelligence to guage patient readiness
3. Patient cues
e.g. body language, facial expressions, open personality 
4. Patient initiates end­of­life topic with health professional
Question 1
*
*
*
*
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
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5. Patient responds when end­of­life topic is alluded to or initiated by the health
professional 
examples: 
l ­ asking whether the patient has made a will;  
l ­ sharing a personal story about a death in the family where end­of­life decisions were 
not made;  
l ­ explaining how if the patient were in crisis what the first health professional to arrive 
on the scene would be expected to do, and that it would be unfortunate if they had 
wishes that were not expressed and therefore not met in this type of situation. 
6. All patients are ready if the health professional frames the discussion appropriately
7. You know a patient is ready to discuss because you know them
Readiness in the patient education context 
8. Attending end­of­life session implies readiness to discuss
*
*
*
*
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments 
5
6
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9. Group setting encourages patients to discuss
10. Patient follows up on end­of­life information received in education session
11. Patients are not given the option of being ready to hear the information in the
education context 
12. Are there any factors not included here that indicate to you that a patient is ready or
willing to discuss end­of­life? Please explain below. 
*
*
*
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments 
5
6
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1. There are situations when ‘readiness’ is not important such as when the topic must
be discussed immediately for practical purposes 
Question 1b
*
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
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Which of the following factors are important when conducting an end­of­life discussion? Please indicate your 
level of agreement with each statement below and comment if you would like to clarify or modify an item 
Family: 
1. Family issues for the patient
E.g. young children at home 
2. Communicating patient wishes to family
3. Presence or absence of family support
Approaching the discussion: 
4. Sense of humour
Question 2
*
*
*
*
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
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5. Sensitivity to the patient’s culture
6. Approaching the topic calmly
7. Approaching topic with a ‘matter­of­factness’
8. Approaching the topic with a caring nature
9. Being open
10. Being honest
*
*
*
*
*
*
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
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11. Being respectful of the client
12. Listening to the patient
13. Giving advice when it’s asked for
14. Letting the patient guide the discussion
15. Readiness of the patient to discuss
16. Accepting the patient’s reactions
*
*
*
*
*
*
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
364
17. Knowing when to step back from the topic
18. Having a pre­existing good relationship with the patient
19. Avoiding dashing hope
20. Raising the topic early before critical situation
21. Having end­of­life on a list of things that need to be talked about
22. Having handouts of example advance care directives (paper resources)
*
*
*
*
*
*
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
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23. Responsibility of health professional to meet patient wishes
24. Sensitivity to health literacy level of the patient
25. Sensitivity to patient's language needs
The Health Professional: 
26. Health professional being comfortable with approaching end­of­life topic
27. Health professional having experience and practice having end­of­life discussions
28. Health professional is familiar with end­of­life planning process
*
*
*
*
*
*
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
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29. Health professional has attended education sessions about discussing end­of­life
30. Health professional has knowledge of palliative care and end­of­life issues
31. Emotional intelligence of health professional
32. Heath professional acts as a neutral party to talk to the family about what is
happening to the patient 
Context of the discussion: 
33. Patient's condition for discussion
e.g. patient is in the hospital with an acute episode, or patient is trying to get their breathing 
under control early in the morning 
*
*
*
*
*
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
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34. Having a support person present during discussion
35. Patient understanding that their condition is life limiting
36. Patient understanding that they can receive palliative care
37. Time available to discuss
38. Time available for follow up discussions
39. Setting of discussion
*
*
*
*
*
*
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
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40. Privacy for discussion
41. Life experience of person that you are having the discussion with in emergency
scenario (usually a family member) 
42. Multi­disciplinary team available to patient
43. Confirming patient understanding of the discussion
44. Personality of the patient
45. Credibility of the health professional (as recognized by the patient)
*
*
*
*
*
*
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
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46. Whether the patient is taking care of themselves
47. Individual patient needs
48. Are there any considerations not included here that are important when conducting an
end­of­life discussion?Please explain below. 
*
*
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
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Which of the following topics would you include in an end­of­life discussion? Please indicate your level of 
agreement with each statement below and comment if you wish to clarify or modify any items. 
1. Patient understanding of their option to make end­of­life choices
2. Patient deciding on a substitute decision maker
3. Patient understanding of the ‘chain of command’ of decision makers, should there be
a dispute when patient is unable to speak for themselves 
4. Option to change your mind after making end­of­life decisions
5. Making sure doctor knows what kind of care the patient wants
Question 3
*
*
*
*
*
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
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6. Levels of advance care directives (supportive care only to full resuscitation)
7. Walking the family through the process of what will happen when the patient dies
8. Explaining implications of end­of­life decisions and care to family
9. Discussing the ‘bother versus benefit' of treatments or interventions with patients
10. How patient wants things to look at the end­of­life
11. Educating patients about their end­of­life choices and implications
*
*
*
*
*
*
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
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12. Goals of care
13. Explaining where they are in their disease e.g. no cure, focus on symptom
management 
14. Are there any topics not included here that are important to discuss when conducting
an end­of­life conversation?Please explain below. 
*
*
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
Strongly agreenmlkj Agreenmlkj Undecidednmlkj Disagreenmlkj Strongly disagreenmlkj
Comments: 
5
6
373
You have completed round two of the Delphi study. 
Thank you very much for your participation. You will be notified via email when the next questionnaire is ready for your participation. To exit the 
survey, click exit below. 
Thank you!
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Page 1
Round Three of the Delphi Study 
Dear Participant, 
The purpose of this round of the Delphi is to give you a chance to see how 
other participants have responded to each item. 
Please review each item, considering the mean score and the comments from 
the previous round. Based on this information re­consider your opinion 
and then rate the item. Also, feel free to add any comments that you feel 
may clarify the item, but note that comments are not required. 
You may notice that some items have been moved from one question to 
another, and some items have been added from suggestions made in the 
previous round. In such cases, there will be no prior information such 
as a mean or comments provided, and therefore you should rate the item 
based on your professional experience. 
Please would you be kind enough to complete the survey by DECEMBER 24th ­ please contact me if you have any questions, technical 
difficulties or 
problems with completing the survey by December 24th as it is very 
important to the validity of the study that you are able to respond. 
Sincerely, 
Nicole Stephen 
nicole.stephen@plymouth.ac.uk 
1. First name:
2. Last name:
Welcome!
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Appendic L.  Canadian Delphi Round 3 Questionnaire
Page 2
Which of the following factors indicate that a patient is ready or willing to discuss end­of­life? 
Please read the mean (average) rating and consider the comments made by participants in the previous round before 
indicating your level of agreement with each item below. 
***Please note that changes to items are indicated by [ ] 
1. 
Mean (average rating in previous round) 
3.41 (undecided) 
Comments from previous round 
l Once the client has settled and their condition has stabilized, during the hospitalization and opportunity to discuss end of life care 
would be appropriate.  
l This is dependant on whether it is their first episode or not, if they have been admitted several times before then they may be willing 
to discuss end of life issues.  
l An acute episode might signal a good opportunity for a health care professional to approach the topic of end­of­life care with a 
patient, however it may not correlate into patient readiness or willingness to talk about the topic.  
l I don't necessarily agree that any clinical indicator (such as having had an AECOPD) means patients "are ready and willing" to discuss 
end­of­life but I do believe that having recently had an AECOPD provides an opening for initiating discussions around patients' goals 
of care and could include discussions about end­of­life care.  
l Not enough information is given with just an exacerbation. 
1.   
2. 
Mean (average rating in previous round) 
4.24 (agree) 
Comments from previous round 
l You have to be able to read people to bring up this delicate topic, without that you can come across rude, offensive and 
inconsiderate.  
l Patients give cues and clinicians need to be intuitive enough to hear and read these cues.  
l not enough information ­ while EI [emotional intelligence] is helpful, it should be based on information gleaned from time spent with 
the client, taking in patient cues and discussions  
 
Question One
Strongly agree Agree Undecided Disagree Strongly disagree
Clinical indicators 
e.g. [length of disease 
process, burden of 
disease], the patient has 
recently had an acute 
episode and required 
hospitalization 
nmlkj nmlkj nmlkj nmlkj nmlkj
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2.   
3. 
Mean (average rating in previous round) 
4.18 (agree) 
Comments from previous round 
l Take your cues from the patient, they will indicate when they are ready to talk.  
l some patient cues can be contrary to what the patient is actually saying.... congruent patient cues along with verbal interaction are 
needed to be able to judge appropriately. These cues, however can be more accurate that words, at times, and a HCP may take these 
cues along with other EI [emotional intelligence] gleaned to decide to introduce the topic. 
3.   
4. 
Mean (average rating in previous round) 
4.53 (strongly agree) 
Comments from previous round 
l If the client brings this at any point in your time together it is a strong indicator that the client is interested and the information should 
be discussed.  
l What better time than now!  
l However, in my experience, at times, patient introducing the topic may be feeling pushed by family or others to open the topic and 
be internally, quite hostile to the discussions. 
4.   
Strongly agree Agree Undecided Disagree Strongly disagree
The health professional 
uses their emotional 
intelligence to guage 
patient readiness
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Patient cues 
e.g. body language, facial 
expressions, open 
personality 
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Patient initiates end­of­life 
topic with health 
professional [either 
directly or indirectly by 
bringing up death or end­
of­life care in relation to 
something or someone 
else]
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
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5. 
Mean (average rating in previous round) 
4.41 (agree) 
Comments from previous round 
l Again, emotional intelligence and client cues are needed to continue a more comfortable discussion. 
5.   
6. 
Mean (average rating in previous round) 
3.12 (undecided) 
Comments from previous round 
l A client may be attending the session because a family member has pressured them into it.  
l Attendance may be out of curiosity it does not guarantee they are accepting of their prognosis or the reality ahead of them. 
Strongly agree Agree Undecided Disagree Strongly disagree
Q27. Patient responds 
when end­of­life topic is 
alluded to or initiated by 
the health professional 
examples:  
l asking whether 
the patient has 
made a will;  
l sharing a 
personal story 
about a death in 
the family where 
end­of­life 
decisions were 
not made;  
l explaining how if 
the patient were 
in crisis what the 
first health 
professional to 
arrive on the 
scene would be 
expected to do, 
and that it would 
be unfortunate if 
they had wishes 
that were not 
expressed and 
therefore not met 
in this type of 
situation. 
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
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6.   
7. 
Mean (average rating in previous round) 
3.18 (undecided) 
Comments from previous round 
l However not all clients will participate in group discussion and it is important for the facilitator to be aware of this during the 
discussion so a follow up can be arranged.  
l Depends on the individual (how comfortable they are in sharing) as well as the cohesiveness of the group  
l I've never participated in a group setting like this ­ I imagine that would be an advantage of a COPD class...  
l In my experience one on one is much better to discuss these issues, however, having a small family group is often ideal.  
l Depends on the personality on the patient; the group setting may be too intimidating, or it may help normalize feelings and 
encourage participation.  
l Many will feel more comfortable in a group setting when discussing death and concerns, however, not all personality types respond 
well in this setting. Some 1:1 discussions are better in this subgroup. In other cases, the introduction of the topic in a 1:1 setting may 
help ease a client into a group setting for ongoing discussions and support.  
7.   
8. 
Mean (average rating in previous round) 
3.76 (undecided) 
Comments from previous round 
l For the clients that I see routinely a follow up is done, if the client is referred by another physician I may never see them again.  
8.   
9.   
Strongly agree Agree Undecided Disagree Strongly disagree
Attending [a group] end­
of­life [education] session 
implies readiness to 
discuss
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Group setting encourages 
patients to discuss
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Patient follows up on end­
of­life information 
received in education 
session [with educator or 
any other HCP]
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Comments from family to 
the HCP ***new item from 
participant comments
nmlkj nmlkj nmlkj nmlkj nmlkj
 
Additional comments 
Additional comments 
Additional comments 
Additional comments 
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1. 
Mean (average rating in previous round) 
4.06 (agree) 
Comments from previous round 
l I don't believe 'is not important' applies to a situation in which the topic must be discussed ie a crisis ­ this is not an unimportant 
situation.  
l "Practical" is open to interpretation so sometimes one must be "practical" but usually some time can be given for patient to "come to 
terms"  
l I agree that there are times in crisis that these issues must be discussed. Even if goals of care have been discussed in the past, goals of 
care can change and are influences by so many things so, in crisis situations, these goals need to be revisited. In the end, some 
clinicians pursue these discussions in very tactful/respectful ways and others are downright abusive!  
l impending acute respiratory and/or cardiac failure. This is when I broach topic by stating: I have seen these symptoms in 100s of 
clients and I expect that we will be facing major decisions. As a Health Care Team member, we want to ensure that your wishes and 
desires are known and are followed. There is nothing worse than having patient families unaware of your wishes, or indeed, fighting 
over what they believe your wishes are about life saving measures, and as a team, we want to ensure that we are following what you 
want and that we are all, along with you and your family, on the same page. I then go on to discuss the specifics of a DNR and 
implications for each part ­ intubation, mechanical ventilation, defibrillation, cardiac and other drugs, and if discussion time permits, 
decisions re feeding tubes, IVs for fluids and comfort measures desires of the client, etc.  
l For the clients that I see routinely a follow up is done, if the client is referred by another physician I may never see them again.  
1.   
 
Question 1b
Strongly agree Agree Undecided Disagree Strongly disagree
There are situations when 
[the patient's] 
‘readiness’ [to discuss end­
of­life] is not important 
such as when the topic 
must be discussed 
immediately for practical 
purposes
nmlkj nmlkj nmlkj nmlkj nmlkj
 
Additional comments 
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Which of the following factors are important when conducting an end­of­life discussion? 
Please read the mean (average) rating and consider the comments made by participants in the previous round before 
indicating your level of agreement with each item below. 
***Please note that changes to items are indicated by [ ] 
1. 
Mean (average rating in previous round) 
4.06 (agree) 
Comments from previous round 
l Clarifying this with the client should be part of end of life discussions. While this (young children at home) is rarely the case of a 
chronic lung disease client, more often it is about a family member in disagreement, or out of the family communication group who 
the client wants to touch base with and try to reconcile with prior to their death. This has had implications for life support in my 
experience ­ clients going on/off modified life support (biPAP) while awaiting arrival of family member to reconcile, see for 1 last 
time. Whether this is appropriate or not, is case sensitive and open for ethical discussion. 
1.   
2. 
Mean (average rating in previous round) 
4.65 (strongly agree) 
Comments from previous round 
l I agree that the family needs to understand the clients wishes and respect them whenever possible.  
l Imperative aspect of discussions. If it is perceived by the client that this will be a difficult discussion for the client to make alone with 
the family, support should be available for the client to discuss with the HCP, or have the HCP broach the subject, stating that it is the 
wish of the client to discuss this with family. This way, the HCP can be 'the bad guy' and take pressure off of the client. This way the 
HCP can also be available for responding when questions are asked, or clarifying meanings of discussions, including family health 
literacy issues, cultural sensitivities, etc. 
2.   
 
Question Two
Strongly agree Agree Undecided Disagree Strongly disagree
Family issues for the 
patient 
E.g. young children at 
home, [unresolved family 
problems] 
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Communicating patient 
wishes to family
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
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3. 
Mean (average rating in previous round) 
4.29 (agree) 
Comments from previous round 
l End of life needs to be discusses with or without family present if the client is willing to discuss it.  
l Whenever possible eliciting family support when it is supportive is of huge importance. 'Family' may be defined in different terms for 
different clients and discussing 'what this looks like' for the client is one of the first discussions needed. It should include Power of 
Attourney whether they are 'family' or not. 
3.   
4. 
Mean (average rating in previous round) 
3.47 (undecided) 
Comments from previous round 
l This has to be used judiciously ­ it depends on the group so much.  
l if appropriate for the patient  
l Depends on your relationship with the patient, patient personality, type of situation (clinic visit, hospital setting, change in health 
status) 
4.   
5. 
Mean (average rating in previous round) 
4.59 (strongly agree) 
Comments from previous round 
l Vital need to be addressed. Eliciting supportive 'family' help in this is vital for after care of the family as well. 
5.   
6. 
Mean (average rating in previous round) 
4.59 (strongly agree) 
Comments from previous round 
l Un­rushed and calmness is vital, otherwise, discussions can be seen as 'wanting to get the HCPs own way of doing things', or 'not in 
the client's best interest', or uncaring, or impression to family and patient that the 'imminence of death is sooner than we think' and is 
more apt to bring on panic ­ poor decision making is often done in these circumstances and should be avoided. 
Strongly agree Agree Undecided Disagree Strongly disagree
Presence or absence of 
family support [in the 
patient's life]
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Sense of humour [when 
appropriate]
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Sensitivity to the patient’s 
culture
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
383
Page 10
6.   
7. 
Mean (average rating in previous round) 
3.59 (undecided) 
Comments from previous round 
l I believe it is individual client bases, however in a group session, presenting with an open attitude will allow for clients to comfortably 
ask questions.  
l This may be seen as being too business­like for such a sensitive topic and may, therefore, shut people down instead of encouraging 
participation  
l Very important for some people to "take out the emotional component"  
l This will depend on the patient and how they react, this type of approach does not work if you bring it up right after a diagnosis or Dr. 
appointment that had bad news.  
l Absolutely. Statistics from resuscitation attempts from the ACLS manual can be used as factual information that may help to break 
patient's 'TV­version' of always a 'good ending' with resuscitation attempts, where as, matter of factness re patient's desires being met 
and remaining family's meeting of goals about a 'good death' are good discussion starters.... everyone has a story about a 'bad death'. 
7.   
8. 
Mean (average rating in previous round) 
4.76 (strongly agree) 
Comments from previous round 
l They can sense when you really " care"  
l Vital need, a part of good communication skills.  
8.   
9. 
Mean (average rating in previous round) 
4.82 (strongly agree) 
Comments from previous round 
l Vital need, a part of good communication skills. 
Strongly agree Agree Undecided Disagree Strongly disagree
Approaching the topic 
calmly
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Approaching topic with a 
‘matter­of­factness’
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Approaching the topic 
with a caring nature
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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9.   
10. 
Mean (average rating in previous round) 
4.76 (strongly agree) 
Comments from previous round 
l Vital need. 
10.   
11. 
Mean (average rating in previous round) 
4.82 (strongly agree) 
Comments from previous round 
l Do not pity but show true compassion  
l Vital need ­ part of good communication. 
11.   
12. 
Mean (average rating in previous round) 
4.82 (strongly agree) 
Comments from previous round 
l Perhaps most important is to listen  
l Vital need, a part of good communication skills. 
12.   
Strongly agree Agree Undecided Disagree Strongly disagree
Being open nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Being honest nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Being respectful of the 
client
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Listening to the patient nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
Additional comments 
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13. 
Mean (average rating in previous round) 
3.88 (undecided) 
Comments from previous round 
l What kind of advice? I would hesitate to make suggestion ­ I would definitely provide information in order for the patient and family 
are better prepared to make decisions  
l The role of the health professional to provide as much information the patient needs, so that the patient can make an informed 
decision.  
l Vital need, a part of good communication skills. Sometimes, giving information, even when it's not asked for can broach areas of 
discussion that the client/family has been avoiding. On the other hand, being honest and discussing with the pt/family that you feel 
uncomfortable in this area of discussion is important too and leading them to another person with expertise in that area is a honest 
and professional way of handling these discussions. 
13.   
14. 
Mean (average rating in previous round) 
4.12 (agree) 
Comments from previous round 
l It depends on the level of the discussion.  
l Although sometimes you have to be the one to start the discussion.  
l We have a responsibility to help them through these discussions. Even though they can lead at times and we stay open, etc...they 
"don't know what they don't know" so it should be our responsibility as clinicians to help direct these discussions, to probe gently when 
more information is required so that we can better understand and support their decision­making processes.  
l Vital need, a part of good communication skills. However, as per the 'advice­giving' response, it may also be important here to guide 
the discussion to broach a topic that the patient/family has been avoiding, but doing so in a caring supportive way. The ability to pull 
back and get permission to re introduce it at another time is also important. There are times that I will introduce a 'touchy' topic and 
state that the physician will need to know about your wishes/desires around topic X. There are pros and cons about topic X and I 
suggest you take some time and discuss it with your family and be prepared to discuss it later with the physician at your next meeting. 
In the mean time, i am willing to be a resource for any questions you may have about this topic and you may contact me in the 
following way. 
14.   
15. 
Mean (average rating in previous round) 
4.35 (agree) 
Comments from previous round 
l It is always best to have the patient (and preferably patient/family) ready to discuss. However, sometimes, a gentle introduction is 
needed, stating something like... "We normally have these discussions at this point of your care, however, I sense that you do not feel 
ready to discuss this at this time... am I correct? Different people are more or less comfortable with these discussions. What makes this 
a difficult topic for discussion for you to talk about?" (elicits clients feelings and past history with the topic, so it is a bit less of a 'hot' 
button trigger). Introducing the topic through a 3rd­hand approach can be helpful ­ client seeing discussions with another patient, or 
another family member, discussions of death of a pet in the past, etc. 
Strongly agree Agree Undecided Disagree Strongly disagree
Giving advice when it’s 
asked for
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Letting the patient guide 
the discussion
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
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15.   
16. 
Mean (average rating in previous round) 
4.29 (agree) 
Comments from previous round 
l If the patient is violent one must try to understand from where that is coming but protection of all in danger of being hurt by this 
violence must be initiated  
l As a HCP, I've seen all kinds of reactions. Being prepared for handling them is imperative. Discussions may follow, but acknowledging 
the emotions are a part of good communication and 'normalizing' the discussions for the client/ family. 
16.   
17. 
Mean (average rating in previous round) 
4.35 (agree) 
Comments from previous round 
l Recognition of negative reactions or 'discussion stoppers' is imperative. Knowing what to do about them is the next step and may be 
multifaceted. Knowing when to step back is only one part of this next step. EI [emotional intelligence]processes of assessing the 
patient/family and when to break off the discussions and change the topic is needed. In rare circumstances, stopping the meeting may 
be necessary. When/if appropriate, stating an expectation that you are always available to discuss further, or answer questions they 
may have at any time can be valuable to the patient/family, whether they have questions alone or together. Being ready to apologize 
for discomfort caused may be needed, depending on the circumstances. 
17.   
18. 
Mean (average rating in previous round) 
3.71 (undecided) 
Comments from previous round 
l What is a 'good relationship'? Being seen as a credible source of information would be more of a factor, I feel.  
l The better the relationship with the patient/family, the more ideal the circumstances for discussion. Finding 'common ground' or 
common values is always a 1st step, even if you have not had time to develop the good relationship as you'd like to.  
Strongly agree Agree Undecided Disagree Strongly disagree
Readiness of the patient 
to discuss
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Accepting the patient’s 
reactions
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Knowing when to step 
back from the topic
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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18.   
19. 
Mean (average rating in previous round) 
3.71 (undecided) 
Comments from previous round 
l This is an unfortunate choice of words ­ I don't believe any HCP worth their salt would intentionally dash hope.  
l this is a tough one when death is inevitable, you don't want to destroy the time left  
l Vital need. Without hope, spirits can be crushed utterly. Finding things to be hopeful for can be a big part of the patient's/ family's 
expectations and modus operandi. Often these hopes and expectations become more centred and smaller in scope, more intimate 
with time, in the client's 'shrinking world'. Looking for appropriate areas for values and hope can be a daily adventure. Celebrating 
them daily can bring joy in even the most difficult circumstances. 
19.   
20. 
Mean (average rating in previous round) 
4.53 (strongly agree) 
Comments from previous round 
l Need to use the word "early" with caution I think. I think it would be best to stick with something like, "it's best to raise the topic at a 
time when the patient can appreciate that it's relevant" i.e., when a patient has had an exacerbation that required a hospitalization, 
this may be a good time to chat about their experience, what was good, what wasn't, how things could have been different, etc...  
l Whenever possible this should ALWAYS be the case. It is without exception, more difficult to discuss when time is of essence and 
people are rushed into decisions that they (especially family) may regret later. We want to avoid having team members and/or family 
on different pages, opening up the possibility for conflict, now or in the future. 
20.   
Strongly agree Agree Undecided Disagree Strongly disagree
Having a pre­existing 
good relationship with the 
patient
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Avoiding dashing hope nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Raising the topic early 
before critical situation
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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21. 
Mean (average rating in previous round) 
4.12 (agree) 
Comments from previous round 
l This allows the client to be prepared for the topics that will be discussed during the appointment time or in group sessions  
l a great idea, but I don't have such a list  
l I don't think it's necessarily a discussion about "end­of­life". Who wants to talk about "end­of­life"? In my experiences in palliative care, 
patients think palliative care is for "when you're dying" and therefore they don't necessarily want palliative care services or decline 
them. When I explain that Palliative care, in my mind, is about providing good care and good symptom control in a disease/illness 
where there is no cure, they are much more willing to accept palliative care services. I think we can talk about end­of­life issues but 
the discussion should be seen as flushing out "goals of care".  
l Absolutely. End of life discussions are about Life discussions and have a wide range of possibilities to discuss. While not everyone is 
comfortable with this topic, it can often be broached in context of other discussions. As HCPs we are concerned about the whole pt's 
life and quality of life, to best enhance where we can, as the patient / family allows. 
21.   
22. 
Mean (average rating in previous round) 
4.29 (agree) 
Comments from previous round 
l would be nice  
l Patients and families often have difficulty emotionally handling these topics. Some may 'forget' or disassociate partially and not 
remember discussions. Having paper to go back to , with pens available for notes to the pt/family to write down may help them to 
come back to the topic on their own and check back and explore more in depth and come back with further questions. It helps clarity 
and ensures all topics are covered without omitting an area of discussion. 
22.   
23. 
Mean (average rating in previous round) 
4.12 (agree) 
Comments from previous round 
l I have seen where patient and or family wishes have been ignored by MDs. The law covers a lot of this, but there is still a lot of 'grey 
areas'. Clarifying 'wishes' into 'decisions' are a part of the HCP's responsibility. Some may be achievable, others may not be ­ eg, wish 
to be made comfortable is perhaps 98% achievable; wish to avoid death is 100% unachievable. Wish to be kept alive until arrival of 
person Y may be achievable but at what cost, is the patient/family willing for the consequences of waiting/not waiting? 
Strongly agree Agree Undecided Disagree Strongly disagree
Having end­of­life on a list 
of things that need to be 
talked about
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Having handouts of 
example advance care 
directives (paper 
resources)
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
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23.   
24. 
Mean (average rating in previous round) 
4.53 (strongly agree) 
Comments from previous round 
l Vital to assess the patient's understanding by having feedback on what is discussed and frequent checking back with the 
patient/family. Assessing the patient/family's ability to understand and navigate the health care system, information and able to 
access what they need is a part of health literacy. Ensuring these needs are met in a way that the client /family can understand and 
use is needful, to the extent that the patient/family wants to be able to access it. ­ needs great assessment and communication skills 
on the part of the HCP. 
24.   
25. 
Mean (average rating in previous round) 
4.59 (strongly agree) 
Comments from previous round 
l Vital need, just as vital as cultural needs, whether verbal or non­verbal. Finding a translator with the above skills is even more difficult. 
The use of music and art and these music & art therapy can be an international language that can help with some of this and is often 
overlooked during palliation. 
25.   
26. 
Mean (average rating in previous round) 
4.53 (strongly agree) 
Comments from previous round 
l Recognizing this is a learned response ­ I feel that, the more a HCP is involved with these discussions, the more comfortable they feel  
l Vital need. Just because a HCP has an "MD" behind their name, doesn't mean that they are the best one to having these discussions. 
EI [emotional intelligence], aptitude, training, personality and experience all weight heavily on the individuals abilities in this area. 
Learn the strengths of your team and use people in their strengths! Being willing to acknowledge our weaker areas is part of being a 
HC Professional and working as a team brings strength to the team to function appropriately for the patient/family. 
Strongly agree Agree Undecided Disagree Strongly disagree
Responsibility of health 
professional to meet 
patient wishes
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Sensitivity to health 
literacy level of the 
patient
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Sensitivity to patient's 
language needs
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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26.   
27. 
Mean (average rating in previous round) 
4.41 (agree) 
Comments from previous round 
l This is a skill. In the US, I believe the "Respecting Choices" program has ACP trainers that assist clinicians in building their skills for 
ACP discussions. I find it interesting that all our staff have to do yearly CPR re­training and yet we don't think about the importance of 
helping our staff to build the communications skills they may need to lead or initiate ACP discussions. Some HCP are simply not 
equipped to have these discussions (they don't want to and patients wouldn't want them to). Maybe we need to seek out clinical 
leaders for this and nurture their skills.  
l Vital need. Just because a HCP has 'experience and practice' at leading discussions, doesn't mean that they are good at it, even 
though they think they may be. Getting feedback after the fact from family members and others on the health care team is invaluable 
for honing our skills, and could/should be a part of the followup with the family and team. Being willing to acknowledge our weaker 
areas and to learn from reflective practice with feedback is part of being a HC Professional and working as a team brings strength to 
the team to function appropriately for the patient/family and to grow in our abilities. 
27.   
28. 
Mean (average rating in previous round) 
4.24 (agree) 
Comments from previous round 
l While you may have small role in the scheme of the end­of­life discussions, knowing the process and where your role fits is in 
important. Working as a team is important, knowing that there are other parts that need to be addressed and your scope in the whole 
process is 1 or more parts, working within that scope is important. 
28.   
Strongly agree Agree Undecided Disagree Strongly disagree
Health professional being 
comfortable with 
approaching end­of­life 
topic
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Health professional having 
experience and practice 
having end­of­life 
discussions
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Health professional is 
familiar with end­of­life 
planning process
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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29. 
Mean (average rating in previous round) 
4.06 (agree) 
Comments from previous round 
l This would be great ­ I have not seen any at conferences or know of any workshops. I have attended sessions relating to the 
importance of having end­of­life discussions, and have not attended any workshops that practically walk a HCP through a number of 
different discussions to role play how these discussions can be done with empathy.  
l Formal education processes may/ may not be important. Attending various discussions is an education in itself, when done correctly, 
but doesn't make you an expert in and of itself. Most of us have not had the opportunity to have didactic education sessions presented 
to us; thus we learn more 'old school' by experience gleaned with good and not so good experiences. Learning from these 
experiences through reflective learning is vital then. Just because there are courses doesn't mean that you can invalidate good 
experience either. The 2 may go hand in hand. Analogy: You may be have received 100% in your university education about playing 
violin, but you are not a good player .... vs. you are good at playing violin, but that doesn't mean you are a good teacher of violin.... 
v.s. You may be a great teacher of violin but you flunked university courses and you are not a concertmaster or soloist, but you play in 
an orchestra and can impart what is needed to have a student become a great one! 
29.   
30. 
Mean (average rating in previous round) 
4.29 (agree) 
Comments from previous round 
l Having knowledge does not ensure you have ability, however, it can be a starting point for some, and can become more and more 
important as you grow in your practice. 
30.   
31. 
Mean (average rating in previous round) 
4.29 (agree) 
Comments from previous round 
l #26 to #34 are not rated higher as the HCP must be able to learn on the job regardless of what background formal education on the 
topic they have received  
l Some people are just 'not wired' in an EI [emotionally intelligent] way to be able to lead these discussions effectively with patients / 
families. Others are not 'wired' to place various catheters in various body parts. While skills can be taught, it doesn't mean you will 
excel in it, nor even become proficient. If you are less capable, desirous, etc, it is wise to enable those with capabilities and desires on 
teh team to lead with their skill sets. Being professional enough to admit your limitations is becoming more and more the norm for our 
professional practice and accepting our limitations. There will always be people better than us and always be people worse than us in 
doing these things. Being humble enough to admit it, and do something about it is the mark of a graceful practitioner. 
Strongly agree Agree Undecided Disagree Strongly disagree
Health professional has 
attended education 
sessions about discussing 
end­of­life
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Health professional has 
knowledge of palliative 
care and end­of­life issues
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
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31.   
32. 
Mean (average rating in previous round) 
4.29 (agree) 
Comments from previous round 
l While it is desirous to be neutral, we really need to admit to ourselves our own cultural and experiential biases that have made us 
whom we have become. Can we fully be neutral, No. Can we try to put aside our acknowledged biases and experiences, Yes, for the 
betterment of the patients and families we serve...... Sometimes, we have to be patient advocates when the family is opposing what 
the patient wishes, especially when the patient is less able to express their own views (health/illness vs. communication difficulties). 
Trying to find common ground is always a good starting point. In the end, it is the patient's life and often their own decision with the 
POA (power of attourney) interpretation at the end. 
32.   
33. 
Mean (average rating in previous round) 
4.0 (agree) 
Comments from previous round 
l It depends on the severity and acuity of the episode.  
l These discussions need to take place in the right place, at the right time, and by the right person. Being aware of the patient's 
physical ability to engage in such as discussion in critically important.  
l Never ideal to start conversations at this point, but if not discussed before, it often must be broached with some urgency but without 
being rushed if possible. If unable to discuss at the time with patient or family, often bringing it up after successful outcome, or 
partially successful outcome may bring about good opportunity.... "You had a tough time this morning. I could see that you were 
struggling and apprehensive about what was happening and decisions that had to be made. I need you to know that this will not be 
the last time you experience something like this. You will have more and more of these episodes as time goes on. We got through this 
one OK, but I need to discuss with you about how you thought about what went on, what went well, what didn't .I'd like to have some 
discussions about what you have decided as a result of what we've gone through... what we should do for next time, and the time after 
that... we want to be on the same page and don't want to do what you don't want have done. Let's talk." 
Strongly agree Agree Undecided Disagree Strongly disagree
Emotional intelligence of 
health professional
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Heath professional acts as 
a neutral party to talk to 
the family about what is 
happening to the patient
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
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33.   
34. 
Mean (average rating in previous round) 
3.71 (undecided) 
Comments from previous round 
l It helps, however not always necessary.  
l This is very individual as well as having cultural issues  
l sometimes this discussion is better without family present  
l Some of our patients don't have support people. Some may feel more comfortable freely discussing their views/beliefs in the absence 
of their support person. Depends on the person.  
l Not necessarily. Some patients may prefer to have the first discussion alone (there are some interesting relationships out there where, 
with some caregivers, patients struggle to articulate their wishes with coercion). I depends on the situation.  
l You did not specify support person for the client or the HCP. I advocate both. A second set of ears and eyes who is also trained may 
bring a further sense of validity and they may be able to interject appropriately. A patient's support person may/may not be family. 
Being sensitive to this is vital and needful as the support person will be the one left behind after the death. A support person may also 
be a clergy member, a family member or friends, or a therapist. 
34.   
35. 
Mean (average rating in previous round) 
3.94 (undecided) 
Comments from previous round 
l I believe, generally, this discussion should not be dependent upon the presence or absence of a life­limiting condition.  
l some know but appear not to , seems to be a defensive postion  
l End of life discussions can and should occur at any time, and not just in times of crises.  
l Many patients don't even know what "COPD" means. Many don't realize that it is progressive and life limiting. It will be difficult for 
patients to appreciate discussions around goals of care (including goals for end­of­life care) if they don't have an understanding of the 
disease process/trajectory.  
l I have seen many patients who are in denial of their limitations. This topic has been introduced and patients can gradually realize 
that this is a deteriorating process that leads to death in some form. Looking at life limiting aspects of any life, whether physical 
limitations, mental or emotional is useful and a part of the natural consequences of living. Broaching it like this can be the platform to 
start discussions. Eventually, the patient must be able to express, as a part of "acceptance" that their life is limited by their condition. 
Strongly agree Agree Undecided Disagree Strongly disagree
Patient's condition for 
discussion 
e.g. patient is in the 
hospital with an acute 
episode, or patient is 
trying to get their 
breathing under control 
early in the morning 
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Having a support person 
present during discussion 
[for the patient]
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
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35. 
36. 
Mean (average rating in previous round) 
4.12 (agree) 
Comments from previous round 
l By having conversations earlier on, it allows the patient to make decisions without distress, under pressure, in crises, etc.  
l As I have mentioned before, many patients do not really understand what palliative care is all about. I make a point of chatting with 
my patients about this so they understand what palliative care is.  
l palliative care' has different meaning for different clients. Clarifying their expectations and hope around end of life care can lead to 
successful good death, whether at home in palliative care, in hospital in palliative care, or in a palliative care unit, or indeed, if they 
choose, through full treatment up until the point of death. Informing patients that they have these choices is part of our responsibilities 
as HCPs.  
36. 
37. 
Mean (average rating in previous round) 
4.29 (agree) 
Comments from previous round 
l Time needs to be made to have these discussions  
l If the patient is deteriorating very quickly, end of life discussions should occur for practical reasons.  
l Many clinicians use the excuse that they don't have enough time. I think that discussing goals of care is a process and not an event 
and therefore, I think this can be discussed in bits and pieces. For example, how many times do clinicians do vital signs (and 
sometimes for no good reason)...this time could be better spent talking about goals of care.  
l being sensitive to the patient's volume of time and the actual timing of discussions for the optional time of day, location, etc. is 
important for the patient to be able to receive and interact appropriately, be given the time to ask questions and ability to come back 
later with more discussions or questions as they choose is vital for clients. 
37. 
Strongly agree Agree Undecided Disagree Strongly disagree
Patient understanding that 
their condition is life 
limiting
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Patient understanding that 
they can receive palliative 
care
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Time available to discuss nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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38. 
Mean (average rating in previous round) 
4.06 (agree) 
Comments from previous round 
l Depends on the situation. If able, follow up discussions are important.  
l This is an essential part of End of Life discussions. It is also a requirement of DNR discussions to allow patients/ family know that they 
can change their mind and communicate their changes as they wish. Some team members may be more or less available for 
discussions and scheduling of the follow ups may be limited based on client preference of team member (MD, for example may be 
less available than an at­the­bedside practitioner) and their availability. 
38. 
39. 
Mean (average rating in previous round) 
3.88 (undecided) 
Comments from previous round 
l Sometimes the opportunity is there and the setting is not important.  
l setting is often not an option ­ discussion takes place in patient room  
l Discussions can occur anywhere.  
l The setting is critical I think.  
l While there is no ideal place or setting for these discussions, in a busy ER room with lots of noise, less privacy and more interruptions 
is always more difficult. Being sensitive to client needs in all these areas is vital and when possible should be accommodated to the 
best of our abilities. 
39. 
40. 
Mean (average rating in previous round) 
4.41 (agree) 
Comments from previous round 
l This is driven by the patient and family somewhat  
l While there is no ideal place or setting for these discussions, in a busy ICU Ward room or ER room with only curtains, lots of noise, less 
privacy and more interruptions is always more difficult. The patient needs to be able to determine for themselves whom they want in 
the room during the discussions. Being sensitive to client needs in all these areas is vital and when possible should be accommodated 
to the best of our abilities. 
40. 
Strongly agree Agree Undecided Disagree Strongly disagree
Time available for follow 
up discussions
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Setting of discussion nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Privacy for discussion nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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41. 
Mean (average rating in previous round) 
3.82 (undecided) 
Comments from previous round 
l It must be recognized that this can impact the discussion greatly!!  
l Life experience with the Client or the Family member has huge effects on the discussions. Listening to their experiences, correcting 
any misconceptions they have had as a result of their experiences and validating their experiences are all a part of the processes 
involved. 
41.   
42. 
Mean (average rating in previous round) 
4.06 (agree) 
Comments from previous round 
l Integral ­ day to day HCP involved is often the person of choice of the patient, the physician, clergy, music and or art therapist, 
palliative care coordinator are some of the possibilities 
42.   
43. 
Mean (average rating in previous round) 
4.18 (agree) 
Comments from previous round 
l Integral to ensure patient is on the same wavelength, and/or the POA [power of attourney]. 
43.   
44. 
Mean (average rating in previous round) 
3.88 (undecided) 
Comments from previous round 
l This is part of the assessment of the patient's needs, based on their personality 
Strongly agree Agree Undecided Disagree Strongly disagree
Life experience of person 
that you are having the 
discussion with in 
emergency scenario 
(usually a family member)
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Multi­disciplinary team 
available to patient
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Confirming patient 
understanding of the 
discussion
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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44.   
45. 
Mean (average rating in previous round) 
4.29 (agree) 
Comments from previous round 
l If a client is going to have meaningful discussions, the pt has to believe in the HCP, no matter who they are. If that person is NOT the 
person who has the aptitude/expertise, however in these discussions, accommodations and/or improvisation with that person may be 
helpful. 
45.   
46. 
Mean (average rating in previous round) 
4.24 (agree) 
Comments from previous round 
l Keeping on checking back with the patient is vital to make sure that their day to day and longer term needs are being met. It is always 
more difficult to assess as the patient becomes less and less competent to communicate effectively. Needs may be physical, 
emotional and spiritual. 
46.   
47.   
Strongly agree Agree Undecided Disagree Strongly disagree
Personality of the patient nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Credibility of the health 
professional (as 
recognized by the patient)
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Individual patient needs nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
The patient's spiritual 
beliefs and how they may 
be incorporated into the 
end­of­life care plan. 
***new items added from 
participant comments
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
Additional comments 
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48.   
Strongly agree Agree Undecided Disagree Strongly disagree
Health care professional 
checking that day to day 
as well as longer term 
needs will be met ***new 
items added from 
participant comments
nmlkj nmlkj nmlkj nmlkj nmlkj
 
Additional comments 
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Which of the following would you include in an end­of­life discussion? 
Please read the mean (average) rating and consider the comments made by participants in the previous round before 
indicating your level of agreement with each item below. 
***Please note that changes to items are indicated by [ ] 
1. 
Mean (average rating in previous round) 
4.59 (strongly agree) 
Comments from previous round 
l Again, important for patients to appreciate that there will inevitably be choices that need to be made and that knowing what they 
would choose is important.  
l within confinements of POA law and pt competence 
1.   
2. 
Mean (average rating in previous round) 
4.24 (agree) 
Comments from previous round 
l The client needs to feel comfortable with their decision as well the substitute decision maker needs to be aware of the clients wishes.  
l Vital in transition time; needs to be someone the patient is comfortable with; best if decided before a stressful time. Communication 
of patient's decision to family members is also crucial to avoid conflict. 
2.   
3. 
Mean (average rating in previous round) 
4.18 (agree) 
Comments from previous round 
l Very important in family dynamics.  
 
Question Three
Strongly agree Agree Undecided Disagree Strongly disagree
Patient understanding of 
their option to make end­
of­life choices
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Patient deciding on a 
substitute decision maker
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
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3.   
4. 
Mean (average rating in previous round) 
4.47 (agree) 
Comments from previous round 
l Part of POA law 
4.   
5. 
Mean (average rating in previous round) 
4.76 (strongly agree) 
Comments from previous round 
l Vital, but in my experience, MDs may not take the time needed for this part which can lead to dissatisfaction of patient and family 
members when delays are experienced because of this missed step. 
5.   
6. 
Mean (average rating in previous round) 
4.53 (strongly agree) 
Comments from previous round 
l Communication of expectations and pros/cons of each decision is helpful to avoid misunderstandings. 
6.   
Strongly agree Agree Undecided Disagree Strongly disagree
Patient understanding of 
the ‘chain of command’ of 
decision makers, should 
there be a dispute when 
patient is unable to speak 
for themselves
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Option to change your 
mind after making end­of­
life decisions
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Making sure doctor knows 
what kind of care the 
patient wants
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Levels of advance care 
directives (supportive care 
only to full resuscitation)
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
Additional comments 
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7. 
Mean (average rating in previous round) 
4.12 (agree) 
Comments from previous round 
l If they ask, otherwise no  
l It depends of what and how much information the patients wants to know.  
l Integral to family support  
7.   
8. 
Mean (average rating in previous round) 
4.47 (agree) 
Comments from previous round 
l Integral to family support 
8.   
9. 
Mean (average rating in previous round) 
3.94 (undecided) 
Comments from previous round 
l I'm not sure I understand this phrase so I am not sure how to respond  
l If patient asks I would tell them how most patients report bother vs benefit  
l "bother vs. benefits" ­ I've never heard it put this way before. "Bother" seems like a funny word here ­ bother for whom? I think 
discussing "risks/benefits" is appropriate and patients can understand this.  
l Not sure what is fully meant by this, but pt desires for Rx/interventions should be top priority when available. 
9.   
Strongly agree Agree Undecided Disagree Strongly disagree
Walking the family 
through the process of 
what will happen when 
the patient dies
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Explaining implications of 
end­of­life decisions and 
care to family
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Discussing the [positive 
and negative 
consequences] of 
treatments or interventions 
with patients phrase 
'bother vs benefit' has 
been replaced due to 
participant comments
nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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10. 
Mean (average rating in previous round) 
4.12 (agree) 
Comments from previous round 
l Brings hope and comfort when assured that this is what they will get. 
10.   
11. 
Mean (average rating in previous round) 
4.35 (agree) 
Comments from previous round 
l Integral to the process 
11.   
12. 
Mean (average rating in previous round) 
4.41 (agree) 
Comments from previous round 
l Integral to the process; and to keep the goals flexible 
12.   
13. 
Mean (average rating in previous round) 
4.35 () 
Comments from previous round 
l I believe this is important, however, I have had experiences where clients don't want to know how "bad" they actually are and want the 
treatment to continue but are comfortable with dying.  
l I stress the symptom management part vs no cure as sometimes, talk of transplantation does enter the discussion  
l Very important, quite often they are unaware  
l We should always be focused on providing patients with a good quality of life and minimizing symptom burden whether they are 
approaching end of life or not. Patients do need to understand however the limitations of some of our treatments but that our goal to 
keep them comfortable is constant and that may mean employing some different types of interventions.  
l Integral to the process 
Strongly agree Agree Undecided Disagree Strongly disagree
How patient wants things 
to look at the end­of­life
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Educating patients about 
their end­of­life choices 
and implications
nmlkj nmlkj nmlkj nmlkj nmlkj
Strongly agree Agree Undecided Disagree Strongly disagree
Goals of care nmlkj nmlkj nmlkj nmlkj nmlkj
Additional comments 
Additional comments 
Additional comments 
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13.   
Strongly agree Agree Undecided Disagree Strongly disagree
Explaining where they are 
in their disease e.g. no 
cure, focus on symptom 
management
nmlkj nmlkj nmlkj nmlkj nmlkj
 
Additional comments 
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Many thanks for participating in Round 3 of the Delphi study. You will receive a link to the fourth and final round of the 
Delphi in February. 
 
Survey Complete!
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